data_2dc2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2dc2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo . . . . . 0 N--CA 1.49 1.297 0 CA-C-O 120.725 0.219 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 tt -78.97 134.79 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.327 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.9 126.33 51.55 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.034 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.3 mmtm -99.75 114.62 27.87 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.571 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.24 128.91 67.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.789 0.328 . . . . 0.0 111.34 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 mp -98.37 119.92 37.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.846 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.13 137.98 50.64 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.262 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.65 115.38 27.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.772 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.8 143.78 37.52 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.707 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -114.54 158.56 21.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.182 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.72 -38.35 78.15 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.807 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -77.6 -28.29 51.51 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.423 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -90.02 159.23 16.96 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.903 0.382 . . . . 0.0 111.223 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.35 -165.82 21.97 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.373 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.56 -44.9 85.31 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.673 0.273 . . . . 0.0 110.834 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.22 3.29 90.25 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.335 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.2 pp -146.74 147.11 18.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 117.033 0.416 . . . . 0.0 110.897 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 3.5 m -108.53 139.78 42.81 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.536 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.2 pt -116.2 156.01 17.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.719 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.5 t -143.96 155.98 44.24 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.33 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.05 -150.1 18.31 Favored Glycine 0 C--N 1.337 0.605 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.393 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.42 109.27 0.22 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.939 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -57.64 -37.28 73.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.586 0.231 . . . . 0.0 111.135 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -58.73 -31.17 68.05 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.949 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -75.86 -24.51 55.75 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.217 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.68 25.4 4.29 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.074 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 m -147.48 140.3 14.69 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.884 0.342 . . . . 0.0 111.244 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.58 157.42 60.78 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.603 2.202 . . . . 0.0 112.285 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.1 mm -82.76 137.9 20.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.757 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mp -131.82 158.69 40.61 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.594 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.7 mm -83.55 128.64 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.756 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.1 t -124.14 -44.27 2.04 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.538 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 0.5 OUTLIER -105.38 144.47 32.12 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.758 0.313 . . . . 0.0 111.172 -179.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.1 mt -131.47 128.98 61.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.747 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -86.27 114.81 59.4 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.955 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.16 122.11 8.7 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.533 2.155 . . . . 0.0 112.149 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.54 34.85 4.86 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.597 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.97 174.2 4.79 Favored Pre-proline 0 C--O 1.233 0.231 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.41 -32.2 33.16 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.521 2.147 . . . . 0.0 112.76 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.83 -46.19 90.03 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.271 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.85 -40.39 79.42 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.703 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -60.03 -33.44 72.02 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.466 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.6 t -71.65 -28.11 63.53 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.52 15.78 62.13 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.188 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.25 -32.53 1.36 Allowed Glycine 0 C--N 1.338 0.667 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.106 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.79 94.36 0.3 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.981 0.419 . . . . 0.0 110.682 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -108.87 157.24 18.8 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.97 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.8 t -67.2 133.31 31.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.375 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.18 45.83 3.73 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.535 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.13 124.09 51.68 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 122.22 0.208 . . . . 0.0 110.595 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.4 120.25 32.09 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.728 0.299 . . . . 0.0 111.177 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.5 mt -75.24 139.93 18.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.556 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.0 mt -128.11 -51.93 1.31 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.703 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -144.54 145.86 32.06 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.854 0.359 . . . . 0.0 111.637 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.0 t -132.83 115.79 25.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.401 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 56.71 38.04 29.24 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.602 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.19 -12.85 42.24 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.449 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.14 128.05 39.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 117.371 0.586 . . . . 0.0 110.83 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.69 130.62 39.84 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.169 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.48 -23.03 13.95 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.641 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -61.4 -31.07 70.98 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.348 0.129 . . . . 0.0 111.348 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.03 9.74 38.33 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.2 p -120.1 159.87 23.97 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.617 0.246 . . . . 0.0 110.653 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.1 161.02 19.1 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.785 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -53.95 -47.6 71.13 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.972 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -60.99 -43.04 99.43 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.73 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -64.5 -39.28 93.49 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.975 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.58 -34.24 77.37 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.57 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.3 t -62.17 -43.28 97.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.834 0.349 . . . . 0.0 110.441 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.0 m -67.41 -45.72 75.32 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.948 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.9 mt -60.91 -44.21 97.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.938 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.42 -37.83 79.05 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.678 0.275 . . . . 0.0 110.714 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.7 m -68.65 -28.35 66.81 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.453 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -64.88 -30.85 71.87 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.498 0.19 . . . . 0.0 111.051 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -66.05 114.47 5.23 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.817 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -114.47 151.87 32.55 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.11 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.72 -102.12 0.42 Allowed Glycine 0 C--N 1.335 0.48 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.556 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -87.98 122.39 31.53 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.654 0.264 . . . . 0.0 110.378 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.5 mt -124.73 125.78 70.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.052 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -93.65 123.37 36.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.336 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.53 130.2 56.27 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.928 0.394 . . . . 0.0 111.517 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -121.18 115.17 22.53 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.572 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.5 m -137.28 170.94 17.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.351 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.7 t -129.07 133.64 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.69 123.66 20.32 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.875 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.0 t -118.71 132.79 67.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.957 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.163 -0.923 . . . . 0.0 111.22 179.93 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 N--CA 1.491 1.34 0 CA-C-O 120.93 0.304 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mp -86.06 141.17 14.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -120.82 122.03 39.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -100.21 113.51 26.23 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.773 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.2 m -128.27 140.42 49.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.458 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.1 mp -107.47 126.86 53.03 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.895 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 mp -113.08 137.32 51.6 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.097 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -104.32 114.75 29.19 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.8 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -99.78 134.26 42.94 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.994 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -115.94 151.55 35.17 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.869 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.14 -33.89 72.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.634 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -81.6 -27.4 34.24 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.783 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -96.55 166.53 11.64 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.883 0.373 . . . . 0.0 111.451 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -105.47 -150.51 19.43 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.091 -0.575 . . . . 0.0 112.679 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.6 tp -78.5 -58.96 2.98 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.689 0.281 . . . . 0.0 110.96 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.77 4.35 75.85 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.687 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.5 pt -140.61 143.46 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 117.259 0.529 . . . . 0.0 111.126 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 t -112.03 136.79 50.93 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.812 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.8 pt -125.29 153.86 33.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.597 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.8 p -139.18 145.35 39.23 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.224 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.18 -155.83 16.85 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.694 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.1 126.02 1.56 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.49 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.7 tptt -54.6 -35.64 63.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.393 0.14 . . . . 0.0 111.136 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.445 ' HG3' ' HG2' ' A' ' 72' ' ' LYS . 0.5 OUTLIER -62.77 -30.62 71.59 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.198 179.653 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -79.31 -34.7 42.12 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.106 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.23 -21.6 3.86 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.865 -0.684 . . . . 0.0 113.292 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 23.8 m -123.03 144.31 42.88 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 117.006 0.403 . . . . 0.0 111.201 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 34.8 Cg_exo -60.87 155.97 46.38 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.749 2.3 . . . . 0.0 112.442 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.2 mt -84.0 130.66 35.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.851 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.24 156.52 46.34 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.027 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.1 mt -81.08 121.87 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.902 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.4 m -106.2 -29.74 9.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.682 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.95 149.64 48.98 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.711 0.291 . . . . 0.0 111.357 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.4 mp -133.98 114.22 19.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.664 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -72.09 131.4 85.4 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.233 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.37 172.42 16.27 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.961 2.441 . . . . 0.0 112.903 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.62 18.52 61.56 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.784 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.454 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -124.97 169.28 11.34 Favored Pre-proline 0 N--CA 1.455 -0.184 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.454 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 9.8 Cg_endo -52.55 -29.1 39.15 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.62 2.214 . . . . 0.0 112.57 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.09 -46.46 87.29 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.317 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -65.32 -40.24 93.48 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.871 0.367 . . . . 0.0 110.605 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.69 -28.47 65.88 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.319 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 11.5 m -70.37 -28.24 64.95 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.42 -55.31 4.64 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.889 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.03 -27.84 31.34 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 121.474 -0.393 . . . . 0.0 113.609 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.14 88.86 0.3 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.003 0.401 . . . . 0.0 110.52 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -118.43 157.24 27.58 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.219 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.7 t -63.28 130.06 27.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.63 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.05 46.37 3.63 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.466 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.01 125.73 51.4 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.475 0.178 . . . . 0.0 110.544 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.25 121.61 33.15 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.769 0.319 . . . . 0.0 111.366 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.9 mt -78.21 130.78 35.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.268 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.1 mt -124.27 -51.97 1.75 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.643 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -145.06 148.89 34.18 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.859 0.361 . . . . 0.0 111.448 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 t -136.98 115.75 14.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.424 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 58.35 33.14 22.86 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.097 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.93 -15.24 58.31 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.181 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.07 133.77 29.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 117.143 0.471 . . . . 0.0 110.891 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -79.17 129.67 34.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.96 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.8 -21.36 13.19 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.645 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.6 ttt85 -60.95 -34.58 74.96 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.662 0.267 . . . . 0.0 110.902 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -84.25 -26.14 28.87 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.656 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.2 p -78.53 167.28 21.51 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.889 0.376 . . . . 0.0 111.011 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.445 ' HG2' ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -93.87 161.03 14.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.645 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -54.26 -47.52 72.19 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.892 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -64.76 -40.42 95.25 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.096 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.93 -37.67 86.65 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.913 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.71 -30.88 71.93 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.328 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.5 t -61.4 -43.43 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.847 0.356 . . . . 0.0 110.554 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.6 m -65.76 -44.69 85.1 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.706 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.3 mt -63.78 -44.04 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.0 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.6 mt -56.4 -42.96 78.83 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.756 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.9 t -68.24 -31.2 70.53 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.038 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -65.13 -24.17 67.34 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.571 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -62.97 97.86 0.12 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.808 0.337 . . . . 0.0 110.891 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.61 146.67 26.19 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.261 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.82 -106.37 1.47 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.555 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -87.74 143.1 27.33 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.73 0.3 . . . . 0.0 110.495 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.424 HD12 HG21 ' A' ' 87' ' ' ILE . 11.6 mt -136.95 122.33 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.033 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -96.64 124.35 40.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.613 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -112.58 129.61 56.31 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.791 0.329 . . . . 0.0 111.139 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -118.89 115.31 24.13 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.23 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.7 m -143.93 169.24 10.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.499 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.1 m -134.33 138.37 50.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.055 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.0 123.67 21.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.903 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.2 m -114.45 143.82 23.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.402 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.039 -0.981 . . . . 0.0 111.545 -179.884 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo . . . . . 0 N--CA 1.49 1.319 0 CA-C-O 120.814 0.256 . . . . 0.0 111.822 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 73.1 mt -80.27 142.98 13.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.55 138.63 51.78 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.08 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.405 ' HD2' ' HG3' ' A' ' 90' ' ' GLU . 1.1 mptm? -115.33 117.43 30.42 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.4 t -132.67 141.01 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.143 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.83 132.5 43.38 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.978 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.07 119.44 37.87 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.749 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.0 mp -110.3 114.25 27.56 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.343 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.0 ptmm? -128.15 146.1 50.81 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.265 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.438 ' HB2' ' HG3' ' A' ' 21' ' ' GLU . 0.4 OUTLIER -75.95 165.23 25.28 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.117 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.07 -36.28 70.37 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.846 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -79.91 -29.81 39.93 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.411 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.438 ' HG3' ' HB2' ' A' ' 18' ' ' GLU . 7.0 mt-10 -70.61 167.57 18.26 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.924 0.393 . . . . 0.0 111.943 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.28 -157.72 10.05 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.293 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.48 -62.52 1.69 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.94 -14.72 28.89 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.608 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.2 pt -143.74 164.1 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 117.186 0.493 . . . . 0.0 111.379 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.9 t -106.93 136.7 46.33 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.697 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.2 pt -118.69 153.11 20.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.241 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -143.2 144.63 32.25 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.248 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.19 -165.98 29.44 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.429 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.84 112.29 0.31 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.794 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -58.21 -37.94 75.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.453 0.168 . . . . 0.0 111.289 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -65.47 -30.96 71.81 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.011 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -73.35 -28.62 62.16 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.07 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.37 22.41 6.14 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.069 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.1 p -149.69 130.95 7.29 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.873 0.337 . . . . 0.0 111.044 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.34 155.61 50.98 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.612 2.208 . . . . 0.0 112.231 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mp -83.04 133.9 28.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.774 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.51 159.65 38.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.485 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.452 HD12 ' CB ' ' A' ' 58' ' ' ASP . 23.1 mt -80.17 122.82 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.993 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.7 -30.46 8.56 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.709 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -130.69 155.5 46.51 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.858 0.361 . . . . 0.0 111.513 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.4 mt -130.36 114.09 27.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.739 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -81.59 128.38 69.65 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.914 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.29 159.89 42.99 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.706 2.271 . . . . 0.0 112.799 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.12 33.07 57.66 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.809 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.97 170.8 8.66 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.43 -30.73 54.69 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.647 2.232 . . . . 0.0 112.953 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.81 -46.14 81.79 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.729 0.3 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -70.52 -41.25 72.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.794 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -64.59 -28.72 69.82 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.566 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -28.36 64.09 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.486 0.184 . . . . 0.0 111.473 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.41 16.85 51.35 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.054 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.06 -31.63 1.08 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.071 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.68 92.8 0.49 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.827 0.346 . . . . 0.0 110.592 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -98.82 156.86 16.65 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.247 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.8 t -64.2 135.43 27.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.564 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.57 50.57 3.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.127 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.452 ' CB ' HD12 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -111.3 124.56 52.47 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.491 0.186 . . . . 0.0 110.624 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.1 120.44 32.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.901 0.382 . . . . 0.0 111.103 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mt -73.71 144.67 12.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.908 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.7 mt -129.45 -53.49 1.17 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.57 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.26 145.94 33.18 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.976 0.417 . . . . 0.0 111.829 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.1 t -130.87 116.77 35.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.511 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 56.77 36.45 27.71 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.675 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.8 -16.35 46.99 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.507 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.37 135.14 25.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 117.229 0.515 . . . . 0.0 111.179 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -78.67 131.25 36.57 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.084 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.01 -27.89 20.55 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.979 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -67.3 -27.17 66.94 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.393 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -91.5 11.77 22.97 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 t -138.79 174.33 10.64 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.637 0.256 . . . . 0.0 110.812 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.43 160.97 14.12 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.047 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -56.11 -51.72 66.89 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.182 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.64 -43.12 84.65 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.964 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -67.2 -37.78 84.22 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.854 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.87 -33.72 76.34 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.363 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -61.72 -39.18 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.837 0.351 . . . . 0.0 110.504 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 49.9 m -65.37 -44.65 86.94 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.493 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.8 mt -61.73 -41.37 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.919 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.7 mt -60.44 -39.69 88.41 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.627 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.5 t -66.22 -30.92 71.46 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.185 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -65.24 -28.92 69.69 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.333 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -68.31 111.64 4.72 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.873 0.368 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.55 148.86 26.8 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.332 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.68 -102.18 0.42 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.581 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -90.09 132.03 35.64 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.908 0.385 . . . . 0.0 110.508 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.4 mt -129.9 133.22 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.07 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.71 122.36 36.09 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.715 0.293 . . . . 0.0 110.705 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.91 130.61 55.82 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.526 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.405 ' HG3' ' HD2' ' A' ' 12' ' ' LYS . 8.2 tt0 -122.18 115.56 22.62 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.581 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.2 m -136.64 170.57 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.479 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.3 t -133.94 143.66 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.308 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.2 126.04 28.56 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.967 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.6 118.79 59.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.015 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.208 179.957 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.49 1.271 0 CA-C-O 120.71 0.212 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.1 tt -89.59 124.93 42.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.277 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -123.99 153.38 41.37 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.082 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.423 ' HG3' ' HG2' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -114.79 120.05 38.72 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.56 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.0 m -129.36 135.29 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.708 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.69 136.71 40.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.834 0.349 . . . . 0.0 111.131 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.0 mp -113.12 124.04 51.65 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.692 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 tt -102.74 115.33 30.39 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.708 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -129.4 134.12 47.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.104 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -90.63 172.87 8.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.887 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.66 -36.94 70.13 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -74.84 -30.87 61.49 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.27 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -79.39 179.42 7.45 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.87 0.367 . . . . 0.0 111.323 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.1 -143.13 4.95 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.014 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.67 -66.97 0.82 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.49 0.186 . . . . 0.0 111.369 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.61 -15.56 45.36 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.614 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.405 ' CG2' HD21 ' A' ' 54' ' ' LEU . 2.2 pp -140.84 157.76 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 117.304 0.552 . . . . 0.0 111.241 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 t -114.49 137.4 51.9 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.0 pt -116.16 151.56 17.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.472 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.2 t -143.61 145.11 32.24 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.065 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 129.72 -172.96 19.87 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.441 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.87 116.54 0.53 Allowed Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.454 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -52.35 -37.68 56.74 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -59.32 -31.16 68.9 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.725 0.298 . . . . 0.0 110.993 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -72.66 -31.31 64.98 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.937 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.18 -23.63 3.16 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.999 -0.619 . . . . 0.0 113.102 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.04 149.7 54.67 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.815 0.307 . . . . 0.0 111.291 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.25 157.53 61.43 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.662 2.241 . . . . 0.0 112.275 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.4 HD11 ' HA ' ' A' ' 73' ' ' HIS . 3.4 mp -82.42 129.86 36.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.578 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.76 161.55 29.49 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.857 0.361 . . . . 0.0 111.607 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.9 mt -82.84 123.29 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.059 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.8 m -106.9 -30.03 9.12 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.578 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -123.95 145.09 49.39 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.865 0.364 . . . . 0.0 111.395 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.2 mt -131.02 114.3 26.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.486 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -85.02 114.46 56.03 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.775 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -62.32 175.34 2.11 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.015 2.477 . . . . 0.0 112.967 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.73 34.91 91.16 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.147 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.16 173.18 4.94 Favored Pre-proline 0 CA--C 1.531 0.242 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.42 -30.86 36.3 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.714 2.276 . . . . 0.0 113.022 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.23 -46.19 89.14 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.696 0.284 . . . . 0.0 111.1 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.98 -38.34 76.0 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.803 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -32.02 73.43 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.216 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.11 -28.28 61.28 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.518 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.84 16.51 61.65 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.054 -0.594 . . . . 0.0 113.089 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.69 -33.75 1.15 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.203 -0.523 . . . . 0.0 113.066 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.405 HD21 ' CG2' ' A' ' 25' ' ' ILE . 1.1 tt -67.72 105.31 1.88 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.881 0.372 . . . . 0.0 110.662 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.401 ' CE1' ' CG ' ' A' ' 93' ' ' TYR . 12.6 p80 -114.86 157.35 23.43 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.207 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.8 p -62.97 139.69 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.127 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.5 49.66 5.08 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.216 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.8 126.63 55.27 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.433 0.159 . . . . 0.0 110.763 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -90.68 128.11 36.53 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.712 0.292 . . . . 0.0 110.687 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 mt -74.7 104.05 2.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.695 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -86.46 -50.64 6.73 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.409 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -150.13 146.15 26.73 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.605 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.1 t -127.92 115.71 40.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.652 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 54.96 37.07 28.24 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.99 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.25 -14.16 58.22 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.375 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.0 t -86.12 127.21 40.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 117.181 0.49 . . . . 0.0 110.97 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -71.55 141.16 50.1 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.949 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tp -116.03 -1.23 12.54 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.722 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -34.25 70.69 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.3 11.59 37.9 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.3 p -109.47 163.66 13.22 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.741 0.305 . . . . 0.0 110.93 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -94.62 161.11 14.33 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.03 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.4 ' HA ' HD11 ' A' ' 37' ' ' ILE . 12.3 t-80 -53.95 -49.66 68.21 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.812 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -43.06 88.15 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.758 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -64.81 -38.34 90.65 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.973 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.63 -41.42 98.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.991 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.67 -39.88 86.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.052 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -46.62 71.39 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.009 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.6 mt -62.21 -39.61 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.557 0.218 . . . . 0.0 110.752 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.97 -42.39 94.02 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.178 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.9 p -64.82 -32.12 73.67 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.304 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -64.95 -28.81 69.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.05 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -62.01 114.22 3.26 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.853 0.358 . . . . 0.0 110.856 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.0 ptt85 -118.63 152.29 36.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.426 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.04 -103.23 0.55 Allowed Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.592 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -89.96 119.06 30.0 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.788 0.328 . . . . 0.0 110.402 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.4 mt -121.04 122.5 67.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.031 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -93.78 122.08 35.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.681 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.31 129.81 56.46 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.943 0.401 . . . . 0.0 111.203 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.423 ' HG2' ' HG3' ' A' ' 12' ' ' LYS . 23.6 mt-10 -120.09 115.4 23.61 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.007 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 8.2 m -137.08 163.7 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.733 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.9 t -131.76 146.08 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.15 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.401 ' CG ' ' CE1' ' A' ' 55' ' ' HIS . 0.1 OUTLIER -70.47 129.07 38.27 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.758 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.32 141.19 43.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.901 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.117 -0.945 . . . . 0.0 111.315 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo . . . . . 0 N--CA 1.49 1.297 0 CA-C-O 120.852 0.272 . . . . 0.0 111.939 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 tt -78.8 132.76 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.381 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -123.71 135.25 53.76 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.057 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.86 126.6 48.78 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.581 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.3 m -128.58 143.14 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.592 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 pp -114.69 132.23 56.48 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.821 0.343 . . . . 0.0 110.928 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -120.7 141.57 50.3 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.869 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.95 118.35 36.51 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.009 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.96 148.09 42.53 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.104 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -114.22 159.75 19.79 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.155 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.3 -38.22 73.64 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.963 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -79.77 -28.17 40.4 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.437 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.65 164.27 16.9 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.932 0.396 . . . . 0.0 111.595 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.41 -166.74 21.95 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.703 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.0 -59.53 5.22 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.539 0.209 . . . . 0.0 111.329 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.27 1.06 55.76 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.382 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 pp -145.48 161.44 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 117.177 0.488 . . . . 0.0 111.139 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.5 t -119.65 136.95 54.18 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 6.5 pt -119.9 154.38 22.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.335 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 p -137.16 153.56 50.44 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.002 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.31 -172.24 16.67 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.785 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.38 113.97 0.55 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.517 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -32.44 70.67 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.478 0.18 . . . . 0.0 111.388 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -60.11 -30.7 69.44 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.609 0.242 . . . . 0.0 110.949 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -76.59 -28.15 56.08 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.078 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.68 31.54 2.51 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.892 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.7 m -146.4 144.17 20.5 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.634 0.217 . . . . 0.0 111.0 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.7 156.97 62.11 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.624 2.216 . . . . 0.0 112.246 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 37' ' ' ILE . 29.5 mm -84.21 139.29 17.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.63 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mp -131.42 160.49 34.95 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.839 0.352 . . . . 0.0 111.287 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.2 mt -89.69 122.54 41.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.946 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.54 -31.6 7.44 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.642 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -127.75 149.41 50.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.668 0.27 . . . . 0.0 110.823 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 mt -135.03 114.55 17.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.74 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -66.67 120.89 74.5 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.096 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.35 156.63 61.38 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.973 2.449 . . . . 0.0 112.667 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.3 36.8 93.66 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.262 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -134.06 177.07 2.42 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -49.95 -31.02 25.79 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.712 2.275 . . . . 0.0 112.912 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.55 -46.1 87.47 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.006 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -69.84 -40.4 75.83 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.792 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.6 mtp85 -56.11 -36.8 68.61 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.552 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 17.8 m -81.24 -27.9 35.03 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.457 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.75 14.58 67.76 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.999 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.34 -30.95 3.93 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.796 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -65.72 101.32 0.62 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.757 0.313 . . . . 0.0 110.569 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -114.41 157.49 22.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.931 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.6 t -71.7 136.18 26.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.443 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.12 47.26 4.77 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.283 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -111.99 132.72 54.61 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.87 123.75 35.48 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.759 0.314 . . . . 0.0 111.624 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.437 ' HA ' HG11 ' A' ' 91' ' ' VAL . 41.7 mt -75.17 132.47 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.174 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.4 mt -117.81 -67.7 0.97 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.033 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.88 145.65 46.56 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.917 0.389 . . . . 0.0 111.504 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.0 t -116.71 115.51 49.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.378 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 54.31 37.94 28.43 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.678 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.25 -14.44 54.09 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.648 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.5 t -85.26 135.2 25.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 117.221 0.51 . . . . 0.0 111.179 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -77.21 138.17 39.28 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.155 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tp -116.2 -1.92 12.29 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.829 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -30.3 68.26 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -98.8 11.25 39.28 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.96 159.07 17.59 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.566 0.222 . . . . 0.0 110.775 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.13 161.27 18.96 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -54.3 -51.28 65.15 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.015 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -65.28 -41.39 94.21 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.776 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -64.28 -37.23 86.76 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.843 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.39 -30.82 71.88 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.392 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.9 -42.35 94.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.836 0.35 . . . . 0.0 110.085 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 32.0 m -64.4 -41.25 96.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.452 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.2 mm -57.86 -45.72 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.734 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -40.88 87.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -73.57 -13.79 61.09 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -69.23 -29.75 67.76 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.681 0.277 . . . . 0.0 111.115 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.454 ' HB3' HG12 ' A' ' 87' ' ' ILE . 17.5 mp0 -76.5 135.99 39.34 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.195 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -130.65 146.94 52.26 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.166 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.82 -90.82 0.17 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.997 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -96.25 115.19 27.03 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.746 0.308 . . . . 0.0 110.304 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.454 HG12 ' HB3' ' A' ' 83' ' ' GLN . 18.9 mt -114.47 126.24 71.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.202 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -99.81 135.52 41.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.749 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -128.63 135.87 49.89 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.921 0.391 . . . . 0.0 111.479 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -123.63 115.59 21.72 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.496 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.437 HG11 ' HA ' ' A' ' 60' ' ' ILE . 18.7 m -144.86 172.49 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.341 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.2 p -141.37 137.03 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.059 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.74 122.6 17.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.058 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.8 m -108.25 120.5 59.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.162 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.123 -179.771 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo . . . . . 0 N--CA 1.492 1.388 0 CA-C-O 120.655 0.19 . . . . 0.0 111.919 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.7 mt -104.77 140.85 21.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.06 146.1 48.8 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.064 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.4 113.19 23.43 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.677 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.33 141.64 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.347 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 20.6 tp -105.84 127.65 53.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.898 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 tp -113.2 125.5 54.4 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.44 114.57 28.52 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.684 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -125.94 135.04 51.41 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.206 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -81.39 171.57 14.6 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.047 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.46 -38.78 75.03 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.095 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -75.42 -30.26 59.99 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.218 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -77.02 166.16 23.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.897 0.379 . . . . 0.0 111.383 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -113.02 -152.86 11.27 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.893 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.98 -41.21 82.71 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.526 0.203 . . . . 0.0 111.464 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.09 -21.32 43.87 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.997 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.6 pp -146.48 171.44 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.808 0.337 . . . . 0.0 111.287 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.449 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 5.9 m -120.44 138.35 53.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.575 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.2 pt -115.96 156.2 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.851 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.5 p -137.26 163.26 31.36 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.365 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.0 -160.71 17.69 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.874 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.4 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . 166.5 131.7 1.29 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.133 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -56.46 -37.6 70.53 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.182 0.193 . . . . 0.0 111.33 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.39 -31.04 71.65 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.125 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -78.31 -26.6 47.02 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.236 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.87 22.93 6.07 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.048 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.419 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 10.1 p -149.57 134.97 9.74 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.926 0.363 . . . . 0.0 110.998 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 38.4 Cg_exo -60.91 156.69 42.43 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.42 2.08 . . . . 0.0 112.181 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.5 mp -83.37 131.64 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.792 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 mp -131.64 160.73 34.55 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.574 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.4 mt -93.63 119.58 41.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.946 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.25 -41.2 4.22 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.262 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 4.1 tt0 -104.83 150.19 25.03 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.716 0.293 . . . . 0.0 111.067 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.3 mt -132.09 121.27 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.746 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -73.78 114.78 35.68 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.817 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -68.03 140.7 50.68 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.707 2.271 . . . . 0.0 112.645 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.34 29.5 52.99 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.746 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.68 172.53 6.63 Favored Pre-proline 0 CA--C 1.531 0.224 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -52.19 -31.66 46.73 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.721 2.281 . . . . 0.0 112.797 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.79 -46.3 90.16 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.09 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.84 -40.34 79.48 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.763 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.07 -31.52 72.78 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.191 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -70.29 -27.97 64.82 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.581 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.38 -56.39 4.67 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.943 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.6 -28.36 37.27 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 121.473 -0.394 . . . . 0.0 113.533 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.94 96.93 0.15 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.033 0.444 . . . . 0.0 110.527 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -119.05 157.4 27.89 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.272 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.1 t -68.38 129.67 33.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.076 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.54 41.83 2.65 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.577 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.05 122.71 47.84 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.191 0.197 . . . . 0.0 110.581 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -94.75 127.1 40.51 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.683 0.278 . . . . 0.0 111.402 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 mt -77.78 142.21 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.338 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 70.4 mt -130.36 -50.88 1.09 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.933 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.32 145.56 49.15 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.889 0.376 . . . . 0.0 111.698 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.467 HG12 ' CE1' ' A' ' 89' ' ' PHE . 24.0 t -115.99 115.34 48.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.238 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 53.16 34.8 18.26 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.956 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.14 -15.91 59.95 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.037 -0.602 . . . . 0.0 113.624 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.9 t -88.39 134.95 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 117.218 0.509 . . . . 0.0 111.152 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -69.65 135.59 50.09 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.319 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.443 ' HG ' ' HB ' ' A' ' 71' ' ' THR . 0.5 OUTLIER -120.79 16.2 11.83 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.715 179.674 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.4 ttt85 -69.64 -32.31 70.92 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.11 12.02 37.32 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.443 ' HB ' ' HG ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -103.45 162.87 12.66 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.617 0.246 . . . . 0.0 110.867 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.37 161.07 13.96 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.12 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.4 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . 58.9 t-80 -54.1 -51.1 65.25 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.066 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -60.45 -41.04 93.27 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.811 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -65.22 -37.22 86.61 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.741 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.56 -35.23 79.79 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.104 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.1 t -62.23 -39.84 85.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.815 0.341 . . . . 0.0 110.424 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -41.93 99.05 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.594 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.7 mm -57.98 -45.41 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.571 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 mt -57.5 -39.29 76.15 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.072 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -61.58 -37.36 83.58 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.07 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -65.72 -25.61 67.38 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.339 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -65.9 131.13 45.53 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.097 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.03 143.7 50.27 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.384 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.03 -101.31 0.22 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.859 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -91.57 126.01 36.5 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.954 0.407 . . . . 0.0 110.495 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.408 HG23 HD11 ' A' ' 87' ' ' ILE . 7.9 mt -117.6 122.99 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.081 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.77 124.37 37.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.414 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.467 ' CE1' HG12 ' A' ' 63' ' ' VAL . 0.7 OUTLIER -128.16 129.8 47.08 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.927 0.394 . . . . 0.0 111.178 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -101.37 115.21 29.99 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.298 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.23 171.5 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.394 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.0 m -133.95 149.37 30.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.292 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.98 120.98 19.36 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.867 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.35 131.27 73.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.798 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.013 179.932 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 N--CA 1.49 1.28 0 CA-C-O 120.788 0.245 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.14 141.01 16.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.13 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.5 124.87 44.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.993 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.8 111.54 23.67 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.472 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -132.01 138.05 53.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.957 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.9 141.66 30.61 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.07 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -121.48 139.6 53.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.971 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tt -107.6 127.11 53.36 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.822 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -116.2 126.56 53.8 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.87 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.43 155.62 20.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.682 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.33 -38.96 74.9 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.189 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -79.0 -27.72 43.36 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.425 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -95.41 -178.34 4.4 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.741 0.305 . . . . 0.0 111.508 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.41 -149.89 5.55 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.974 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.94 -56.97 6.2 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.608 0.242 . . . . 0.0 110.781 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.02 -14.52 61.38 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.445 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.6 pp -140.13 154.08 22.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 117.104 0.452 . . . . 0.0 111.166 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -103.8 136.75 42.89 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.793 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.7 pt -119.66 149.7 22.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.464 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.5 t -135.86 146.94 47.98 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.217 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.96 -154.72 25.71 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.364 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 159.45 117.5 0.48 Allowed Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.095 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.88 -33.67 72.14 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.38 0.133 . . . . 0.0 111.321 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -57.26 -29.9 64.21 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.549 0.214 . . . . 0.0 111.331 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -83.15 -29.14 28.88 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.001 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.0 26.03 5.66 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.898 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 16.1 m -144.58 131.98 10.4 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 116.75 0.275 . . . . 0.0 111.115 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 32.6 Cg_exo -61.14 153.97 60.84 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.647 2.231 . . . . 0.0 112.005 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mp -82.53 132.07 32.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.426 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.4 159.05 35.64 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.618 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 mt -83.01 129.96 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.958 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.3 m -119.71 -40.95 2.71 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.353 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -105.32 144.52 31.99 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.702 0.287 . . . . 0.0 111.081 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.9 mm -129.26 111.62 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.697 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -84.87 127.58 64.23 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.97 157.86 53.78 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.843 2.362 . . . . 0.0 113.063 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.94 37.58 43.55 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.835 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.06 170.29 8.68 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-O 120.45 0.166 . . . . 0.0 110.799 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.12 -31.24 34.91 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.728 2.285 . . . . 0.0 112.684 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.41 83.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.463 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.77 -42.53 77.3 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.851 0.358 . . . . 0.0 110.498 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -65.02 -30.55 71.54 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.299 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -70.57 -28.34 64.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.535 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.17 -58.8 3.99 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.764 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.85 -23.27 44.54 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.541 -0.362 . . . . 0.0 113.526 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.93 96.05 0.18 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.111 0.456 . . . . 0.0 110.403 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -119.33 157.41 28.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.299 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 m -68.28 134.9 29.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.56 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.85 44.9 4.37 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.587 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.15 122.49 47.89 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.26 122.58 34.0 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.764 0.316 . . . . 0.0 111.633 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.6 mt -69.59 132.19 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.366 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.1 mt -114.88 -54.58 2.56 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.802 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -150.76 145.98 26.11 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.454 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.3 t -125.61 120.51 57.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.54 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 57.39 34.54 24.83 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.08 -11.08 61.26 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.359 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.58 136.33 23.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 117.258 0.529 . . . . 0.0 110.934 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.5 134.39 35.21 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.056 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 mp -108.63 -12.33 14.98 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.034 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -29.05 69.58 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -96.51 9.19 42.16 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.62 0.229 . . . . 0.0 111.62 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.6 p -119.04 157.9 26.88 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.677 0.275 . . . . 0.0 110.8 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.03 161.05 20.85 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.817 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -53.82 -50.55 65.94 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.904 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -59.69 -41.56 91.01 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.949 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.28 -38.66 85.44 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.954 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.44 -35.2 79.65 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.402 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.86 -40.46 87.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.726 0.298 . . . . 0.0 110.469 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.9 m -66.77 -44.25 81.9 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.782 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.2 mt -62.06 -43.06 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.825 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.5 mt -62.4 -36.53 82.6 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.684 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.4 t -65.57 -32.69 74.41 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.012 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -65.03 -28.8 69.73 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.325 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -61.85 112.75 2.42 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.813 0.34 . . . . 0.0 110.767 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -112.57 148.88 33.61 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.378 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.56 -103.02 0.55 Allowed Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.59 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -89.07 126.41 35.43 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.812 0.339 . . . . 0.0 110.385 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.0 mt -126.05 129.23 72.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.826 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -93.82 135.49 35.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.474 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -130.58 129.28 42.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.879 0.371 . . . . 0.0 111.026 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -122.07 115.36 22.35 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.227 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.9 m -138.83 171.54 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.518 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.71 143.18 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.501 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.98 122.92 27.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.961 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.82 133.41 66.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.088 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.434 -0.794 . . . . 0.0 111.34 -179.865 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo . . . . . 0 N--CA 1.491 1.364 0 CA-C-O 120.99 0.329 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mp -78.77 143.43 12.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.204 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.17 143.95 46.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.263 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -111.97 115.1 28.4 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 t -125.68 130.15 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.776 0.322 . . . . 0.0 111.175 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.93 132.47 43.48 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.169 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.5 tt -129.67 144.53 51.33 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.985 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.76 114.81 28.92 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.95 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -94.41 136.3 34.86 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.758 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.07 154.56 32.98 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.183 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.63 -37.16 72.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.218 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -82.47 -26.78 32.33 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.503 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -102.17 110.04 21.89 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.659 0.266 . . . . 0.0 110.946 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.8 -152.14 0.13 Allowed Glycine 0 CA--C 1.522 0.523 0 C-N-CA 121.255 -0.498 . . . . 0.0 113.439 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.56 -59.98 4.54 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.9 -11.95 65.92 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.598 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 pt -138.36 152.68 25.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 117.1 0.45 . . . . 0.0 110.977 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.53 136.68 52.84 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.762 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.0 pt -117.34 155.8 18.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.592 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 t -140.46 147.13 39.16 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.993 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.63 -165.49 20.69 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.43 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.35 114.41 0.44 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.679 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.2 tptp -60.99 -29.89 69.95 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -57.53 -31.15 65.78 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.653 0.263 . . . . 0.0 110.966 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -79.38 -23.11 43.53 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.324 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.15 21.25 4.93 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.309 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.1 m -145.38 140.32 15.83 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 117.007 0.403 . . . . 0.0 111.212 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.57 157.07 63.46 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.57 2.18 . . . . 0.0 112.385 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mt -85.64 137.52 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.842 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.3 mp -128.37 151.19 49.64 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.368 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.2 mt -86.92 122.12 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.824 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.54 -27.72 8.12 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.877 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -109.75 144.27 38.39 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.662 0.268 . . . . 0.0 111.121 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.4 mm -133.55 121.21 40.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.637 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -97.91 112.41 61.64 Favored Pre-proline 0 C--O 1.234 0.287 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.149 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.93 151.58 73.66 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.709 2.273 . . . . 0.0 112.492 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.06 -37.27 3.84 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.734 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.66 176.14 4.11 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-O 120.45 0.167 . . . . 0.0 110.724 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -51.02 -30.65 31.83 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.918 2.412 . . . . 0.0 113.15 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.69 -46.19 84.65 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.685 0.278 . . . . 0.0 111.211 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.54 -42.12 71.62 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.787 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.6 mtp85 -62.09 -30.08 70.76 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.108 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.94 -28.22 65.4 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.418 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.12 -56.69 3.61 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.712 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.95 -23.58 39.07 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 119.867 -0.407 . . . . 0.0 113.776 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.05 90.28 0.13 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.161 0.481 . . . . 0.0 110.422 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -114.17 157.24 22.91 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.11 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.4 t -64.01 137.71 24.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.676 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.71 46.17 4.35 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.385 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.58 121.25 44.23 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.445 0.164 . . . . 0.0 111.017 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.11 122.05 37.37 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.671 0.272 . . . . 0.0 111.258 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 mp -77.14 134.7 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.442 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.1 mt -121.93 -50.62 2.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.941 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.56 146.44 34.61 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.762 0.315 . . . . 0.0 111.361 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.0 t -136.02 115.88 17.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.59 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 59.79 33.03 21.64 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.015 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.55 -14.44 58.1 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.305 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 t -81.79 132.58 31.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 117.044 0.422 . . . . 0.0 110.604 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -76.26 126.74 31.54 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.658 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.58 0.97 10.57 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.529 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -71.1 -31.48 67.84 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 111.247 0.091 . . . . 0.0 111.247 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.47 11.88 33.94 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.7 p -100.91 149.7 23.62 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.588 0.232 . . . . 0.0 111.002 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -75.5 161.13 29.46 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.433 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -54.59 -49.63 69.95 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.213 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -62.3 -37.72 86.62 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.588 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -62.67 -37.33 86.0 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.746 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.34 -35.34 80.07 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.347 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.16 -42.96 97.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.635 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.32 -48.3 70.73 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.814 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 mt -61.41 -42.19 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.092 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -39.24 80.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.8 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -33.27 75.44 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.009 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -65.3 -27.11 68.39 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.14 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -65.79 95.63 0.25 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 110.79 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -98.68 144.23 28.18 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.123 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.73 -109.08 2.53 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.818 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -79.99 135.96 36.5 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.692 0.282 . . . . 0.0 110.574 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.1 mt -137.03 122.36 25.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.289 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -95.79 122.25 38.38 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.428 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -111.8 128.79 56.22 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.007 0.432 . . . . 0.0 111.338 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -117.24 115.36 25.15 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.299 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.6 m -137.76 171.05 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.465 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.6 p -135.94 137.57 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.987 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.19 119.99 13.64 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.834 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.1 t -111.13 125.03 68.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.167 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.991 179.914 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo . . . . . 0 N--CA 1.489 1.222 0 CA-C-O 120.725 0.219 . . . . 0.0 111.842 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 tt -109.3 124.6 66.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.067 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -113.65 127.03 55.9 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.053 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.24 113.91 27.78 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.998 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.93 135.87 60.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.003 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.71 130.95 44.65 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.824 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.24 139.47 50.32 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.069 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.2 mp -109.02 114.54 28.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.87 139.03 54.13 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.056 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -109.28 168.09 9.64 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.949 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.87 -37.14 75.87 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.282 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -74.62 -29.89 61.46 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.596 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -94.75 166.18 12.12 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 111.641 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.88 -154.22 9.12 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.91 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.08 -67.01 0.52 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.577 0.227 . . . . 0.0 111.03 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.22 4.13 63.0 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.071 -0.585 . . . . 0.0 113.634 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.2 pt -138.29 145.36 28.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 117.256 0.528 . . . . 0.0 111.088 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.75 140.23 34.26 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.099 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.2 pt -116.49 155.62 17.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.684 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.9 p -133.9 153.79 51.51 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.347 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.49 -153.75 19.66 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.803 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.81 138.21 2.74 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.26 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -58.97 -37.74 77.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.066 0.146 . . . . 0.0 111.38 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.84 -31.19 71.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.595 0.236 . . . . 0.0 111.017 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -81.14 -28.19 35.19 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.103 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.19 25.83 5.95 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.101 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.8 m -147.82 140.08 14.37 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.864 0.332 . . . . 0.0 110.992 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.78 155.83 46.69 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.613 2.208 . . . . 0.0 112.19 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.7 mt -84.89 136.56 22.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.857 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.8 154.5 48.48 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.301 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.1 mm -83.87 118.23 30.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.763 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -108.19 -28.51 9.44 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.705 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.67 144.45 50.2 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.735 0.302 . . . . 0.0 111.198 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.426 HD13 HG22 ' A' ' 42' ' ' ILE . 20.9 mm -128.92 112.19 25.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.383 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -87.01 130.96 46.27 Favored Pre-proline 0 C--O 1.232 0.158 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.106 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.37 172.8 15.63 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.846 2.364 . . . . 0.0 112.535 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.52 30.38 77.43 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.467 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.443 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -137.01 169.08 14.21 Favored Pre-proline 0 C--O 1.233 0.203 0 C-N-CA 122.248 0.219 . . . . 0.0 110.44 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.443 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 9.3 Cg_endo -53.09 -27.02 34.95 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.768 2.312 . . . . 0.0 112.75 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.72 -46.35 89.37 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.061 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -67.85 -40.49 83.66 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.618 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -58.71 -33.05 69.76 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.347 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.3 m -80.57 -28.36 37.23 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.56 -51.7 4.27 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.182 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.48 -24.37 23.49 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.56 -0.353 . . . . 0.0 113.795 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.19 89.52 0.09 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.15 0.475 . . . . 0.0 110.743 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -114.25 157.37 22.8 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.348 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.1 t -72.56 136.55 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.68 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.29 40.34 4.83 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.899 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -112.08 135.03 53.25 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.602 0.201 . . . . 0.0 110.987 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.53 124.01 47.31 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.686 0.279 . . . . 0.0 111.403 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 mt -80.04 150.72 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.494 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.3 mt -136.25 -50.45 0.69 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.354 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.74 145.95 32.78 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.773 0.321 . . . . 0.0 111.476 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.4 t -135.39 115.87 18.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.769 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 57.15 34.53 24.99 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.875 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.83 -19.73 46.68 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.321 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 t -80.13 135.98 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 117.065 0.433 . . . . 0.0 111.0 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -80.51 137.33 36.43 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.213 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tp -87.12 -33.06 19.57 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.038 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -67.4 -27.69 67.29 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.427 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -89.51 9.99 24.52 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 t -134.15 154.43 51.22 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.773 0.321 . . . . 0.0 110.959 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.18 161.16 20.67 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -54.0 -51.66 63.24 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.008 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -61.16 -42.15 98.03 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.031 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -38.68 84.96 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.963 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.49 -33.73 76.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.348 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.7 t -61.91 -43.46 97.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.76 0.314 . . . . 0.0 110.25 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.11 -47.34 77.53 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.544 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.2 mt -59.23 -49.29 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.92 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.5 mt -55.45 -35.97 66.04 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.132 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -20.06 60.45 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.652 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -74.22 -28.86 61.45 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.748 0.308 . . . . 0.0 110.57 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -68.79 104.82 2.13 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.66 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 149.9 25.68 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.375 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.98 -107.11 1.63 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.469 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -79.37 115.37 18.98 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.761 0.315 . . . . 0.0 110.433 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.3 mt -122.55 122.74 66.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.042 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -93.93 121.86 35.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.447 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.06 129.69 55.71 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.877 0.37 . . . . 0.0 111.642 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -118.1 115.35 24.66 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.394 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.3 169.26 20.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.513 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.4 m -137.69 131.23 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.111 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.15 123.48 22.27 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.935 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.3 m -108.34 141.9 22.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.4 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.42 -0.8 . . . . 0.0 111.323 -179.89 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo . . . . . 0 N--CA 1.49 1.274 0 CA-C-O 120.539 0.141 . . . . 0.0 111.827 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -100.87 128.67 52.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.462 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -123.43 121.56 36.03 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.968 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -111.47 111.61 22.75 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.566 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.42 134.95 56.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.073 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 mp -97.97 139.54 33.65 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.81 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 tp -108.32 119.6 39.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.829 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 tp -109.55 115.18 29.43 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.487 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.63 153.14 44.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.018 0.437 . . . . 0.0 111.242 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.84 173.14 7.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.997 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -58.83 -38.37 78.53 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -72.96 -30.26 63.71 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.18 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -75.19 168.95 19.0 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.852 0.358 . . . . 0.0 111.238 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.1 -149.93 8.88 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.888 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 tp -76.88 -61.08 2.09 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.517 0.199 . . . . 0.0 111.323 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.78 -14.25 49.63 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.581 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -143.89 165.09 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 117.123 0.461 . . . . 0.0 111.132 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.8 t -120.99 136.76 54.91 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.675 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.402 HG23 HD11 ' A' ' 60' ' ' ILE . 15.2 pt -117.99 153.4 20.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.496 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.2 t -139.6 145.87 39.09 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.22 -151.51 23.46 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.447 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.53 105.44 0.19 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.847 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -57.57 -34.92 69.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.474 0.178 . . . . 0.0 111.18 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -60.72 -31.17 70.48 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.186 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -82.61 -31.36 28.92 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.087 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.65 32.27 2.33 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.709 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 10.9 p -140.42 130.92 13.75 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-O 120.66 0.267 . . . . 0.0 110.846 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 25.9 Cg_exo -62.35 156.23 52.58 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.551 2.168 . . . . 0.0 112.072 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.3 mm -84.85 136.96 21.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.593 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.44 158.56 43.82 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.909 0.385 . . . . 0.0 111.611 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.7 mt -88.48 125.88 41.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.158 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.6 t -110.42 -34.26 6.38 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.395 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -123.58 147.35 47.39 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.817 0.341 . . . . 0.0 111.371 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.3 mt -127.13 120.11 54.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.54 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -78.68 113.58 36.13 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.703 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.17 149.78 83.15 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.745 2.296 . . . . 0.0 112.648 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.84 39.59 28.17 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.563 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.93 172.95 4.89 Favored Pre-proline 0 C--N 1.331 -0.22 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -51.33 -32.72 42.84 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.61 2.207 . . . . 0.0 112.792 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.35 -46.31 89.24 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.113 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.36 -41.6 96.64 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.665 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.43 -29.86 67.67 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.611 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 10.8 m -70.36 -28.38 65.07 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.18 -57.8 4.01 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.89 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.44 -25.17 33.41 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.514 -0.374 . . . . 0.0 113.47 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.21 90.28 0.09 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.964 0.412 . . . . 0.0 110.471 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -115.79 157.47 24.33 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.217 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.1 t -63.92 132.08 29.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.247 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.6 40.78 4.93 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.815 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.55 119.07 37.97 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.21 130.34 38.94 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.402 HD11 HG23 ' A' ' 27' ' ' ILE . 3.2 mp -81.6 151.04 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.357 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.9 mt -136.6 -51.75 0.69 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.976 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.91 147.39 40.5 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.806 0.336 . . . . 0.0 111.448 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -130.01 115.62 33.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.529 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 54.4 32.91 17.46 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.864 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.77 -17.0 58.91 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.339 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.8 t -83.79 137.97 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 117.063 0.432 . . . . 0.0 111.045 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -75.23 131.18 40.2 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.27 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.0 tt -108.09 -22.61 12.32 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.501 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -61.16 -28.48 69.16 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.6 12.12 28.66 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.4 p -113.45 162.65 15.87 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.742 0.306 . . . . 0.0 110.583 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.82 161.24 16.84 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.198 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -54.03 -50.68 66.12 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.069 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -68.29 -43.16 78.31 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.874 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -38.1 89.34 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.997 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.66 -30.74 71.81 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.4 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.9 t -61.93 -41.43 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.743 0.306 . . . . 0.0 110.651 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.3 m -69.84 -39.98 76.11 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.493 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.0 mt -65.06 -48.89 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.163 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.6 pp -62.67 -36.6 83.39 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.108 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 86.9 p -74.54 -16.0 60.84 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -71.22 -30.53 66.48 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.772 0.32 . . . . 0.0 110.858 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.416 ' HB3' HG12 ' A' ' 87' ' ' ILE . 2.2 mp0 -67.47 117.02 8.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.851 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -107.33 147.26 30.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.446 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.93 -98.39 0.19 Allowed Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.559 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -82.66 115.0 21.41 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.721 0.296 . . . . 0.0 110.304 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.416 HG12 ' HB3' ' A' ' 83' ' ' GLN . 16.7 mt -119.64 122.36 68.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.974 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.39 122.88 43.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.351 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -122.83 129.42 51.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.826 0.346 . . . . 0.0 110.736 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -111.85 114.98 28.26 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.825 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.6 m -134.52 169.31 21.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.566 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.9 m -139.96 141.24 34.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.954 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.47 116.26 7.26 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.825 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.3 p -105.01 139.63 25.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.517 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.124 -0.941 . . . . 0.0 111.065 -179.957 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo . . . . . 0 N--CA 1.494 1.541 0 CA-C-O 120.831 0.263 . . . . 0.0 112.21 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.416 ' CD1' HD11 ' A' ' 61' ' ' LEU . 1.2 tt -92.66 136.89 23.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.168 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.4 ttt180 -123.62 148.07 46.77 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.049 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.436 ' HD2' ' HG3' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -101.1 118.86 37.84 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.659 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.0 t -122.13 129.56 75.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.304 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.4 tp -101.91 120.06 39.79 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.672 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.7 mp -108.28 121.09 44.18 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.149 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.8 tp -108.32 115.22 29.72 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.635 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.08 147.27 45.99 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.209 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -86.75 172.26 10.29 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.975 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -58.89 -38.46 78.91 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.061 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -73.92 -29.53 62.09 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.108 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -68.29 154.19 42.24 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.817 0.342 . . . . 0.0 111.533 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.22 -157.85 26.11 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.937 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.55 -62.05 1.6 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.492 0.187 . . . . 0.0 111.49 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.08 -21.17 34.21 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.365 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -139.93 151.96 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 117.072 0.436 . . . . 0.0 111.31 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.406 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -105.49 137.1 43.87 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.986 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.0 pt -119.09 158.49 20.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.576 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.6 t -144.53 150.3 37.31 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.2 -159.58 15.73 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.478 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.427 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . 161.78 123.31 0.66 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.79 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -56.35 -37.87 70.6 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.457 0.169 . . . . 0.0 111.457 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -68.07 -31.15 70.59 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.734 0.302 . . . . 0.0 110.863 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -76.79 -30.5 56.49 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.028 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.96 21.69 5.23 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.113 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.4 p -149.76 130.81 7.2 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.95 0.375 . . . . 0.0 110.921 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -61.77 154.06 63.36 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.575 2.183 . . . . 0.0 112.26 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.9 mt -82.79 136.79 22.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.642 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.38 163.5 32.78 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.886 0.374 . . . . 0.0 111.766 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 mm -87.83 125.19 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.59 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.39 -46.77 2.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.136 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.406 ' HB2' ' CB ' ' A' ' 26' ' ' SER . 45.5 mt-10 -111.24 146.4 37.02 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.228 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.8 mt -131.72 113.08 21.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.6 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -69.72 124.61 90.95 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.924 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.06 147.02 53.64 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.695 2.263 . . . . 0.0 112.658 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.46 40.66 22.64 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.569 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.71 173.16 5.37 Favored Pre-proline 0 C--N 1.332 -0.196 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -51.8 -31.8 43.6 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.629 2.219 . . . . 0.0 112.662 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.57 -45.87 84.67 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.225 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -70.56 -43.08 70.22 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.635 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -59.57 -30.42 68.62 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.464 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 94.8 m -80.24 -28.02 38.57 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.833 -0.167 . . . . 0.0 111.353 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.95 17.66 63.46 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.865 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.29 -30.74 2.38 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.062 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.9 89.16 0.58 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.845 0.355 . . . . 0.0 110.738 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -106.34 156.83 18.1 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.4 t -64.56 135.09 28.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.688 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.95 46.06 4.31 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.411 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.38 122.74 48.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.397 0.142 . . . . 0.0 110.81 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.35 121.3 32.97 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.816 0.341 . . . . 0.0 111.216 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.6 mt -74.06 145.92 10.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.608 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.416 HD11 ' CD1' ' A' ' 10' ' ' ILE . 64.0 mt -137.83 -52.58 0.63 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.092 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.45 145.58 48.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.836 0.35 . . . . 0.0 111.702 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.0 t -131.3 117.04 34.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.403 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 57.82 34.46 24.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.931 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.99 -18.54 47.27 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.589 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.31 130.77 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 117.183 0.491 . . . . 0.0 110.926 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -74.78 140.78 44.25 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.172 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.8 tp -114.83 16.27 17.33 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.416 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.13 -34.57 71.17 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.807 -0.178 . . . . 0.0 111.425 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.88 12.03 38.42 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.405 HG23 ' CD1' ' A' ' 79' ' ' ILE . 7.3 m -103.51 154.36 19.54 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.776 0.322 . . . . 0.0 111.191 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.22 161.0 15.91 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.283 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.427 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . 8.4 t-80 -54.1 -52.4 61.13 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.037 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -61.57 -38.36 87.23 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.028 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -65.23 -40.91 94.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.824 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.38 77.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.481 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.9 t -61.81 -43.76 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.72 0.295 . . . . 0.0 110.694 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.9 m -69.67 -44.92 69.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.005 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.405 ' CD1' HG23 ' A' ' 71' ' ' THR . 13.4 mt -62.95 -47.99 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.482 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 pp -63.51 -33.62 75.98 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.46 0.172 . . . . 0.0 111.09 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.7 t -66.64 -30.79 71.14 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.151 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -65.31 -29.24 69.97 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.147 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -60.88 115.14 3.47 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.725 0.298 . . . . 0.0 110.651 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -115.01 143.83 44.56 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.961 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.18 -100.8 0.27 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.567 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -77.39 119.5 21.09 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.738 0.304 . . . . 0.0 110.544 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.0 mt -129.83 122.47 54.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.101 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -94.6 126.95 40.22 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.355 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -124.52 129.43 50.59 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.899 0.38 . . . . 0.0 111.391 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.436 ' HG3' ' HD2' ' A' ' 12' ' ' LYS . 6.5 tt0 -119.9 115.57 24.07 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.233 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.0 m -138.25 169.02 19.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.0 0.429 . . . . 0.0 111.888 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 32.2 t -129.5 138.53 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.751 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.27 124.18 21.52 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.87 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.46 130.82 71.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.242 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.588 179.788 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.49 1.281 0 CA-C-O 120.679 0.2 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.86 115.74 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.12 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -122.18 127.14 49.66 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.068 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.35 114.22 26.34 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.82 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.0 t -111.26 144.57 18.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.827 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.0 tt -97.72 122.09 40.4 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.594 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.92 123.61 49.36 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.256 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tt -107.76 115.51 30.27 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.708 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -130.33 139.4 50.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.55 164.29 23.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.993 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.11 -38.5 73.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.969 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -76.71 -29.54 56.28 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.079 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -77.25 176.04 9.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.724 0.297 . . . . 0.0 111.38 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -132.99 -144.26 5.19 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.05 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.6 mt -94.11 -67.7 0.84 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.549 0.214 . . . . 0.0 111.141 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.02 4.58 51.02 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.723 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.438 HG22 ' CD2' ' A' ' 54' ' ' LEU . 2.6 pp -137.12 157.79 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 117.287 0.544 . . . . 0.0 111.321 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.6 m -112.99 136.71 52.38 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.822 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.7 pt -117.64 158.14 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.364 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 t -143.48 153.97 43.18 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.289 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.31 -167.1 24.28 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.619 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.18 122.28 0.64 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.842 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.19 -37.76 78.19 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.658 0.266 . . . . 0.0 111.058 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -59.04 -31.2 68.63 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.936 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -80.27 -28.02 38.45 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.108 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.04 30.35 4.83 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.958 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 6.8 m -146.48 132.96 9.73 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-N 116.76 0.28 . . . . 0.0 111.162 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 34.4 Cg_exo -61.26 157.41 40.35 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.718 2.279 . . . . 0.0 112.049 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.9 mm -82.18 135.19 25.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.563 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 pp -138.65 155.99 47.81 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.934 0.397 . . . . 0.0 111.513 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.3 mt -79.97 125.78 39.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.948 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.7 t -101.63 -42.42 6.22 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.623 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -127.94 150.55 49.84 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.982 0.42 . . . . 0.0 111.796 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.6 mt -132.91 122.67 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.571 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -82.59 132.2 52.82 Favored Pre-proline 0 N--CA 1.462 0.162 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.928 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.92 148.19 40.19 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.747 2.298 . . . . 0.0 112.58 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.42 37.99 46.08 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.65 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.9 172.49 7.25 Favored Pre-proline 0 C--O 1.233 0.191 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -50.86 -32.4 37.26 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.669 2.246 . . . . 0.0 112.916 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.27 78.33 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.088 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.28 -40.05 77.98 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.683 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -60.04 -31.7 70.22 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.395 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 m -76.53 -27.98 56.18 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.46 16.75 67.79 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.132 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.01 -35.15 1.54 Allowed Glycine 0 C--N 1.337 0.593 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.834 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.438 ' CD2' HG22 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -69.24 105.51 2.54 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.818 0.342 . . . . 0.0 110.907 -179.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -111.98 157.34 20.83 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.208 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.4 t -62.86 137.97 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.61 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.89 53.36 7.21 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.627 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -111.93 120.8 43.14 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.3 126.75 36.48 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.866 0.365 . . . . 0.0 111.854 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mt -85.83 149.9 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.907 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.2 mt -135.47 -50.0 0.73 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.874 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.68 145.69 45.05 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.745 0.307 . . . . 0.0 111.432 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.1 t -135.1 115.99 19.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 56.54 36.83 28.2 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.806 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.28 -14.4 50.39 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.429 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.3 t -83.92 136.49 22.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 117.19 0.495 . . . . 0.0 110.923 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -76.91 137.53 39.16 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.285 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.97 -1.53 13.08 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.652 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -71.31 -34.15 70.33 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.35 12.19 33.8 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 64.7 p -103.88 138.61 40.21 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.655 0.264 . . . . 0.0 110.939 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.35 161.16 30.79 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.816 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -53.91 -49.28 68.98 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.956 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.95 -41.94 99.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.683 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.7 -39.58 94.47 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.105 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.64 -34.28 77.49 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.476 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.7 t -62.04 -43.01 97.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.791 0.329 . . . . 0.0 110.311 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 m -63.8 -44.37 93.49 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.74 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.5 mt -62.86 -41.2 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.955 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.12 -41.72 88.89 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.833 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.6 m -69.2 -27.12 65.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.442 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -65.08 -28.16 69.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.42 0.152 . . . . 0.0 111.139 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -67.06 117.33 8.96 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.65 0.262 . . . . 0.0 110.938 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.96 143.68 44.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.071 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.61 -106.88 0.95 Allowed Glycine 0 C--N 1.337 0.604 0 C-N-CA 121.298 -0.477 . . . . 0.0 112.916 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -78.6 122.78 26.36 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.661 0.267 . . . . 0.0 110.465 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.4 mt -127.7 123.12 60.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.404 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -93.84 123.89 37.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.232 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.51 133.2 56.23 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.855 0.359 . . . . 0.0 111.654 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.88 115.51 23.97 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.421 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.0 m -136.97 169.69 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.743 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.4 t -136.95 133.7 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.666 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.44 117.85 8.54 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.791 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 13.3 p -99.4 126.82 52.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.859 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.234 -179.601 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.489 1.22 0 CA-C-O 120.843 0.268 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.87 127.39 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.175 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.67 128.28 55.22 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.104 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -100.32 117.57 34.81 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.799 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.0 m -127.52 128.43 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.461 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 tp -105.02 120.29 41.11 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.088 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 tp -108.72 137.01 47.35 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.685 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.4 114.94 28.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.786 0.326 . . . . 0.0 110.877 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.72 132.59 56.45 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.029 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.44 169.73 8.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.699 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -57.31 -38.44 74.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.921 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -81.65 -26.27 34.9 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.726 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -88.9 153.35 21.12 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.973 0.416 . . . . 0.0 111.606 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.35 -149.7 15.75 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.804 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.38 -65.63 0.96 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.545 0.212 . . . . 0.0 111.209 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.01 4.42 60.09 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.525 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.4 pt -142.17 151.8 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 117.389 0.594 . . . . 0.0 111.337 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.0 136.76 49.52 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.781 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.1 pt -124.84 158.74 32.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.421 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.0 t -143.11 150.92 40.14 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.135 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.82 -148.17 17.2 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.576 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.54 111.65 0.39 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.532 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -58.25 -30.28 66.43 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.455 0.169 . . . . 0.0 111.205 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -58.66 -31.37 68.12 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.006 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -86.06 -24.3 26.4 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.235 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.0 27.37 2.98 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.154 -0.546 . . . . 0.0 113.003 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.6 m -142.37 138.78 16.81 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.923 0.361 . . . . 0.0 110.966 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.48 155.77 65.92 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.52 2.147 . . . . 0.0 112.322 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.6 mm -84.15 125.3 40.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.754 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.09 145.13 50.46 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.09 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.9 mt -85.31 120.64 35.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.852 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.3 -37.04 5.86 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.476 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -117.65 149.64 40.36 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.765 0.317 . . . . 0.0 111.198 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.2 mt -134.28 113.42 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.766 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -72.83 127.02 90.27 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.293 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.0 166.07 28.66 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.819 2.346 . . . . 0.0 112.789 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.21 23.45 74.77 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.71 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -131.82 172.77 6.79 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.01 -22.01 29.2 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.484 2.123 . . . . 0.0 113.206 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.32 -46.94 88.1 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -71.41 -38.03 71.46 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.671 0.272 . . . . 0.0 110.57 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -67.03 -27.72 67.64 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.015 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 7.5 t -70.28 -28.03 64.89 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.338 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.62 -60.52 3.69 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.737 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.48 -26.18 37.02 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 121.447 -0.406 . . . . 0.0 113.39 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.09 92.12 0.1 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.009 0.433 . . . . 0.0 110.502 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -119.19 157.65 27.54 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.294 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.0 m -63.77 138.86 22.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.49 46.14 7.02 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.739 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.99 127.82 55.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.416 0.15 . . . . 0.0 110.954 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -94.65 125.24 39.17 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.192 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.3 mt -80.14 136.85 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.461 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.24 -52.07 2.6 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.944 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.07 156.06 42.7 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.813 0.34 . . . . 0.0 111.55 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.2 t -138.51 115.76 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.761 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 55.28 42.49 30.3 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.063 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.42 2.01 62.34 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.307 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.6 t -97.27 122.59 48.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 117.149 0.474 . . . . 0.0 110.508 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -66.31 128.51 36.42 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tp -103.84 -17.07 15.19 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.789 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.6 ttm105 -61.17 -32.5 72.23 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -98.75 7.0 46.57 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -101.92 148.11 25.73 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.746 0.307 . . . . 0.0 110.97 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.79 161.08 23.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.605 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -54.12 -49.66 68.66 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.958 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -40.68 90.46 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.926 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -64.75 -38.69 91.83 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.19 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.98 79.06 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.272 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.1 t -61.7 -42.08 92.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.38 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -44.77 93.82 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.697 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.7 mt -63.84 -46.47 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.04 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.61 -41.33 73.32 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.112 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.94 -34.3 77.47 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.983 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -65.74 -24.82 67.04 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.422 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.406 ' HB3' HG12 ' A' ' 87' ' ' ILE . 32.5 mm-40 -63.38 103.98 0.57 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.769 0.319 . . . . 0.0 110.766 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -112.06 155.03 24.49 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.073 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.07 -103.23 0.68 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.39 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.61 130.97 44.6 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.706 0.289 . . . . 0.0 110.551 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.418 HG22 HD13 ' A' ' 87' ' ' ILE . 14.2 mt -126.19 122.48 61.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -93.91 122.87 36.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.444 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.88 134.17 55.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.991 0.424 . . . . 0.0 111.438 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -122.69 115.44 22.08 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.096 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.9 m -138.52 170.27 16.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.59 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.96 136.77 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.863 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.78 121.83 16.31 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.961 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.5 t -115.28 137.47 48.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.086 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.387 179.92 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo . . . . . 0 N--CA 1.49 1.301 0 CA-C-O 120.671 0.196 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 tt -83.29 141.31 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.379 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -122.45 132.82 54.53 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.122 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -103.48 111.96 24.65 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.501 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.7 t -118.22 138.13 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.815 0.341 . . . . 0.0 111.338 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.408 HD21 ' HG3' ' A' ' 86' ' ' GLU . 2.5 tt -108.34 127.54 53.96 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.855 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 tp -115.01 144.1 44.15 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.034 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mt -109.22 116.17 31.39 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.964 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.57 137.86 52.31 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.07 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -114.99 167.66 10.6 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.706 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.82 -38.21 72.28 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.192 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -84.07 -25.26 29.94 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.529 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -92.08 173.91 7.59 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.787 0.327 . . . . 0.0 111.498 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -132.83 -146.4 5.59 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.998 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 mt -82.79 -66.59 0.87 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.525 0.203 . . . . 0.0 111.168 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.16 4.52 35.54 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.694 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 pp -146.44 147.96 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 117.297 0.549 . . . . 0.0 111.114 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.1 t -101.85 137.84 39.61 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.727 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.2 pt -116.11 153.82 17.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.543 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.9 t -141.9 152.16 43.31 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.37 -152.55 19.82 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.496 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.57 119.74 0.49 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.934 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.91 -35.61 75.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.522 0.201 . . . . 0.0 111.328 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.39 -31.03 65.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.139 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -78.48 -27.52 46.26 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.138 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.76 26.53 5.54 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.807 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.1 m -141.1 133.29 14.02 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 116.787 0.293 . . . . 0.0 111.082 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.27 157.6 39.47 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.823 2.349 . . . . 0.0 112.157 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.5 mm -82.48 130.68 35.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.733 0.301 . . . . 0.0 110.44 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.7 mp -121.78 156.29 33.5 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.604 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.8 mm -88.05 124.83 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.1 m -117.73 -45.02 2.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.557 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.51 145.23 33.39 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.796 0.331 . . . . 0.0 111.254 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.6 mt -132.94 113.46 20.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.566 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -71.76 126.45 91.48 Favored Pre-proline 0 C--O 1.232 0.145 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.823 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.8 154.39 63.63 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.774 2.316 . . . . 0.0 112.624 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.38 32.95 80.66 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.774 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.96 175.19 3.81 Favored Pre-proline 0 C--O 1.233 0.213 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -51.13 -33.11 42.5 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.672 2.248 . . . . 0.0 112.774 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.03 -46.14 85.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.214 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.12 -38.75 72.31 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.837 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -61.62 -33.96 74.83 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.795 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.5 p -90.35 -27.36 19.43 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.598 0.221 . . . . 0.0 111.598 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.58 16.14 65.04 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.109 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.68 -28.7 5.87 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.403 -0.427 . . . . 0.0 112.73 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.5 mt -77.1 71.72 3.6 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.245 0.545 . . . . 0.0 110.497 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -86.1 157.41 20.05 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.278 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.1 t -66.42 137.95 23.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.065 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.25 36.58 9.72 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.543 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -100.29 150.1 22.92 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.55 121.08 37.63 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.619 0.247 . . . . 0.0 111.416 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mt -81.72 148.05 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.519 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 36.8 mt -131.44 -51.51 1.0 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.993 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.73 145.81 47.04 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.911 0.386 . . . . 0.0 111.759 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.74 115.67 40.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.294 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 57.4 34.24 24.39 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.656 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.05 -19.02 44.85 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.68 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.8 t -88.05 137.37 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 117.268 0.534 . . . . 0.0 111.078 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -71.26 132.81 45.48 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.265 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.6 tp -89.95 -29.36 18.54 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.183 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -18.93 65.41 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.775 -0.193 . . . . 0.0 111.394 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.14 9.22 34.45 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.4 t -133.77 165.69 24.39 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.559 0.219 . . . . 0.0 110.751 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.05 161.0 16.79 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.064 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -55.66 -51.4 67.36 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.181 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -61.38 -43.13 99.4 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.889 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.0 -38.26 88.03 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.917 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.79 -30.73 71.79 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.564 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.86 -45.02 99.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 120.789 0.328 . . . . 0.0 110.312 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.4 -40.14 96.4 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.595 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.5 mt -61.09 -41.73 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.884 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 69.4 mt -61.71 -39.23 90.77 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.783 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.6 m -64.39 -32.48 74.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.895 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -65.18 -29.25 70.06 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.243 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -65.43 106.33 1.37 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.759 0.314 . . . . 0.0 110.808 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.52 148.7 29.87 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.222 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.94 -100.95 0.43 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.618 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.408 ' HG3' HD21 ' A' ' 14' ' ' LEU . 9.2 tt0 -88.37 128.34 35.51 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.645 0.259 . . . . 0.0 110.436 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.413 HD13 HG23 ' A' ' 87' ' ' ILE . 19.0 mt -128.96 122.5 56.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.149 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -97.14 138.49 34.57 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.814 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -133.37 129.91 38.06 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.088 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -113.25 115.2 27.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.272 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.91 169.36 21.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.511 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.6 t -138.66 136.53 43.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.937 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.55 123.58 22.17 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.753 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.7 m -122.58 113.35 37.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.078 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.453 -179.715 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.489 1.217 0 CA-C-O 120.689 0.204 . . . . 0.0 111.834 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.7 mp -79.18 140.19 17.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.185 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.16 132.74 54.61 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.994 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.84 118.2 35.99 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.607 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.2 m -128.94 142.17 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.394 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 mt -105.45 122.55 46.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -109.79 139.66 44.59 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.953 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 49.9 mt -111.77 119.08 37.39 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.768 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.64 130.56 54.9 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.991 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.69 163.72 16.43 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.95 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.38 -38.57 71.64 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.185 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -86.39 -23.5 26.1 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.801 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -92.53 161.34 14.65 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.933 0.396 . . . . 0.0 111.232 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.87 -158.88 10.0 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.91 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.98 -67.43 0.54 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.575 0.226 . . . . 0.0 110.982 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.63 4.43 67.78 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.701 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 pt -136.77 143.73 34.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 117.459 0.63 . . . . 0.0 111.331 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.2 m -105.17 136.61 44.34 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.716 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.5 pt -121.98 155.7 26.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.483 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.8 p -139.35 173.88 11.09 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.368 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.74 -159.49 19.05 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.668 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.53 125.07 0.78 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.861 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -61.06 -37.79 83.91 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.455 0.169 . . . . 0.0 111.289 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.4 -31.22 72.33 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.206 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -78.38 -29.26 47.26 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.108 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.77 30.24 3.56 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.93 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.8 m -144.06 132.62 11.09 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-N 116.838 0.319 . . . . 0.0 111.108 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.14 157.33 40.2 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.614 2.209 . . . . 0.0 112.153 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.6 mm -83.75 127.99 39.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.632 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.1 149.97 51.58 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.407 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.5 mm -75.98 114.9 16.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.577 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.11 -45.9 12.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.382 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -145.04 161.51 39.24 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.861 0.362 . . . . 0.0 111.273 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.13 116.69 30.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.68 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -65.9 133.48 94.91 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.069 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.91 153.08 47.37 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.797 2.331 . . . . 0.0 112.756 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.57 31.5 62.88 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.676 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.441 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.2 OUTLIER -129.34 169.4 13.27 Favored Pre-proline 0 C--O 1.233 0.196 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 9.8 Cg_endo -53.92 -26.98 42.35 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.684 2.256 . . . . 0.0 112.721 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.431 ' HB3' ' CB ' ' A' ' 54' ' ' LEU . . . -57.37 -46.07 83.75 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.197 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.62 -38.63 73.95 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.862 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -56.83 -39.41 74.18 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.244 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.66 -27.76 64.28 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.755 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.79 19.96 75.51 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.678 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -119.8 -31.68 1.3 Allowed Glycine 0 C--N 1.338 0.681 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.17 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.431 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . 4.3 mm? -70.01 89.2 0.6 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.104 0.478 . . . . 0.0 110.413 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -111.08 157.54 19.87 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.339 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.7 t -63.19 140.05 20.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.291 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.15 52.92 8.24 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.871 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -112.19 139.02 48.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.22 0.208 . . . . 0.0 111.211 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.65 127.14 53.4 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.8 mt -91.54 148.08 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 120.852 0.358 . . . . 0.0 111.631 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 78.8 mt -133.33 -52.94 0.89 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.806 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.99 147.68 46.42 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.865 0.364 . . . . 0.0 111.385 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.32 115.66 16.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.409 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 57.99 33.36 23.1 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.214 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.76 -16.03 57.64 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.24 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.7 t -88.68 137.33 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 117.065 0.433 . . . . 0.0 110.912 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -76.5 135.58 39.34 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.305 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 tt -96.71 -26.71 15.07 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.406 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -18.1 63.15 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -97.52 11.78 35.67 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 t -133.48 150.69 51.72 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.752 0.311 . . . . 0.0 111.11 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -75.67 161.25 29.25 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.359 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -53.92 -52.03 61.88 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.104 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -61.84 -42.44 99.04 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.947 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -64.61 -38.54 91.36 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.102 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.59 -33.31 75.33 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.363 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 37.2 t -62.09 -43.7 98.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.76 0.314 . . . . 0.0 110.341 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 29.3 m -60.54 -43.6 97.03 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.602 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 64.7 mt -58.45 -42.72 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.623 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.25 -40.75 78.27 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.838 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.5 t -62.79 -36.26 82.54 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.773 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -65.35 -24.89 67.37 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.269 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.433 ' HB3' HG12 ' A' ' 87' ' ' ILE . 38.2 mm-40 -65.45 91.48 0.12 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.932 0.396 . . . . 0.0 110.755 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.37 149.61 24.6 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.984 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.46 -98.7 0.29 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.291 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -92.75 137.6 32.22 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.703 0.287 . . . . 0.0 110.524 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.433 HG12 ' HB3' ' A' ' 83' ' ' GLN . 15.0 mt -137.62 124.44 28.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -101.27 129.9 47.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.694 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.89 129.03 54.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.782 0.325 . . . . 0.0 110.786 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.72 116.3 25.66 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.017 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.0 m -138.85 171.6 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.985 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.18 132.16 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.722 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.66 127.46 33.04 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.724 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.5 t -114.84 135.33 55.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.364 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.44 -0.79 . . . . 0.0 111.11 179.802 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo . . . . . 0 N--CA 1.489 1.252 0 CA-C-O 120.685 0.202 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.3 mt -87.3 142.27 13.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.166 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -122.04 129.25 52.26 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.95 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.4 118.2 36.15 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.694 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.1 t -127.7 141.25 46.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.379 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.5 mt -102.54 128.13 49.32 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 tp -112.87 136.98 51.91 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.142 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.63 116.37 31.86 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.826 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.17 153.96 47.21 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.113 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.99 164.17 13.43 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.038 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -57.63 -38.53 75.14 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.966 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -79.33 -27.94 42.1 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.298 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.68 161.84 22.01 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.849 0.357 . . . . 0.0 111.324 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.32 -146.31 19.22 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.944 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.3 tp -87.64 -52.74 5.16 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.552 0.215 . . . . 0.0 111.319 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.12 -11.64 51.99 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.418 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.46 HD13 HG21 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -140.35 151.89 21.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.931 0.366 . . . . 0.0 111.041 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.51 136.71 47.66 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.029 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.8 pt -116.15 153.22 17.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.489 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.8 t -143.59 145.64 32.67 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.012 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.71 -170.07 15.95 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.497 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.92 122.5 0.82 Allowed Glycine 0 C--N 1.335 0.528 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.801 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -30.27 65.47 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -30.94 65.35 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.61 0.243 . . . . 0.0 111.069 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -79.45 -32.66 42.74 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.978 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.95 -29.9 3.02 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.669 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 11.6 m -101.86 132.83 21.18 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-O 120.707 0.289 . . . . 0.0 111.196 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 35.6 Cg_exo -61.09 157.21 40.44 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.799 2.333 . . . . 0.0 112.295 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -83.25 138.02 19.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.817 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.44 163.12 31.21 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.295 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.5 mt -85.28 120.19 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.262 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 t -108.43 -33.07 7.18 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.633 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.37 144.93 44.42 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.677 0.275 . . . . 0.0 111.126 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.3 mm -125.96 121.63 60.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.647 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -75.73 121.07 84.35 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.881 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.8 155.57 62.27 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.774 2.316 . . . . 0.0 112.545 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.93 38.24 95.8 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.354 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.77 176.06 3.17 Favored Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.33 -29.5 30.49 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.643 2.228 . . . . 0.0 112.77 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.16 -46.19 86.15 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.992 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.55 -42.11 75.01 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.763 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -59.73 -33.27 71.42 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.429 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.2 t -83.35 -28.19 29.16 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.85 16.66 59.64 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.091 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.88 -29.39 2.86 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.197 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.0 mt -76.09 71.84 2.87 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.142 0.496 . . . . 0.0 110.753 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -84.15 157.25 21.75 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.058 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.4 t -65.08 135.01 28.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.44 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.25 47.11 3.91 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.554 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.06 124.28 51.2 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.5 121.2 32.98 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.722 0.296 . . . . 0.0 111.194 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.5 mt -70.72 142.2 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.575 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.4 mt -127.29 -53.82 1.37 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.969 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.54 158.76 43.99 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.882 0.372 . . . . 0.0 111.813 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.4 HG21 HD13 ' A' ' 68' ' ' LEU . 15.1 t -133.66 117.52 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.727 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.08 37.47 28.64 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.95 0.405 . . . . 0.0 110.964 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.52 6.09 89.43 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.441 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.4 t -97.79 119.95 46.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 117.278 0.539 . . . . 0.0 110.699 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -63.83 126.79 28.75 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.4 HD13 HG21 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -113.02 4.19 16.57 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.686 179.817 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -68.84 -34.83 76.14 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.447 0.165 . . . . 0.0 111.133 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.67 11.9 33.54 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.423 HG22 ' CD1' ' A' ' 79' ' ' ILE . 15.8 m -100.97 156.39 17.42 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.645 0.259 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -92.62 161.22 14.66 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.535 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -54.47 -50.69 67.13 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.054 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.16 -39.5 90.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.788 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.56 -38.78 92.18 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.059 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.6 -32.79 74.37 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.362 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.8 t -61.85 -41.53 91.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.763 0.316 . . . . 0.0 110.56 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -41.89 74.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.899 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.423 ' CD1' HG22 ' A' ' 71' ' ' THR . 11.6 mt -62.74 -48.69 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.651 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.2 pp -62.36 -35.17 78.29 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.019 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.3 m -65.91 -33.88 76.85 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.136 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -65.26 -27.74 68.86 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.232 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -65.16 111.74 3.08 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.904 0.383 . . . . 0.0 111.119 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -105.19 143.79 32.88 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.109 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.77 -105.12 0.83 Allowed Glycine 0 C--N 1.337 0.59 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.894 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -81.2 127.16 32.37 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.723 0.297 . . . . 0.0 110.665 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.2 mt -127.95 122.39 58.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.05 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -93.87 130.77 39.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.438 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -126.25 129.75 49.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.764 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.03 115.17 29.29 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.308 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.5 m -135.62 164.03 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.352 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.1 m -129.45 133.54 65.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.838 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.09 117.24 8.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.879 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.6 m -123.76 118.31 53.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.108 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.354 -0.831 . . . . 0.0 111.391 -179.712 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo . . . . . 0 N--CA 1.489 1.246 0 CA-C-O 120.802 0.251 . . . . 0.0 111.84 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.39 118.71 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.213 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.78 130.04 55.38 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.043 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.56 120.24 40.84 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.2 t -125.67 134.25 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.176 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 mt -98.38 124.7 43.19 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.855 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.1 131.55 54.5 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.57 115.42 28.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.777 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.46 129.73 33.66 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.94 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.17 170.71 9.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.992 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -59.27 -38.17 79.44 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.953 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -76.75 -25.77 53.84 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.715 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -91.51 167.61 12.12 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.918 0.39 . . . . 0.0 111.74 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.88 -166.48 12.85 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 115.932 -0.577 . . . . 0.0 113.03 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.08 -68.33 0.38 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.517 0.199 . . . . 0.0 111.255 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.417 ' HA2' ' OE1' ' A' ' 46' ' ' GLN . . . 106.02 4.02 38.92 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.015 -0.612 . . . . 0.0 114.113 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.44 HG21 HD11 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -145.13 153.92 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 117.341 0.571 . . . . 0.0 111.101 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.2 136.97 38.38 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.654 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.2 pt -116.77 143.59 26.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.292 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.2 t -123.2 158.03 31.72 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.173 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.3 -143.19 15.7 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.357 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.43 134.85 3.35 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.935 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -52.54 -31.15 34.3 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -57.56 -29.4 64.39 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.18 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -93.82 19.48 8.82 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.45 29.09 68.48 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.166 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 8.7 m -147.08 139.64 14.23 Favored Pre-proline 0 CA--C 1.529 0.163 0 CA-C-N 116.704 0.252 . . . . 0.0 111.402 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 29.7 Cg_exo -61.59 155.5 52.96 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.637 2.225 . . . . 0.0 112.229 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.84 139.11 17.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.865 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 mp -134.67 156.75 48.21 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.261 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.8 mt -87.6 129.55 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.19 -42.83 2.45 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.558 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.57 144.84 35.72 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.71 0.291 . . . . 0.0 111.159 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.0 mt -134.47 133.14 55.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.754 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -102.21 105.65 43.98 Favored Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.885 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.82 150.03 47.64 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.716 2.277 . . . . 0.0 112.545 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.13 -30.81 8.8 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.661 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.417 ' OE1' ' HA2' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -77.23 167.16 38.85 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-O 120.552 0.215 . . . . 0.0 110.754 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.89 -29.01 80.15 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.68 2.253 . . . . 0.0 112.77 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.06 -46.07 92.17 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.784 0.326 . . . . 0.0 110.983 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -70.16 -39.48 75.31 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.744 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -61.69 -29.09 69.87 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.408 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.06 -28.31 63.25 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.34 -54.57 4.77 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.014 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.53 -34.57 27.63 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 121.542 -0.361 . . . . 0.0 113.509 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.418 ' CD2' HG23 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -71.17 93.71 1.09 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.112 0.482 . . . . 0.0 110.602 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -114.4 157.43 22.88 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.36 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.25 130.46 25.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.445 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.49 45.03 4.14 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.435 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.03 122.35 47.51 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 122.149 0.18 . . . . 0.0 110.739 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.14 122.66 33.96 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.639 0.257 . . . . 0.0 111.16 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.9 mt -76.72 145.79 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.412 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 mt -139.68 -51.48 0.51 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.123 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.47 146.02 50.27 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.972 0.415 . . . . 0.0 111.878 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.7 t -135.82 115.73 17.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.367 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 54.6 35.34 23.38 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.696 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.64 -18.68 45.21 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 120.993 -0.623 . . . . 0.0 113.713 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.21 128.03 48.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 117.315 0.557 . . . . 0.0 111.052 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -68.06 139.12 56.25 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.044 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.4 tp -108.85 13.2 25.03 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.382 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.2 ttp85 -71.18 -31.59 67.85 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.444 0.164 . . . . 0.0 111.433 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -102.3 10.83 38.91 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.73 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -108.04 132.71 53.26 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -64.59 158.52 24.07 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.149 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -56.66 -50.41 72.15 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.236 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -61.71 -39.32 91.07 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.516 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -64.71 -38.0 89.51 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.84 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.92 -35.37 80.44 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.477 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.0 t -61.95 -39.05 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.639 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 41.2 m -65.05 -48.64 73.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.641 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.8 mt -62.22 -42.65 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.796 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.16 -39.71 75.81 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.853 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -33.06 74.85 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.982 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -65.55 -27.89 68.76 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.325 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -61.13 114.07 2.92 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.77 0.319 . . . . 0.0 110.956 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.84 144.82 47.14 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.448 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.56 -104.78 1.13 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.513 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -88.01 122.1 31.2 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.753 0.311 . . . . 0.0 110.358 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.45 HD13 HG23 ' A' ' 87' ' ' ILE . 15.5 mt -122.02 125.61 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.968 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.79 127.89 39.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -121.94 129.9 52.89 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.094 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -120.56 115.35 23.24 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.349 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.0 m -140.84 170.1 14.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.435 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 25.1 t -132.55 139.55 49.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.875 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.09 120.2 12.75 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.839 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.03 107.71 17.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.213 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.911 -179.855 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo . . . . . 0 N--CA 1.49 1.302 0 CA-C-O 120.643 0.185 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.9 mp -97.59 139.84 19.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.351 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -110.65 115.79 30.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.026 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -97.27 111.59 23.77 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.593 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.7 t -129.95 133.21 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.795 0.331 . . . . 0.0 111.326 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mt -100.97 134.98 43.15 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mp -118.67 119.86 35.7 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.834 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.23 124.25 51.83 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.755 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.04 147.14 45.99 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.291 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -100.37 169.3 9.2 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.161 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.39 -37.98 82.48 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.947 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -72.77 -28.8 62.82 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.048 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -84.96 177.32 7.99 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.779 0.323 . . . . 0.0 111.144 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -125.05 -154.82 8.89 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.111 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.6 mt -71.51 -67.85 0.49 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.6 0.238 . . . . 0.0 111.153 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.7 4.38 63.74 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.059 -0.591 . . . . 0.0 113.71 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.5 pp -143.49 150.39 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 117.284 0.542 . . . . 0.0 111.252 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 1.1 m -121.62 136.93 54.93 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.733 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.5 pt -123.76 158.27 29.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.489 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -142.59 147.5 35.97 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.088 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.41 -159.59 21.41 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.45 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.23 120.43 0.52 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.613 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -55.22 -34.54 64.03 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.469 0.176 . . . . 0.0 111.354 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -31.23 65.6 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.082 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -77.5 -30.0 52.8 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.055 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.72 -29.96 3.04 Favored Glycine 0 C--N 1.335 0.472 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.888 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 11.5 m -109.48 138.15 20.49 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-O 120.708 0.289 . . . . 0.0 111.402 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 35.8 Cg_exo -61.11 157.17 40.77 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.761 2.308 . . . . 0.0 112.239 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mp -82.36 136.98 21.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.832 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 pp -133.25 162.92 30.49 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.938 0.399 . . . . 0.0 111.672 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.4 mt -85.09 129.38 37.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.981 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.9 m -117.13 -38.98 3.27 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.626 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 18.9 tt0 -114.37 145.96 41.16 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.938 0.399 . . . . 0.0 111.412 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.4 mt -131.03 133.49 62.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.513 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -88.75 112.85 53.03 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.026 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.53 139.31 75.39 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.798 2.332 . . . . 0.0 112.401 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.53 -30.14 8.72 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.902 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.472 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -71.17 169.77 13.92 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.638 0.219 . . . . 0.0 110.921 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.472 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 7.1 Cg_endo -50.48 -30.52 27.84 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.753 2.302 . . . . 0.0 112.791 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.13 -46.01 92.33 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.711 0.291 . . . . 0.0 111.004 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.07 -38.94 75.89 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.776 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -58.1 -33.3 68.95 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.488 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.45 -28.01 64.69 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.575 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.84 15.76 60.56 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.859 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.81 -34.94 1.1 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.786 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.92 99.6 0.17 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.928 0.394 . . . . 0.0 110.513 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.426 ' CE1' ' CD2' ' A' ' 93' ' ' TYR . 11.4 p80 -110.43 156.69 20.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.014 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.3 t -63.86 132.58 29.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.74 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.94 46.89 2.56 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.635 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' CG ' HG21 ' A' ' 91' ' ' VAL . 1.3 m-20 -112.59 118.97 36.55 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.96 123.49 34.49 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.928 0.394 . . . . 0.0 111.428 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.0 mt -76.51 134.12 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.785 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.4 mp -126.55 -49.78 1.51 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.565 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.76 145.54 48.52 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.323 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.3 t -139.47 116.59 10.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.543 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 57.95 33.75 23.54 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.999 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.55 -15.4 54.76 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.352 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.8 128.8 41.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 117.151 0.475 . . . . 0.0 110.789 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -80.86 141.23 34.82 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.733 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 mp -117.04 21.07 13.48 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.634 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.42 -34.07 70.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.385 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -103.73 8.49 37.29 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 50.9 p -96.06 179.98 4.88 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.655 0.264 . . . . 0.0 110.831 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.17 161.21 18.08 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.964 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -54.05 -51.01 65.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.973 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -60.57 -42.08 95.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.652 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.24 -37.98 89.38 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.957 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.59 -38.03 89.58 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.249 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.85 -44.41 98.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.702 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.7 m -62.51 -45.28 93.7 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.8 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.8 mt -61.82 -40.55 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.918 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.9 mt -58.14 -39.01 77.67 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.661 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.6 t -67.58 -32.97 74.08 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.005 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -64.91 -28.64 69.67 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.307 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -64.08 110.53 2.19 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.747 0.308 . . . . 0.0 110.957 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -111.63 147.39 35.59 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.122 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.91 -108.12 1.99 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.508 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -82.14 124.8 30.19 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.712 0.291 . . . . 0.0 110.535 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.9 mt -124.76 122.32 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.975 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -94.06 129.77 40.46 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.891 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.12 129.78 51.44 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.267 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -123.58 115.19 21.09 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.022 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.411 HG21 ' CG ' ' A' ' 58' ' ' ASP . 16.5 m -138.67 170.6 16.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.222 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.9 m -132.9 138.82 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.808 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.426 ' CD2' ' CE1' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -67.17 116.02 7.5 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.733 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.8 p -101.68 133.8 44.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.184 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.24 -179.872 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 N--CA 1.49 1.309 0 CA-C-O 120.784 0.243 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.9 mp -96.84 143.47 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.136 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.96 145.88 48.87 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.19 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.1 mmtm -114.72 111.47 21.33 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.827 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.1 t -112.85 131.23 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.037 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mp -102.82 126.46 49.97 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 tt -117.58 141.32 48.51 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.224 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.41 127.11 54.13 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.794 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -104.34 121.61 43.72 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.138 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -100.46 156.64 17.16 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.993 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -58.29 -38.29 76.72 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.177 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -86.14 -22.07 27.25 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.32 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -90.03 176.63 6.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.815 0.34 . . . . 0.0 111.282 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.02 -145.37 4.66 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.835 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.8 tp -77.36 -63.16 1.44 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.535 0.207 . . . . 0.0 110.939 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.74 4.52 87.31 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.035 -0.602 . . . . 0.0 114.037 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.1 pt -139.85 164.16 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 117.348 0.574 . . . . 0.0 111.369 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.0 t -121.51 137.33 54.77 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.917 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.4 pt -115.83 152.1 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.632 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.3 p -137.85 153.41 49.6 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.085 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.9 -169.47 13.3 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.84 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.44 119.27 0.52 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.69 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.7 -29.63 68.23 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -31.33 69.2 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.668 0.27 . . . . 0.0 111.117 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -87.69 -28.09 22.02 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.154 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.28 35.67 1.43 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.695 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.3 p -149.35 134.51 9.51 Favored Pre-proline 0 C--O 1.232 0.176 0 CA-C-O 120.652 0.263 . . . . 0.0 110.963 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.82 157.72 57.52 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.582 2.188 . . . . 0.0 112.107 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.5 mm -82.75 131.07 34.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mp -132.91 155.04 49.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.445 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.5 mm -80.56 120.13 31.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.852 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.39 -38.2 5.78 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.387 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.49 145.87 49.29 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.774 0.321 . . . . 0.0 111.214 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.8 mt -135.19 114.33 16.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.55 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -71.95 132.87 84.41 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.095 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.82 159.35 45.38 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.819 2.346 . . . . 0.0 112.891 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.14 50.47 66.85 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.482 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.33 175.19 2.87 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 110.59 -0.152 . . . . 0.0 110.59 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -49.84 -34.6 36.98 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.783 2.322 . . . . 0.0 112.966 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.57 -46.14 89.78 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.783 0.325 . . . . 0.0 110.755 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -69.78 -37.44 76.36 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.796 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -57.8 -32.78 67.88 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.416 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.4 m -82.99 -28.14 29.91 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.521 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.61 14.5 60.41 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.991 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.98 -33.58 2.77 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.311 -0.471 . . . . 0.0 112.751 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.37 100.82 0.87 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.984 0.421 . . . . 0.0 110.504 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -113.3 157.14 22.19 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.125 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.3 t -63.95 132.94 29.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.314 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.54 49.32 4.18 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.277 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -109.35 126.6 53.58 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.69 120.99 32.93 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.4 mt -81.06 149.17 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.469 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.9 mt -134.83 -54.9 0.82 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.014 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -148.67 159.84 43.73 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.826 0.346 . . . . 0.0 111.689 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.5 t -137.19 120.35 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.674 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 56.15 36.36 27.29 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.918 0.39 . . . . 0.0 111.138 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.67 13.63 83.33 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.226 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.6 t -98.71 134.88 35.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 117.009 0.404 . . . . 0.0 110.672 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -72.08 126.86 30.82 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.012 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tt -112.15 -17.89 12.69 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.34 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -32.6 72.55 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -98.95 11.91 37.51 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m -110.02 161.66 15.31 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.815 0.34 . . . . 0.0 111.03 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.9 mmtm -95.7 161.3 14.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.24 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -54.12 -51.54 63.9 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.017 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -62.99 -41.2 99.51 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.829 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.02 -38.11 89.84 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.011 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.79 -30.83 71.88 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.385 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.414 ' O ' ' HG ' ' A' ' 80' ' ' LEU . 24.5 t -61.7 -41.82 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.923 0.392 . . . . 0.0 110.624 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.1 m -69.96 -37.94 75.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.101 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.2 mt -67.28 -47.19 82.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.384 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 77' ' ' VAL . 3.8 pp -63.91 -34.04 77.07 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.314 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.2 p -73.28 -27.43 61.56 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.85 -0.159 . . . . 0.0 111.221 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -65.25 -28.16 69.16 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.52 0.2 . . . . 0.0 111.348 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -58.67 113.7 2.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.757 0.313 . . . . 0.0 110.902 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.55 146.29 28.35 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.369 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.89 -99.92 0.4 Allowed Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.618 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -92.28 135.8 33.71 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.761 0.315 . . . . 0.0 110.386 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.3 mt -128.36 122.08 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.063 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.37 121.28 40.11 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.513 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -114.54 129.47 56.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 110.895 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -110.1 115.78 30.37 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.154 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.4 m -137.22 168.79 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.79 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.4 t -134.12 132.41 55.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.656 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.28 118.52 10.77 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.741 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.1 p -118.2 135.57 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.084 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.13 -0.938 . . . . 0.0 111.34 -179.694 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo . . . . . 0 N--CA 1.489 1.247 0 CA-C-O 120.55 0.146 . . . . 0.0 111.726 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 tt -78.66 121.81 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.922 0.391 . . . . 0.0 111.247 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.08 135.56 54.08 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.096 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.27 111.5 21.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.638 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.94 142.33 42.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.952 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.81 135.5 39.48 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.975 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.1 tp -108.84 121.91 46.08 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.088 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.21 115.09 29.7 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.671 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -127.52 147.19 50.32 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.111 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.61 161.86 14.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.026 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -56.85 -38.8 73.19 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -80.18 -28.31 38.76 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.462 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -84.56 165.56 17.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.993 0.425 . . . . 0.0 111.606 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -112.06 -169.73 18.3 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.709 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 tp -67.93 -57.38 6.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.446 0.165 . . . . 0.0 111.342 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.54 4.55 63.9 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.767 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 pt -144.98 154.98 14.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 117.364 0.582 . . . . 0.0 111.348 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.4 m -113.62 138.14 50.6 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.0 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.0 pt -115.92 154.73 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.601 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.0 p -137.63 163.34 31.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.32 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.82 -150.56 19.35 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.778 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.424 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . 153.51 124.47 0.99 Allowed Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.009 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.68 -31.5 57.88 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.1 0.16 . . . . 0.0 111.409 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -57.26 -31.23 65.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.151 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -84.5 -21.36 30.61 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.422 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.05 19.5 5.93 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.993 -0.623 . . . . 0.0 113.284 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 m -147.08 139.65 14.24 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.93 0.365 . . . . 0.0 111.076 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.8 157.39 38.21 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.522 2.148 . . . . 0.0 112.032 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 mp -82.71 126.06 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.676 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 mp -122.54 162.53 21.61 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.908 0.385 . . . . 0.0 111.6 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.3 mt -94.4 125.67 46.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.797 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.4 m -109.63 -34.6 6.44 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.709 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -123.0 146.79 47.32 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.742 0.306 . . . . 0.0 111.391 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.3 mp -134.21 112.26 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.578 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -71.6 129.88 88.0 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.144 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -74.4 155.72 45.85 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.772 2.315 . . . . 0.0 112.618 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.61 33.33 52.41 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.734 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.92 174.49 4.37 Favored Pre-proline 0 CA--C 1.53 0.205 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.58 -32.14 34.19 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.588 2.192 . . . . 0.0 112.771 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.414 ' HB1' ' CB ' ' A' ' 54' ' ' LEU . . . -61.0 -46.06 92.32 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.164 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.49 -43.86 72.31 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.986 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -58.59 -32.74 69.25 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.496 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -77.07 -27.96 54.46 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.464 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.16 17.78 68.41 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.025 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.8 -29.99 2.28 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 121.11 -0.567 . . . . 0.0 113.171 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.414 ' CB ' ' HB1' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -64.69 96.87 0.19 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.861 0.362 . . . . 0.0 110.823 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -115.8 157.23 24.7 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.252 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.2 t -66.4 131.4 32.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.665 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.04 43.54 3.79 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.931 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.43 119.19 37.38 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.499 0.15 . . . . 0.0 110.794 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -92.06 123.07 35.14 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.644 0.259 . . . . 0.0 111.509 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.8 mt -72.59 137.64 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.214 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.2 mt -125.32 -52.73 1.62 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.775 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.56 145.53 45.1 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.821 0.343 . . . . 0.0 111.475 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.97 116.14 32.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.393 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 58.83 34.6 23.8 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.051 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.65 -15.95 52.37 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.386 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.5 t -88.15 134.6 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 117.146 0.473 . . . . 0.0 110.778 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -71.28 131.53 43.6 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.196 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 tp -117.49 1.58 12.33 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.828 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -71.37 -28.1 63.81 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.24 8.18 45.02 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 p -105.3 146.54 29.22 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.751 0.31 . . . . 0.0 111.088 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -71.82 161.19 31.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.113 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.424 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . 46.2 t-80 -54.01 -50.56 66.34 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.933 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.68 -42.98 94.12 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.894 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -67.21 -37.59 83.87 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.841 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.86 -31.32 72.46 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.473 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.3 t -61.83 -40.8 88.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.862 0.363 . . . . 0.0 110.358 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.9 m -65.72 -40.54 92.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.518 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.1 mm -58.13 -43.52 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.643 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.0 mt -60.57 -43.9 96.8 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.671 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.4 t -65.84 -31.54 72.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.091 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -65.15 -28.29 69.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.15 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -62.65 135.23 57.28 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.793 0.33 . . . . 0.0 111.006 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.23 144.25 48.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.175 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.06 -104.55 0.35 Allowed Glycine 0 C--N 1.335 0.52 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.634 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -82.29 118.2 22.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.853 0.358 . . . . 0.0 110.396 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.6 mt -119.32 123.77 71.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.893 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.63 121.38 35.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.52 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -113.11 129.62 56.45 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.119 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.0 115.19 22.07 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.805 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.2 170.73 15.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.4 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.33 133.52 62.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.835 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.42 115.86 10.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.715 0.293 . . . . 0.0 110.705 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.7 p -126.57 122.65 61.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.952 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.4 -0.81 . . . . 0.0 111.408 -179.536 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo . . . . . 0 N--CA 1.49 1.297 0 CA-C-O 120.725 0.219 . . . . 0.0 111.924 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.6 tt -78.97 134.79 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.327 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.9 126.33 51.55 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.034 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.3 mmtm -99.75 114.62 27.87 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.571 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.24 128.91 67.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.789 0.328 . . . . 0.0 111.34 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 mp -98.37 119.92 37.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.846 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.13 137.98 50.64 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.262 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.65 115.38 27.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.772 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.8 143.78 37.52 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.707 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -114.54 158.56 21.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.182 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.72 -38.35 78.15 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.807 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -77.6 -28.29 51.51 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.423 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -90.02 159.23 16.96 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.903 0.382 . . . . 0.0 111.223 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.35 -165.82 21.97 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.373 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.56 -44.9 85.31 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.673 0.273 . . . . 0.0 110.834 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.22 3.29 90.25 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.335 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.2 pp -146.74 147.11 18.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 117.033 0.416 . . . . 0.0 110.897 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 3.5 m -108.53 139.78 42.81 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.536 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.2 pt -116.2 156.01 17.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.719 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.5 t -143.96 155.98 44.24 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.33 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.05 -150.1 18.31 Favored Glycine 0 C--N 1.337 0.605 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.393 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.42 109.27 0.22 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.939 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -57.64 -37.28 73.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.586 0.231 . . . . 0.0 111.135 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -58.73 -31.17 68.05 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.949 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -75.86 -24.51 55.75 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.217 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.68 25.4 4.29 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.074 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 m -147.48 140.3 14.69 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.884 0.342 . . . . 0.0 111.244 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.58 157.42 60.78 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.603 2.202 . . . . 0.0 112.285 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 26.1 mm -82.76 137.9 20.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.757 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 mp -131.82 158.69 40.61 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.594 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.7 mm -83.55 128.64 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.756 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.1 t -124.14 -44.27 2.04 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.538 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 0.5 OUTLIER -105.38 144.47 32.12 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.758 0.313 . . . . 0.0 111.172 -179.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.1 mt -131.47 128.98 61.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.747 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -86.27 114.81 59.4 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.955 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.16 122.11 8.7 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.533 2.155 . . . . 0.0 112.149 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.54 34.85 4.86 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.597 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.97 174.2 4.79 Favored Pre-proline 0 C--O 1.233 0.231 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.41 -32.2 33.16 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.521 2.147 . . . . 0.0 112.76 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.83 -46.19 90.03 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.271 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.85 -40.39 79.42 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.703 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -60.03 -33.44 72.02 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.466 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.6 t -71.65 -28.11 63.53 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.52 15.78 62.13 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.188 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.25 -32.53 1.36 Allowed Glycine 0 C--N 1.338 0.667 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.106 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.79 94.36 0.3 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.981 0.419 . . . . 0.0 110.682 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -108.87 157.24 18.8 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.97 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.8 t -67.2 133.31 31.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.375 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.18 45.83 3.73 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.535 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.13 124.09 51.68 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 122.22 0.208 . . . . 0.0 110.595 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.4 120.25 32.09 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.728 0.299 . . . . 0.0 111.177 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 20.5 mt -75.24 139.93 18.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.556 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.0 mt -128.11 -51.93 1.31 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.703 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -144.54 145.86 32.06 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.854 0.359 . . . . 0.0 111.637 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.0 t -132.83 115.79 25.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.401 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 56.71 38.04 29.24 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.602 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.19 -12.85 42.24 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.449 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.14 128.05 39.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 117.371 0.586 . . . . 0.0 110.83 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.69 130.62 39.84 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.169 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.48 -23.03 13.95 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.641 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -61.4 -31.07 70.98 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.348 0.129 . . . . 0.0 111.348 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.03 9.74 38.33 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.2 p -120.1 159.87 23.97 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.617 0.246 . . . . 0.0 110.653 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.1 161.02 19.1 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.785 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -53.95 -47.6 71.13 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.972 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -60.99 -43.04 99.43 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.73 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -64.5 -39.28 93.49 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.975 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.58 -34.24 77.37 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.57 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.3 t -62.17 -43.28 97.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.834 0.349 . . . . 0.0 110.441 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.0 m -67.41 -45.72 75.32 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.948 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.9 mt -60.91 -44.21 97.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.938 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.42 -37.83 79.05 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.678 0.275 . . . . 0.0 110.714 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.7 m -68.65 -28.35 66.81 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.453 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -64.88 -30.85 71.87 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.498 0.19 . . . . 0.0 111.051 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -66.05 114.47 5.23 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.817 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -114.47 151.87 32.55 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.11 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.72 -102.12 0.42 Allowed Glycine 0 C--N 1.335 0.48 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.556 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -87.98 122.39 31.53 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.654 0.264 . . . . 0.0 110.378 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.5 mt -124.73 125.78 70.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.052 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -93.65 123.37 36.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.336 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.53 130.2 56.27 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.928 0.394 . . . . 0.0 111.517 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -121.18 115.17 22.53 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.572 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.5 m -137.28 170.94 17.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.351 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.7 t -129.07 133.64 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.69 123.66 20.32 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.875 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.0 t -118.71 132.79 67.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.957 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.163 -0.923 . . . . 0.0 111.22 179.93 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 N--CA 1.491 1.34 0 CA-C-O 120.93 0.304 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.6 mp -86.06 141.17 14.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -120.82 122.03 39.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -100.21 113.51 26.23 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.773 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.2 m -128.27 140.42 49.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.458 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.1 mp -107.47 126.86 53.03 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.895 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 mp -113.08 137.32 51.6 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.097 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -104.32 114.75 29.19 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.8 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -99.78 134.26 42.94 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.994 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -115.94 151.55 35.17 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.869 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.14 -33.89 72.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.634 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -81.6 -27.4 34.24 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.783 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -96.55 166.53 11.64 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.883 0.373 . . . . 0.0 111.451 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -105.47 -150.51 19.43 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.091 -0.575 . . . . 0.0 112.679 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.6 tp -78.5 -58.96 2.98 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.689 0.281 . . . . 0.0 110.96 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.77 4.35 75.85 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.687 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.5 pt -140.61 143.46 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 117.259 0.529 . . . . 0.0 111.126 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 t -112.03 136.79 50.93 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.812 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.8 pt -125.29 153.86 33.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.597 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.8 p -139.18 145.35 39.23 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.224 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.18 -155.83 16.85 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.694 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.1 126.02 1.56 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.49 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.7 tptt -54.6 -35.64 63.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.393 0.14 . . . . 0.0 111.136 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.445 ' HG3' ' HG2' ' A' ' 72' ' ' LYS . 0.5 OUTLIER -62.77 -30.62 71.59 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.198 179.653 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -79.31 -34.7 42.12 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.106 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.23 -21.6 3.86 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.865 -0.684 . . . . 0.0 113.292 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.414 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 23.8 m -123.03 144.31 42.88 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 117.006 0.403 . . . . 0.0 111.201 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 34.8 Cg_exo -60.87 155.97 46.38 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.749 2.3 . . . . 0.0 112.442 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.2 mt -84.0 130.66 35.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.851 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.24 156.52 46.34 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.027 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.1 mt -81.08 121.87 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.902 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.4 m -106.2 -29.74 9.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.682 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.95 149.64 48.98 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.711 0.291 . . . . 0.0 111.357 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.4 mp -133.98 114.22 19.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.664 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -72.09 131.4 85.4 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.233 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.37 172.42 16.27 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.961 2.441 . . . . 0.0 112.903 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.62 18.52 61.56 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.784 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.454 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -124.97 169.28 11.34 Favored Pre-proline 0 N--CA 1.455 -0.184 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.454 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 9.8 Cg_endo -52.55 -29.1 39.15 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.62 2.214 . . . . 0.0 112.57 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.09 -46.46 87.29 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.317 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -65.32 -40.24 93.48 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.871 0.367 . . . . 0.0 110.605 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.69 -28.47 65.88 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.319 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 11.5 m -70.37 -28.24 64.95 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.42 -55.31 4.64 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.889 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.03 -27.84 31.34 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 121.474 -0.393 . . . . 0.0 113.609 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -68.14 88.86 0.3 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.003 0.401 . . . . 0.0 110.52 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -118.43 157.24 27.58 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.219 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.7 t -63.28 130.06 27.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.63 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.05 46.37 3.63 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.466 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.01 125.73 51.4 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.475 0.178 . . . . 0.0 110.544 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.25 121.61 33.15 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.769 0.319 . . . . 0.0 111.366 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 21.9 mt -78.21 130.78 35.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.268 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.1 mt -124.27 -51.97 1.75 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.643 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -145.06 148.89 34.18 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.859 0.361 . . . . 0.0 111.448 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 t -136.98 115.75 14.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.424 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 58.35 33.14 22.86 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.097 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.93 -15.24 58.31 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.181 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.07 133.77 29.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 117.143 0.471 . . . . 0.0 110.891 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -79.17 129.67 34.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.96 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.8 -21.36 13.19 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.645 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.6 ttt85 -60.95 -34.58 74.96 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.662 0.267 . . . . 0.0 110.902 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -84.25 -26.14 28.87 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.656 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.2 p -78.53 167.28 21.51 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.889 0.376 . . . . 0.0 111.011 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.445 ' HG2' ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -93.87 161.03 14.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.645 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -54.26 -47.52 72.19 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.892 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -64.76 -40.42 95.25 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.096 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.93 -37.67 86.65 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.913 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.71 -30.88 71.93 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.328 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.5 t -61.4 -43.43 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.847 0.356 . . . . 0.0 110.554 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.6 m -65.76 -44.69 85.1 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.706 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.3 mt -63.78 -44.04 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.0 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.6 mt -56.4 -42.96 78.83 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.756 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.9 t -68.24 -31.2 70.53 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.038 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -65.13 -24.17 67.34 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.571 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 41.7 mm-40 -62.97 97.86 0.12 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.808 0.337 . . . . 0.0 110.891 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.61 146.67 26.19 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.261 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.82 -106.37 1.47 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.555 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -87.74 143.1 27.33 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.73 0.3 . . . . 0.0 110.495 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.424 HD12 HG21 ' A' ' 87' ' ' ILE . 11.6 mt -136.95 122.33 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.033 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -96.64 124.35 40.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.613 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -112.58 129.61 56.31 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.791 0.329 . . . . 0.0 111.139 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -118.89 115.31 24.13 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.23 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.7 m -143.93 169.24 10.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.499 -179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.1 m -134.33 138.37 50.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.055 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.0 123.67 21.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.903 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.2 m -114.45 143.82 23.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.402 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.039 -0.981 . . . . 0.0 111.545 -179.884 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo . . . . . 0 N--CA 1.49 1.319 0 CA-C-O 120.814 0.256 . . . . 0.0 111.822 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 73.1 mt -80.27 142.98 13.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.55 138.63 51.78 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.08 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.405 ' HD2' ' HG3' ' A' ' 90' ' ' GLU . 1.1 mptm? -115.33 117.43 30.42 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.4 t -132.67 141.01 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.143 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.83 132.5 43.38 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.978 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.07 119.44 37.87 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.749 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.0 mp -110.3 114.25 27.56 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.343 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.0 ptmm? -128.15 146.1 50.81 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.265 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.438 ' HB2' ' HG3' ' A' ' 21' ' ' GLU . 0.4 OUTLIER -75.95 165.23 25.28 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.117 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.07 -36.28 70.37 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.846 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -79.91 -29.81 39.93 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.411 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.438 ' HG3' ' HB2' ' A' ' 18' ' ' GLU . 7.0 mt-10 -70.61 167.57 18.26 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.924 0.393 . . . . 0.0 111.943 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.28 -157.72 10.05 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.293 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.48 -62.52 1.69 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.94 -14.72 28.89 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.608 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.2 pt -143.74 164.1 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 117.186 0.493 . . . . 0.0 111.379 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.9 t -106.93 136.7 46.33 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.697 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.2 pt -118.69 153.11 20.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.241 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -143.2 144.63 32.25 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.248 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.19 -165.98 29.44 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.429 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.84 112.29 0.31 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.794 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -58.21 -37.94 75.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.453 0.168 . . . . 0.0 111.289 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -65.47 -30.96 71.81 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.011 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -73.35 -28.62 62.16 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.07 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.37 22.41 6.14 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.069 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.1 p -149.69 130.95 7.29 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.873 0.337 . . . . 0.0 111.044 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.34 155.61 50.98 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.612 2.208 . . . . 0.0 112.231 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mp -83.04 133.9 28.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.774 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.51 159.65 38.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.485 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.452 HD12 ' CB ' ' A' ' 58' ' ' ASP . 23.1 mt -80.17 122.82 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.993 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.7 -30.46 8.56 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.709 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -130.69 155.5 46.51 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.858 0.361 . . . . 0.0 111.513 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.4 mt -130.36 114.09 27.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.739 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -81.59 128.38 69.65 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.914 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.29 159.89 42.99 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.706 2.271 . . . . 0.0 112.799 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.12 33.07 57.66 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.809 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.97 170.8 8.66 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.43 -30.73 54.69 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.647 2.232 . . . . 0.0 112.953 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.81 -46.14 81.79 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.729 0.3 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -70.52 -41.25 72.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.794 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -64.59 -28.72 69.82 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.566 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -28.36 64.09 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.486 0.184 . . . . 0.0 111.473 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.41 16.85 51.35 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.054 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.06 -31.63 1.08 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.071 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.68 92.8 0.49 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.827 0.346 . . . . 0.0 110.592 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -98.82 156.86 16.65 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.247 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.8 t -64.2 135.43 27.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.564 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.57 50.57 3.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.127 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.452 ' CB ' HD12 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -111.3 124.56 52.47 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.491 0.186 . . . . 0.0 110.624 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.1 120.44 32.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.901 0.382 . . . . 0.0 111.103 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.2 mt -73.71 144.67 12.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.908 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.7 mt -129.45 -53.49 1.17 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.57 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.26 145.94 33.18 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.976 0.417 . . . . 0.0 111.829 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.1 t -130.87 116.77 35.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.511 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 56.77 36.45 27.71 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.675 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.8 -16.35 46.99 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.507 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.37 135.14 25.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 117.229 0.515 . . . . 0.0 111.179 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -78.67 131.25 36.57 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.084 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.01 -27.89 20.55 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.979 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -67.3 -27.17 66.94 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.393 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -91.5 11.77 22.97 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 t -138.79 174.33 10.64 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.637 0.256 . . . . 0.0 110.812 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.43 160.97 14.12 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.047 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -56.11 -51.72 66.89 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.182 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.64 -43.12 84.65 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.964 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -67.2 -37.78 84.22 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.854 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.87 -33.72 76.34 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.363 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -61.72 -39.18 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.837 0.351 . . . . 0.0 110.504 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 49.9 m -65.37 -44.65 86.94 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.493 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.8 mt -61.73 -41.37 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.919 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.7 mt -60.44 -39.69 88.41 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.627 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.5 t -66.22 -30.92 71.46 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.185 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -65.24 -28.92 69.69 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.333 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -68.31 111.64 4.72 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.873 0.368 . . . . 0.0 110.844 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.55 148.86 26.8 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.332 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.68 -102.18 0.42 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.581 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -90.09 132.03 35.64 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.908 0.385 . . . . 0.0 110.508 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 12.4 mt -129.9 133.22 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.07 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.71 122.36 36.09 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.715 0.293 . . . . 0.0 110.705 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.91 130.61 55.82 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.526 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.405 ' HG3' ' HD2' ' A' ' 12' ' ' LYS . 8.2 tt0 -122.18 115.56 22.62 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.581 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.2 m -136.64 170.57 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.479 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.3 t -133.94 143.66 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.308 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.2 126.04 28.56 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.967 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.6 118.79 59.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.015 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.208 179.957 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.49 1.271 0 CA-C-O 120.71 0.212 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.1 tt -89.59 124.93 42.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.277 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -123.99 153.38 41.37 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.082 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.423 ' HG3' ' HG2' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -114.79 120.05 38.72 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.56 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.0 m -129.36 135.29 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.708 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.69 136.71 40.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.834 0.349 . . . . 0.0 111.131 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.0 mp -113.12 124.04 51.65 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.692 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 tt -102.74 115.33 30.39 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.708 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -129.4 134.12 47.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.104 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -90.63 172.87 8.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.887 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.66 -36.94 70.13 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -74.84 -30.87 61.49 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.27 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -79.39 179.42 7.45 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.87 0.367 . . . . 0.0 111.323 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.1 -143.13 4.95 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.014 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.67 -66.97 0.82 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.49 0.186 . . . . 0.0 111.369 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.61 -15.56 45.36 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.614 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.405 ' CG2' HD21 ' A' ' 54' ' ' LEU . 2.2 pp -140.84 157.76 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 117.304 0.552 . . . . 0.0 111.241 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 t -114.49 137.4 51.9 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.0 pt -116.16 151.56 17.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.472 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.2 t -143.61 145.11 32.24 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.065 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 129.72 -172.96 19.87 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.441 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.87 116.54 0.53 Allowed Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.454 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -52.35 -37.68 56.74 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -59.32 -31.16 68.9 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.725 0.298 . . . . 0.0 110.993 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -72.66 -31.31 64.98 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.937 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.18 -23.63 3.16 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.999 -0.619 . . . . 0.0 113.102 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.04 149.7 54.67 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.815 0.307 . . . . 0.0 111.291 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.25 157.53 61.43 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.662 2.241 . . . . 0.0 112.275 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.4 HD11 ' HA ' ' A' ' 73' ' ' HIS . 3.4 mp -82.42 129.86 36.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.578 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.76 161.55 29.49 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.857 0.361 . . . . 0.0 111.607 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 32.9 mt -82.84 123.29 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.059 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.8 m -106.9 -30.03 9.12 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.578 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -123.95 145.09 49.39 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.865 0.364 . . . . 0.0 111.395 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.2 mt -131.02 114.3 26.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.486 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -85.02 114.46 56.03 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.775 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -62.32 175.34 2.11 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.015 2.477 . . . . 0.0 112.967 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.73 34.91 91.16 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.147 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.16 173.18 4.94 Favored Pre-proline 0 CA--C 1.531 0.242 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.42 -30.86 36.3 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.714 2.276 . . . . 0.0 113.022 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.23 -46.19 89.14 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.696 0.284 . . . . 0.0 111.1 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.98 -38.34 76.0 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.803 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -32.02 73.43 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.216 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.11 -28.28 61.28 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.518 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.84 16.51 61.65 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.054 -0.594 . . . . 0.0 113.089 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.69 -33.75 1.15 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.203 -0.523 . . . . 0.0 113.066 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.405 HD21 ' CG2' ' A' ' 25' ' ' ILE . 1.1 tt -67.72 105.31 1.88 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.881 0.372 . . . . 0.0 110.662 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.401 ' CE1' ' CG ' ' A' ' 93' ' ' TYR . 12.6 p80 -114.86 157.35 23.43 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.207 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.8 p -62.97 139.69 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.127 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.5 49.66 5.08 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.216 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.8 126.63 55.27 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.433 0.159 . . . . 0.0 110.763 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -90.68 128.11 36.53 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.712 0.292 . . . . 0.0 110.687 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 12.3 mt -74.7 104.05 2.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.695 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -86.46 -50.64 6.73 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.409 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -150.13 146.15 26.73 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.605 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.1 t -127.92 115.71 40.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.652 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 54.96 37.07 28.24 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.99 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.25 -14.16 58.22 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.375 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.0 t -86.12 127.21 40.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 117.181 0.49 . . . . 0.0 110.97 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -71.55 141.16 50.1 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.949 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tp -116.03 -1.23 12.54 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.722 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -34.25 70.69 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.3 11.59 37.9 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.3 p -109.47 163.66 13.22 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.741 0.305 . . . . 0.0 110.93 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -94.62 161.11 14.33 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.03 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.4 ' HA ' HD11 ' A' ' 37' ' ' ILE . 12.3 t-80 -53.95 -49.66 68.21 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.812 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -43.06 88.15 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.758 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -64.81 -38.34 90.65 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.973 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.63 -41.42 98.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.991 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.67 -39.88 86.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.052 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -46.62 71.39 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.009 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.6 mt -62.21 -39.61 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.557 0.218 . . . . 0.0 110.752 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.97 -42.39 94.02 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.178 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.9 p -64.82 -32.12 73.67 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.304 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -64.95 -28.81 69.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.05 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 24.4 mm-40 -62.01 114.22 3.26 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.853 0.358 . . . . 0.0 110.856 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.0 ptt85 -118.63 152.29 36.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.426 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.04 -103.23 0.55 Allowed Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.592 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -89.96 119.06 30.0 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.788 0.328 . . . . 0.0 110.402 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.4 mt -121.04 122.5 67.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.031 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -93.78 122.08 35.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.681 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.31 129.81 56.46 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.943 0.401 . . . . 0.0 111.203 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.423 ' HG2' ' HG3' ' A' ' 12' ' ' LYS . 23.6 mt-10 -120.09 115.4 23.61 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.007 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 8.2 m -137.08 163.7 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.733 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.9 t -131.76 146.08 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.15 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.401 ' CG ' ' CE1' ' A' ' 55' ' ' HIS . 0.1 OUTLIER -70.47 129.07 38.27 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.758 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.32 141.19 43.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.901 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.117 -0.945 . . . . 0.0 111.315 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo . . . . . 0 N--CA 1.49 1.297 0 CA-C-O 120.852 0.272 . . . . 0.0 111.939 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 tt -78.8 132.76 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.381 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -123.71 135.25 53.76 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.057 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.86 126.6 48.78 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.581 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.3 m -128.58 143.14 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.592 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 pp -114.69 132.23 56.48 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.821 0.343 . . . . 0.0 110.928 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -120.7 141.57 50.3 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.869 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.95 118.35 36.51 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.009 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.96 148.09 42.53 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.104 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -114.22 159.75 19.79 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.155 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.3 -38.22 73.64 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.963 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -79.77 -28.17 40.4 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.437 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.65 164.27 16.9 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.932 0.396 . . . . 0.0 111.595 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.41 -166.74 21.95 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.703 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.0 -59.53 5.22 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.539 0.209 . . . . 0.0 111.329 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.27 1.06 55.76 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.382 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 pp -145.48 161.44 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 117.177 0.488 . . . . 0.0 111.139 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.5 t -119.65 136.95 54.18 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 6.5 pt -119.9 154.38 22.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.335 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 p -137.16 153.56 50.44 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.002 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.31 -172.24 16.67 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.785 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.38 113.97 0.55 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.517 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -32.44 70.67 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.478 0.18 . . . . 0.0 111.388 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -60.11 -30.7 69.44 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.609 0.242 . . . . 0.0 110.949 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -76.59 -28.15 56.08 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.078 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.68 31.54 2.51 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.892 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.7 m -146.4 144.17 20.5 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.634 0.217 . . . . 0.0 111.0 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.7 156.97 62.11 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.624 2.216 . . . . 0.0 112.246 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 37' ' ' ILE . 29.5 mm -84.21 139.29 17.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.63 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mp -131.42 160.49 34.95 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.839 0.352 . . . . 0.0 111.287 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.2 mt -89.69 122.54 41.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.946 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.54 -31.6 7.44 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.642 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -127.75 149.41 50.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.668 0.27 . . . . 0.0 110.823 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 17.9 mt -135.03 114.55 17.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.74 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -66.67 120.89 74.5 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.096 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.35 156.63 61.38 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.973 2.449 . . . . 0.0 112.667 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.3 36.8 93.66 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.262 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -134.06 177.07 2.42 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -49.95 -31.02 25.79 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.712 2.275 . . . . 0.0 112.912 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.55 -46.1 87.47 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.006 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -69.84 -40.4 75.83 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.792 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.6 mtp85 -56.11 -36.8 68.61 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.552 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 17.8 m -81.24 -27.9 35.03 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.457 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.75 14.58 67.76 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.999 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.34 -30.95 3.93 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.796 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -65.72 101.32 0.62 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.757 0.313 . . . . 0.0 110.569 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -114.41 157.49 22.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.931 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.6 t -71.7 136.18 26.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.443 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.12 47.26 4.77 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.283 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -111.99 132.72 54.61 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.87 123.75 35.48 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.759 0.314 . . . . 0.0 111.624 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.437 ' HA ' HG11 ' A' ' 91' ' ' VAL . 41.7 mt -75.17 132.47 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.174 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.4 mt -117.81 -67.7 0.97 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.033 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.88 145.65 46.56 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.917 0.389 . . . . 0.0 111.504 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.0 t -116.71 115.51 49.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.378 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 54.31 37.94 28.43 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.678 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.25 -14.44 54.09 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.648 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.5 t -85.26 135.2 25.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 117.221 0.51 . . . . 0.0 111.179 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -77.21 138.17 39.28 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.155 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tp -116.2 -1.92 12.29 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.829 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -30.3 68.26 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -98.8 11.25 39.28 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.96 159.07 17.59 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.566 0.222 . . . . 0.0 110.775 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.13 161.27 18.96 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -54.3 -51.28 65.15 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.015 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -65.28 -41.39 94.21 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.776 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -64.28 -37.23 86.76 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.843 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.39 -30.82 71.88 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.392 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.9 -42.35 94.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.836 0.35 . . . . 0.0 110.085 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 32.0 m -64.4 -41.25 96.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.452 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.2 mm -57.86 -45.72 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.734 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -40.88 87.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -73.57 -13.79 61.09 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -69.23 -29.75 67.76 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.681 0.277 . . . . 0.0 111.115 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.454 ' HB3' HG12 ' A' ' 87' ' ' ILE . 17.5 mp0 -76.5 135.99 39.34 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.195 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -130.65 146.94 52.26 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.166 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.82 -90.82 0.17 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.997 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -96.25 115.19 27.03 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.746 0.308 . . . . 0.0 110.304 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.454 HG12 ' HB3' ' A' ' 83' ' ' GLN . 18.9 mt -114.47 126.24 71.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.202 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -99.81 135.52 41.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.749 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -128.63 135.87 49.89 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.921 0.391 . . . . 0.0 111.479 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -123.63 115.59 21.72 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.496 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.437 HG11 ' HA ' ' A' ' 60' ' ' ILE . 18.7 m -144.86 172.49 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.341 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.2 p -141.37 137.03 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.059 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.74 122.6 17.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.058 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.8 m -108.25 120.5 59.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.162 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.123 -179.771 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo . . . . . 0 N--CA 1.492 1.388 0 CA-C-O 120.655 0.19 . . . . 0.0 111.919 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.7 mt -104.77 140.85 21.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.06 146.1 48.8 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.064 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.4 113.19 23.43 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.677 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.33 141.64 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.347 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 20.6 tp -105.84 127.65 53.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.898 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 tp -113.2 125.5 54.4 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.44 114.57 28.52 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.684 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -125.94 135.04 51.41 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.206 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -81.39 171.57 14.6 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.047 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.46 -38.78 75.03 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.095 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -75.42 -30.26 59.99 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.218 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -77.02 166.16 23.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.897 0.379 . . . . 0.0 111.383 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -113.02 -152.86 11.27 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.893 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.98 -41.21 82.71 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.526 0.203 . . . . 0.0 111.464 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.09 -21.32 43.87 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.997 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.6 pp -146.48 171.44 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.808 0.337 . . . . 0.0 111.287 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.449 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 5.9 m -120.44 138.35 53.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.575 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.2 pt -115.96 156.2 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.851 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.5 p -137.26 163.26 31.36 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.365 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.0 -160.71 17.69 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.874 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.4 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . 166.5 131.7 1.29 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.133 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -56.46 -37.6 70.53 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.182 0.193 . . . . 0.0 111.33 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.39 -31.04 71.65 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.125 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -78.31 -26.6 47.02 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.236 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.87 22.93 6.07 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.048 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.419 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 10.1 p -149.57 134.97 9.74 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.926 0.363 . . . . 0.0 110.998 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 38.4 Cg_exo -60.91 156.69 42.43 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.42 2.08 . . . . 0.0 112.181 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.5 mp -83.37 131.64 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.792 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.9 mp -131.64 160.73 34.55 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.574 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.4 mt -93.63 119.58 41.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.946 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.25 -41.2 4.22 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.262 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 4.1 tt0 -104.83 150.19 25.03 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.716 0.293 . . . . 0.0 111.067 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 32.3 mt -132.09 121.27 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.746 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -73.78 114.78 35.68 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.817 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -68.03 140.7 50.68 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.707 2.271 . . . . 0.0 112.645 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.34 29.5 52.99 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.746 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.68 172.53 6.63 Favored Pre-proline 0 CA--C 1.531 0.224 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -52.19 -31.66 46.73 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.721 2.281 . . . . 0.0 112.797 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.79 -46.3 90.16 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.09 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.84 -40.34 79.48 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.763 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.07 -31.52 72.78 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.191 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -70.29 -27.97 64.82 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.581 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.38 -56.39 4.67 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.943 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.6 -28.36 37.27 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 121.473 -0.394 . . . . 0.0 113.533 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.94 96.93 0.15 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.033 0.444 . . . . 0.0 110.527 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -119.05 157.4 27.89 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.272 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.1 t -68.38 129.67 33.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.076 179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.54 41.83 2.65 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.577 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.05 122.71 47.84 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.191 0.197 . . . . 0.0 110.581 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -94.75 127.1 40.51 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.683 0.278 . . . . 0.0 111.402 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 9.5 mt -77.78 142.21 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.338 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 70.4 mt -130.36 -50.88 1.09 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.933 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.32 145.56 49.15 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.889 0.376 . . . . 0.0 111.698 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.467 HG12 ' CE1' ' A' ' 89' ' ' PHE . 24.0 t -115.99 115.34 48.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.238 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 53.16 34.8 18.26 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.956 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.14 -15.91 59.95 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.037 -0.602 . . . . 0.0 113.624 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.9 t -88.39 134.95 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 117.218 0.509 . . . . 0.0 111.152 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -69.65 135.59 50.09 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.319 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.443 ' HG ' ' HB ' ' A' ' 71' ' ' THR . 0.5 OUTLIER -120.79 16.2 11.83 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.715 179.674 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.4 ttt85 -69.64 -32.31 70.92 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.11 12.02 37.32 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.443 ' HB ' ' HG ' ' A' ' 68' ' ' LEU . 0.2 OUTLIER -103.45 162.87 12.66 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.617 0.246 . . . . 0.0 110.867 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.37 161.07 13.96 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.12 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.4 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . 58.9 t-80 -54.1 -51.1 65.25 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.066 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -60.45 -41.04 93.27 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.811 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -65.22 -37.22 86.61 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.741 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.56 -35.23 79.79 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.104 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.1 t -62.23 -39.84 85.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.815 0.341 . . . . 0.0 110.424 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -41.93 99.05 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.594 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.7 mm -57.98 -45.41 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.571 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 mt -57.5 -39.29 76.15 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.072 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -61.58 -37.36 83.58 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.07 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -65.72 -25.61 67.38 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.339 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -65.9 131.13 45.53 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.097 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.03 143.7 50.27 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.384 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.03 -101.31 0.22 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.859 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -91.57 126.01 36.5 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.954 0.407 . . . . 0.0 110.495 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.408 HG23 HD11 ' A' ' 87' ' ' ILE . 7.9 mt -117.6 122.99 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.081 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.77 124.37 37.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.414 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.467 ' CE1' HG12 ' A' ' 63' ' ' VAL . 0.7 OUTLIER -128.16 129.8 47.08 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.927 0.394 . . . . 0.0 111.178 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -101.37 115.21 29.99 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.298 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.8 m -138.23 171.5 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.394 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.0 m -133.95 149.37 30.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.292 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.98 120.98 19.36 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.867 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.35 131.27 73.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.798 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.013 179.932 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 N--CA 1.49 1.28 0 CA-C-O 120.788 0.245 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.6 mt -96.14 141.01 16.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.13 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.5 124.87 44.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.993 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.8 111.54 23.67 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.472 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -132.01 138.05 53.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.957 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.9 141.66 30.61 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.07 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -121.48 139.6 53.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.971 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tt -107.6 127.11 53.36 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.822 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -116.2 126.56 53.8 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.87 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.43 155.62 20.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.682 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.33 -38.96 74.9 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.189 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -79.0 -27.72 43.36 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.425 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -95.41 -178.34 4.4 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.741 0.305 . . . . 0.0 111.508 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.41 -149.89 5.55 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.974 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.94 -56.97 6.2 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.608 0.242 . . . . 0.0 110.781 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.02 -14.52 61.38 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.445 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.6 pp -140.13 154.08 22.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 117.104 0.452 . . . . 0.0 111.166 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -103.8 136.75 42.89 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.793 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.7 pt -119.66 149.7 22.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.464 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.5 t -135.86 146.94 47.98 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.217 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.96 -154.72 25.71 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.364 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 159.45 117.5 0.48 Allowed Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.095 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.88 -33.67 72.14 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.38 0.133 . . . . 0.0 111.321 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -57.26 -29.9 64.21 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.549 0.214 . . . . 0.0 111.331 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -83.15 -29.14 28.88 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.001 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.0 26.03 5.66 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.898 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 16.1 m -144.58 131.98 10.4 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 116.75 0.275 . . . . 0.0 111.115 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 32.6 Cg_exo -61.14 153.97 60.84 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.647 2.231 . . . . 0.0 112.005 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mp -82.53 132.07 32.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.426 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.4 159.05 35.64 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.618 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 mt -83.01 129.96 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.958 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.3 m -119.71 -40.95 2.71 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.353 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -105.32 144.52 31.99 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.702 0.287 . . . . 0.0 111.081 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.9 mm -129.26 111.62 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.697 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -84.87 127.58 64.23 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.97 157.86 53.78 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.843 2.362 . . . . 0.0 113.063 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.94 37.58 43.55 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.835 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.06 170.29 8.68 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-O 120.45 0.166 . . . . 0.0 110.799 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.12 -31.24 34.91 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.728 2.285 . . . . 0.0 112.684 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.41 83.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.463 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.77 -42.53 77.3 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.851 0.358 . . . . 0.0 110.498 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -65.02 -30.55 71.54 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.299 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -70.57 -28.34 64.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.535 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.17 -58.8 3.99 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.764 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.85 -23.27 44.54 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.541 -0.362 . . . . 0.0 113.526 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.93 96.05 0.18 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.111 0.456 . . . . 0.0 110.403 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -119.33 157.41 28.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.299 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 m -68.28 134.9 29.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.56 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.85 44.9 4.37 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.587 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.15 122.49 47.89 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.26 122.58 34.0 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.764 0.316 . . . . 0.0 111.633 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.6 mt -69.59 132.19 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.366 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.1 mt -114.88 -54.58 2.56 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.802 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -150.76 145.98 26.11 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.454 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.3 t -125.61 120.51 57.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.54 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 57.39 34.54 24.83 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.08 -11.08 61.26 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.359 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.58 136.33 23.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 117.258 0.529 . . . . 0.0 110.934 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.5 134.39 35.21 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.056 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 mp -108.63 -12.33 14.98 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.034 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -29.05 69.58 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -96.51 9.19 42.16 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.62 0.229 . . . . 0.0 111.62 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.6 p -119.04 157.9 26.88 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.677 0.275 . . . . 0.0 110.8 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.03 161.05 20.85 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.817 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -53.82 -50.55 65.94 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.904 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -59.69 -41.56 91.01 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.949 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.28 -38.66 85.44 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.954 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.44 -35.2 79.65 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.402 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.86 -40.46 87.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.726 0.298 . . . . 0.0 110.469 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.9 m -66.77 -44.25 81.9 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.782 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.2 mt -62.06 -43.06 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.825 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.5 mt -62.4 -36.53 82.6 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.684 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.4 t -65.57 -32.69 74.41 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.012 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -65.03 -28.8 69.73 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.325 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -61.85 112.75 2.42 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.813 0.34 . . . . 0.0 110.767 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -112.57 148.88 33.61 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.378 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.56 -103.02 0.55 Allowed Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.59 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -89.07 126.41 35.43 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.812 0.339 . . . . 0.0 110.385 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.0 mt -126.05 129.23 72.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.826 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -93.82 135.49 35.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.474 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -130.58 129.28 42.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.879 0.371 . . . . 0.0 111.026 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -122.07 115.36 22.35 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.227 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.9 m -138.83 171.54 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.518 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.71 143.18 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.501 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.98 122.92 27.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.961 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.82 133.41 66.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.088 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.434 -0.794 . . . . 0.0 111.34 -179.865 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo . . . . . 0 N--CA 1.491 1.364 0 CA-C-O 120.99 0.329 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mp -78.77 143.43 12.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.204 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.17 143.95 46.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.263 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -111.97 115.1 28.4 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 t -125.68 130.15 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.776 0.322 . . . . 0.0 111.175 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.93 132.47 43.48 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.169 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.5 tt -129.67 144.53 51.33 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.985 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.76 114.81 28.92 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.95 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -94.41 136.3 34.86 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.758 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.07 154.56 32.98 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.183 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.63 -37.16 72.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.218 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -82.47 -26.78 32.33 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.503 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -102.17 110.04 21.89 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.659 0.266 . . . . 0.0 110.946 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.8 -152.14 0.13 Allowed Glycine 0 CA--C 1.522 0.523 0 C-N-CA 121.255 -0.498 . . . . 0.0 113.439 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.56 -59.98 4.54 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.9 -11.95 65.92 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.598 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.0 pt -138.36 152.68 25.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 117.1 0.45 . . . . 0.0 110.977 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -115.53 136.68 52.84 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.762 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.0 pt -117.34 155.8 18.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.592 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 t -140.46 147.13 39.16 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.993 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.63 -165.49 20.69 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.43 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -179.35 114.41 0.44 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.679 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.2 tptp -60.99 -29.89 69.95 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -57.53 -31.15 65.78 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.653 0.263 . . . . 0.0 110.966 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -79.38 -23.11 43.53 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.324 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.15 21.25 4.93 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.309 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.1 m -145.38 140.32 15.83 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 117.007 0.403 . . . . 0.0 111.212 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.57 157.07 63.46 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.57 2.18 . . . . 0.0 112.385 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mt -85.64 137.52 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.842 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.3 mp -128.37 151.19 49.64 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.368 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.2 mt -86.92 122.12 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.824 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.54 -27.72 8.12 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.877 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -109.75 144.27 38.39 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.662 0.268 . . . . 0.0 111.121 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.4 mm -133.55 121.21 40.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.637 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -97.91 112.41 61.64 Favored Pre-proline 0 C--O 1.234 0.287 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.149 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.93 151.58 73.66 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.709 2.273 . . . . 0.0 112.492 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.06 -37.27 3.84 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.734 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.66 176.14 4.11 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-O 120.45 0.167 . . . . 0.0 110.724 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -51.02 -30.65 31.83 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.918 2.412 . . . . 0.0 113.15 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.69 -46.19 84.65 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.685 0.278 . . . . 0.0 111.211 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.54 -42.12 71.62 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.787 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.6 mtp85 -62.09 -30.08 70.76 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.108 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.94 -28.22 65.4 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.418 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.12 -56.69 3.61 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.712 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.95 -23.58 39.07 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 119.867 -0.407 . . . . 0.0 113.776 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.05 90.28 0.13 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.161 0.481 . . . . 0.0 110.422 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -114.17 157.24 22.91 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.11 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.4 t -64.01 137.71 24.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.676 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.71 46.17 4.35 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.385 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.58 121.25 44.23 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.445 0.164 . . . . 0.0 111.017 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.11 122.05 37.37 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.671 0.272 . . . . 0.0 111.258 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 mp -77.14 134.7 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.442 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.1 mt -121.93 -50.62 2.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.941 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.56 146.44 34.61 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.762 0.315 . . . . 0.0 111.361 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.0 t -136.02 115.88 17.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.59 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 59.79 33.03 21.64 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.015 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.55 -14.44 58.1 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.305 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 t -81.79 132.58 31.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 117.044 0.422 . . . . 0.0 110.604 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -76.26 126.74 31.54 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.658 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.58 0.97 10.57 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.529 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -71.1 -31.48 67.84 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 111.247 0.091 . . . . 0.0 111.247 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.47 11.88 33.94 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.7 p -100.91 149.7 23.62 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.588 0.232 . . . . 0.0 111.002 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -75.5 161.13 29.46 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.433 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -54.59 -49.63 69.95 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.213 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -62.3 -37.72 86.62 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.588 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -62.67 -37.33 86.0 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.746 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.34 -35.34 80.07 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.347 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.16 -42.96 97.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.635 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.32 -48.3 70.73 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.814 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 mt -61.41 -42.19 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.092 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -39.24 80.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.8 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -33.27 75.44 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.009 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -65.3 -27.11 68.39 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.14 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -65.79 95.63 0.25 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 110.79 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -98.68 144.23 28.18 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.123 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.73 -109.08 2.53 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.818 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -79.99 135.96 36.5 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.692 0.282 . . . . 0.0 110.574 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.1 mt -137.03 122.36 25.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.289 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -95.79 122.25 38.38 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.428 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -111.8 128.79 56.22 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.007 0.432 . . . . 0.0 111.338 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -117.24 115.36 25.15 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.299 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.6 m -137.76 171.05 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.465 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.6 p -135.94 137.57 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.987 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.19 119.99 13.64 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.834 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.1 t -111.13 125.03 68.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.167 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.991 179.914 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo . . . . . 0 N--CA 1.489 1.222 0 CA-C-O 120.725 0.219 . . . . 0.0 111.842 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 tt -109.3 124.6 66.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.067 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -113.65 127.03 55.9 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.053 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.24 113.91 27.78 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.998 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.93 135.87 60.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.003 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.71 130.95 44.65 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.824 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.24 139.47 50.32 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.069 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.2 mp -109.02 114.54 28.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.87 139.03 54.13 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.056 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -109.28 168.09 9.64 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.949 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.87 -37.14 75.87 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.282 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.1 p80 -74.62 -29.89 61.46 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.596 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -94.75 166.18 12.12 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 111.641 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.88 -154.22 9.12 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.91 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.08 -67.01 0.52 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.577 0.227 . . . . 0.0 111.03 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.22 4.13 63.0 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.071 -0.585 . . . . 0.0 113.634 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.2 pt -138.29 145.36 28.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 117.256 0.528 . . . . 0.0 111.088 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.75 140.23 34.26 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.099 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.2 pt -116.49 155.62 17.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.684 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.9 p -133.9 153.79 51.51 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.347 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.49 -153.75 19.66 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.803 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.81 138.21 2.74 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.26 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -58.97 -37.74 77.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.066 0.146 . . . . 0.0 111.38 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.84 -31.19 71.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.595 0.236 . . . . 0.0 111.017 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -81.14 -28.19 35.19 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.103 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.19 25.83 5.95 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.101 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.8 m -147.82 140.08 14.37 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.864 0.332 . . . . 0.0 110.992 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.78 155.83 46.69 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.613 2.208 . . . . 0.0 112.19 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 19.7 mt -84.89 136.56 22.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.857 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.8 154.5 48.48 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.301 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.1 mm -83.87 118.23 30.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.763 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.0 t -108.19 -28.51 9.44 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.705 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.67 144.45 50.2 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.735 0.302 . . . . 0.0 111.198 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.426 HD13 HG22 ' A' ' 42' ' ' ILE . 20.9 mm -128.92 112.19 25.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.383 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -87.01 130.96 46.27 Favored Pre-proline 0 C--O 1.232 0.158 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.106 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.37 172.8 15.63 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.846 2.364 . . . . 0.0 112.535 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.52 30.38 77.43 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.467 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.443 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -137.01 169.08 14.21 Favored Pre-proline 0 C--O 1.233 0.203 0 C-N-CA 122.248 0.219 . . . . 0.0 110.44 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.443 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 9.3 Cg_endo -53.09 -27.02 34.95 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.768 2.312 . . . . 0.0 112.75 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.72 -46.35 89.37 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.061 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -67.85 -40.49 83.66 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.618 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -58.71 -33.05 69.76 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.347 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.3 m -80.57 -28.36 37.23 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.56 -51.7 4.27 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.182 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.48 -24.37 23.49 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.56 -0.353 . . . . 0.0 113.795 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -65.19 89.52 0.09 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.15 0.475 . . . . 0.0 110.743 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -114.25 157.37 22.8 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.348 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 42.1 t -72.56 136.55 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.68 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.29 40.34 4.83 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.899 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -112.08 135.03 53.25 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.602 0.201 . . . . 0.0 110.987 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.53 124.01 47.31 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.686 0.279 . . . . 0.0 111.403 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 mt -80.04 150.72 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.494 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 13.3 mt -136.25 -50.45 0.69 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.354 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.74 145.95 32.78 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.773 0.321 . . . . 0.0 111.476 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.4 t -135.39 115.87 18.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.769 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 57.15 34.53 24.99 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.875 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.83 -19.73 46.68 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.321 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 t -80.13 135.98 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 117.065 0.433 . . . . 0.0 111.0 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -80.51 137.33 36.43 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.213 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.2 tp -87.12 -33.06 19.57 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.038 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -67.4 -27.69 67.29 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.427 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -89.51 9.99 24.52 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 t -134.15 154.43 51.22 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.773 0.321 . . . . 0.0 110.959 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.18 161.16 20.67 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -54.0 -51.66 63.24 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.008 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -61.16 -42.15 98.03 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.031 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -38.68 84.96 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.963 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.49 -33.73 76.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.348 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 24.7 t -61.91 -43.46 97.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.76 0.314 . . . . 0.0 110.25 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.11 -47.34 77.53 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.544 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.2 mt -59.23 -49.29 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.92 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 85.5 mt -55.45 -35.97 66.04 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.132 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -20.06 60.45 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.652 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -74.22 -28.86 61.45 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.748 0.308 . . . . 0.0 110.57 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -68.79 104.82 2.13 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.66 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 149.9 25.68 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.375 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.98 -107.11 1.63 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.469 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -79.37 115.37 18.98 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.761 0.315 . . . . 0.0 110.433 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.3 mt -122.55 122.74 66.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.042 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -93.93 121.86 35.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.447 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.06 129.69 55.71 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.877 0.37 . . . . 0.0 111.642 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -118.1 115.35 24.66 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.394 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.3 169.26 20.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.513 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.4 m -137.69 131.23 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.111 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.15 123.48 22.27 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.935 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.3 m -108.34 141.9 22.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.4 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.42 -0.8 . . . . 0.0 111.323 -179.89 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo . . . . . 0 N--CA 1.49 1.274 0 CA-C-O 120.539 0.141 . . . . 0.0 111.827 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -100.87 128.67 52.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.462 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -123.43 121.56 36.03 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.968 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -111.47 111.61 22.75 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.566 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.42 134.95 56.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.073 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 mp -97.97 139.54 33.65 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.81 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 tp -108.32 119.6 39.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.829 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 tp -109.55 115.18 29.43 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.487 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.63 153.14 44.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.018 0.437 . . . . 0.0 111.242 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.84 173.14 7.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.997 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -58.83 -38.37 78.53 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -72.96 -30.26 63.71 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.18 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -75.19 168.95 19.0 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.852 0.358 . . . . 0.0 111.238 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.1 -149.93 8.88 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.888 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 tp -76.88 -61.08 2.09 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.517 0.199 . . . . 0.0 111.323 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.78 -14.25 49.63 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.581 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -143.89 165.09 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 117.123 0.461 . . . . 0.0 111.132 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.8 t -120.99 136.76 54.91 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.675 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.402 HG23 HD11 ' A' ' 60' ' ' ILE . 15.2 pt -117.99 153.4 20.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.496 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.2 t -139.6 145.87 39.09 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.22 -151.51 23.46 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.447 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.53 105.44 0.19 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.847 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -57.57 -34.92 69.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.474 0.178 . . . . 0.0 111.18 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -60.72 -31.17 70.48 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.186 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -82.61 -31.36 28.92 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.087 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.65 32.27 2.33 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.709 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 10.9 p -140.42 130.92 13.75 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-O 120.66 0.267 . . . . 0.0 110.846 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 25.9 Cg_exo -62.35 156.23 52.58 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.551 2.168 . . . . 0.0 112.072 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 30.3 mm -84.85 136.96 21.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.593 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.44 158.56 43.82 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.909 0.385 . . . . 0.0 111.611 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.7 mt -88.48 125.88 41.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.158 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.6 t -110.42 -34.26 6.38 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.395 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -123.58 147.35 47.39 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.817 0.341 . . . . 0.0 111.371 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.3 mt -127.13 120.11 54.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.54 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -78.68 113.58 36.13 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.703 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.17 149.78 83.15 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.745 2.296 . . . . 0.0 112.648 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.84 39.59 28.17 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.563 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.93 172.95 4.89 Favored Pre-proline 0 C--N 1.331 -0.22 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -51.33 -32.72 42.84 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.61 2.207 . . . . 0.0 112.792 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.35 -46.31 89.24 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.113 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.36 -41.6 96.64 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.665 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.43 -29.86 67.67 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.611 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 10.8 m -70.36 -28.38 65.07 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.18 -57.8 4.01 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.89 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.44 -25.17 33.41 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.514 -0.374 . . . . 0.0 113.47 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.21 90.28 0.09 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.964 0.412 . . . . 0.0 110.471 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -115.79 157.47 24.33 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.217 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.1 t -63.92 132.08 29.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.247 179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.6 40.78 4.93 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.815 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.55 119.07 37.97 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.21 130.34 38.94 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.402 HD11 HG23 ' A' ' 27' ' ' ILE . 3.2 mp -81.6 151.04 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.357 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.9 mt -136.6 -51.75 0.69 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.976 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.91 147.39 40.5 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.806 0.336 . . . . 0.0 111.448 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -130.01 115.62 33.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.529 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 54.4 32.91 17.46 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.864 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.77 -17.0 58.91 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.339 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.8 t -83.79 137.97 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 117.063 0.432 . . . . 0.0 111.045 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -75.23 131.18 40.2 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.27 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.0 tt -108.09 -22.61 12.32 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.501 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -61.16 -28.48 69.16 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.6 12.12 28.66 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.4 p -113.45 162.65 15.87 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.742 0.306 . . . . 0.0 110.583 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.82 161.24 16.84 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.198 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -54.03 -50.68 66.12 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.069 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -68.29 -43.16 78.31 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.874 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -38.1 89.34 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.997 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.66 -30.74 71.81 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.4 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.9 t -61.93 -41.43 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.743 0.306 . . . . 0.0 110.651 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.3 m -69.84 -39.98 76.11 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.493 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.0 mt -65.06 -48.89 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.163 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.6 pp -62.67 -36.6 83.39 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.108 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 86.9 p -74.54 -16.0 60.84 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -71.22 -30.53 66.48 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.772 0.32 . . . . 0.0 110.858 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.416 ' HB3' HG12 ' A' ' 87' ' ' ILE . 2.2 mp0 -67.47 117.02 8.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.851 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -107.33 147.26 30.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.446 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.93 -98.39 0.19 Allowed Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.559 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -82.66 115.0 21.41 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.721 0.296 . . . . 0.0 110.304 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.416 HG12 ' HB3' ' A' ' 83' ' ' GLN . 16.7 mt -119.64 122.36 68.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.974 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.39 122.88 43.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.351 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -122.83 129.42 51.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.826 0.346 . . . . 0.0 110.736 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -111.85 114.98 28.26 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.825 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.6 m -134.52 169.31 21.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.566 -179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.9 m -139.96 141.24 34.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.954 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.47 116.26 7.26 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.825 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.3 p -105.01 139.63 25.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.517 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.124 -0.941 . . . . 0.0 111.065 -179.957 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo . . . . . 0 N--CA 1.494 1.541 0 CA-C-O 120.831 0.263 . . . . 0.0 112.21 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.416 ' CD1' HD11 ' A' ' 61' ' ' LEU . 1.2 tt -92.66 136.89 23.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.168 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.4 ttt180 -123.62 148.07 46.77 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.049 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.436 ' HD2' ' HG3' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -101.1 118.86 37.84 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.659 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.0 t -122.13 129.56 75.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.304 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.4 tp -101.91 120.06 39.79 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.672 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.7 mp -108.28 121.09 44.18 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.149 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.8 tp -108.32 115.22 29.72 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.635 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.08 147.27 45.99 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.209 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -86.75 172.26 10.29 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.975 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -58.89 -38.46 78.91 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.061 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -73.92 -29.53 62.09 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.108 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -68.29 154.19 42.24 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.817 0.342 . . . . 0.0 111.533 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.22 -157.85 26.11 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.937 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.55 -62.05 1.6 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.492 0.187 . . . . 0.0 111.49 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.08 -21.17 34.21 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.365 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.1 pp -139.93 151.96 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 117.072 0.436 . . . . 0.0 111.31 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.406 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -105.49 137.1 43.87 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.986 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.0 pt -119.09 158.49 20.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.576 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.6 t -144.53 150.3 37.31 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.2 -159.58 15.73 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.478 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.427 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . 161.78 123.31 0.66 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.79 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -56.35 -37.87 70.6 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.457 0.169 . . . . 0.0 111.457 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -68.07 -31.15 70.59 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.734 0.302 . . . . 0.0 110.863 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -76.79 -30.5 56.49 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.028 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.96 21.69 5.23 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.113 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.4 p -149.76 130.81 7.2 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.95 0.375 . . . . 0.0 110.921 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -61.77 154.06 63.36 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.575 2.183 . . . . 0.0 112.26 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.9 mt -82.79 136.79 22.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.642 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.38 163.5 32.78 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.886 0.374 . . . . 0.0 111.766 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.5 mm -87.83 125.19 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.59 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.39 -46.77 2.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.136 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.406 ' HB2' ' CB ' ' A' ' 26' ' ' SER . 45.5 mt-10 -111.24 146.4 37.02 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.228 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.8 mt -131.72 113.08 21.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.6 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -69.72 124.61 90.95 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.924 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.06 147.02 53.64 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.695 2.263 . . . . 0.0 112.658 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.46 40.66 22.64 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.569 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.71 173.16 5.37 Favored Pre-proline 0 C--N 1.332 -0.196 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -51.8 -31.8 43.6 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.629 2.219 . . . . 0.0 112.662 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.57 -45.87 84.67 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.225 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -70.56 -43.08 70.22 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.635 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -59.57 -30.42 68.62 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.464 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 94.8 m -80.24 -28.02 38.57 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.833 -0.167 . . . . 0.0 111.353 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.95 17.66 63.46 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.865 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.29 -30.74 2.38 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.062 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.9 89.16 0.58 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.845 0.355 . . . . 0.0 110.738 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -106.34 156.83 18.1 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.4 t -64.56 135.09 28.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.688 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.95 46.06 4.31 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.411 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.38 122.74 48.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.397 0.142 . . . . 0.0 110.81 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.35 121.3 32.97 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.816 0.341 . . . . 0.0 111.216 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.6 mt -74.06 145.92 10.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.608 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.416 HD11 ' CD1' ' A' ' 10' ' ' ILE . 64.0 mt -137.83 -52.58 0.63 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.092 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.45 145.58 48.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.836 0.35 . . . . 0.0 111.702 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.0 t -131.3 117.04 34.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.403 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 57.82 34.46 24.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.931 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.99 -18.54 47.27 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.589 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.31 130.77 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 117.183 0.491 . . . . 0.0 110.926 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -74.78 140.78 44.25 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.172 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.8 tp -114.83 16.27 17.33 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.416 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.13 -34.57 71.17 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.807 -0.178 . . . . 0.0 111.425 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.88 12.03 38.42 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.405 HG23 ' CD1' ' A' ' 79' ' ' ILE . 7.3 m -103.51 154.36 19.54 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.776 0.322 . . . . 0.0 111.191 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.22 161.0 15.91 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.283 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.427 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . 8.4 t-80 -54.1 -52.4 61.13 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.037 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -61.57 -38.36 87.23 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.028 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -65.23 -40.91 94.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.824 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.41 -34.38 77.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.481 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.9 t -61.81 -43.76 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.72 0.295 . . . . 0.0 110.694 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.9 m -69.67 -44.92 69.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.005 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.405 ' CD1' HG23 ' A' ' 71' ' ' THR . 13.4 mt -62.95 -47.99 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.482 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.4 pp -63.51 -33.62 75.98 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.46 0.172 . . . . 0.0 111.09 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.7 t -66.64 -30.79 71.14 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.151 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -65.31 -29.24 69.97 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.147 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -60.88 115.14 3.47 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.725 0.298 . . . . 0.0 110.651 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -115.01 143.83 44.56 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.961 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.18 -100.8 0.27 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.567 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -77.39 119.5 21.09 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.738 0.304 . . . . 0.0 110.544 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.0 mt -129.83 122.47 54.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.101 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -94.6 126.95 40.22 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.355 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -124.52 129.43 50.59 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.899 0.38 . . . . 0.0 111.391 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' HG3' ' HD2' ' A' ' 12' ' ' LYS . 6.5 tt0 -119.9 115.57 24.07 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.233 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.0 m -138.25 169.02 19.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.0 0.429 . . . . 0.0 111.888 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 32.2 t -129.5 138.53 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.751 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.27 124.18 21.52 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.87 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.7 t -126.46 130.82 71.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.242 -179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.588 179.788 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.49 1.281 0 CA-C-O 120.679 0.2 . . . . 0.0 111.983 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.86 115.74 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.12 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -122.18 127.14 49.66 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.068 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.35 114.22 26.34 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.82 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.0 t -111.26 144.57 18.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.827 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.0 tt -97.72 122.09 40.4 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.594 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.92 123.61 49.36 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.256 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tt -107.76 115.51 30.27 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.708 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -130.33 139.4 50.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.55 164.29 23.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.993 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.11 -38.5 73.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.969 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -76.71 -29.54 56.28 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.079 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -77.25 176.04 9.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.724 0.297 . . . . 0.0 111.38 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -132.99 -144.26 5.19 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.05 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.6 mt -94.11 -67.7 0.84 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.549 0.214 . . . . 0.0 111.141 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.02 4.58 51.02 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.723 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.438 HG22 ' CD2' ' A' ' 54' ' ' LEU . 2.6 pp -137.12 157.79 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 117.287 0.544 . . . . 0.0 111.321 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.6 m -112.99 136.71 52.38 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.822 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.7 pt -117.64 158.14 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.364 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 t -143.48 153.97 43.18 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.289 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.31 -167.1 24.28 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.619 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.18 122.28 0.64 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.842 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.19 -37.76 78.19 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.658 0.266 . . . . 0.0 111.058 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -59.04 -31.2 68.63 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.936 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -80.27 -28.02 38.45 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.108 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.04 30.35 4.83 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.958 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.42 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 6.8 m -146.48 132.96 9.73 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-N 116.76 0.28 . . . . 0.0 111.162 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 34.4 Cg_exo -61.26 157.41 40.35 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.718 2.279 . . . . 0.0 112.049 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.9 mm -82.18 135.19 25.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.563 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 pp -138.65 155.99 47.81 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.934 0.397 . . . . 0.0 111.513 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 19.3 mt -79.97 125.78 39.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.948 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.7 t -101.63 -42.42 6.22 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.623 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -127.94 150.55 49.84 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.982 0.42 . . . . 0.0 111.796 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.6 mt -132.91 122.67 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.571 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -82.59 132.2 52.82 Favored Pre-proline 0 N--CA 1.462 0.162 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.928 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.92 148.19 40.19 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.747 2.298 . . . . 0.0 112.58 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.42 37.99 46.08 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.65 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.9 172.49 7.25 Favored Pre-proline 0 C--O 1.233 0.191 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -50.86 -32.4 37.26 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.669 2.246 . . . . 0.0 112.916 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.27 78.33 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.088 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.28 -40.05 77.98 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.683 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -60.04 -31.7 70.22 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.395 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 m -76.53 -27.98 56.18 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.46 16.75 67.79 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.132 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.01 -35.15 1.54 Allowed Glycine 0 C--N 1.337 0.593 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.834 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.438 ' CD2' HG22 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -69.24 105.51 2.54 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.818 0.342 . . . . 0.0 110.907 -179.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -111.98 157.34 20.83 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.208 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.4 t -62.86 137.97 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.61 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.89 53.36 7.21 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.627 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -111.93 120.8 43.14 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.3 126.75 36.48 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.866 0.365 . . . . 0.0 111.854 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mt -85.83 149.9 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.907 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.2 mt -135.47 -50.0 0.73 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.874 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.68 145.69 45.05 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.745 0.307 . . . . 0.0 111.432 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.1 t -135.1 115.99 19.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 56.54 36.83 28.2 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.806 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.28 -14.4 50.39 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.429 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.3 t -83.92 136.49 22.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 117.19 0.495 . . . . 0.0 110.923 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -76.91 137.53 39.16 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.285 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.97 -1.53 13.08 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.652 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -71.31 -34.15 70.33 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.35 12.19 33.8 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 64.7 p -103.88 138.61 40.21 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.655 0.264 . . . . 0.0 110.939 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.35 161.16 30.79 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.816 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -53.91 -49.28 68.98 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.956 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.95 -41.94 99.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.683 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.7 -39.58 94.47 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.105 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.64 -34.28 77.49 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.476 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.7 t -62.04 -43.01 97.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.791 0.329 . . . . 0.0 110.311 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 m -63.8 -44.37 93.49 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.74 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.5 mt -62.86 -41.2 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.955 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.12 -41.72 88.89 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.833 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.6 m -69.2 -27.12 65.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.442 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -65.08 -28.16 69.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.42 0.152 . . . . 0.0 111.139 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -67.06 117.33 8.96 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.65 0.262 . . . . 0.0 110.938 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.96 143.68 44.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.071 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.61 -106.88 0.95 Allowed Glycine 0 C--N 1.337 0.604 0 C-N-CA 121.298 -0.477 . . . . 0.0 112.916 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -78.6 122.78 26.36 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.661 0.267 . . . . 0.0 110.465 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.4 mt -127.7 123.12 60.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.404 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -93.84 123.89 37.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.232 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.51 133.2 56.23 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.855 0.359 . . . . 0.0 111.654 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.88 115.51 23.97 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.421 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.0 m -136.97 169.69 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.743 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.4 t -136.95 133.7 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.666 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.44 117.85 8.54 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.791 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 13.3 p -99.4 126.82 52.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.859 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.234 -179.601 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.489 1.22 0 CA-C-O 120.843 0.268 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.87 127.39 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.175 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.67 128.28 55.22 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.104 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -100.32 117.57 34.81 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.799 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.0 m -127.52 128.43 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.461 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 tp -105.02 120.29 41.11 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.088 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 tp -108.72 137.01 47.35 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.685 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.4 114.94 28.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.786 0.326 . . . . 0.0 110.877 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.72 132.59 56.45 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.029 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.44 169.73 8.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.699 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -57.31 -38.44 74.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.921 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -81.65 -26.27 34.9 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.726 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -88.9 153.35 21.12 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.973 0.416 . . . . 0.0 111.606 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.35 -149.7 15.75 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.804 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.38 -65.63 0.96 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.545 0.212 . . . . 0.0 111.209 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.01 4.42 60.09 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.525 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.4 pt -142.17 151.8 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 117.389 0.594 . . . . 0.0 111.337 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.0 136.76 49.52 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.781 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.1 pt -124.84 158.74 32.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.421 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.0 t -143.11 150.92 40.14 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.135 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.82 -148.17 17.2 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.576 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.54 111.65 0.39 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.532 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -58.25 -30.28 66.43 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.455 0.169 . . . . 0.0 111.205 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -58.66 -31.37 68.12 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.006 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -86.06 -24.3 26.4 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.235 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.0 27.37 2.98 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.154 -0.546 . . . . 0.0 113.003 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.6 m -142.37 138.78 16.81 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.923 0.361 . . . . 0.0 110.966 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.48 155.77 65.92 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.52 2.147 . . . . 0.0 112.322 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.6 mm -84.15 125.3 40.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.754 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.09 145.13 50.46 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.09 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.9 mt -85.31 120.64 35.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.852 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.3 -37.04 5.86 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.476 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -117.65 149.64 40.36 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.765 0.317 . . . . 0.0 111.198 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.2 mt -134.28 113.42 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.766 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -72.83 127.02 90.27 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.293 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.0 166.07 28.66 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.819 2.346 . . . . 0.0 112.789 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.21 23.45 74.77 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.71 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -131.82 172.77 6.79 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.01 -22.01 29.2 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.484 2.123 . . . . 0.0 113.206 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.32 -46.94 88.1 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -71.41 -38.03 71.46 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.671 0.272 . . . . 0.0 110.57 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -67.03 -27.72 67.64 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.015 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 7.5 t -70.28 -28.03 64.89 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.338 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.62 -60.52 3.69 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.737 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.48 -26.18 37.02 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 121.447 -0.406 . . . . 0.0 113.39 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.09 92.12 0.1 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.009 0.433 . . . . 0.0 110.502 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -119.19 157.65 27.54 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.294 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.0 m -63.77 138.86 22.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.49 46.14 7.02 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.739 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.99 127.82 55.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.416 0.15 . . . . 0.0 110.954 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -94.65 125.24 39.17 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.192 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.3 mt -80.14 136.85 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.461 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.24 -52.07 2.6 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.944 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.07 156.06 42.7 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.813 0.34 . . . . 0.0 111.55 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.2 t -138.51 115.76 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.761 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 55.28 42.49 30.3 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.063 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.42 2.01 62.34 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.307 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.6 t -97.27 122.59 48.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 117.149 0.474 . . . . 0.0 110.508 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -66.31 128.51 36.42 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tp -103.84 -17.07 15.19 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.789 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.6 ttm105 -61.17 -32.5 72.23 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -98.75 7.0 46.57 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -101.92 148.11 25.73 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.746 0.307 . . . . 0.0 110.97 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.79 161.08 23.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.605 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -54.12 -49.66 68.66 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.958 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -40.68 90.46 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.926 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -64.75 -38.69 91.83 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.19 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.98 79.06 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.272 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.1 t -61.7 -42.08 92.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.38 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -44.77 93.82 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.697 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.7 mt -63.84 -46.47 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.04 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.61 -41.33 73.32 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.112 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.94 -34.3 77.47 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.983 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -65.74 -24.82 67.04 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.422 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.406 ' HB3' HG12 ' A' ' 87' ' ' ILE . 32.5 mm-40 -63.38 103.98 0.57 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.769 0.319 . . . . 0.0 110.766 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -112.06 155.03 24.49 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.073 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.07 -103.23 0.68 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.39 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.61 130.97 44.6 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.706 0.289 . . . . 0.0 110.551 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.418 HG22 HD13 ' A' ' 87' ' ' ILE . 14.2 mt -126.19 122.48 61.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -93.91 122.87 36.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.444 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.88 134.17 55.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.991 0.424 . . . . 0.0 111.438 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -122.69 115.44 22.08 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.096 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.9 m -138.52 170.27 16.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.59 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.96 136.77 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.863 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.78 121.83 16.31 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.961 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.5 t -115.28 137.47 48.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.086 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.387 179.92 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo . . . . . 0 N--CA 1.49 1.301 0 CA-C-O 120.671 0.196 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 tt -83.29 141.31 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.379 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -122.45 132.82 54.53 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.122 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -103.48 111.96 24.65 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.501 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.7 t -118.22 138.13 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.815 0.341 . . . . 0.0 111.338 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.408 HD21 ' HG3' ' A' ' 86' ' ' GLU . 2.5 tt -108.34 127.54 53.96 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.855 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 tp -115.01 144.1 44.15 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.034 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mt -109.22 116.17 31.39 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.964 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.57 137.86 52.31 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.07 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -114.99 167.66 10.6 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.706 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.82 -38.21 72.28 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.192 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -84.07 -25.26 29.94 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.529 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -92.08 173.91 7.59 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.787 0.327 . . . . 0.0 111.498 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -132.83 -146.4 5.59 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.998 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 mt -82.79 -66.59 0.87 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.525 0.203 . . . . 0.0 111.168 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.16 4.52 35.54 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.694 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 pp -146.44 147.96 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 117.297 0.549 . . . . 0.0 111.114 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.1 t -101.85 137.84 39.61 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.727 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.2 pt -116.11 153.82 17.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.543 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.9 t -141.9 152.16 43.31 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.37 -152.55 19.82 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.496 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.57 119.74 0.49 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.934 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.91 -35.61 75.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.522 0.201 . . . . 0.0 111.328 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.39 -31.03 65.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.139 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -78.48 -27.52 46.26 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.138 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.76 26.53 5.54 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.807 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.1 m -141.1 133.29 14.02 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 116.787 0.293 . . . . 0.0 111.082 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.27 157.6 39.47 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.823 2.349 . . . . 0.0 112.157 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.5 mm -82.48 130.68 35.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.733 0.301 . . . . 0.0 110.44 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.7 mp -121.78 156.29 33.5 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.604 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.8 mm -88.05 124.83 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.1 m -117.73 -45.02 2.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.557 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.51 145.23 33.39 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.796 0.331 . . . . 0.0 111.254 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 12.6 mt -132.94 113.46 20.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.566 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -71.76 126.45 91.48 Favored Pre-proline 0 C--O 1.232 0.145 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.823 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.8 154.39 63.63 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.774 2.316 . . . . 0.0 112.624 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.38 32.95 80.66 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.774 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.96 175.19 3.81 Favored Pre-proline 0 C--O 1.233 0.213 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -51.13 -33.11 42.5 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.672 2.248 . . . . 0.0 112.774 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.03 -46.14 85.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.214 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.12 -38.75 72.31 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.837 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -61.62 -33.96 74.83 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.795 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.5 p -90.35 -27.36 19.43 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.598 0.221 . . . . 0.0 111.598 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.58 16.14 65.04 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.109 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.68 -28.7 5.87 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.403 -0.427 . . . . 0.0 112.73 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.5 mt -77.1 71.72 3.6 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.245 0.545 . . . . 0.0 110.497 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -86.1 157.41 20.05 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.278 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 26.1 t -66.42 137.95 23.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.065 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.25 36.58 9.72 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.543 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -100.29 150.1 22.92 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.55 121.08 37.63 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.619 0.247 . . . . 0.0 111.416 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mt -81.72 148.05 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.519 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 36.8 mt -131.44 -51.51 1.0 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.993 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.73 145.81 47.04 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.911 0.386 . . . . 0.0 111.759 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.74 115.67 40.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.294 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 57.4 34.24 24.39 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.656 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.05 -19.02 44.85 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.68 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.8 t -88.05 137.37 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 117.268 0.534 . . . . 0.0 111.078 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -71.26 132.81 45.48 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.265 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.6 tp -89.95 -29.36 18.54 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.183 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -18.93 65.41 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.775 -0.193 . . . . 0.0 111.394 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.14 9.22 34.45 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.4 t -133.77 165.69 24.39 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.559 0.219 . . . . 0.0 110.751 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.05 161.0 16.79 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.064 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -55.66 -51.4 67.36 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.181 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -61.38 -43.13 99.4 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.889 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.0 -38.26 88.03 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.917 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.79 -30.73 71.79 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.564 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.86 -45.02 99.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 120.789 0.328 . . . . 0.0 110.312 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.4 -40.14 96.4 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.595 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.5 mt -61.09 -41.73 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.884 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 69.4 mt -61.71 -39.23 90.77 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.783 179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.6 m -64.39 -32.48 74.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.895 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -65.18 -29.25 70.06 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.243 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -65.43 106.33 1.37 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.759 0.314 . . . . 0.0 110.808 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.52 148.7 29.87 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.222 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.94 -100.95 0.43 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.618 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.408 ' HG3' HD21 ' A' ' 14' ' ' LEU . 9.2 tt0 -88.37 128.34 35.51 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.645 0.259 . . . . 0.0 110.436 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.413 HD13 HG23 ' A' ' 87' ' ' ILE . 19.0 mt -128.96 122.5 56.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.149 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -97.14 138.49 34.57 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.814 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -133.37 129.91 38.06 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.088 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -113.25 115.2 27.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.272 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.91 169.36 21.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.511 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.6 t -138.66 136.53 43.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.937 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.55 123.58 22.17 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.753 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.7 m -122.58 113.35 37.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.078 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.453 -179.715 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.489 1.217 0 CA-C-O 120.689 0.204 . . . . 0.0 111.834 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.7 mp -79.18 140.19 17.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.185 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.16 132.74 54.61 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.994 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.84 118.2 35.99 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.607 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.2 m -128.94 142.17 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.394 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.7 mt -105.45 122.55 46.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -109.79 139.66 44.59 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.953 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 49.9 mt -111.77 119.08 37.39 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.768 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.64 130.56 54.9 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.991 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.69 163.72 16.43 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.95 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.38 -38.57 71.64 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.185 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -86.39 -23.5 26.1 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.801 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -92.53 161.34 14.65 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.933 0.396 . . . . 0.0 111.232 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.87 -158.88 10.0 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.91 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.98 -67.43 0.54 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.575 0.226 . . . . 0.0 110.982 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.63 4.43 67.78 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.701 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.3 pt -136.77 143.73 34.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 117.459 0.63 . . . . 0.0 111.331 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.2 m -105.17 136.61 44.34 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.716 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.5 pt -121.98 155.7 26.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.483 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.8 p -139.35 173.88 11.09 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.368 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.74 -159.49 19.05 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.668 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.53 125.07 0.78 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.861 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -61.06 -37.79 83.91 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.455 0.169 . . . . 0.0 111.289 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.4 -31.22 72.33 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.206 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -78.38 -29.26 47.26 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.108 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.77 30.24 3.56 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.93 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.8 m -144.06 132.62 11.09 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-N 116.838 0.319 . . . . 0.0 111.108 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -61.14 157.33 40.2 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.614 2.209 . . . . 0.0 112.153 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 24.6 mm -83.75 127.99 39.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.632 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.1 149.97 51.58 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.407 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 30.5 mm -75.98 114.9 16.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.577 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -84.11 -45.9 12.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.382 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -145.04 161.51 39.24 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.861 0.362 . . . . 0.0 111.273 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.0 mp -132.13 116.69 30.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.68 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -65.9 133.48 94.91 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.069 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.91 153.08 47.37 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.797 2.331 . . . . 0.0 112.756 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.57 31.5 62.88 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.676 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.441 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.2 OUTLIER -129.34 169.4 13.27 Favored Pre-proline 0 C--O 1.233 0.196 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 9.8 Cg_endo -53.92 -26.98 42.35 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.684 2.256 . . . . 0.0 112.721 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.431 ' HB3' ' CB ' ' A' ' 54' ' ' LEU . . . -57.37 -46.07 83.75 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.197 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.62 -38.63 73.95 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.862 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -56.83 -39.41 74.18 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.244 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.66 -27.76 64.28 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.755 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.79 19.96 75.51 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.678 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -119.8 -31.68 1.3 Allowed Glycine 0 C--N 1.338 0.681 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.17 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.431 ' CB ' ' HB3' ' A' ' 48' ' ' ALA . 4.3 mm? -70.01 89.2 0.6 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.104 0.478 . . . . 0.0 110.413 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -111.08 157.54 19.87 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.339 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.7 t -63.19 140.05 20.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.291 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.15 52.92 8.24 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.871 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -112.19 139.02 48.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.22 0.208 . . . . 0.0 111.211 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.65 127.14 53.4 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.8 mt -91.54 148.08 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 120.852 0.358 . . . . 0.0 111.631 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 78.8 mt -133.33 -52.94 0.89 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.806 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.99 147.68 46.42 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.865 0.364 . . . . 0.0 111.385 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.32 115.66 16.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.409 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 57.99 33.36 23.1 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.214 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.76 -16.03 57.64 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.24 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.7 t -88.68 137.33 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 117.065 0.433 . . . . 0.0 110.912 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -76.5 135.58 39.34 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.305 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.1 tt -96.71 -26.71 15.07 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.406 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -18.1 63.15 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -97.52 11.78 35.67 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 t -133.48 150.69 51.72 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.752 0.311 . . . . 0.0 111.11 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -75.67 161.25 29.25 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.359 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -53.92 -52.03 61.88 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.104 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -61.84 -42.44 99.04 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.947 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -64.61 -38.54 91.36 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.102 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.59 -33.31 75.33 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.363 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 37.2 t -62.09 -43.7 98.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.76 0.314 . . . . 0.0 110.341 179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 29.3 m -60.54 -43.6 97.03 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.602 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 64.7 mt -58.45 -42.72 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.623 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.25 -40.75 78.27 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.838 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.5 t -62.79 -36.26 82.54 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.773 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -65.35 -24.89 67.37 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.269 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.433 ' HB3' HG12 ' A' ' 87' ' ' ILE . 38.2 mm-40 -65.45 91.48 0.12 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.932 0.396 . . . . 0.0 110.755 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.37 149.61 24.6 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.984 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.46 -98.7 0.29 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.291 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -92.75 137.6 32.22 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.703 0.287 . . . . 0.0 110.524 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.433 HG12 ' HB3' ' A' ' 83' ' ' GLN . 15.0 mt -137.62 124.44 28.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -101.27 129.9 47.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.694 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.89 129.03 54.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.782 0.325 . . . . 0.0 110.786 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.72 116.3 25.66 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.017 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 9.0 m -138.85 171.6 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.985 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.18 132.16 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.722 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.66 127.46 33.04 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.724 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.5 t -114.84 135.33 55.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.364 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.44 -0.79 . . . . 0.0 111.11 179.802 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo . . . . . 0 N--CA 1.489 1.252 0 CA-C-O 120.685 0.202 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 31.3 mt -87.3 142.27 13.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.166 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -122.04 129.25 52.26 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.95 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.4 118.2 36.15 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.694 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.1 t -127.7 141.25 46.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.379 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.5 mt -102.54 128.13 49.32 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 tp -112.87 136.98 51.91 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.142 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.63 116.37 31.86 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.826 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.17 153.96 47.21 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.113 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.99 164.17 13.43 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.038 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -57.63 -38.53 75.14 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.966 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -79.33 -27.94 42.1 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.298 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.68 161.84 22.01 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.849 0.357 . . . . 0.0 111.324 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.32 -146.31 19.22 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.944 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.3 tp -87.64 -52.74 5.16 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.552 0.215 . . . . 0.0 111.319 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.12 -11.64 51.99 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.418 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.46 HD13 HG21 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -140.35 151.89 21.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.931 0.366 . . . . 0.0 111.041 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.51 136.71 47.66 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.029 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.8 pt -116.15 153.22 17.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.489 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.8 t -143.59 145.64 32.67 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.012 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.71 -170.07 15.95 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.497 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.92 122.5 0.82 Allowed Glycine 0 C--N 1.335 0.528 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.801 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -30.27 65.47 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -30.94 65.35 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.61 0.243 . . . . 0.0 111.069 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -79.45 -32.66 42.74 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.978 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.95 -29.9 3.02 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.669 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 11.6 m -101.86 132.83 21.18 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-O 120.707 0.289 . . . . 0.0 111.196 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 35.6 Cg_exo -61.09 157.21 40.44 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.799 2.333 . . . . 0.0 112.295 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -83.25 138.02 19.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.817 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.44 163.12 31.21 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.295 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.5 mt -85.28 120.19 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.262 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 t -108.43 -33.07 7.18 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.633 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.37 144.93 44.42 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.677 0.275 . . . . 0.0 111.126 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.3 mm -125.96 121.63 60.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.647 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -75.73 121.07 84.35 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.881 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.8 155.57 62.27 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.774 2.316 . . . . 0.0 112.545 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.93 38.24 95.8 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.354 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.77 176.06 3.17 Favored Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.33 -29.5 30.49 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.643 2.228 . . . . 0.0 112.77 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.16 -46.19 86.15 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.992 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.55 -42.11 75.01 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.763 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -59.73 -33.27 71.42 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.429 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.2 t -83.35 -28.19 29.16 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.85 16.66 59.64 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.091 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.88 -29.39 2.86 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.197 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.0 mt -76.09 71.84 2.87 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.142 0.496 . . . . 0.0 110.753 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -84.15 157.25 21.75 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.058 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.4 t -65.08 135.01 28.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.44 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.25 47.11 3.91 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.554 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.06 124.28 51.2 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.5 121.2 32.98 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.722 0.296 . . . . 0.0 111.194 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.5 mt -70.72 142.2 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.575 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.4 mt -127.29 -53.82 1.37 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.969 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.54 158.76 43.99 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.882 0.372 . . . . 0.0 111.813 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.4 HG21 HD13 ' A' ' 68' ' ' LEU . 15.1 t -133.66 117.52 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.727 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.08 37.47 28.64 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.95 0.405 . . . . 0.0 110.964 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.52 6.09 89.43 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.441 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.4 t -97.79 119.95 46.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 117.278 0.539 . . . . 0.0 110.699 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -63.83 126.79 28.75 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.4 HD13 HG21 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -113.02 4.19 16.57 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.686 179.817 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -68.84 -34.83 76.14 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.447 0.165 . . . . 0.0 111.133 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.67 11.9 33.54 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.423 HG22 ' CD1' ' A' ' 79' ' ' ILE . 15.8 m -100.97 156.39 17.42 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.645 0.259 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -92.62 161.22 14.66 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.535 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -54.47 -50.69 67.13 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.054 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.16 -39.5 90.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.788 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.56 -38.78 92.18 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.059 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.6 -32.79 74.37 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.362 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 40.8 t -61.85 -41.53 91.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.763 0.316 . . . . 0.0 110.56 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -41.89 74.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.899 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.423 ' CD1' HG22 ' A' ' 71' ' ' THR . 11.6 mt -62.74 -48.69 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.651 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.2 pp -62.36 -35.17 78.29 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.019 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.3 m -65.91 -33.88 76.85 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.136 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -65.26 -27.74 68.86 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.232 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -65.16 111.74 3.08 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.904 0.383 . . . . 0.0 111.119 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -105.19 143.79 32.88 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.109 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.77 -105.12 0.83 Allowed Glycine 0 C--N 1.337 0.59 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.894 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -81.2 127.16 32.37 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.723 0.297 . . . . 0.0 110.665 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.2 mt -127.95 122.39 58.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.05 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -93.87 130.77 39.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.438 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -126.25 129.75 49.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.764 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.03 115.17 29.29 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.308 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.5 m -135.62 164.03 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.352 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.1 m -129.45 133.54 65.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.838 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.09 117.24 8.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.879 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.6 m -123.76 118.31 53.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.108 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.354 -0.831 . . . . 0.0 111.391 -179.712 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo . . . . . 0 N--CA 1.489 1.246 0 CA-C-O 120.802 0.251 . . . . 0.0 111.84 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.39 118.71 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.213 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.78 130.04 55.38 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.043 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.56 120.24 40.84 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.2 t -125.67 134.25 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.176 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 mt -98.38 124.7 43.19 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.855 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.1 131.55 54.5 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.57 115.42 28.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.777 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.46 129.73 33.66 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.94 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.17 170.71 9.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.992 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -59.27 -38.17 79.44 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.953 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -76.75 -25.77 53.84 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.715 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -91.51 167.61 12.12 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.918 0.39 . . . . 0.0 111.74 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.88 -166.48 12.85 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 115.932 -0.577 . . . . 0.0 113.03 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.08 -68.33 0.38 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.517 0.199 . . . . 0.0 111.255 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.417 ' HA2' ' OE1' ' A' ' 46' ' ' GLN . . . 106.02 4.02 38.92 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.015 -0.612 . . . . 0.0 114.113 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.44 HG21 HD11 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -145.13 153.92 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 117.341 0.571 . . . . 0.0 111.101 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.2 136.97 38.38 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.654 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.2 pt -116.77 143.59 26.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.292 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.2 t -123.2 158.03 31.72 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.173 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.3 -143.19 15.7 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.357 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.43 134.85 3.35 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.935 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -52.54 -31.15 34.3 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -57.56 -29.4 64.39 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.18 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -93.82 19.48 8.82 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.45 29.09 68.48 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.166 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 8.7 m -147.08 139.64 14.23 Favored Pre-proline 0 CA--C 1.529 0.163 0 CA-C-N 116.704 0.252 . . . . 0.0 111.402 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 29.7 Cg_exo -61.59 155.5 52.96 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.637 2.225 . . . . 0.0 112.229 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.84 139.11 17.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.865 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 mp -134.67 156.75 48.21 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.261 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 27.8 mt -87.6 129.55 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -121.19 -42.83 2.45 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.558 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.57 144.84 35.72 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.71 0.291 . . . . 0.0 111.159 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.0 mt -134.47 133.14 55.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.754 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -102.21 105.65 43.98 Favored Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.885 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.82 150.03 47.64 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.716 2.277 . . . . 0.0 112.545 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.13 -30.81 8.8 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.661 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.417 ' OE1' ' HA2' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -77.23 167.16 38.85 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-O 120.552 0.215 . . . . 0.0 110.754 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.89 -29.01 80.15 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.68 2.253 . . . . 0.0 112.77 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.06 -46.07 92.17 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.784 0.326 . . . . 0.0 110.983 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -70.16 -39.48 75.31 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.744 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -61.69 -29.09 69.87 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.408 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.06 -28.31 63.25 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.34 -54.57 4.77 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.014 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.53 -34.57 27.63 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 121.542 -0.361 . . . . 0.0 113.509 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.418 ' CD2' HG23 ' A' ' 25' ' ' ILE . 0.9 OUTLIER -71.17 93.71 1.09 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.112 0.482 . . . . 0.0 110.602 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -114.4 157.43 22.88 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.36 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.25 130.46 25.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.445 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.49 45.03 4.14 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.435 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.03 122.35 47.51 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 122.149 0.18 . . . . 0.0 110.739 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.14 122.66 33.96 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.639 0.257 . . . . 0.0 111.16 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.9 mt -76.72 145.79 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.412 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 mt -139.68 -51.48 0.51 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.123 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.47 146.02 50.27 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.972 0.415 . . . . 0.0 111.878 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.7 t -135.82 115.73 17.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.367 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 54.6 35.34 23.38 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.696 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.64 -18.68 45.21 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 120.993 -0.623 . . . . 0.0 113.713 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.21 128.03 48.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 117.315 0.557 . . . . 0.0 111.052 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -68.06 139.12 56.25 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.044 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.4 tp -108.85 13.2 25.03 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.382 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.2 ttp85 -71.18 -31.59 67.85 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.444 0.164 . . . . 0.0 111.433 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -102.3 10.83 38.91 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.73 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -108.04 132.71 53.26 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -64.59 158.52 24.07 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.149 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -56.66 -50.41 72.15 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.236 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -61.71 -39.32 91.07 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.516 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -64.71 -38.0 89.51 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.84 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.92 -35.37 80.44 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.477 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.0 t -61.95 -39.05 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.639 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 41.2 m -65.05 -48.64 73.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.641 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.8 mt -62.22 -42.65 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.796 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.16 -39.71 75.81 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.853 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -33.06 74.85 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.982 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -65.55 -27.89 68.76 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.325 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 74.2 mm-40 -61.13 114.07 2.92 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.77 0.319 . . . . 0.0 110.956 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.84 144.82 47.14 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.448 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.56 -104.78 1.13 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.513 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -88.01 122.1 31.2 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.753 0.311 . . . . 0.0 110.358 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.45 HD13 HG23 ' A' ' 87' ' ' ILE . 15.5 mt -122.02 125.61 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.968 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.79 127.89 39.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -121.94 129.9 52.89 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.094 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -120.56 115.35 23.24 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.349 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.0 m -140.84 170.1 14.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.435 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 25.1 t -132.55 139.55 49.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.875 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.09 120.2 12.75 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.839 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.0 t -127.03 107.71 17.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.213 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.911 -179.855 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo . . . . . 0 N--CA 1.49 1.302 0 CA-C-O 120.643 0.185 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.9 mp -97.59 139.84 19.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.351 -179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -110.65 115.79 30.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.026 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -97.27 111.59 23.77 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.593 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.7 t -129.95 133.21 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.795 0.331 . . . . 0.0 111.326 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mt -100.97 134.98 43.15 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mp -118.67 119.86 35.7 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.834 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.23 124.25 51.83 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.755 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.04 147.14 45.99 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.291 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -100.37 169.3 9.2 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.161 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.39 -37.98 82.48 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.947 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -72.77 -28.8 62.82 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.048 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -84.96 177.32 7.99 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.779 0.323 . . . . 0.0 111.144 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -125.05 -154.82 8.89 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.111 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.6 mt -71.51 -67.85 0.49 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.6 0.238 . . . . 0.0 111.153 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.7 4.38 63.74 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.059 -0.591 . . . . 0.0 113.71 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.5 pp -143.49 150.39 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 117.284 0.542 . . . . 0.0 111.252 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.515 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 1.1 m -121.62 136.93 54.93 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.733 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.5 pt -123.76 158.27 29.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.489 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -142.59 147.5 35.97 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.088 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.41 -159.59 21.41 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.45 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.23 120.43 0.52 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.613 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -55.22 -34.54 64.03 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.469 0.176 . . . . 0.0 111.354 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -31.23 65.6 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.082 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -77.5 -30.0 52.8 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.055 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.72 -29.96 3.04 Favored Glycine 0 C--N 1.335 0.472 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.888 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 11.5 m -109.48 138.15 20.49 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-O 120.708 0.289 . . . . 0.0 111.402 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 35.8 Cg_exo -61.11 157.17 40.77 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.761 2.308 . . . . 0.0 112.239 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mp -82.36 136.98 21.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.832 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 pp -133.25 162.92 30.49 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.938 0.399 . . . . 0.0 111.672 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 18.4 mt -85.09 129.38 37.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.981 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.9 m -117.13 -38.98 3.27 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.626 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 18.9 tt0 -114.37 145.96 41.16 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.938 0.399 . . . . 0.0 111.412 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.4 mt -131.03 133.49 62.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.513 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -88.75 112.85 53.03 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.026 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.53 139.31 75.39 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.798 2.332 . . . . 0.0 112.401 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.53 -30.14 8.72 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.902 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.472 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -71.17 169.77 13.92 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.638 0.219 . . . . 0.0 110.921 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.472 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 7.1 Cg_endo -50.48 -30.52 27.84 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.753 2.302 . . . . 0.0 112.791 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.13 -46.01 92.33 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.711 0.291 . . . . 0.0 111.004 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.07 -38.94 75.89 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.776 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -58.1 -33.3 68.95 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.488 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.45 -28.01 64.69 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.575 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.84 15.76 60.56 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.859 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.81 -34.94 1.1 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.786 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.92 99.6 0.17 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.928 0.394 . . . . 0.0 110.513 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.426 ' CE1' ' CD2' ' A' ' 93' ' ' TYR . 11.4 p80 -110.43 156.69 20.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.014 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 38.3 t -63.86 132.58 29.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.74 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.94 46.89 2.56 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.635 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.411 ' CG ' HG21 ' A' ' 91' ' ' VAL . 1.3 m-20 -112.59 118.97 36.55 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.96 123.49 34.49 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.928 0.394 . . . . 0.0 111.428 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.0 mt -76.51 134.12 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.785 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.4 mp -126.55 -49.78 1.51 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.565 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.76 145.54 48.52 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.323 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.3 t -139.47 116.59 10.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.543 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 57.95 33.75 23.54 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.999 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.55 -15.4 54.76 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.352 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.8 128.8 41.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 117.151 0.475 . . . . 0.0 110.789 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -80.86 141.23 34.82 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.733 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 mp -117.04 21.07 13.48 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.634 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.42 -34.07 70.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.385 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -103.73 8.49 37.29 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 50.9 p -96.06 179.98 4.88 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.655 0.264 . . . . 0.0 110.831 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.17 161.21 18.08 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.964 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -54.05 -51.01 65.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.973 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -60.57 -42.08 95.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.652 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.24 -37.98 89.38 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.957 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.59 -38.03 89.58 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.249 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.85 -44.41 98.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.702 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.7 m -62.51 -45.28 93.7 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.8 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.8 mt -61.82 -40.55 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.918 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.9 mt -58.14 -39.01 77.67 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.661 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.6 t -67.58 -32.97 74.08 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.005 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -64.91 -28.64 69.67 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.307 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -64.08 110.53 2.19 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.747 0.308 . . . . 0.0 110.957 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -111.63 147.39 35.59 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.122 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.91 -108.12 1.99 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.508 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -82.14 124.8 30.19 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.712 0.291 . . . . 0.0 110.535 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.9 mt -124.76 122.32 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.975 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -94.06 129.77 40.46 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.891 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.12 129.78 51.44 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.267 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -123.58 115.19 21.09 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.022 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.411 HG21 ' CG ' ' A' ' 58' ' ' ASP . 16.5 m -138.67 170.6 16.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.222 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 22.9 m -132.9 138.82 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.808 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.426 ' CD2' ' CE1' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -67.17 116.02 7.5 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.733 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.8 p -101.68 133.8 44.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.184 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.24 -179.872 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 N--CA 1.49 1.309 0 CA-C-O 120.784 0.243 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.9 mp -96.84 143.47 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.136 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.96 145.88 48.87 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.19 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.1 mmtm -114.72 111.47 21.33 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.827 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.1 t -112.85 131.23 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.037 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mp -102.82 126.46 49.97 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 tt -117.58 141.32 48.51 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.224 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.41 127.11 54.13 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.794 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -104.34 121.61 43.72 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.138 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -100.46 156.64 17.16 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.993 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -58.29 -38.29 76.72 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.177 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -86.14 -22.07 27.25 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.32 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -90.03 176.63 6.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.815 0.34 . . . . 0.0 111.282 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.02 -145.37 4.66 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.835 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.8 tp -77.36 -63.16 1.44 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.535 0.207 . . . . 0.0 110.939 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.74 4.52 87.31 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.035 -0.602 . . . . 0.0 114.037 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.1 pt -139.85 164.16 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 117.348 0.574 . . . . 0.0 111.369 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.0 t -121.51 137.33 54.77 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.917 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.4 pt -115.83 152.1 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.632 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.3 p -137.85 153.41 49.6 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.085 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.9 -169.47 13.3 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.84 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.44 119.27 0.52 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.69 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.7 -29.63 68.23 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -31.33 69.2 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.668 0.27 . . . . 0.0 111.117 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -87.69 -28.09 22.02 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.154 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.28 35.67 1.43 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.695 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.3 p -149.35 134.51 9.51 Favored Pre-proline 0 C--O 1.232 0.176 0 CA-C-O 120.652 0.263 . . . . 0.0 110.963 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -65.82 157.72 57.52 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.582 2.188 . . . . 0.0 112.107 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 22.5 mm -82.75 131.07 34.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 mp -132.91 155.04 49.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.445 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.5 mm -80.56 120.13 31.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.852 179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.39 -38.2 5.78 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.387 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.49 145.87 49.29 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.774 0.321 . . . . 0.0 111.214 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 26.8 mt -135.19 114.33 16.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.55 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -71.95 132.87 84.41 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.095 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.82 159.35 45.38 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.819 2.346 . . . . 0.0 112.891 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.14 50.47 66.85 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.482 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.33 175.19 2.87 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 110.59 -0.152 . . . . 0.0 110.59 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -49.84 -34.6 36.98 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.783 2.322 . . . . 0.0 112.966 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.57 -46.14 89.78 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.783 0.325 . . . . 0.0 110.755 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -69.78 -37.44 76.36 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.796 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -57.8 -32.78 67.88 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.416 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.4 m -82.99 -28.14 29.91 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.521 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.61 14.5 60.41 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.991 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.98 -33.58 2.77 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.311 -0.471 . . . . 0.0 112.751 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.37 100.82 0.87 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.984 0.421 . . . . 0.0 110.504 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -113.3 157.14 22.19 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.125 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.3 t -63.95 132.94 29.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.314 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.54 49.32 4.18 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.277 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -109.35 126.6 53.58 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.69 120.99 32.93 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.4 mt -81.06 149.17 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.469 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.9 mt -134.83 -54.9 0.82 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.014 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -148.67 159.84 43.73 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.826 0.346 . . . . 0.0 111.689 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.5 t -137.19 120.35 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.674 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 56.15 36.36 27.29 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.918 0.39 . . . . 0.0 111.138 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.67 13.63 83.33 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.226 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.6 t -98.71 134.88 35.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 117.009 0.404 . . . . 0.0 110.672 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -72.08 126.86 30.82 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.012 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tt -112.15 -17.89 12.69 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.34 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -32.6 72.55 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -98.95 11.91 37.51 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 m -110.02 161.66 15.31 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.815 0.34 . . . . 0.0 111.03 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.9 mmtm -95.7 161.3 14.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.24 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -54.12 -51.54 63.9 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.017 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -62.99 -41.2 99.51 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.829 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -65.02 -38.11 89.84 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.011 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.79 -30.83 71.88 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.385 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.414 ' O ' ' HG ' ' A' ' 80' ' ' LEU . 24.5 t -61.7 -41.82 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.923 0.392 . . . . 0.0 110.624 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.1 m -69.96 -37.94 75.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.101 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 23.2 mt -67.28 -47.19 82.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.384 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 77' ' ' VAL . 3.8 pp -63.91 -34.04 77.07 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.314 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.2 p -73.28 -27.43 61.56 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.85 -0.159 . . . . 0.0 111.221 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -65.25 -28.16 69.16 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.52 0.2 . . . . 0.0 111.348 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -58.67 113.7 2.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.757 0.313 . . . . 0.0 110.902 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.55 146.29 28.35 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.369 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.89 -99.92 0.4 Allowed Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.618 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -92.28 135.8 33.71 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.761 0.315 . . . . 0.0 110.386 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.3 mt -128.36 122.08 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.063 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.37 121.28 40.11 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.513 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -114.54 129.47 56.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 110.895 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -110.1 115.78 30.37 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.154 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.4 m -137.22 168.79 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.79 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.4 t -134.12 132.41 55.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.656 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.28 118.52 10.77 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.741 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.1 p -118.2 135.57 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.084 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.13 -0.938 . . . . 0.0 111.34 -179.694 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo . . . . . 0 N--CA 1.489 1.247 0 CA-C-O 120.55 0.146 . . . . 0.0 111.726 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 tt -78.66 121.81 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.922 0.391 . . . . 0.0 111.247 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.08 135.56 54.08 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.096 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.27 111.5 21.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.638 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.94 142.33 42.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.952 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.81 135.5 39.48 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.975 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.1 tp -108.84 121.91 46.08 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.088 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.21 115.09 29.7 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.671 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -127.52 147.19 50.32 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.111 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.61 161.86 14.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.026 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -56.85 -38.8 73.19 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -80.18 -28.31 38.76 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.462 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -84.56 165.56 17.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.993 0.425 . . . . 0.0 111.606 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -112.06 -169.73 18.3 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.709 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 tp -67.93 -57.38 6.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.446 0.165 . . . . 0.0 111.342 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.54 4.55 63.9 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.767 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.5 pt -144.98 154.98 14.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 117.364 0.582 . . . . 0.0 111.348 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.4 m -113.62 138.14 50.6 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.0 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.0 pt -115.92 154.73 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.601 -179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.0 p -137.63 163.34 31.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.32 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.82 -150.56 19.35 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.778 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.424 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . 153.51 124.47 0.99 Allowed Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.009 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.68 -31.5 57.88 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.1 0.16 . . . . 0.0 111.409 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -57.26 -31.23 65.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.151 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -84.5 -21.36 30.61 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.422 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.05 19.5 5.93 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.993 -0.623 . . . . 0.0 113.284 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 m -147.08 139.65 14.24 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.93 0.365 . . . . 0.0 111.076 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.8 157.39 38.21 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.522 2.148 . . . . 0.0 112.032 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 mp -82.71 126.06 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.676 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 mp -122.54 162.53 21.61 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.908 0.385 . . . . 0.0 111.6 -179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 17.3 mt -94.4 125.67 46.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.797 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.4 m -109.63 -34.6 6.44 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.709 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -123.0 146.79 47.32 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.742 0.306 . . . . 0.0 111.391 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.3 mp -134.21 112.26 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.578 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -71.6 129.88 88.0 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.144 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -74.4 155.72 45.85 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.772 2.315 . . . . 0.0 112.618 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.61 33.33 52.41 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.734 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.92 174.49 4.37 Favored Pre-proline 0 CA--C 1.53 0.205 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.58 -32.14 34.19 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.588 2.192 . . . . 0.0 112.771 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.414 ' HB1' ' CB ' ' A' ' 54' ' ' LEU . . . -61.0 -46.06 92.32 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.164 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.49 -43.86 72.31 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.986 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -58.59 -32.74 69.25 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.496 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -77.07 -27.96 54.46 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.464 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.16 17.78 68.41 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.025 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.8 -29.99 2.28 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 121.11 -0.567 . . . . 0.0 113.171 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.414 ' CB ' ' HB1' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -64.69 96.87 0.19 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.861 0.362 . . . . 0.0 110.823 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -115.8 157.23 24.7 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.252 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.2 t -66.4 131.4 32.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.665 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.04 43.54 3.79 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.931 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.43 119.19 37.38 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.499 0.15 . . . . 0.0 110.794 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -92.06 123.07 35.14 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.644 0.259 . . . . 0.0 111.509 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.8 mt -72.59 137.64 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.214 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.2 mt -125.32 -52.73 1.62 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.775 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.56 145.53 45.1 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.821 0.343 . . . . 0.0 111.475 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.97 116.14 32.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.393 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 58.83 34.6 23.8 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.051 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.65 -15.95 52.37 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.386 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.5 t -88.15 134.6 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 117.146 0.473 . . . . 0.0 110.778 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -71.28 131.53 43.6 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.196 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.8 tp -117.49 1.58 12.33 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.828 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -71.37 -28.1 63.81 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.24 8.18 45.02 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 p -105.3 146.54 29.22 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.751 0.31 . . . . 0.0 111.088 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -71.82 161.19 31.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.113 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.424 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . 46.2 t-80 -54.01 -50.56 66.34 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.933 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.68 -42.98 94.12 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.894 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -67.21 -37.59 83.87 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.841 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.86 -31.32 72.46 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.473 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.3 t -61.83 -40.8 88.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.862 0.363 . . . . 0.0 110.358 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.9 m -65.72 -40.54 92.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.518 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.1 mm -58.13 -43.52 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.643 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.0 mt -60.57 -43.9 96.8 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.671 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.4 t -65.84 -31.54 72.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.091 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -65.15 -28.29 69.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.15 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 48.3 mm-40 -62.65 135.23 57.28 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.793 0.33 . . . . 0.0 111.006 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.23 144.25 48.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.175 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.06 -104.55 0.35 Allowed Glycine 0 C--N 1.335 0.52 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.634 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -82.29 118.2 22.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.853 0.358 . . . . 0.0 110.396 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.6 mt -119.32 123.77 71.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.893 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.63 121.38 35.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.52 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -113.11 129.62 56.45 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.119 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.0 115.19 22.07 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.805 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.2 170.73 15.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.4 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.7 m -131.33 133.52 62.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.835 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.42 115.86 10.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.715 0.293 . . . . 0.0 110.705 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.7 p -126.57 122.65 61.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.952 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.4 -0.81 . . . . 0.0 111.408 -179.536 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.526 ' O ' HG13 ' A' ' 92' ' ' VAL . 3.4 Cg_exo . . . . . 0 N--CA 1.49 1.297 0 CA-C-O 120.725 0.219 . . . . 0.0 111.924 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.536 ' HA ' HG22 ' A' ' 92' ' ' VAL . 2.6 tt -78.97 134.79 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.327 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.9 126.33 51.55 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.034 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.3 mmtm -99.75 114.62 27.87 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.571 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.24 128.91 67.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.789 0.328 . . . . 0.0 111.34 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 mp -98.37 119.92 37.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.846 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.43 HD11 ' HA ' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -113.13 137.98 50.64 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.262 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.402 ' H ' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -97.65 115.38 27.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.772 179.638 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.8 143.78 37.52 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.707 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -114.54 158.56 21.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.182 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.72 -38.35 78.15 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.807 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -77.6 -28.29 51.51 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.423 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -90.02 159.23 16.96 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.903 0.382 . . . . 0.0 111.223 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.35 -165.82 21.97 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.373 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.56 -44.9 85.31 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.673 0.273 . . . . 0.0 110.834 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.22 3.29 90.25 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.335 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.759 HD13 HD12 ' A' ' 39' ' ' ILE . 2.2 pp -146.74 147.11 18.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 117.033 0.416 . . . . 0.0 110.897 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.505 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 3.5 m -108.53 139.78 42.81 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.536 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.762 HG22 HD13 ' A' ' 39' ' ' ILE . 20.2 pt -116.2 156.01 17.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.719 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.5 t -143.96 155.98 44.24 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.33 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.05 -150.1 18.31 Favored Glycine 0 C--N 1.337 0.605 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.393 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.42 109.27 0.22 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.939 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -57.64 -37.28 73.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.586 0.231 . . . . 0.0 111.135 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -58.73 -31.17 68.05 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.949 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -75.86 -24.51 55.75 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.217 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.68 25.4 4.29 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.074 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 m -147.48 140.3 14.69 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.884 0.342 . . . . 0.0 111.244 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.58 157.42 60.78 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.603 2.202 . . . . 0.0 112.285 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.464 HG21 HD12 ' A' ' 27' ' ' ILE . 26.1 mm -82.76 137.9 20.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.757 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 59' ' ' ALA . 2.9 mp -131.82 158.69 40.61 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.594 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.762 HD13 HG22 ' A' ' 27' ' ' ILE . 17.7 mm -83.55 128.64 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.756 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.406 ' O ' HG13 ' A' ' 56' ' ' VAL . 4.1 t -124.14 -44.27 2.04 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.538 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 0.5 OUTLIER -105.38 144.47 32.12 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.758 0.313 . . . . 0.0 111.172 -179.681 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.1 mt -131.47 128.98 61.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.747 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -86.27 114.81 59.4 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.955 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.16 122.11 8.7 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.533 2.155 . . . . 0.0 112.149 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.54 34.85 4.86 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.597 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.97 174.2 4.79 Favored Pre-proline 0 C--O 1.233 0.231 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.41 -32.2 33.16 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.521 2.147 . . . . 0.0 112.76 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.43 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -59.83 -46.19 90.03 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.271 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.85 -40.39 79.42 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.703 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -60.03 -33.44 72.02 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.466 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.6 t -71.65 -28.11 63.53 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.52 15.78 62.13 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.188 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.25 -32.53 1.36 Allowed Glycine 0 C--N 1.338 0.667 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.106 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.467 ' HG ' HG21 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -66.79 94.36 0.3 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.981 0.419 . . . . 0.0 110.682 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -108.87 157.24 18.8 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.97 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 40' ' ' SER . 25.8 t -67.2 133.31 31.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.375 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.18 45.83 3.73 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.535 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.13 124.09 51.68 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 122.22 0.208 . . . . 0.0 110.595 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.542 ' HB2' HD23 ' A' ' 38' ' ' LEU . . . -91.4 120.25 32.09 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.728 0.299 . . . . 0.0 111.177 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.798 ' HA ' HG12 ' A' ' 91' ' ' VAL . 20.5 mt -75.24 139.93 18.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.556 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 61' ' ' LEU . 14.0 mt -128.11 -51.93 1.31 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.703 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -144.54 145.86 32.06 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.854 0.359 . . . . 0.0 111.637 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.0 t -132.83 115.79 25.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.401 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 56.71 38.04 29.24 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.602 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.19 -12.85 42.24 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.449 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.14 128.05 39.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 117.371 0.586 . . . . 0.0 110.83 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.69 130.62 39.84 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.169 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.562 HD11 ' HB1' ' A' ' 76' ' ' ALA . 0.5 OUTLIER -102.48 -23.03 13.95 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.641 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -61.4 -31.07 70.98 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.348 0.129 . . . . 0.0 111.348 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.03 9.74 38.33 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.2 p -120.1 159.87 23.97 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.617 0.246 . . . . 0.0 110.653 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.1 161.02 19.1 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.785 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.623 ' O ' HG23 ' A' ' 77' ' ' VAL . 76.2 t60 -53.95 -47.6 71.13 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.972 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -60.99 -43.04 99.43 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.73 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -64.5 -39.28 93.49 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.975 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.562 ' HB1' HD11 ' A' ' 68' ' ' LEU . . . -63.58 -34.24 77.37 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.57 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 73' ' ' HIS . 38.3 t -62.17 -43.28 97.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.834 0.349 . . . . 0.0 110.441 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.0 m -67.41 -45.72 75.32 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.948 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 76' ' ' ALA . 13.9 mt -60.91 -44.21 97.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.938 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.42 -37.83 79.05 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.678 0.275 . . . . 0.0 110.714 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.7 m -68.65 -28.35 66.81 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.453 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -64.88 -30.85 71.87 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.498 0.19 . . . . 0.0 111.051 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.402 ' HB2' HD13 ' A' ' 87' ' ' ILE . 31.7 mm-40 -66.05 114.47 5.23 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.817 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -114.47 151.87 32.55 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.11 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.72 -102.12 0.42 Allowed Glycine 0 C--N 1.335 0.48 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.556 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -87.98 122.39 31.53 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.654 0.264 . . . . 0.0 110.378 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.402 HD13 ' HB2' ' A' ' 83' ' ' GLN . 21.5 mt -124.73 125.78 70.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.052 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -93.65 123.37 36.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.336 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.53 130.2 56.27 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.928 0.394 . . . . 0.0 111.517 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -121.18 115.17 22.53 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.572 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.798 HG12 ' HA ' ' A' ' 60' ' ' ILE . 5.5 m -137.28 170.94 17.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.351 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.536 HG22 ' HA ' ' A' ' 10' ' ' ILE . 39.7 t -129.07 133.64 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.69 123.66 20.32 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.875 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.0 t -118.71 132.79 67.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.957 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.163 -0.923 . . . . 0.0 111.22 179.93 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 N--CA 1.491 1.34 0 CA-C-O 120.93 0.304 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.699 ' HA ' HG12 ' A' ' 92' ' ' VAL . 4.6 mp -86.06 141.17 14.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -120.82 122.03 39.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -100.21 113.51 26.23 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.773 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.454 HG11 ' HA3' ' A' ' 53' ' ' GLY . 9.2 m -128.27 140.42 49.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.458 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.441 ' C ' HD12 ' A' ' 15' ' ' LEU . 5.1 mp -107.47 126.86 53.03 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.895 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.529 HD11 HD21 ' A' ' 54' ' ' LEU . 10.0 mp -113.08 137.32 51.6 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.097 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -104.32 114.75 29.19 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.8 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -99.78 134.26 42.94 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.994 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.403 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 9.4 mm-40 -115.94 151.55 35.17 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.869 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.14 -33.89 72.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.634 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.403 ' CD2' ' HB3' ' A' ' 18' ' ' GLU . 15.4 p80 -81.6 -27.4 34.24 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.783 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -96.55 166.53 11.64 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.883 0.373 . . . . 0.0 111.451 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -105.47 -150.51 19.43 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.091 -0.575 . . . . 0.0 112.679 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 25' ' ' ILE . 6.6 tp -78.5 -58.96 2.98 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.689 0.281 . . . . 0.0 110.96 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.77 4.35 75.85 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.687 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.615 HG22 HG23 ' A' ' 42' ' ' ILE . 23.5 pt -140.61 143.46 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 117.259 0.529 . . . . 0.0 111.126 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 t -112.03 136.79 50.93 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.812 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.688 HD12 HG21 ' A' ' 37' ' ' ILE . 26.8 pt -125.29 153.86 33.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.597 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.8 p -139.18 145.35 39.23 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.224 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.18 -155.83 16.85 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.694 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.1 126.02 1.56 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.49 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.7 tptt -54.6 -35.64 63.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.393 0.14 . . . . 0.0 111.136 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.481 ' HG3' ' HG2' ' A' ' 72' ' ' LYS . 0.5 OUTLIER -62.77 -30.62 71.59 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.198 179.653 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -79.31 -34.7 42.12 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.106 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.23 -21.6 3.86 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.865 -0.684 . . . . 0.0 113.292 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 23.8 m -123.03 144.31 42.88 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 117.006 0.403 . . . . 0.0 111.201 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 34.8 Cg_exo -60.87 155.97 46.38 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.749 2.3 . . . . 0.0 112.442 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.688 HG21 HD12 ' A' ' 27' ' ' ILE . 2.2 mt -84.0 130.66 35.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.851 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.525 HD23 ' CB ' ' A' ' 59' ' ' ALA . 0.8 OUTLIER -132.24 156.52 46.34 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.027 -179.53 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.545 HD12 ' CB ' ' A' ' 58' ' ' ASP . 32.1 mt -81.08 121.87 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.902 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.4 m -106.2 -29.74 9.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.682 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.95 149.64 48.98 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.711 0.291 . . . . 0.0 111.357 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.615 HG23 HG22 ' A' ' 25' ' ' ILE . 3.4 mp -133.98 114.22 19.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.664 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -72.09 131.4 85.4 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.233 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.37 172.42 16.27 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.961 2.441 . . . . 0.0 112.903 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.62 18.52 61.56 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.784 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.46 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -124.97 169.28 11.34 Favored Pre-proline 0 N--CA 1.455 -0.184 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 9.8 Cg_endo -52.55 -29.1 39.15 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.62 2.214 . . . . 0.0 112.57 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.465 ' HB1' ' HG ' ' A' ' 54' ' ' LEU . . . -63.09 -46.46 87.29 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.317 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -65.32 -40.24 93.48 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.871 0.367 . . . . 0.0 110.605 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.69 -28.47 65.88 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.319 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 11.5 m -70.37 -28.24 64.95 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.42 -55.31 4.64 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.889 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.454 ' HA3' HG11 ' A' ' 13' ' ' VAL . . . -53.03 -27.84 31.34 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 121.474 -0.393 . . . . 0.0 113.609 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.529 HD21 HD11 ' A' ' 15' ' ' LEU . 4.3 mm? -68.14 88.86 0.3 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.003 0.401 . . . . 0.0 110.52 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -118.43 157.24 27.58 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.219 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.7 t -63.28 130.06 27.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.63 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.05 46.37 3.63 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.466 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.545 ' CB ' HD12 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -107.01 125.73 51.4 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.475 0.178 . . . . 0.0 110.544 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.525 ' CB ' HD23 ' A' ' 38' ' ' LEU . . . -91.25 121.61 33.15 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.769 0.319 . . . . 0.0 111.366 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.658 ' HA ' HG12 ' A' ' 91' ' ' VAL . 21.9 mt -78.21 130.78 35.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.268 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.1 mt -124.27 -51.97 1.75 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.643 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -145.06 148.89 34.18 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.859 0.361 . . . . 0.0 111.448 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 t -136.98 115.75 14.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.424 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 58.35 33.14 22.86 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.097 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.93 -15.24 58.31 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.181 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.07 133.77 29.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 117.143 0.471 . . . . 0.0 110.891 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -79.17 129.67 34.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.96 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.562 HD21 ' CB ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -105.8 -21.36 13.19 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.645 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.6 ttt85 -60.95 -34.58 74.96 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.662 0.267 . . . . 0.0 110.902 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -84.25 -26.14 28.87 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.656 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.2 p -78.53 167.28 21.51 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.889 0.376 . . . . 0.0 111.011 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.481 ' HG2' ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -93.87 161.03 14.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.645 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.548 ' O ' HG23 ' A' ' 77' ' ' VAL . 6.5 t-160 -54.26 -47.52 72.19 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.892 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -64.76 -40.42 95.25 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.096 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.93 -37.67 86.65 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.913 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.693 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.71 -30.88 71.93 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.328 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 73' ' ' HIS . 24.5 t -61.4 -43.43 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.847 0.356 . . . . 0.0 110.554 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.6 m -65.76 -44.69 85.1 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.706 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 76' ' ' ALA . 7.3 mt -63.78 -44.04 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.0 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.6 mt -56.4 -42.96 78.83 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.756 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.9 t -68.24 -31.2 70.53 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.038 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -65.13 -24.17 67.34 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.571 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.411 ' HB3' HG12 ' A' ' 87' ' ' ILE . 41.7 mm-40 -62.97 97.86 0.12 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.808 0.337 . . . . 0.0 110.891 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.61 146.67 26.19 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.261 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.82 -106.37 1.47 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.555 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -87.74 143.1 27.33 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.73 0.3 . . . . 0.0 110.495 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.411 HG12 ' HB3' ' A' ' 83' ' ' GLN . 11.6 mt -136.95 122.33 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.033 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -96.64 124.35 40.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.613 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -112.58 129.61 56.31 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.791 0.329 . . . . 0.0 111.139 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -118.89 115.31 24.13 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.23 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' A' ' 60' ' ' ILE . 23.7 m -143.93 169.24 10.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.499 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.699 HG12 ' HA ' ' A' ' 10' ' ' ILE . 11.1 m -134.33 138.37 50.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.055 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.0 123.67 21.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.903 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.2 m -114.45 143.82 23.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.402 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.039 -0.981 . . . . 0.0 111.545 -179.884 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo . . . . . 0 N--CA 1.49 1.319 0 CA-C-O 120.814 0.256 . . . . 0.0 111.822 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.413 ' HA ' HG22 ' A' ' 92' ' ' VAL . 73.1 mt -80.27 142.98 13.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.55 138.63 51.78 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.08 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.408 ' HD2' ' HG3' ' A' ' 90' ' ' GLU . 1.1 mptm? -115.33 117.43 30.42 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.4 t -132.67 141.01 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.143 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 87' ' ' ILE . 0.4 OUTLIER -97.83 132.5 43.38 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.978 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.07 119.44 37.87 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.749 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.458 HD11 HD22 ' A' ' 14' ' ' LEU . 7.0 mp -110.3 114.25 27.56 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.343 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.0 ptmm? -128.15 146.1 50.81 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.265 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.457 ' HB2' ' HG3' ' A' ' 21' ' ' GLU . 0.4 OUTLIER -75.95 165.23 25.28 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.117 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.07 -36.28 70.37 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.846 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 44.8 p-80 -79.91 -29.81 39.93 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.411 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.457 ' HG3' ' HB2' ' A' ' 18' ' ' GLU . 7.0 mt-10 -70.61 167.57 18.26 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.924 0.393 . . . . 0.0 111.943 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.28 -157.72 10.05 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.293 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.648 HD22 HG13 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -62.48 -62.52 1.69 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.506 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.94 -14.72 28.89 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.608 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.749 HG21 HD23 ' A' ' 54' ' ' LEU . 2.2 pt -143.74 164.1 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 117.186 0.493 . . . . 0.0 111.379 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.9 t -106.93 136.7 46.33 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.697 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.2 pt -118.69 153.11 20.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.241 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -143.2 144.63 32.25 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.248 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.19 -165.98 29.44 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.429 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.84 112.29 0.31 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.794 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -58.21 -37.94 75.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.453 0.168 . . . . 0.0 111.289 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -65.47 -30.96 71.81 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.011 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -73.35 -28.62 62.16 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.07 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.37 22.41 6.14 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.069 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.1 p -149.69 130.95 7.29 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.873 0.337 . . . . 0.0 111.044 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.34 155.61 50.98 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.612 2.208 . . . . 0.0 112.231 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mp -83.04 133.9 28.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.774 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.51 159.65 38.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.485 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.498 HD13 HD13 ' A' ' 25' ' ' ILE . 23.1 mt -80.17 122.82 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.993 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.7 -30.46 8.56 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.709 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -130.69 155.5 46.51 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.858 0.361 . . . . 0.0 111.513 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.735 ' HA ' HG22 ' A' ' 25' ' ' ILE . 48.4 mt -130.36 114.09 27.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.739 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -81.59 128.38 69.65 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.914 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.29 159.89 42.99 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.706 2.271 . . . . 0.0 112.799 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.12 33.07 57.66 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.809 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.97 170.8 8.66 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.43 -30.73 54.69 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.647 2.232 . . . . 0.0 112.953 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.81 -46.14 81.79 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.729 0.3 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -70.52 -41.25 72.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.794 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -64.59 -28.72 69.82 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.566 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -28.36 64.09 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.486 0.184 . . . . 0.0 111.473 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.41 16.85 51.35 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.054 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.06 -31.63 1.08 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.071 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.749 HD23 HG21 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -68.68 92.8 0.49 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.827 0.346 . . . . 0.0 110.592 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -98.82 156.86 16.65 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.247 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.8 t -64.2 135.43 27.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.564 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.57 50.57 3.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.127 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.462 ' CB ' HD12 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -111.3 124.56 52.47 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.491 0.186 . . . . 0.0 110.624 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.577 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -91.1 120.44 32.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.901 0.382 . . . . 0.0 111.103 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.811 ' HA ' HG12 ' A' ' 91' ' ' VAL . 17.2 mt -73.71 144.67 12.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.908 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.7 mt -129.45 -53.49 1.17 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.57 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.26 145.94 33.18 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.976 0.417 . . . . 0.0 111.829 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.597 HG11 HD23 ' A' ' 80' ' ' LEU . 21.1 t -130.87 116.77 35.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.511 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.77 36.45 27.71 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.675 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.8 -16.35 46.99 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.507 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.37 135.14 25.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 117.229 0.515 . . . . 0.0 111.179 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -78.67 131.25 36.57 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.084 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.606 HD11 ' HB1' ' A' ' 76' ' ' ALA . 0.5 OUTLIER -89.01 -27.89 20.55 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.979 179.442 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -67.3 -27.17 66.94 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.393 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -91.5 11.77 22.97 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 t -138.79 174.33 10.64 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.637 0.256 . . . . 0.0 110.812 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.43 160.97 14.12 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.047 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.669 ' O ' HG23 ' A' ' 77' ' ' VAL . 44.1 t-80 -56.11 -51.72 66.89 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.182 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.64 -43.12 84.65 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.964 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -67.2 -37.78 84.22 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.854 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.729 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.87 -33.72 76.34 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.363 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 73' ' ' HIS . 22.0 t -61.72 -39.18 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.837 0.351 . . . . 0.0 110.504 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 49.9 m -65.37 -44.65 86.94 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.493 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' ' 76' ' ' ALA . 12.8 mt -61.73 -41.37 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.919 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.597 HD23 HG11 ' A' ' 63' ' ' VAL . 6.7 mt -60.44 -39.69 88.41 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.627 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.5 t -66.22 -30.92 71.46 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.185 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -65.24 -28.92 69.69 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.333 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.475 ' HB3' HG23 ' A' ' 87' ' ' ILE . 16.8 mm-40 -68.31 111.64 4.72 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.873 0.368 . . . . 0.0 110.844 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.55 148.86 26.8 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.332 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.68 -102.18 0.42 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.581 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -90.09 132.03 35.64 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.908 0.385 . . . . 0.0 110.508 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.475 HG23 ' HB3' ' A' ' 83' ' ' GLN . 12.4 mt -129.9 133.22 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.07 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.71 122.36 36.09 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.715 0.293 . . . . 0.0 110.705 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.91 130.61 55.82 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.526 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.408 ' HG3' ' HD2' ' A' ' 12' ' ' LYS . 8.2 tt0 -122.18 115.56 22.62 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.581 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.811 HG12 ' HA ' ' A' ' 60' ' ' ILE . 5.2 m -136.64 170.57 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.479 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.413 HG22 ' HA ' ' A' ' 10' ' ' ILE . 17.3 t -133.94 143.66 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.308 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.2 126.04 28.56 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.967 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.577 HG21 ' HB2' ' A' ' 59' ' ' ALA . 21.7 t -113.6 118.79 59.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.015 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.208 179.957 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.49 1.271 0 CA-C-O 120.71 0.212 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.1 tt -89.59 124.93 42.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.277 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -123.99 153.38 41.37 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.082 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.431 ' HG3' ' HG2' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -114.79 120.05 38.72 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.56 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.0 m -129.36 135.29 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.708 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.69 136.71 40.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.834 0.349 . . . . 0.0 111.131 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.0 mp -113.12 124.04 51.65 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.692 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 tt -102.74 115.33 30.39 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.708 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -129.4 134.12 47.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.104 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -90.63 172.87 8.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.887 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.66 -36.94 70.13 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -74.84 -30.87 61.49 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.27 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -79.39 179.42 7.45 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.87 0.367 . . . . 0.0 111.323 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.1 -143.13 4.95 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.014 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.67 -66.97 0.82 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.49 0.186 . . . . 0.0 111.369 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.61 -15.56 45.36 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.614 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.746 HG22 HG23 ' A' ' 42' ' ' ILE . 2.2 pp -140.84 157.76 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 117.304 0.552 . . . . 0.0 111.241 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 t -114.49 137.4 51.9 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.557 HG22 HG12 ' A' ' 39' ' ' ILE . 17.0 pt -116.16 151.56 17.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.472 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.2 t -143.61 145.11 32.24 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.065 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 129.72 -172.96 19.87 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.441 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . -178.87 116.54 0.53 Allowed Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.454 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -52.35 -37.68 56.74 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.432 ' HB2' ' HG3' ' A' ' 72' ' ' LYS . 50.5 tt0 -59.32 -31.16 68.9 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.725 0.298 . . . . 0.0 110.993 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -72.66 -31.31 64.98 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.937 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.18 -23.63 3.16 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.999 -0.619 . . . . 0.0 113.102 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.04 149.7 54.67 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.815 0.307 . . . . 0.0 111.291 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.25 157.53 61.43 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.662 2.241 . . . . 0.0 112.275 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.414 ' H ' HD12 ' A' ' 37' ' ' ILE . 3.4 mp -82.42 129.86 36.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.578 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.76 161.55 29.49 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.857 0.361 . . . . 0.0 111.607 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.606 HD13 HD21 ' A' ' 54' ' ' LEU . 32.9 mt -82.84 123.29 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.059 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.8 m -106.9 -30.03 9.12 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.578 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -123.95 145.09 49.39 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.865 0.364 . . . . 0.0 111.395 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.746 HG23 HG22 ' A' ' 25' ' ' ILE . 32.2 mt -131.02 114.3 26.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.486 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -85.02 114.46 56.03 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.775 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -62.32 175.34 2.11 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.015 2.477 . . . . 0.0 112.967 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.73 34.91 91.16 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.147 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.16 173.18 4.94 Favored Pre-proline 0 CA--C 1.531 0.242 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.42 -30.86 36.3 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.714 2.276 . . . . 0.0 113.022 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.23 -46.19 89.14 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.696 0.284 . . . . 0.0 111.1 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.98 -38.34 76.0 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.803 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -32.02 73.43 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.216 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.11 -28.28 61.28 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.518 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.84 16.51 61.65 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.054 -0.594 . . . . 0.0 113.089 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.69 -33.75 1.15 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.203 -0.523 . . . . 0.0 113.066 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.606 HD21 HD13 ' A' ' 39' ' ' ILE . 1.1 tt -67.72 105.31 1.88 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.881 0.372 . . . . 0.0 110.662 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.512 ' C ' HD11 ' A' ' 42' ' ' ILE . 12.6 p80 -114.86 157.35 23.43 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.207 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.431 ' N ' HD11 ' A' ' 42' ' ' ILE . 13.8 p -62.97 139.69 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.127 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.5 49.66 5.08 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.216 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.8 126.63 55.27 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.433 0.159 . . . . 0.0 110.763 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -90.68 128.11 36.53 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.712 0.292 . . . . 0.0 110.687 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.766 HG21 HD22 ' A' ' 68' ' ' LEU . 12.3 mt -74.7 104.05 2.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.695 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -86.46 -50.64 6.73 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.409 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -150.13 146.15 26.73 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.605 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.1 t -127.92 115.71 40.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.652 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 54.96 37.07 28.24 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.99 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.25 -14.16 58.22 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.375 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.0 t -86.12 127.21 40.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 117.181 0.49 . . . . 0.0 110.97 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -71.55 141.16 50.1 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.949 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.766 HD22 HG21 ' A' ' 60' ' ' ILE . 1.2 tp -116.03 -1.23 12.54 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.722 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -34.25 70.69 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.3 11.59 37.9 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.3 p -109.47 163.66 13.22 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.741 0.305 . . . . 0.0 110.93 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.432 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 2.3 mppt? -94.62 161.11 14.33 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.03 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.597 ' O ' HG23 ' A' ' 77' ' ' VAL . 36.3 t60 -53.95 -49.66 68.21 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.812 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -43.06 88.15 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.758 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -64.81 -38.34 90.65 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.973 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.52 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -63.63 -41.42 98.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.991 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 73' ' ' HIS . 21.7 t -62.67 -39.88 86.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.052 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -46.62 71.39 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.009 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.446 HG22 HE21 ' A' ' 83' ' ' GLN . 14.6 mt -62.21 -39.61 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.557 0.218 . . . . 0.0 110.752 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.636 HD21 ' CE2' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -59.97 -42.39 94.02 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.178 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.9 p -64.82 -32.12 73.67 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.304 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -64.95 -28.81 69.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.05 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.485 ' HB3' HG23 ' A' ' 87' ' ' ILE . 24.4 mm-40 -62.01 114.22 3.26 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.853 0.358 . . . . 0.0 110.856 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.0 ptt85 -118.63 152.29 36.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.426 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.04 -103.23 0.55 Allowed Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.592 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -89.96 119.06 30.0 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.788 0.328 . . . . 0.0 110.402 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.485 HG23 ' HB3' ' A' ' 83' ' ' GLN . 18.4 mt -121.04 122.5 67.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.031 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -93.78 122.08 35.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.681 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.636 ' CE2' HD21 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -116.31 129.81 56.46 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.943 0.401 . . . . 0.0 111.203 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.431 ' HG2' ' HG3' ' A' ' 12' ' ' LYS . 23.6 mt-10 -120.09 115.4 23.61 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.007 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 60' ' ' ILE . 8.2 m -137.08 163.7 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.733 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.9 t -131.76 146.08 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.15 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.401 ' CG ' ' CE1' ' A' ' 55' ' ' HIS . 0.1 OUTLIER -70.47 129.07 38.27 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.758 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.32 141.19 43.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.901 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.117 -0.945 . . . . 0.0 111.315 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.532 ' O ' HG23 ' A' ' 92' ' ' VAL . 4.6 Cg_endo . . . . . 0 N--CA 1.49 1.297 0 CA-C-O 120.852 0.272 . . . . 0.0 111.939 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 tt -78.8 132.76 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.381 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -123.71 135.25 53.76 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.057 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.86 126.6 48.78 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.581 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.3 m -128.58 143.14 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.592 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 pp -114.69 132.23 56.48 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.821 0.343 . . . . 0.0 110.928 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -120.7 141.57 50.3 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.869 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.95 118.35 36.51 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.009 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.96 148.09 42.53 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.104 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -114.22 159.75 19.79 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.155 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.3 -38.22 73.64 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.963 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -79.77 -28.17 40.4 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.437 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.65 164.27 16.9 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.932 0.396 . . . . 0.0 111.595 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.41 -166.74 21.95 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.703 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.591 HD22 HG13 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -61.0 -59.53 5.22 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.539 0.209 . . . . 0.0 111.329 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.27 1.06 55.76 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.382 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.745 HG22 HG23 ' A' ' 42' ' ' ILE . 1.8 pp -145.48 161.44 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 117.177 0.488 . . . . 0.0 111.139 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.5 t -119.65 136.95 54.18 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.604 HD12 HG21 ' A' ' 37' ' ' ILE . 6.5 pt -119.9 154.38 22.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.335 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 p -137.16 153.56 50.44 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.002 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.31 -172.24 16.67 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.785 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.38 113.97 0.55 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.517 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -32.44 70.67 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.478 0.18 . . . . 0.0 111.388 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -60.11 -30.7 69.44 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.609 0.242 . . . . 0.0 110.949 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -76.59 -28.15 56.08 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.078 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.68 31.54 2.51 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.892 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.7 m -146.4 144.17 20.5 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.634 0.217 . . . . 0.0 111.0 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.7 156.97 62.11 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.624 2.216 . . . . 0.0 112.246 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.627 ' HB ' HD12 ' A' ' 60' ' ' ILE . 29.5 mm -84.21 139.29 17.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.63 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mp -131.42 160.49 34.95 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.839 0.352 . . . . 0.0 111.287 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.578 HD12 ' HB3' ' A' ' 58' ' ' ASP . 23.2 mt -89.69 122.54 41.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.946 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.468 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -109.54 -31.6 7.44 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.642 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -127.75 149.41 50.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.668 0.27 . . . . 0.0 110.823 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.745 HG23 HG22 ' A' ' 25' ' ' ILE . 17.9 mt -135.03 114.55 17.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.74 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -66.67 120.89 74.5 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.096 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.35 156.63 61.38 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.973 2.449 . . . . 0.0 112.667 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.3 36.8 93.66 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.262 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -134.06 177.07 2.42 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -49.95 -31.02 25.79 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.712 2.275 . . . . 0.0 112.912 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.495 ' HB1' ' CB ' ' A' ' 54' ' ' LEU . . . -63.55 -46.1 87.47 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.006 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -69.84 -40.4 75.83 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.792 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.6 mtp85 -56.11 -36.8 68.61 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.552 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 17.8 m -81.24 -27.9 35.03 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.457 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.75 14.58 67.76 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.999 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.34 -30.95 3.93 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.796 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.601 ' O ' HD13 ' A' ' 42' ' ' ILE . 2.2 mm? -65.72 101.32 0.62 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.757 0.313 . . . . 0.0 110.569 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.579 ' C ' HD11 ' A' ' 42' ' ' ILE . 15.8 p80 -114.41 157.49 22.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.931 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 40' ' ' SER . 40.6 t -71.7 136.18 26.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.443 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.12 47.26 4.77 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.283 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.578 ' HB3' HD12 ' A' ' 39' ' ' ILE . 3.2 t0 -111.99 132.72 54.61 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.87 123.75 35.48 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.759 0.314 . . . . 0.0 111.624 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.837 ' HA ' HG12 ' A' ' 91' ' ' VAL . 41.7 mt -75.17 132.47 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.174 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.4 mt -117.81 -67.7 0.97 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.033 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.88 145.65 46.56 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.917 0.389 . . . . 0.0 111.504 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.0 t -116.71 115.51 49.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.378 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 54.31 37.94 28.43 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.678 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.25 -14.44 54.09 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.648 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.5 t -85.26 135.2 25.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 117.221 0.51 . . . . 0.0 111.179 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -77.21 138.17 39.28 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.155 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.839 HD21 ' HB1' ' A' ' 76' ' ' ALA . 1.2 tp -116.2 -1.92 12.29 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.829 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -30.3 68.26 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -98.8 11.25 39.28 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.44 HG22 ' HB2' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -109.96 159.07 17.59 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.566 0.222 . . . . 0.0 110.775 179.754 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.13 161.27 18.96 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.449 ' O ' HG23 ' A' ' 77' ' ' VAL . 38.8 t-80 -54.3 -51.28 65.15 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.015 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -65.28 -41.39 94.21 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.776 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.44 ' HB2' HG22 ' A' ' 71' ' ' THR . 64.7 mt-10 -64.28 -37.23 86.76 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.843 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.839 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -63.39 -30.82 71.88 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.392 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 73' ' ' HIS . 38.9 t -61.9 -42.35 94.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.836 0.35 . . . . 0.0 110.085 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 32.0 m -64.4 -41.25 96.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.452 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.2 mm -57.86 -45.72 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.734 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -40.88 87.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -73.57 -13.79 61.09 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -69.23 -29.75 67.76 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.681 0.277 . . . . 0.0 111.115 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.477 ' HB3' HG12 ' A' ' 87' ' ' ILE . 17.5 mp0 -76.5 135.99 39.34 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.195 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -130.65 146.94 52.26 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.166 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.82 -90.82 0.17 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.997 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -96.25 115.19 27.03 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.746 0.308 . . . . 0.0 110.304 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.477 HG12 ' HB3' ' A' ' 83' ' ' GLN . 18.9 mt -114.47 126.24 71.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.202 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -99.81 135.52 41.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.749 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -128.63 135.87 49.89 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.921 0.391 . . . . 0.0 111.479 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -123.63 115.59 21.72 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.496 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.837 HG12 ' HA ' ' A' ' 60' ' ' ILE . 18.7 m -144.86 172.49 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.341 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 9' ' ' PRO . 9.2 p -141.37 137.03 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.059 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.74 122.6 17.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.058 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.8 m -108.25 120.5 59.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.162 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.123 -179.771 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo . . . . . 0 N--CA 1.492 1.388 0 CA-C-O 120.655 0.19 . . . . 0.0 111.919 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.783 ' HA ' HG12 ' A' ' 92' ' ' VAL . 65.7 mt -104.77 140.85 21.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.06 146.1 48.8 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.064 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.4 113.19 23.43 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.677 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.33 141.64 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.347 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 20.6 tp -105.84 127.65 53.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.898 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 tp -113.2 125.5 54.4 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.44 114.57 28.52 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.684 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -125.94 135.04 51.41 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.206 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -81.39 171.57 14.6 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.047 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.46 -38.78 75.03 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.095 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.414 ' CE1' ' HG2' ' A' ' 21' ' ' GLU . 16.8 p80 -75.42 -30.26 59.99 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.218 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HG2' ' CE1' ' A' ' 20' ' ' HIS . 2.5 mm-40 -77.02 166.16 23.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.897 0.379 . . . . 0.0 111.383 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -113.02 -152.86 11.27 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.893 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.741 HD11 HD13 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -67.98 -41.21 82.71 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.526 0.203 . . . . 0.0 111.464 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.09 -21.32 43.87 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.997 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.755 HG21 ' CD1' ' A' ' 54' ' ' LEU . 2.6 pp -146.48 171.44 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.808 0.337 . . . . 0.0 111.287 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 5.9 m -120.44 138.35 53.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.575 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.777 HD12 HG21 ' A' ' 37' ' ' ILE . 15.2 pt -115.96 156.2 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.851 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.5 p -137.26 163.26 31.36 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.365 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.0 -160.71 17.69 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.874 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.43 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . 166.5 131.7 1.29 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.133 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -56.46 -37.6 70.53 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.182 0.193 . . . . 0.0 111.33 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.39 -31.04 71.65 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.125 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -78.31 -26.6 47.02 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.236 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.87 22.93 6.07 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.048 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 10.1 p -149.57 134.97 9.74 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.926 0.363 . . . . 0.0 110.998 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.45 ' O ' HD12 ' A' ' 38' ' ' LEU . 38.4 Cg_exo -60.91 156.69 42.43 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.42 2.08 . . . . 0.0 112.181 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.777 HG21 HD12 ' A' ' 27' ' ' ILE . 3.5 mp -83.37 131.64 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.792 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.486 ' CD2' ' HB2' ' A' ' 59' ' ' ALA . 3.9 mp -131.64 160.73 34.55 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.574 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.516 HD13 HD11 ' A' ' 54' ' ' LEU . 30.4 mt -93.63 119.58 41.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.946 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.475 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -111.25 -41.2 4.22 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.262 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 4.1 tt0 -104.83 150.19 25.03 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.716 0.293 . . . . 0.0 111.067 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.705 HG23 HG22 ' A' ' 25' ' ' ILE . 32.3 mt -132.09 121.27 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.746 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -73.78 114.78 35.68 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.817 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -68.03 140.7 50.68 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.707 2.271 . . . . 0.0 112.645 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.34 29.5 52.99 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.746 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.68 172.53 6.63 Favored Pre-proline 0 CA--C 1.531 0.224 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -52.19 -31.66 46.73 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.721 2.281 . . . . 0.0 112.797 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.614 ' HB1' ' HG ' ' A' ' 54' ' ' LEU . . . -61.79 -46.3 90.16 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.09 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.84 -40.34 79.48 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.763 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.07 -31.52 72.78 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.191 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -70.29 -27.97 64.82 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.581 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.38 -56.39 4.67 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.943 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.6 -28.36 37.27 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 121.473 -0.394 . . . . 0.0 113.533 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.755 ' CD1' HG21 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -63.94 96.93 0.15 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.033 0.444 . . . . 0.0 110.527 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -119.05 157.4 27.89 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.272 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 40' ' ' SER . 40.1 t -68.38 129.67 33.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.076 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.54 41.83 2.65 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.577 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.05 122.71 47.84 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.191 0.197 . . . . 0.0 110.581 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.486 ' HB2' ' CD2' ' A' ' 38' ' ' LEU . . . -94.75 127.1 40.51 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.683 0.278 . . . . 0.0 111.402 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.824 ' HA ' HG12 ' A' ' 91' ' ' VAL . 9.5 mt -77.78 142.21 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.338 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 70.4 mt -130.36 -50.88 1.09 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.933 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.32 145.56 49.15 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.889 0.376 . . . . 0.0 111.698 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.479 HG21 HD13 ' A' ' 68' ' ' LEU . 24.0 t -115.99 115.34 48.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.238 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 53.16 34.8 18.26 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.956 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.14 -15.91 59.95 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.037 -0.602 . . . . 0.0 113.624 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.9 t -88.39 134.95 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 117.218 0.509 . . . . 0.0 111.152 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -69.65 135.59 50.09 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.319 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.592 HD21 ' HB2' ' A' ' 76' ' ' ALA . 0.5 OUTLIER -120.79 16.2 11.83 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.715 179.674 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.4 ttt85 -69.64 -32.31 70.92 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.11 12.02 37.32 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.474 HG22 ' HB2' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -103.45 162.87 12.66 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.617 0.246 . . . . 0.0 110.867 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.37 161.07 13.96 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.12 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.526 ' O ' HG23 ' A' ' 77' ' ' VAL . 58.9 t-80 -54.1 -51.1 65.25 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.066 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -60.45 -41.04 93.27 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.811 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.474 ' HB2' HG22 ' A' ' 71' ' ' THR . 26.6 mt-10 -65.22 -37.22 86.61 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.741 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.592 ' HB2' HD21 ' A' ' 68' ' ' LEU . . . -63.56 -35.23 79.79 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.104 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 73' ' ' HIS . 22.1 t -62.23 -39.84 85.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.815 0.341 . . . . 0.0 110.424 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -41.93 99.05 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.594 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.7 mm -57.98 -45.41 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.571 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.741 HD13 HD11 ' A' ' 23' ' ' LEU . 1.2 mt -57.5 -39.29 76.15 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.072 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -61.58 -37.36 83.58 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.07 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -65.72 -25.61 67.38 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.339 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.457 ' HB2' HD13 ' A' ' 87' ' ' ILE . 33.9 mm-40 -65.9 131.13 45.53 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.097 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.03 143.7 50.27 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.384 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.03 -101.31 0.22 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.859 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -91.57 126.01 36.5 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.954 0.407 . . . . 0.0 110.495 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.457 HD13 ' HB2' ' A' ' 83' ' ' GLN . 7.9 mt -117.6 122.99 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.081 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.77 124.37 37.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.414 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.471 ' CE1' HG13 ' A' ' 63' ' ' VAL . 0.7 OUTLIER -128.16 129.8 47.08 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.927 0.394 . . . . 0.0 111.178 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -101.37 115.21 29.99 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.298 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.824 HG12 ' HA ' ' A' ' 60' ' ' ILE . 15.8 m -138.23 171.5 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.394 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.783 HG12 ' HA ' ' A' ' 10' ' ' ILE . 31.0 m -133.95 149.37 30.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.292 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.98 120.98 19.36 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.867 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.35 131.27 73.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.798 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.013 179.932 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 N--CA 1.49 1.28 0 CA-C-O 120.788 0.245 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.812 ' HA ' HG12 ' A' ' 92' ' ' VAL . 67.6 mt -96.14 141.01 16.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.13 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.5 124.87 44.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.993 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.8 111.54 23.67 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.472 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -132.01 138.05 53.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.957 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.9 141.66 30.61 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.07 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -121.48 139.6 53.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.971 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tt -107.6 127.11 53.36 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.822 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -116.2 126.56 53.8 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.87 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.43 155.62 20.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.682 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.33 -38.96 74.9 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.189 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -79.0 -27.72 43.36 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.425 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -95.41 -178.34 4.4 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.741 0.305 . . . . 0.0 111.508 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.41 -149.89 5.55 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.974 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.94 -56.97 6.2 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.608 0.242 . . . . 0.0 110.781 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.02 -14.52 61.38 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.445 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.603 HD13 HG12 ' A' ' 39' ' ' ILE . 2.6 pp -140.13 154.08 22.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 117.104 0.452 . . . . 0.0 111.166 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 1.5 m -103.8 136.75 42.89 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.793 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.534 ' HB ' HG22 ' A' ' 37' ' ' ILE . 14.7 pt -119.66 149.7 22.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.464 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.456 ' C ' HG23 ' A' ' 37' ' ' ILE . 14.5 t -135.86 146.94 47.98 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.217 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.96 -154.72 25.71 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.364 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 159.45 117.5 0.48 Allowed Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.095 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.88 -33.67 72.14 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.38 0.133 . . . . 0.0 111.321 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -57.26 -29.9 64.21 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.549 0.214 . . . . 0.0 111.331 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -83.15 -29.14 28.88 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.001 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.0 26.03 5.66 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.898 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.423 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 16.1 m -144.58 131.98 10.4 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 116.75 0.275 . . . . 0.0 111.115 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 32.6 Cg_exo -61.14 153.97 60.84 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.647 2.231 . . . . 0.0 112.005 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.534 HG22 ' HB ' ' A' ' 27' ' ' ILE . 3.3 mp -82.53 132.07 32.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.426 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.4 159.05 35.64 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.618 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.603 HG12 HD13 ' A' ' 25' ' ' ILE . 13.6 mt -83.01 129.96 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.958 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.3 m -119.71 -40.95 2.71 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.353 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 18.0 tt0 -105.32 144.52 31.99 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.702 0.287 . . . . 0.0 111.081 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.42 ' HA ' HG22 ' A' ' 25' ' ' ILE . 18.9 mm -129.26 111.62 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.697 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -84.87 127.58 64.23 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.97 157.86 53.78 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.843 2.362 . . . . 0.0 113.063 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.94 37.58 43.55 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.835 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -144.06 170.29 8.68 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-O 120.45 0.166 . . . . 0.0 110.799 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.12 -31.24 34.91 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.728 2.285 . . . . 0.0 112.684 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.447 ' CB ' HG23 ' A' ' 25' ' ' ILE . . . -57.34 -46.41 83.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.463 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.77 -42.53 77.3 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.851 0.358 . . . . 0.0 110.498 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -65.02 -30.55 71.54 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.299 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -70.57 -28.34 64.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.535 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.17 -58.8 3.99 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.764 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.85 -23.27 44.54 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.541 -0.362 . . . . 0.0 113.526 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.516 HD11 HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -64.93 96.05 0.18 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.111 0.456 . . . . 0.0 110.403 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.419 ' CE1' ' CD2' ' A' ' 93' ' ' TYR . 6.0 p-80 -119.33 157.41 28.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.299 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 m -68.28 134.9 29.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.56 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.85 44.9 4.37 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.587 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.15 122.49 47.89 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.26 122.58 34.0 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.764 0.316 . . . . 0.0 111.633 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.843 ' HA ' HG12 ' A' ' 91' ' ' VAL . 15.6 mt -69.59 132.19 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.366 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.1 mt -114.88 -54.58 2.56 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.802 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -150.76 145.98 26.11 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.454 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.839 HG21 HD21 ' A' ' 80' ' ' LEU . 24.3 t -125.61 120.51 57.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.54 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 57.39 34.54 24.83 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.08 -11.08 61.26 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.359 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.58 136.33 23.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 117.258 0.529 . . . . 0.0 110.934 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.5 134.39 35.21 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.056 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.417 ' CD2' ' HB1' ' A' ' 76' ' ' ALA . 1.8 mp -108.63 -12.33 14.98 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.034 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -29.05 69.58 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -96.51 9.19 42.16 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.62 0.229 . . . . 0.0 111.62 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.6 p -119.04 157.9 26.88 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.677 0.275 . . . . 0.0 110.8 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.03 161.05 20.85 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.817 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.63 ' O ' HG23 ' A' ' 77' ' ' VAL . 86.0 t60 -53.82 -50.55 65.94 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.904 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -59.69 -41.56 91.01 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.949 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.28 -38.66 85.44 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.954 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.678 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.44 -35.2 79.65 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.402 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 73' ' ' HIS . 39.5 t -61.86 -40.46 87.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.726 0.298 . . . . 0.0 110.469 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.9 m -66.77 -44.25 81.9 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.782 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 76' ' ' ALA . 11.2 mt -62.06 -43.06 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.825 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.839 HD21 HG21 ' A' ' 63' ' ' VAL . 24.5 mt -62.4 -36.53 82.6 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.684 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.4 t -65.57 -32.69 74.41 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.012 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -65.03 -28.8 69.73 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.325 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.475 ' HB3' HG23 ' A' ' 87' ' ' ILE . 26.2 mm-40 -61.85 112.75 2.42 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.813 0.34 . . . . 0.0 110.767 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -112.57 148.88 33.61 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.378 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.56 -103.02 0.55 Allowed Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.59 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -89.07 126.41 35.43 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.812 0.339 . . . . 0.0 110.385 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.475 HG23 ' HB3' ' A' ' 83' ' ' GLN . 13.0 mt -126.05 129.23 72.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.826 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -93.82 135.49 35.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.474 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.469 ' HZ ' HD22 ' A' ' 80' ' ' LEU . 3.4 m-85 -130.58 129.28 42.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.879 0.371 . . . . 0.0 111.026 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -122.07 115.36 22.35 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.227 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.843 HG12 ' HA ' ' A' ' 60' ' ' ILE . 15.9 m -138.83 171.54 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.518 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.812 HG12 ' HA ' ' A' ' 10' ' ' ILE . 15.6 m -134.71 143.18 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.501 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.419 ' CD2' ' CE1' ' A' ' 55' ' ' HIS . 0.1 OUTLIER -79.98 122.92 27.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.961 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.82 133.41 66.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.088 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.434 -0.794 . . . . 0.0 111.34 -179.865 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.654 ' O ' HG23 ' A' ' 92' ' ' VAL . 6.1 Cg_endo . . . . . 0 N--CA 1.491 1.364 0 CA-C-O 120.99 0.329 . . . . 0.0 111.736 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mp -78.77 143.43 12.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.204 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.17 143.95 46.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.263 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -111.97 115.1 28.4 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 t -125.68 130.15 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.776 0.322 . . . . 0.0 111.175 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.93 132.47 43.48 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.169 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.5 tt -129.67 144.53 51.33 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.985 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.76 114.81 28.92 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.95 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -94.41 136.3 34.86 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.758 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.07 154.56 32.98 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.183 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.63 -37.16 72.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.218 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.422 ' CE1' ' HG2' ' A' ' 21' ' ' GLU . 13.4 p80 -82.47 -26.78 32.33 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.503 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.422 ' HG2' ' CE1' ' A' ' 20' ' ' HIS . 5.0 mm-40 -102.17 110.04 21.89 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.659 0.266 . . . . 0.0 110.946 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.8 -152.14 0.13 Allowed Glycine 0 CA--C 1.522 0.523 0 C-N-CA 121.255 -0.498 . . . . 0.0 113.439 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.418 HD22 HG13 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -60.56 -59.98 4.54 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 -179.46 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.9 -11.95 65.92 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.598 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.549 HG21 ' CD1' ' A' ' 54' ' ' LEU . 15.0 pt -138.36 152.68 25.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 117.1 0.45 . . . . 0.0 110.977 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 0.9 OUTLIER -115.53 136.68 52.84 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.762 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.614 HD12 HG21 ' A' ' 37' ' ' ILE . 18.0 pt -117.34 155.8 18.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.592 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 t -140.46 147.13 39.16 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.993 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.63 -165.49 20.69 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.43 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.423 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . -179.35 114.41 0.44 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.679 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.2 tptp -60.99 -29.89 69.95 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -57.53 -31.15 65.78 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.653 0.263 . . . . 0.0 110.966 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -79.38 -23.11 43.53 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.324 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.15 21.25 4.93 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.309 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.1 m -145.38 140.32 15.83 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 117.007 0.403 . . . . 0.0 111.212 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.57 157.07 63.46 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.57 2.18 . . . . 0.0 112.385 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.614 HG21 HD12 ' A' ' 27' ' ' ILE . 3.3 mt -85.64 137.52 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.842 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.411 HD12 ' C ' ' A' ' 37' ' ' ILE . 6.3 mp -128.37 151.19 49.64 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.368 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.2 mt -86.92 122.12 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.824 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.54 -27.72 8.12 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.877 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 26' ' ' SER . 1.8 mt-10 -109.75 144.27 38.39 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.662 0.268 . . . . 0.0 111.121 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.409 HD12 HD12 ' A' ' 54' ' ' LEU . 22.4 mm -133.55 121.21 40.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.637 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -97.91 112.41 61.64 Favored Pre-proline 0 C--O 1.234 0.287 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.149 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.424 ' HA ' ' HB2' ' A' ' 49' ' ' ASP . 42.0 Cg_endo -68.93 151.58 73.66 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.709 2.273 . . . . 0.0 112.492 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.06 -37.27 3.84 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.734 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.66 176.14 4.11 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-O 120.45 0.167 . . . . 0.0 110.724 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -51.02 -30.65 31.83 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.918 2.412 . . . . 0.0 113.15 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.446 ' CB ' HG23 ' A' ' 25' ' ' ILE . . . -57.69 -46.19 84.65 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.685 0.278 . . . . 0.0 111.211 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.424 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.6 OUTLIER -70.54 -42.12 71.62 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.787 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.6 mtp85 -62.09 -30.08 70.76 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.108 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.94 -28.22 65.4 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.418 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.12 -56.69 3.61 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.712 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.95 -23.58 39.07 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 119.867 -0.407 . . . . 0.0 113.776 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.549 ' CD1' HG21 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -66.05 90.28 0.13 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.161 0.481 . . . . 0.0 110.422 179.721 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -114.17 157.24 22.91 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.11 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.4 t -64.01 137.71 24.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.676 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.71 46.17 4.35 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.385 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.58 121.25 44.23 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.445 0.164 . . . . 0.0 111.017 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.11 122.05 37.37 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.671 0.272 . . . . 0.0 111.258 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.834 ' HA ' HG12 ' A' ' 91' ' ' VAL . 3.2 mp -77.14 134.7 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.442 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.1 mt -121.93 -50.62 2.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.941 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.56 146.44 34.61 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.762 0.315 . . . . 0.0 111.361 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.0 t -136.02 115.88 17.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.59 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 59.79 33.03 21.64 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.015 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.55 -14.44 58.1 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.305 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 t -81.79 132.58 31.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 117.044 0.422 . . . . 0.0 110.604 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -76.26 126.74 31.54 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.658 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.67 HD21 ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -120.58 0.97 10.57 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.529 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -71.1 -31.48 67.84 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 111.247 0.091 . . . . 0.0 111.247 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.47 11.88 33.94 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.52 ' OG1' HD23 ' A' ' 68' ' ' LEU . 25.7 p -100.91 149.7 23.62 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.588 0.232 . . . . 0.0 111.002 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -75.5 161.13 29.46 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.433 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.423 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . 24.2 t-80 -54.59 -49.63 69.95 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.213 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -62.3 -37.72 86.62 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.588 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -62.67 -37.33 86.0 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.746 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.67 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -63.34 -35.34 80.07 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.347 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.16 -42.96 97.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.635 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.32 -48.3 70.73 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.814 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 mt -61.41 -42.19 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.092 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -39.24 80.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.8 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -33.27 75.44 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.009 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -65.3 -27.11 68.39 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.14 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.478 ' HB3' HG23 ' A' ' 87' ' ' ILE . 75.9 mm-40 -65.79 95.63 0.25 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 110.79 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -98.68 144.23 28.18 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.123 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.73 -109.08 2.53 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.818 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -79.99 135.96 36.5 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.692 0.282 . . . . 0.0 110.574 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.478 HG23 ' HB3' ' A' ' 83' ' ' GLN . 10.1 mt -137.03 122.36 25.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.289 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -95.79 122.25 38.38 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.428 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -111.8 128.79 56.22 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.007 0.432 . . . . 0.0 111.338 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -117.24 115.36 25.15 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.299 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.834 HG12 ' HA ' ' A' ' 60' ' ' ILE . 17.6 m -137.76 171.05 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.465 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 9' ' ' PRO . 8.6 p -135.94 137.57 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.987 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.19 119.99 13.64 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.834 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.1 t -111.13 125.03 68.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.167 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.991 179.914 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo . . . . . 0 N--CA 1.489 1.222 0 CA-C-O 120.725 0.219 . . . . 0.0 111.842 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.57 ' HA ' HG12 ' A' ' 92' ' ' VAL . 2.7 tt -109.3 124.6 66.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.067 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -113.65 127.03 55.9 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.053 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.24 113.91 27.78 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.998 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.93 135.87 60.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.003 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.415 HD21 ' CG ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -97.71 130.95 44.65 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.824 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.24 139.47 50.32 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.069 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.2 mp -109.02 114.54 28.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.87 139.03 54.13 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.056 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -109.28 168.09 9.64 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.949 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.87 -37.14 75.87 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.282 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.401 ' CE1' ' HG2' ' A' ' 21' ' ' GLU . 32.1 p80 -74.62 -29.89 61.46 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.596 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.401 ' HG2' ' CE1' ' A' ' 20' ' ' HIS . 10.0 mm-40 -94.75 166.18 12.12 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 111.641 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.88 -154.22 9.12 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.91 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.08 -67.01 0.52 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.577 0.227 . . . . 0.0 111.03 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.22 4.13 63.0 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.071 -0.585 . . . . 0.0 113.634 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.727 HG21 HD12 ' A' ' 54' ' ' LEU . 17.2 pt -138.29 145.36 28.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 117.256 0.528 . . . . 0.0 111.088 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.75 140.23 34.26 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.099 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.809 HG22 HD13 ' A' ' 39' ' ' ILE . 13.2 pt -116.49 155.62 17.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.684 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.9 p -133.9 153.79 51.51 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.347 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.49 -153.75 19.66 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.803 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.404 ' CA ' ' HB2' ' A' ' 73' ' ' HIS . . . 151.81 138.21 2.74 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.26 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -58.97 -37.74 77.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.066 0.146 . . . . 0.0 111.38 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.84 -31.19 71.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.595 0.236 . . . . 0.0 111.017 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -81.14 -28.19 35.19 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.103 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.19 25.83 5.95 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.101 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.8 m -147.82 140.08 14.37 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.864 0.332 . . . . 0.0 110.992 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.78 155.83 46.69 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.613 2.208 . . . . 0.0 112.19 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.526 HD12 HD11 ' A' ' 68' ' ' LEU . 19.7 mt -84.89 136.56 22.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.857 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.8 154.5 48.48 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.301 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.809 HD13 HG22 ' A' ' 27' ' ' ILE . 16.1 mm -83.87 118.23 30.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.763 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 56' ' ' VAL . 23.0 t -108.19 -28.51 9.44 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.705 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.67 144.45 50.2 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.735 0.302 . . . . 0.0 111.198 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.536 HG12 HG22 ' A' ' 56' ' ' VAL . 20.9 mm -128.92 112.19 25.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.383 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -87.01 130.96 46.27 Favored Pre-proline 0 C--O 1.232 0.158 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.106 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.37 172.8 15.63 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.846 2.364 . . . . 0.0 112.535 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.52 30.38 77.43 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.467 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.448 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.9 OUTLIER -137.01 169.08 14.21 Favored Pre-proline 0 C--O 1.233 0.203 0 C-N-CA 122.248 0.219 . . . . 0.0 110.44 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.448 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 9.3 Cg_endo -53.09 -27.02 34.95 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.768 2.312 . . . . 0.0 112.75 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.72 -46.35 89.37 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.061 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -67.85 -40.49 83.66 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.618 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -58.71 -33.05 69.76 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.347 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.3 m -80.57 -28.36 37.23 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.56 -51.7 4.27 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.182 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.48 -24.37 23.49 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.56 -0.353 . . . . 0.0 113.795 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.727 HD12 HG21 ' A' ' 25' ' ' ILE . 4.2 mm? -65.19 89.52 0.09 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.15 0.475 . . . . 0.0 110.743 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -114.25 157.37 22.8 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.348 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.536 HG22 HG12 ' A' ' 42' ' ' ILE . 42.1 t -72.56 136.55 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.68 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.29 40.34 4.83 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.899 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -112.08 135.03 53.25 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.602 0.201 . . . . 0.0 110.987 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.53 124.01 47.31 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.686 0.279 . . . . 0.0 111.403 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.868 ' HA ' HG12 ' A' ' 91' ' ' VAL . 3.2 mt -80.04 150.72 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.494 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 61' ' ' LEU . 13.3 mt -136.25 -50.45 0.69 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.354 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.74 145.95 32.78 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.773 0.321 . . . . 0.0 111.476 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.779 HG21 HD21 ' A' ' 80' ' ' LEU . 24.4 t -135.39 115.87 18.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.769 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 57.15 34.53 24.99 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.875 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.83 -19.73 46.68 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.321 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 t -80.13 135.98 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 117.065 0.433 . . . . 0.0 111.0 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -80.51 137.33 36.43 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.213 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.587 HD22 ' HB ' ' A' ' 60' ' ' ILE . 1.2 tp -87.12 -33.06 19.57 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.038 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -67.4 -27.69 67.29 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.427 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -89.51 9.99 24.52 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 t -134.15 154.43 51.22 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.773 0.321 . . . . 0.0 110.959 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.18 161.16 20.67 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.706 ' O ' HG23 ' A' ' 77' ' ' VAL . 51.3 t-80 -54.0 -51.66 63.24 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.008 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -61.16 -42.15 98.03 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.031 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -38.68 84.96 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.963 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.511 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.49 -33.73 76.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.348 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 73' ' ' HIS . 24.7 t -61.91 -43.46 97.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.76 0.314 . . . . 0.0 110.25 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.11 -47.34 77.53 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.544 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 76' ' ' ALA . 17.2 mt -59.23 -49.29 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.92 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.779 HD21 HG21 ' A' ' 63' ' ' VAL . 85.5 mt -55.45 -35.97 66.04 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.132 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -20.06 60.45 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.652 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -74.22 -28.86 61.45 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.748 0.308 . . . . 0.0 110.57 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.567 ' HB3' HG23 ' A' ' 87' ' ' ILE . 1.5 mp0 -68.79 104.82 2.13 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.66 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 149.9 25.68 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.375 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.98 -107.11 1.63 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.469 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.415 ' CG ' HD21 ' A' ' 14' ' ' LEU . 15.9 tt0 -79.37 115.37 18.98 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.761 0.315 . . . . 0.0 110.433 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.567 HG23 ' HB3' ' A' ' 83' ' ' GLN . 11.3 mt -122.55 122.74 66.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.042 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -93.93 121.86 35.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.447 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.404 ' CE1' HD22 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -118.06 129.69 55.71 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.877 0.37 . . . . 0.0 111.642 -179.524 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -118.1 115.35 24.66 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.394 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.868 HG12 ' HA ' ' A' ' 60' ' ' ILE . 17.2 m -136.3 169.26 20.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.513 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 10' ' ' ILE . 29.4 m -137.69 131.23 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.111 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.15 123.48 22.27 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.935 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.3 m -108.34 141.9 22.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.4 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.42 -0.8 . . . . 0.0 111.323 -179.89 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.435 ' O ' HG12 ' A' ' 92' ' ' VAL . 5.3 Cg_endo . . . . . 0 N--CA 1.49 1.274 0 CA-C-O 120.539 0.141 . . . . 0.0 111.827 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.473 ' HA ' HG12 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -100.87 128.67 52.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.462 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -123.43 121.56 36.03 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.968 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -111.47 111.61 22.75 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.566 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.42 134.95 56.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.073 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 mp -97.97 139.54 33.65 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.81 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 tp -108.32 119.6 39.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.829 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 tp -109.55 115.18 29.43 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.487 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.63 153.14 44.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.018 0.437 . . . . 0.0 111.242 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.84 173.14 7.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.997 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -58.83 -38.37 78.53 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -72.96 -30.26 63.71 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.18 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -75.19 168.95 19.0 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.852 0.358 . . . . 0.0 111.238 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.1 -149.93 8.88 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.888 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.797 HD11 HD13 ' A' ' 80' ' ' LEU . 1.9 tp -76.88 -61.08 2.09 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.517 0.199 . . . . 0.0 111.323 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.78 -14.25 49.63 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.581 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.614 HG22 HG23 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -143.89 165.09 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 117.123 0.461 . . . . 0.0 111.132 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.8 t -120.99 136.76 54.91 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.675 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.605 HD12 HG21 ' A' ' 37' ' ' ILE . 15.2 pt -117.99 153.4 20.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.496 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.2 t -139.6 145.87 39.09 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.22 -151.51 23.46 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.447 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.53 105.44 0.19 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.847 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -57.57 -34.92 69.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.474 0.178 . . . . 0.0 111.18 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -60.72 -31.17 70.48 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.186 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -82.61 -31.36 28.92 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.087 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.65 32.27 2.33 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.709 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.443 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 10.9 p -140.42 130.92 13.75 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-O 120.66 0.267 . . . . 0.0 110.846 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.445 ' O ' HD23 ' A' ' 38' ' ' LEU . 25.9 Cg_exo -62.35 156.23 52.58 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.551 2.168 . . . . 0.0 112.072 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.605 HG21 HD12 ' A' ' 27' ' ' ILE . 30.3 mm -84.85 136.96 21.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.593 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 36' ' ' PRO . 0.3 OUTLIER -145.44 158.56 43.82 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.909 0.385 . . . . 0.0 111.611 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.589 HD13 HD13 ' A' ' 25' ' ' ILE . 16.7 mt -88.48 125.88 41.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.158 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.515 ' O ' HG13 ' A' ' 56' ' ' VAL . 8.6 t -110.42 -34.26 6.38 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.395 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -123.58 147.35 47.39 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.817 0.341 . . . . 0.0 111.371 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.614 HG23 HG22 ' A' ' 25' ' ' ILE . 2.3 mt -127.13 120.11 54.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.54 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -78.68 113.58 36.13 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.703 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.17 149.78 83.15 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.745 2.296 . . . . 0.0 112.648 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.84 39.59 28.17 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.563 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.93 172.95 4.89 Favored Pre-proline 0 C--N 1.331 -0.22 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -51.33 -32.72 42.84 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.61 2.207 . . . . 0.0 112.792 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.556 ' CB ' HG23 ' A' ' 25' ' ' ILE . . . -62.35 -46.31 89.24 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.113 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.36 -41.6 96.64 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.665 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.43 -29.86 67.67 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.611 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 10.8 m -70.36 -28.38 65.07 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.18 -57.8 4.01 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.89 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.44 -25.17 33.41 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.514 -0.374 . . . . 0.0 113.47 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.471 HD12 HG21 ' A' ' 25' ' ' ILE . 3.9 mm? -65.21 90.28 0.09 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.964 0.412 . . . . 0.0 110.471 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -115.79 157.47 24.33 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.217 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 40' ' ' SER . 43.1 t -63.92 132.08 29.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.247 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.6 40.78 4.93 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.815 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.55 119.07 37.97 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.21 130.34 38.94 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.879 ' HA ' HG12 ' A' ' 91' ' ' VAL . 3.2 mp -81.6 151.04 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.357 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.9 mt -136.6 -51.75 0.69 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.976 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.91 147.39 40.5 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.806 0.336 . . . . 0.0 111.448 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.424 HG13 ' CD1' ' A' ' 89' ' ' PHE . 38.2 t -130.01 115.62 33.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.529 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 54.4 32.91 17.46 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.864 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.77 -17.0 58.91 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.339 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.8 t -83.79 137.97 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 117.063 0.432 . . . . 0.0 111.045 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -75.23 131.18 40.2 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.27 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.656 HD13 HG21 ' A' ' 60' ' ' ILE . 7.0 tt -108.09 -22.61 12.32 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.501 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -61.16 -28.48 69.16 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.6 12.12 28.66 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.4 p -113.45 162.65 15.87 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.742 0.306 . . . . 0.0 110.583 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.82 161.24 16.84 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.198 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.559 ' O ' HG23 ' A' ' 77' ' ' VAL . 7.4 t-160 -54.03 -50.68 66.12 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.069 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -68.29 -43.16 78.31 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.874 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -38.1 89.34 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.997 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.674 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.66 -30.74 71.81 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.4 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 73' ' ' HIS . 22.9 t -61.93 -41.43 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.743 0.306 . . . . 0.0 110.651 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.3 m -69.84 -39.98 76.11 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.493 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 76' ' ' ALA . 16.0 mt -65.06 -48.89 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.163 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.797 HD13 HD11 ' A' ' 23' ' ' LEU . 4.6 pp -62.67 -36.6 83.39 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.108 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.625 ' N ' HD12 ' A' ' 80' ' ' LEU . 86.9 p -74.54 -16.0 60.84 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -71.22 -30.53 66.48 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.772 0.32 . . . . 0.0 110.858 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.444 ' CB ' HG23 ' A' ' 87' ' ' ILE . 2.2 mp0 -67.47 117.02 8.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.851 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -107.33 147.26 30.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.446 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.93 -98.39 0.19 Allowed Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.559 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -82.66 115.0 21.41 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.721 0.296 . . . . 0.0 110.304 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.444 HG23 ' CB ' ' A' ' 83' ' ' GLN . 16.7 mt -119.64 122.36 68.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.974 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.39 122.88 43.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.351 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.424 ' CD1' HG13 ' A' ' 63' ' ' VAL . 0.5 OUTLIER -122.83 129.42 51.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.826 0.346 . . . . 0.0 110.736 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -111.85 114.98 28.26 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.825 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.879 HG12 ' HA ' ' A' ' 60' ' ' ILE . 19.6 m -134.52 169.31 21.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.566 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 10' ' ' ILE . 16.9 m -139.96 141.24 34.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.954 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.47 116.26 7.26 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.825 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.3 p -105.01 139.63 25.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.517 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.124 -0.941 . . . . 0.0 111.065 -179.957 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.64 ' O ' HG13 ' A' ' 92' ' ' VAL . 6.4 Cg_exo . . . . . 0 N--CA 1.494 1.541 0 CA-C-O 120.831 0.263 . . . . 0.0 112.21 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.666 HD12 HD12 ' A' ' 61' ' ' LEU . 1.2 tt -92.66 136.89 23.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.168 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.4 ttt180 -123.62 148.07 46.77 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.049 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.467 ' HD2' ' HG3' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -101.1 118.86 37.84 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.659 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.0 t -122.13 129.56 75.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.304 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.4 tp -101.91 120.06 39.79 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.672 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.56 HD11 HD23 ' A' ' 54' ' ' LEU . 5.7 mp -108.28 121.09 44.18 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.149 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.8 tp -108.32 115.22 29.72 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.635 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.08 147.27 45.99 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.209 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -86.75 172.26 10.29 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.975 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -58.89 -38.46 78.91 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.061 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -73.92 -29.53 62.09 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.108 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -68.29 154.19 42.24 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.817 0.342 . . . . 0.0 111.533 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.22 -157.85 26.11 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.937 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.55 -62.05 1.6 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.492 0.187 . . . . 0.0 111.49 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.08 -21.17 34.21 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.365 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.914 HD13 HD12 ' A' ' 39' ' ' ILE . 1.1 pp -139.93 151.96 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 117.072 0.436 . . . . 0.0 111.31 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -105.49 137.1 43.87 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.986 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.717 HG22 HD13 ' A' ' 39' ' ' ILE . 14.0 pt -119.09 158.49 20.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.576 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.6 t -144.53 150.3 37.31 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.2 -159.58 15.73 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.478 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . 161.78 123.31 0.66 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.79 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -56.35 -37.87 70.6 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.457 0.169 . . . . 0.0 111.457 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -68.07 -31.15 70.59 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.734 0.302 . . . . 0.0 110.863 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -76.79 -30.5 56.49 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.028 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.96 21.69 5.23 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.113 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.4 p -149.76 130.81 7.2 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.95 0.375 . . . . 0.0 110.921 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -61.77 154.06 63.36 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.575 2.183 . . . . 0.0 112.26 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.511 HG21 HD12 ' A' ' 27' ' ' ILE . 15.9 mt -82.79 136.79 22.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.642 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.38 163.5 32.78 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.886 0.374 . . . . 0.0 111.766 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.914 HD12 HD13 ' A' ' 25' ' ' ILE . 10.5 mm -87.83 125.19 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.59 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.417 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.6 OUTLIER -117.39 -46.77 2.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.136 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 26' ' ' SER . 45.5 mt-10 -111.24 146.4 37.02 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.228 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.567 HG23 HG22 ' A' ' 25' ' ' ILE . 12.8 mt -131.72 113.08 21.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.6 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -69.72 124.61 90.95 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.924 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.06 147.02 53.64 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.695 2.263 . . . . 0.0 112.658 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.46 40.66 22.64 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.569 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.71 173.16 5.37 Favored Pre-proline 0 C--N 1.332 -0.196 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -51.8 -31.8 43.6 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.629 2.219 . . . . 0.0 112.662 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.57 -45.87 84.67 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.225 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -70.56 -43.08 70.22 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.635 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -59.57 -30.42 68.62 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.464 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 94.8 m -80.24 -28.02 38.57 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.833 -0.167 . . . . 0.0 111.353 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.95 17.66 63.46 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.865 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.29 -30.74 2.38 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.062 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.69 HD12 HG21 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -69.9 89.16 0.58 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.845 0.355 . . . . 0.0 110.738 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -106.34 156.83 18.1 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 40' ' ' SER . 22.4 t -64.56 135.09 28.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.688 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.95 46.06 4.31 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.411 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.38 122.74 48.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.397 0.142 . . . . 0.0 110.81 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.698 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -91.35 121.3 32.97 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.816 0.341 . . . . 0.0 111.216 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.875 ' HA ' HG12 ' A' ' 91' ' ' VAL . 5.6 mt -74.06 145.92 10.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.608 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.666 HD12 HD12 ' A' ' 10' ' ' ILE . 64.0 mt -137.83 -52.58 0.63 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.092 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.45 145.58 48.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.836 0.35 . . . . 0.0 111.702 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.0 t -131.3 117.04 34.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.403 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 57.82 34.46 24.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.931 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.99 -18.54 47.27 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.589 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.31 130.77 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 117.183 0.491 . . . . 0.0 110.926 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -74.78 140.78 44.25 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.172 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.659 HD21 ' CB ' ' A' ' 76' ' ' ALA . 9.8 tp -114.83 16.27 17.33 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.416 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.13 -34.57 71.17 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.807 -0.178 . . . . 0.0 111.425 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.88 12.03 38.42 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.3 m -103.51 154.36 19.54 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.776 0.322 . . . . 0.0 111.191 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.22 161.0 15.91 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.283 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.588 ' O ' HG23 ' A' ' 77' ' ' VAL . 8.4 t-80 -54.1 -52.4 61.13 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.037 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -61.57 -38.36 87.23 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.028 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -65.23 -40.91 94.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.824 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.659 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -63.41 -34.38 77.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.481 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 73' ' ' HIS . 21.9 t -61.81 -43.76 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.72 0.295 . . . . 0.0 110.694 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.9 m -69.67 -44.92 69.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.005 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.4 mt -62.95 -47.99 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.482 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.548 HD12 ' N ' ' A' ' 81' ' ' SER . 4.4 pp -63.51 -33.62 75.98 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.46 0.172 . . . . 0.0 111.09 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.548 ' N ' HD12 ' A' ' 80' ' ' LEU . 12.7 t -66.64 -30.79 71.14 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.151 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -65.31 -29.24 69.97 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.147 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -60.88 115.14 3.47 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.725 0.298 . . . . 0.0 110.651 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -115.01 143.83 44.56 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.961 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.18 -100.8 0.27 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.567 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -77.39 119.5 21.09 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.738 0.304 . . . . 0.0 110.544 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.0 mt -129.83 122.47 54.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.101 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -94.6 126.95 40.22 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.355 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -124.52 129.43 50.59 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.899 0.38 . . . . 0.0 111.391 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.467 ' HG3' ' HD2' ' A' ' 12' ' ' LYS . 6.5 tt0 -119.9 115.57 24.07 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.233 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.875 HG12 ' HA ' ' A' ' 60' ' ' ILE . 17.0 m -138.25 169.02 19.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.0 0.429 . . . . 0.0 111.888 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 9' ' ' PRO . 32.2 t -129.5 138.53 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.751 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.27 124.18 21.52 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.87 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.698 HG21 ' HB2' ' A' ' 59' ' ' ALA . 21.7 t -126.46 130.82 71.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.242 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 94' ' ' VAL . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.588 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.45 ' O ' HG13 ' A' ' 92' ' ' VAL . 4.0 Cg_endo . . . . . 0 N--CA 1.49 1.281 0 CA-C-O 120.679 0.2 . . . . 0.0 111.983 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.529 ' HA ' HG22 ' A' ' 92' ' ' VAL . 1.0 OUTLIER -78.86 115.74 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.12 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -122.18 127.14 49.66 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.068 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.35 114.22 26.34 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.82 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.0 t -111.26 144.57 18.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.827 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.0 tt -97.72 122.09 40.4 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.594 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.516 HD21 ' HB2' ' A' ' 47' ' ' PRO . 0.5 OUTLIER -108.92 123.61 49.36 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.256 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tt -107.76 115.51 30.27 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.708 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -130.33 139.4 50.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.55 164.29 23.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.993 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.11 -38.5 73.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.969 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -76.71 -29.54 56.28 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.079 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -77.25 176.04 9.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.724 0.297 . . . . 0.0 111.38 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -132.99 -144.26 5.19 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.05 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.546 HD11 HD22 ' A' ' 80' ' ' LEU . 7.6 mt -94.11 -67.7 0.84 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.549 0.214 . . . . 0.0 111.141 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.02 4.58 51.02 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.723 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.75 HG22 HG23 ' A' ' 42' ' ' ILE . 2.6 pp -137.12 157.79 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 117.287 0.544 . . . . 0.0 111.321 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.6 m -112.99 136.71 52.38 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.822 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.551 HD12 HG21 ' A' ' 37' ' ' ILE . 2.7 pt -117.64 158.14 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.364 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 t -143.48 153.97 43.18 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.289 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.31 -167.1 24.28 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.619 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.18 122.28 0.64 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.842 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.19 -37.76 78.19 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.658 0.266 . . . . 0.0 111.058 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -59.04 -31.2 68.63 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.936 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -80.27 -28.02 38.45 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.108 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.04 30.35 4.83 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.958 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 6.8 m -146.48 132.96 9.73 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-N 116.76 0.28 . . . . 0.0 111.162 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 34.4 Cg_exo -61.26 157.41 40.35 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.718 2.279 . . . . 0.0 112.049 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.551 HG21 HD12 ' A' ' 27' ' ' ILE . 21.9 mm -82.18 135.19 25.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.563 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 pp -138.65 155.99 47.81 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.934 0.397 . . . . 0.0 111.513 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.917 HD13 HD21 ' A' ' 54' ' ' LEU . 19.3 mt -79.97 125.78 39.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.948 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.7 t -101.63 -42.42 6.22 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.623 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -127.94 150.55 49.84 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.982 0.42 . . . . 0.0 111.796 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.75 HG23 HG22 ' A' ' 25' ' ' ILE . 37.6 mt -132.91 122.67 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.571 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -82.59 132.2 52.82 Favored Pre-proline 0 N--CA 1.462 0.162 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.928 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.92 148.19 40.19 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.747 2.298 . . . . 0.0 112.58 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.42 37.99 46.08 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.65 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.9 172.49 7.25 Favored Pre-proline 0 C--O 1.233 0.191 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.516 ' HB2' HD21 ' A' ' 15' ' ' LEU . 76.2 Cg_exo -50.86 -32.4 37.26 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.669 2.246 . . . . 0.0 112.916 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.475 ' CB ' HD13 ' A' ' 54' ' ' LEU . . . -66.07 -46.27 78.33 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.088 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.28 -40.05 77.98 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.683 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -60.04 -31.7 70.22 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.395 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 m -76.53 -27.98 56.18 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.46 16.75 67.79 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.132 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.01 -35.15 1.54 Allowed Glycine 0 C--N 1.337 0.593 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.834 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.917 HD21 HD13 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -69.24 105.51 2.54 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.818 0.342 . . . . 0.0 110.907 -179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.469 ' C ' HD11 ' A' ' 42' ' ' ILE . 19.2 p80 -111.98 157.34 20.83 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.208 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.4 t -62.86 137.97 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.61 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.89 53.36 7.21 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.627 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -111.93 120.8 43.14 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.3 126.75 36.48 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.866 0.365 . . . . 0.0 111.854 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.848 ' HA ' HG12 ' A' ' 91' ' ' VAL . 3.4 mt -85.83 149.9 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.907 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.2 mt -135.47 -50.0 0.73 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.874 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.68 145.69 45.05 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.745 0.307 . . . . 0.0 111.432 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.1 t -135.1 115.99 19.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.54 36.83 28.2 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.806 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.28 -14.4 50.39 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.429 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.3 t -83.92 136.49 22.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 117.19 0.495 . . . . 0.0 110.923 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -76.91 137.53 39.16 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.285 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.401 HD11 ' HB1' ' A' ' 76' ' ' ALA . 0.4 OUTLIER -114.97 -1.53 13.08 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.652 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -71.31 -34.15 70.33 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.35 12.19 33.8 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 64.7 p -103.88 138.61 40.21 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.655 0.264 . . . . 0.0 110.939 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.35 161.16 30.79 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.816 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.537 ' O ' HG23 ' A' ' 77' ' ' VAL . 10.3 t-80 -53.91 -49.28 68.98 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.956 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.95 -41.94 99.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.683 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.7 -39.58 94.47 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.105 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.615 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.64 -34.28 77.49 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.476 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 73' ' ' HIS . 39.7 t -62.04 -43.01 97.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.791 0.329 . . . . 0.0 110.311 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 m -63.8 -44.37 93.49 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.74 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 76' ' ' ALA . 12.5 mt -62.86 -41.2 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.955 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.546 HD22 HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -59.12 -41.72 88.89 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.833 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.6 m -69.2 -27.12 65.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.442 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -65.08 -28.16 69.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.42 0.152 . . . . 0.0 111.139 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.529 ' HB3' HG23 ' A' ' 87' ' ' ILE . 50.9 mm-40 -67.06 117.33 8.96 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.65 0.262 . . . . 0.0 110.938 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.96 143.68 44.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.071 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.61 -106.88 0.95 Allowed Glycine 0 C--N 1.337 0.604 0 C-N-CA 121.298 -0.477 . . . . 0.0 112.916 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -78.6 122.78 26.36 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.661 0.267 . . . . 0.0 110.465 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.529 HG23 ' HB3' ' A' ' 83' ' ' GLN . 13.4 mt -127.7 123.12 60.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.404 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -93.84 123.89 37.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.232 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.523 ' HZ ' HD21 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -117.51 133.2 56.23 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.855 0.359 . . . . 0.0 111.654 -179.299 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.88 115.51 23.97 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.421 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.848 HG12 ' HA ' ' A' ' 60' ' ' ILE . 15.0 m -136.97 169.69 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.743 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.529 HG22 ' HA ' ' A' ' 10' ' ' ILE . 23.4 t -136.95 133.7 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.666 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.44 117.85 8.54 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.791 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 13.3 p -99.4 126.82 52.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.859 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.234 -179.601 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.489 1.22 0 CA-C-O 120.843 0.268 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.662 ' HA ' HG12 ' A' ' 92' ' ' VAL . 1.0 OUTLIER -79.87 127.39 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.175 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.67 128.28 55.22 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.104 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -100.32 117.57 34.81 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.799 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.594 HG23 ' HB3' ' A' ' 89' ' ' PHE . 5.0 m -127.52 128.43 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.461 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 tp -105.02 120.29 41.11 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.088 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 tp -108.72 137.01 47.35 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.685 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.4 114.94 28.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.786 0.326 . . . . 0.0 110.877 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.555 ' HB3' HD11 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -117.72 132.59 56.45 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.029 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.44 169.73 8.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.699 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.404 ' HA ' ' NH1' ' A' ' 84' ' ' ARG . 53.1 m-20 -57.31 -38.44 74.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.921 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -81.65 -26.27 34.9 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.726 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -88.9 153.35 21.12 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.973 0.416 . . . . 0.0 111.606 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.35 -149.7 15.75 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.804 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.38 -65.63 0.96 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.545 0.212 . . . . 0.0 111.209 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.01 4.42 60.09 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.525 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.684 HG22 HG23 ' A' ' 42' ' ' ILE . 10.4 pt -142.17 151.8 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 117.389 0.594 . . . . 0.0 111.337 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.0 136.76 49.52 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.781 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.1 pt -124.84 158.74 32.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.421 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.0 t -143.11 150.92 40.14 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.135 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.82 -148.17 17.2 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.576 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.458 ' HA2' HD11 ' A' ' 37' ' ' ILE . . . 155.54 111.65 0.39 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.532 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -58.25 -30.28 66.43 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.455 0.169 . . . . 0.0 111.205 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -58.66 -31.37 68.12 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.006 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -86.06 -24.3 26.4 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.235 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.0 27.37 2.98 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.154 -0.546 . . . . 0.0 113.003 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.6 m -142.37 138.78 16.81 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.923 0.361 . . . . 0.0 110.966 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.48 155.77 65.92 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.52 2.147 . . . . 0.0 112.322 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.458 HD11 ' HA2' ' A' ' 30' ' ' GLY . 23.6 mm -84.15 125.3 40.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.754 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.09 145.13 50.46 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.09 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.578 HD12 ' HB3' ' A' ' 58' ' ' ASP . 23.9 mt -85.31 120.64 35.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.852 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.3 -37.04 5.86 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.476 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -117.65 149.64 40.36 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.765 0.317 . . . . 0.0 111.198 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.684 HG23 HG22 ' A' ' 25' ' ' ILE . 24.2 mt -134.28 113.42 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.766 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -72.83 127.02 90.27 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.293 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.0 166.07 28.66 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.819 2.346 . . . . 0.0 112.789 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.21 23.45 74.77 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.71 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -131.82 172.77 6.79 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.01 -22.01 29.2 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.484 2.123 . . . . 0.0 113.206 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.536 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -60.32 -46.94 88.1 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -71.41 -38.03 71.46 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.671 0.272 . . . . 0.0 110.57 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -67.03 -27.72 67.64 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.015 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 7.5 t -70.28 -28.03 64.89 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.338 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.62 -60.52 3.69 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.737 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.48 -26.18 37.02 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 121.447 -0.406 . . . . 0.0 113.39 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.463 HD11 HG21 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -65.09 92.12 0.1 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.009 0.433 . . . . 0.0 110.502 179.658 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -119.19 157.65 27.54 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.294 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.0 m -63.77 138.86 22.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.49 46.14 7.02 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.739 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.578 ' HB3' HD12 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -111.99 127.82 55.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.416 0.15 . . . . 0.0 110.954 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -94.65 125.24 39.17 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.192 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.909 ' HA ' HG12 ' A' ' 91' ' ' VAL . 3.3 mt -80.14 136.85 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.461 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.24 -52.07 2.6 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.944 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.07 156.06 42.7 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.813 0.34 . . . . 0.0 111.55 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.2 t -138.51 115.76 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.761 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.401 ' HB2' ' OE1' ' A' ' 83' ' ' GLN . 4.2 t-20 55.28 42.49 30.3 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.063 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.42 2.01 62.34 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.307 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.6 t -97.27 122.59 48.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 117.149 0.474 . . . . 0.0 110.508 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -66.31 128.51 36.42 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.541 HD22 HG21 ' A' ' 60' ' ' ILE . 1.9 tp -103.84 -17.07 15.19 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.789 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.6 ttm105 -61.17 -32.5 72.23 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -98.75 7.0 46.57 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -101.92 148.11 25.73 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.746 0.307 . . . . 0.0 110.97 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.79 161.08 23.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.605 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.59 ' O ' HG23 ' A' ' 77' ' ' VAL . 58.5 t-80 -54.12 -49.66 68.66 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.958 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -40.68 90.46 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.926 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -64.75 -38.69 91.83 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.19 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.432 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.69 -34.98 79.06 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.272 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 73' ' ' HIS . 39.1 t -61.7 -42.08 92.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.38 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -44.77 93.82 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.697 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 76' ' ' ALA . 21.7 mt -63.84 -46.47 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.04 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.447 HD21 ' HZ ' ' A' ' 89' ' ' PHE . 0.4 OUTLIER -55.61 -41.33 73.32 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.112 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.94 -34.3 77.47 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.983 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -65.74 -24.82 67.04 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.422 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.45 ' HB2' HD13 ' A' ' 87' ' ' ILE . 32.5 mm-40 -63.38 103.98 0.57 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.769 0.319 . . . . 0.0 110.766 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.404 ' NH1' ' HA ' ' A' ' 19' ' ' ASP . 11.0 mmt180 -112.06 155.03 24.49 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.073 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.07 -103.23 0.68 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.39 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.61 130.97 44.6 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.706 0.289 . . . . 0.0 110.551 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.555 HD11 ' HB3' ' A' ' 17' ' ' LYS . 14.2 mt -126.19 122.48 61.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -93.91 122.87 36.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.444 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.594 ' HB3' HG23 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -116.88 134.17 55.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.991 0.424 . . . . 0.0 111.438 -179.684 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -122.69 115.44 22.08 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.096 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.909 HG12 ' HA ' ' A' ' 60' ' ' ILE . 25.9 m -138.52 170.27 16.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.59 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.662 HG12 ' HA ' ' A' ' 10' ' ' ILE . 6.2 m -134.96 136.77 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.863 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.78 121.83 16.31 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.961 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.5 t -115.28 137.47 48.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.086 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.387 179.92 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.433 ' O ' HG13 ' A' ' 92' ' ' VAL . 4.4 Cg_endo . . . . . 0 N--CA 1.49 1.301 0 CA-C-O 120.671 0.196 . . . . 0.0 111.884 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 tt -83.29 141.31 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.379 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -122.45 132.82 54.53 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.122 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -103.48 111.96 24.65 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.501 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.7 t -118.22 138.13 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.815 0.341 . . . . 0.0 111.338 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.779 HD21 ' HG3' ' A' ' 86' ' ' GLU . 2.5 tt -108.34 127.54 53.96 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.855 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 tp -115.01 144.1 44.15 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.034 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mt -109.22 116.17 31.39 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.964 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.57 137.86 52.31 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.07 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -114.99 167.66 10.6 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.706 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.82 -38.21 72.28 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.192 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -84.07 -25.26 29.94 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.529 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -92.08 173.91 7.59 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.787 0.327 . . . . 0.0 111.498 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -132.83 -146.4 5.59 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.998 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 mt -82.79 -66.59 0.87 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.525 0.203 . . . . 0.0 111.168 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.16 4.52 35.54 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.694 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.769 HD13 HD12 ' A' ' 39' ' ' ILE . 1.5 pp -146.44 147.96 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 117.297 0.549 . . . . 0.0 111.114 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.1 t -101.85 137.84 39.61 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.727 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.743 HG22 HD13 ' A' ' 39' ' ' ILE . 16.2 pt -116.11 153.82 17.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.543 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.9 t -141.9 152.16 43.31 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.37 -152.55 19.82 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.496 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . 166.57 119.74 0.49 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.934 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.91 -35.61 75.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.522 0.201 . . . . 0.0 111.328 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.39 -31.03 65.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.139 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -78.48 -27.52 46.26 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.138 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.76 26.53 5.54 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.807 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 13.1 m -141.1 133.29 14.02 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 116.787 0.293 . . . . 0.0 111.082 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 34.4 Cg_exo -61.27 157.6 39.47 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.823 2.349 . . . . 0.0 112.157 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.569 ' O ' HD12 ' A' ' 60' ' ' ILE . 23.5 mm -82.48 130.68 35.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.733 0.301 . . . . 0.0 110.44 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.561 HD12 ' C ' ' A' ' 37' ' ' ILE . 9.7 mp -121.78 156.29 33.5 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.604 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.769 HD12 HD13 ' A' ' 25' ' ' ILE . 17.8 mm -88.05 124.83 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.402 ' O ' HG13 ' A' ' 56' ' ' VAL . 3.1 m -117.73 -45.02 2.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.557 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.51 145.23 33.39 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.796 0.331 . . . . 0.0 111.254 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.617 HG23 HG22 ' A' ' 25' ' ' ILE . 12.6 mt -132.94 113.46 20.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.566 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -71.76 126.45 91.48 Favored Pre-proline 0 C--O 1.232 0.145 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.823 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.8 154.39 63.63 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.774 2.316 . . . . 0.0 112.624 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.38 32.95 80.66 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.774 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.96 175.19 3.81 Favored Pre-proline 0 C--O 1.233 0.213 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -51.13 -33.11 42.5 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.672 2.248 . . . . 0.0 112.774 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.4 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -58.03 -46.14 85.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.214 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.12 -38.75 72.31 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.837 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -61.62 -33.96 74.83 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.795 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.5 p -90.35 -27.36 19.43 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.598 0.221 . . . . 0.0 111.598 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.58 16.14 65.04 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.109 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.68 -28.7 5.87 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.403 -0.427 . . . . 0.0 112.73 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.45 HD22 HG21 ' A' ' 25' ' ' ILE . 3.5 mt -77.1 71.72 3.6 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.245 0.545 . . . . 0.0 110.497 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -86.1 157.41 20.05 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.278 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 40' ' ' SER . 26.1 t -66.42 137.95 23.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.065 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.25 36.58 9.72 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.543 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -100.29 150.1 22.92 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.55 121.08 37.63 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.619 0.247 . . . . 0.0 111.416 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.831 ' HA ' HG12 ' A' ' 91' ' ' VAL . 2.0 mt -81.72 148.05 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.519 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 36.8 mt -131.44 -51.51 1.0 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.993 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.73 145.81 47.04 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.911 0.386 . . . . 0.0 111.759 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.436 ' CG2' HD13 ' A' ' 68' ' ' LEU . 21.7 t -127.74 115.67 40.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.294 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.4 34.24 24.39 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.656 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.05 -19.02 44.85 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.68 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.8 t -88.05 137.37 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 117.268 0.534 . . . . 0.0 111.078 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -71.26 132.81 45.48 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.265 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.524 HD22 HG21 ' A' ' 60' ' ' ILE . 7.6 tp -89.95 -29.36 18.54 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.183 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -18.93 65.41 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.775 -0.193 . . . . 0.0 111.394 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.14 9.22 34.45 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.4 t -133.77 165.69 24.39 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.559 0.219 . . . . 0.0 110.751 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.05 161.0 16.79 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.064 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.662 ' O ' HG23 ' A' ' 77' ' ' VAL . 80.3 t60 -55.66 -51.4 67.36 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.181 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -61.38 -43.13 99.4 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.889 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.0 -38.26 88.03 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.917 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.75 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.79 -30.73 71.79 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.564 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 73' ' ' HIS . 22.1 t -61.86 -45.02 99.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 120.789 0.328 . . . . 0.0 110.312 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.4 -40.14 96.4 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.595 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.75 HD12 ' HA ' ' A' ' 76' ' ' ALA . 34.5 mt -61.09 -41.73 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.884 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.434 HD23 HG11 ' A' ' 63' ' ' VAL . 69.4 mt -61.71 -39.23 90.77 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.783 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.6 m -64.39 -32.48 74.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.895 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -65.18 -29.25 70.06 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.243 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -65.43 106.33 1.37 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.759 0.314 . . . . 0.0 110.808 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.52 148.7 29.87 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.222 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.94 -100.95 0.43 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.618 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.779 ' HG3' HD21 ' A' ' 14' ' ' LEU . 9.2 tt0 -88.37 128.34 35.51 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.645 0.259 . . . . 0.0 110.436 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.0 mt -128.96 122.5 56.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.149 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -97.14 138.49 34.57 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.814 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -133.37 129.91 38.06 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.088 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -113.25 115.2 27.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.272 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.831 HG12 ' HA ' ' A' ' 60' ' ' ILE . 26.8 m -134.91 169.36 21.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.511 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 9' ' ' PRO . 17.6 t -138.66 136.53 43.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.937 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.55 123.58 22.17 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.753 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.7 m -122.58 113.35 37.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.078 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.453 -179.715 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.489 1.217 0 CA-C-O 120.689 0.204 . . . . 0.0 111.834 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.424 ' HA ' HG22 ' A' ' 92' ' ' VAL . 3.7 mp -79.18 140.19 17.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.185 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.16 132.74 54.61 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.994 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.84 118.2 35.99 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.607 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.2 m -128.94 142.17 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.394 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 87' ' ' ILE . 1.7 mt -105.45 122.55 46.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -109.79 139.66 44.59 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.953 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 49.9 mt -111.77 119.08 37.39 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.768 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.41 ' HB2' ' CD1' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -107.64 130.56 54.9 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.991 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.69 163.72 16.43 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.95 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.38 -38.57 71.64 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.185 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 49.3 p-80 -86.39 -23.5 26.1 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.801 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -92.53 161.34 14.65 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.933 0.396 . . . . 0.0 111.232 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.87 -158.88 10.0 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.91 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.737 HD21 ' CD2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -71.98 -67.43 0.54 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.575 0.226 . . . . 0.0 110.982 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.63 4.43 67.78 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.701 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.855 HG22 HG23 ' A' ' 42' ' ' ILE . 2.3 pt -136.77 143.73 34.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 117.459 0.63 . . . . 0.0 111.331 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.2 m -105.17 136.61 44.34 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.716 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.847 HG22 HD13 ' A' ' 39' ' ' ILE . 43.5 pt -121.98 155.7 26.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.483 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.8 p -139.35 173.88 11.09 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.368 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.74 -159.49 19.05 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.668 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.427 ' H ' HG23 ' A' ' 35' ' ' VAL . . . 170.53 125.07 0.78 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.861 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -61.06 -37.79 83.91 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.455 0.169 . . . . 0.0 111.289 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.4 -31.22 72.33 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.206 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -78.38 -29.26 47.26 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.108 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.77 30.24 3.56 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.93 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.427 HG23 ' H ' ' A' ' 30' ' ' GLY . 14.8 m -144.06 132.62 11.09 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-N 116.838 0.319 . . . . 0.0 111.108 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.556 ' O ' HD12 ' A' ' 38' ' ' LEU . 26.7 Cg_exo -61.14 157.33 40.2 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.614 2.209 . . . . 0.0 112.153 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.491 HD12 ' ND1' ' A' ' 73' ' ' HIS . 24.6 mm -83.75 127.99 39.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.632 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.556 HD12 ' O ' ' A' ' 36' ' ' PRO . 5.3 mp -130.1 149.97 51.58 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.407 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.847 HD13 HG22 ' A' ' 27' ' ' ILE . 30.5 mm -75.98 114.9 16.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.577 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.444 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.7 OUTLIER -84.11 -45.9 12.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.382 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -145.04 161.51 39.24 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.861 0.362 . . . . 0.0 111.273 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.855 HG23 HG22 ' A' ' 25' ' ' ILE . 4.0 mp -132.13 116.69 30.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.68 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -65.9 133.48 94.91 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.069 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.91 153.08 47.37 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.797 2.331 . . . . 0.0 112.756 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.57 31.5 62.88 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.676 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.442 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.2 OUTLIER -129.34 169.4 13.27 Favored Pre-proline 0 C--O 1.233 0.196 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.442 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 9.8 Cg_endo -53.92 -26.98 42.35 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.684 2.256 . . . . 0.0 112.721 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -57.37 -46.07 83.75 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.197 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.62 -38.63 73.95 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.862 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -56.83 -39.41 74.18 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.244 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.66 -27.76 64.28 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.755 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.79 19.96 75.51 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.678 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -119.8 -31.68 1.3 Allowed Glycine 0 C--N 1.338 0.681 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.17 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.647 HD12 HG21 ' A' ' 25' ' ' ILE . 4.3 mm? -70.01 89.2 0.6 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.104 0.478 . . . . 0.0 110.413 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -111.08 157.54 19.87 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.339 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 40' ' ' SER . 20.7 t -63.19 140.05 20.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.291 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.15 52.92 8.24 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.871 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -112.19 139.02 48.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.22 0.208 . . . . 0.0 111.211 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.65 127.14 53.4 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.895 HG21 HD13 ' A' ' 68' ' ' LEU . 2.8 mt -91.54 148.08 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 120.852 0.358 . . . . 0.0 111.631 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 78.8 mt -133.33 -52.94 0.89 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.806 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.99 147.68 46.42 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.865 0.364 . . . . 0.0 111.385 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.32 115.66 16.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.409 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 57.99 33.36 23.1 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.214 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.76 -16.03 57.64 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.24 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.7 t -88.68 137.33 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 117.065 0.433 . . . . 0.0 110.912 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -76.5 135.58 39.34 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.305 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.895 HD13 HG21 ' A' ' 60' ' ' ILE . 1.1 tt -96.71 -26.71 15.07 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.406 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -18.1 63.15 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -97.52 11.78 35.67 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 t -133.48 150.69 51.72 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.752 0.311 . . . . 0.0 111.11 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -75.67 161.25 29.25 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.359 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.598 ' O ' HG23 ' A' ' 77' ' ' VAL . 1.7 t60 -53.92 -52.03 61.88 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.104 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -61.84 -42.44 99.04 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.947 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -64.61 -38.54 91.36 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.102 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.59 -33.31 75.33 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.363 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 73' ' ' HIS . 37.2 t -62.09 -43.7 98.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.76 0.314 . . . . 0.0 110.341 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 29.3 m -60.54 -43.6 97.03 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.602 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 64.7 mt -58.45 -42.72 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.623 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.737 ' CD2' HD21 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -57.25 -40.75 78.27 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.838 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.5 t -62.79 -36.26 82.54 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.773 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -65.35 -24.89 67.37 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.269 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.479 ' HB3' HG23 ' A' ' 87' ' ' ILE . 38.2 mm-40 -65.45 91.48 0.12 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.932 0.396 . . . . 0.0 110.755 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.37 149.61 24.6 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.984 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.46 -98.7 0.29 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.291 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -92.75 137.6 32.22 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.703 0.287 . . . . 0.0 110.524 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.487 ' O ' HD23 ' A' ' 14' ' ' LEU . 15.0 mt -137.62 124.44 28.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -101.27 129.9 47.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.694 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.89 129.03 54.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.782 0.325 . . . . 0.0 110.786 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.72 116.3 25.66 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.017 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.857 HG12 ' HA ' ' A' ' 60' ' ' ILE . 9.0 m -138.85 171.6 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.985 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 10' ' ' ILE . 21.6 t -137.18 132.16 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.722 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.66 127.46 33.04 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.724 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.5 t -114.84 135.33 55.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.364 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.44 -0.79 . . . . 0.0 111.11 179.802 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo . . . . . 0 N--CA 1.489 1.252 0 CA-C-O 120.685 0.202 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.726 ' HA ' HG12 ' A' ' 92' ' ' VAL . 31.3 mt -87.3 142.27 13.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.166 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -122.04 129.25 52.26 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.95 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.4 118.2 36.15 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.694 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.1 t -127.7 141.25 46.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.379 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.5 mt -102.54 128.13 49.32 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 tp -112.87 136.98 51.91 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.142 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.63 116.37 31.86 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.826 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.438 ' HG2' HD12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -129.17 153.96 47.21 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.113 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.99 164.17 13.43 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.038 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -57.63 -38.53 75.14 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.966 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -79.33 -27.94 42.1 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.298 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.68 161.84 22.01 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.849 0.357 . . . . 0.0 111.324 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.32 -146.31 19.22 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.944 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.3 tp -87.64 -52.74 5.16 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.552 0.215 . . . . 0.0 111.319 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.12 -11.64 51.99 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.418 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.662 HD12 HD13 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -140.35 151.89 21.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.931 0.366 . . . . 0.0 111.041 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.435 ' O ' HG23 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -108.51 136.71 47.66 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.029 179.9 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.443 HG21 HD11 ' A' ' 60' ' ' ILE . 14.8 pt -116.15 153.22 17.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.489 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.8 t -143.59 145.64 32.67 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.012 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.71 -170.07 15.95 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.497 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.92 122.5 0.82 Allowed Glycine 0 C--N 1.335 0.528 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.801 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -30.27 65.47 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -30.94 65.35 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.61 0.243 . . . . 0.0 111.069 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -79.45 -32.66 42.74 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.978 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.95 -29.9 3.02 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.669 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 11.6 m -101.86 132.83 21.18 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-O 120.707 0.289 . . . . 0.0 111.196 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 35.6 Cg_exo -61.09 157.21 40.44 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.799 2.333 . . . . 0.0 112.295 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.46 ' H ' HD12 ' A' ' 37' ' ' ILE . 3.9 mp -83.25 138.02 19.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.817 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.44 163.12 31.21 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.295 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 26' ' ' SER . 25.5 mt -85.28 120.19 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.262 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.469 ' O ' HG13 ' A' ' 56' ' ' VAL . 2.6 t -108.43 -33.07 7.18 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.633 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.37 144.93 44.42 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.677 0.275 . . . . 0.0 111.126 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.48 HG23 HG22 ' A' ' 25' ' ' ILE . 22.3 mm -125.96 121.63 60.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.647 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -75.73 121.07 84.35 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.881 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.8 155.57 62.27 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.774 2.316 . . . . 0.0 112.545 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.93 38.24 95.8 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.354 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.77 176.06 3.17 Favored Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.33 -29.5 30.49 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.643 2.228 . . . . 0.0 112.77 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' A' ' 54' ' ' LEU . . . -58.16 -46.19 86.15 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.992 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.55 -42.11 75.01 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.763 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -59.73 -33.27 71.42 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.429 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.2 t -83.35 -28.19 29.16 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.85 16.66 59.64 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.091 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.88 -29.39 2.86 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.197 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.662 HD13 HD12 ' A' ' 25' ' ' ILE . 32.0 mt -76.09 71.84 2.87 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.142 0.496 . . . . 0.0 110.753 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -84.15 157.25 21.75 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.058 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 40' ' ' SER . 23.4 t -65.08 135.01 28.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.44 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.25 47.11 3.91 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.554 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.06 124.28 51.2 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.5 121.2 32.98 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.722 0.296 . . . . 0.0 111.194 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.757 ' HA ' HG12 ' A' ' 91' ' ' VAL . 7.5 mt -70.72 142.2 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.575 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.4 mt -127.29 -53.82 1.37 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.969 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.54 158.76 43.99 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.882 0.372 . . . . 0.0 111.813 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.517 HG22 ' CE1' ' A' ' 89' ' ' PHE . 15.1 t -133.66 117.52 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.727 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.08 37.47 28.64 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.95 0.405 . . . . 0.0 110.964 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.52 6.09 89.43 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.441 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.4 t -97.79 119.95 46.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 117.278 0.539 . . . . 0.0 110.699 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -63.83 126.79 28.75 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.454 HD13 HG23 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -113.02 4.19 16.57 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.686 179.817 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -68.84 -34.83 76.14 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.447 0.165 . . . . 0.0 111.133 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.67 11.9 33.54 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.47 HG21 ' CD1' ' A' ' 79' ' ' ILE . 15.8 m -100.97 156.39 17.42 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.645 0.259 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -92.62 161.22 14.66 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.535 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.438 ' O ' HG23 ' A' ' 77' ' ' VAL . 81.8 t60 -54.47 -50.69 67.13 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.054 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.16 -39.5 90.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.788 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.56 -38.78 92.18 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.059 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.676 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.6 -32.79 74.37 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.362 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 73' ' ' HIS . 40.8 t -61.85 -41.53 91.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.763 0.316 . . . . 0.0 110.56 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -41.89 74.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.899 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' A' ' 76' ' ' ALA . 11.6 mt -62.74 -48.69 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.651 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 81' ' ' SER . 4.2 pp -62.36 -35.17 78.29 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.019 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.511 ' N ' HD12 ' A' ' 80' ' ' LEU . 2.3 m -65.91 -33.88 76.85 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.136 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -65.26 -27.74 68.86 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.232 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.456 ' HB3' HG23 ' A' ' 87' ' ' ILE . 46.7 mm-40 -65.16 111.74 3.08 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.904 0.383 . . . . 0.0 111.119 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -105.19 143.79 32.88 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.109 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.77 -105.12 0.83 Allowed Glycine 0 C--N 1.337 0.59 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.894 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -81.2 127.16 32.37 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.723 0.297 . . . . 0.0 110.665 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.456 HG23 ' HB3' ' A' ' 83' ' ' GLN . 11.2 mt -127.95 122.39 58.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.05 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -93.87 130.77 39.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.438 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE1' HG22 ' A' ' 63' ' ' VAL . 0.5 OUTLIER -126.25 129.75 49.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.764 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.03 115.17 29.29 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.308 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.757 HG12 ' HA ' ' A' ' 60' ' ' ILE . 15.5 m -135.62 164.03 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.352 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.726 HG12 ' HA ' ' A' ' 10' ' ' ILE . 13.1 m -129.45 133.54 65.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.838 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.09 117.24 8.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.879 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.6 m -123.76 118.31 53.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.108 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.354 -0.831 . . . . 0.0 111.391 -179.712 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.448 ' O ' HG13 ' A' ' 92' ' ' VAL . 5.2 Cg_exo . . . . . 0 N--CA 1.489 1.246 0 CA-C-O 120.802 0.251 . . . . 0.0 111.84 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.5 HD11 ' HG2' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -84.39 118.71 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.213 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.78 130.04 55.38 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.043 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.56 120.24 40.84 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.2 t -125.67 134.25 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.176 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 mt -98.38 124.7 43.19 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.855 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.1 131.55 54.5 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.57 115.42 28.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.777 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.46 129.73 33.66 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.94 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.17 170.71 9.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.992 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -59.27 -38.17 79.44 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.953 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -76.75 -25.77 53.84 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.715 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -91.51 167.61 12.12 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.918 0.39 . . . . 0.0 111.74 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.88 -166.48 12.85 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 115.932 -0.577 . . . . 0.0 113.03 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.981 HD12 HD11 ' A' ' 25' ' ' ILE . 0.3 OUTLIER -66.08 -68.33 0.38 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.517 0.199 . . . . 0.0 111.255 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.436 ' HA2' ' OE1' ' A' ' 46' ' ' GLN . . . 106.02 4.02 38.92 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.015 -0.612 . . . . 0.0 114.113 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.981 HD11 HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -145.13 153.92 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 117.341 0.571 . . . . 0.0 111.101 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.2 136.97 38.38 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.654 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.2 pt -116.77 143.59 26.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.292 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.2 t -123.2 158.03 31.72 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.173 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.3 -143.19 15.7 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.357 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.41 ' HA3' ' HB2' ' A' ' 73' ' ' HIS . . . 136.43 134.85 3.35 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.935 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -52.54 -31.15 34.3 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -57.56 -29.4 64.39 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.18 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -93.82 19.48 8.82 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.45 29.09 68.48 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.166 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 8.7 m -147.08 139.64 14.23 Favored Pre-proline 0 CA--C 1.529 0.163 0 CA-C-N 116.704 0.252 . . . . 0.0 111.402 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 29.7 Cg_exo -61.59 155.5 52.96 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.637 2.225 . . . . 0.0 112.229 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.84 139.11 17.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.865 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.746 HD23 ' HB2' ' A' ' 59' ' ' ALA . 1.1 mp -134.67 156.75 48.21 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.261 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.768 HD13 HD21 ' A' ' 54' ' ' LEU . 27.8 mt -87.6 129.55 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.567 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -121.19 -42.83 2.45 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.558 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.57 144.84 35.72 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.71 0.291 . . . . 0.0 111.159 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.727 HG23 HG22 ' A' ' 25' ' ' ILE . 41.0 mt -134.47 133.14 55.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.754 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -102.21 105.65 43.98 Favored Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.885 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.82 150.03 47.64 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.716 2.277 . . . . 0.0 112.545 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.13 -30.81 8.8 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.661 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.436 ' OE1' ' HA2' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -77.23 167.16 38.85 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-O 120.552 0.215 . . . . 0.0 110.754 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 13.6 Cg_endo -56.89 -29.01 80.15 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.68 2.253 . . . . 0.0 112.77 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.954 ' HB1' HD13 ' A' ' 54' ' ' LEU . . . -61.06 -46.07 92.17 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.784 0.326 . . . . 0.0 110.983 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -70.16 -39.48 75.31 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.744 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -61.69 -29.09 69.87 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.408 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.06 -28.31 63.25 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.34 -54.57 4.77 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.014 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.53 -34.57 27.63 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 121.542 -0.361 . . . . 0.0 113.509 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.954 HD13 ' HB1' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -71.17 93.71 1.09 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.112 0.482 . . . . 0.0 110.602 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -114.4 157.43 22.88 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.36 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 40' ' ' SER . 38.9 t -61.25 130.46 25.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.445 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.49 45.03 4.14 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.435 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.03 122.35 47.51 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 122.149 0.18 . . . . 0.0 110.739 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.746 ' HB2' HD23 ' A' ' 38' ' ' LEU . . . -91.14 122.66 33.96 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.639 0.257 . . . . 0.0 111.16 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.809 ' HA ' HG12 ' A' ' 91' ' ' VAL . 6.9 mt -76.72 145.79 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.412 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 mt -139.68 -51.48 0.51 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.123 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.47 146.02 50.27 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.972 0.415 . . . . 0.0 111.878 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.7 t -135.82 115.73 17.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.367 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.6 35.34 23.38 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.696 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.64 -18.68 45.21 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 120.993 -0.623 . . . . 0.0 113.713 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.21 128.03 48.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 117.315 0.557 . . . . 0.0 111.052 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -68.06 139.12 56.25 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.044 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.899 HD21 ' HB1' ' A' ' 76' ' ' ALA . 5.4 tp -108.85 13.2 25.03 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.382 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.2 ttp85 -71.18 -31.59 67.85 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.444 0.164 . . . . 0.0 111.433 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -102.3 10.83 38.91 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.73 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.433 HG22 ' HB3' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -108.04 132.71 53.26 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -64.59 158.52 24.07 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.149 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.503 ' O ' HG23 ' A' ' 77' ' ' VAL . 6.4 t-160 -56.66 -50.41 72.15 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.236 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -61.71 -39.32 91.07 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.516 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HB3' HG22 ' A' ' 71' ' ' THR . 13.5 tp10 -64.71 -38.0 89.51 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.84 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.899 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -63.92 -35.37 80.44 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.477 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 73' ' ' HIS . 23.0 t -61.95 -39.05 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.639 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 41.2 m -65.05 -48.64 73.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.641 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' A' ' 76' ' ' ALA . 7.8 mt -62.22 -42.65 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.796 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.16 -39.71 75.81 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.853 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -33.06 74.85 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.982 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -65.55 -27.89 68.76 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.325 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.419 ' HB3' HG23 ' A' ' 87' ' ' ILE . 74.2 mm-40 -61.13 114.07 2.92 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.77 0.319 . . . . 0.0 110.956 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.84 144.82 47.14 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.448 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.56 -104.78 1.13 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.513 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -88.01 122.1 31.2 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.753 0.311 . . . . 0.0 110.358 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.419 HG23 ' HB3' ' A' ' 83' ' ' GLN . 15.5 mt -122.02 125.61 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.968 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.79 127.89 39.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -121.94 129.9 52.89 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.094 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.5 ' HG2' HD11 ' A' ' 10' ' ' ILE . 16.9 tt0 -120.56 115.35 23.24 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.349 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.809 HG12 ' HA ' ' A' ' 60' ' ' ILE . 7.0 m -140.84 170.1 14.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.435 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 9' ' ' PRO . 25.1 t -132.55 139.55 49.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.875 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.09 120.2 12.75 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.839 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 92' ' ' VAL . 22.0 t -127.03 107.71 17.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.213 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.911 -179.855 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo . . . . . 0 N--CA 1.49 1.302 0 CA-C-O 120.643 0.185 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.736 ' HA ' HG12 ' A' ' 92' ' ' VAL . 4.9 mp -97.59 139.84 19.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.351 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -110.65 115.79 30.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.026 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -97.27 111.59 23.77 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.593 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.7 t -129.95 133.21 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.795 0.331 . . . . 0.0 111.326 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mt -100.97 134.98 43.15 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.583 HD11 HD12 ' A' ' 54' ' ' LEU . 3.4 mp -118.67 119.86 35.7 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.834 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -111.23 124.25 51.83 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.755 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.04 147.14 45.99 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.291 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -100.37 169.3 9.2 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.161 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.39 -37.98 82.48 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.947 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -72.77 -28.8 62.82 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.048 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -84.96 177.32 7.99 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.779 0.323 . . . . 0.0 111.144 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -125.05 -154.82 8.89 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.111 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.6 mt -71.51 -67.85 0.49 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.6 0.238 . . . . 0.0 111.153 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.7 4.38 63.74 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.059 -0.591 . . . . 0.0 113.71 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.437 HG21 ' CD1' ' A' ' 54' ' ' LEU . 2.5 pp -143.49 150.39 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 117.284 0.542 . . . . 0.0 111.252 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.524 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 1.1 m -121.62 136.93 54.93 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.733 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.732 HD12 HG21 ' A' ' 37' ' ' ILE . 31.5 pt -123.76 158.27 29.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.489 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -142.59 147.5 35.97 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.088 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.41 -159.59 21.41 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.45 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.23 120.43 0.52 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.613 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -55.22 -34.54 64.03 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.469 0.176 . . . . 0.0 111.354 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -31.23 65.6 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.082 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -77.5 -30.0 52.8 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.055 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.72 -29.96 3.04 Favored Glycine 0 C--N 1.335 0.472 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.888 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 11.5 m -109.48 138.15 20.49 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-O 120.708 0.289 . . . . 0.0 111.402 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 35.8 Cg_exo -61.11 157.17 40.77 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.761 2.308 . . . . 0.0 112.239 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.732 HG21 HD12 ' A' ' 27' ' ' ILE . 3.6 mp -82.36 136.98 21.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.832 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 pp -133.25 162.92 30.49 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.938 0.399 . . . . 0.0 111.672 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.571 HD13 HD21 ' A' ' 54' ' ' LEU . 18.4 mt -85.09 129.38 37.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.981 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.475 ' O ' HG13 ' A' ' 56' ' ' VAL . 70.9 m -117.13 -38.98 3.27 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.626 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.524 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 18.9 tt0 -114.37 145.96 41.16 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.938 0.399 . . . . 0.0 111.412 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.495 HD13 ' O ' ' A' ' 54' ' ' LEU . 26.4 mt -131.03 133.49 62.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.513 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -88.75 112.85 53.03 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.026 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.53 139.31 75.39 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.798 2.332 . . . . 0.0 112.401 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.53 -30.14 8.72 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.902 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.477 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -71.17 169.77 13.92 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.638 0.219 . . . . 0.0 110.921 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 7.1 Cg_endo -50.48 -30.52 27.84 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.753 2.302 . . . . 0.0 112.791 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.408 ' HB1' HD13 ' A' ' 54' ' ' LEU . . . -61.13 -46.01 92.33 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.711 0.291 . . . . 0.0 111.004 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.07 -38.94 75.89 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.776 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -58.1 -33.3 68.95 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.488 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.45 -28.01 64.69 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.575 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.84 15.76 60.56 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.859 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.81 -34.94 1.1 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.786 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.583 HD12 HD11 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -62.92 99.6 0.17 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.928 0.394 . . . . 0.0 110.513 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.426 ' CE1' ' CD2' ' A' ' 93' ' ' TYR . 11.4 p80 -110.43 156.69 20.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.014 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 40' ' ' SER . 38.3 t -63.86 132.58 29.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.74 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.94 46.89 2.56 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.635 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -112.59 118.97 36.55 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.96 123.49 34.49 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.928 0.394 . . . . 0.0 111.428 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.847 ' HA ' HG12 ' A' ' 91' ' ' VAL . 4.0 mt -76.51 134.12 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.785 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.4 mp -126.55 -49.78 1.51 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.565 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.76 145.54 48.52 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.323 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.486 HG23 HD13 ' A' ' 68' ' ' LEU . 25.3 t -139.47 116.59 10.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.543 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.95 33.75 23.54 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.999 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.55 -15.4 54.76 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.352 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.8 128.8 41.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 117.151 0.475 . . . . 0.0 110.789 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -80.86 141.23 34.82 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.733 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.486 HD13 HG23 ' A' ' 63' ' ' VAL . 2.7 mp -117.04 21.07 13.48 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.634 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.42 -34.07 70.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.385 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -103.73 8.49 37.29 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 50.9 p -96.06 179.98 4.88 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.655 0.264 . . . . 0.0 110.831 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.17 161.21 18.08 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.964 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.533 ' O ' HG23 ' A' ' 77' ' ' VAL . 46.9 t60 -54.05 -51.01 65.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.973 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -60.57 -42.08 95.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.652 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.24 -37.98 89.38 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.957 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.529 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.59 -38.03 89.58 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.249 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.646 ' HA ' HD12 ' A' ' 80' ' ' LEU . 22.1 t -61.85 -44.41 98.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.702 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.7 m -62.51 -45.28 93.7 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.8 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 76' ' ' ALA . 11.8 mt -61.82 -40.55 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.918 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.646 HD12 ' HA ' ' A' ' 77' ' ' VAL . 12.9 mt -58.14 -39.01 77.67 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.661 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.6 t -67.58 -32.97 74.08 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.005 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -64.91 -28.64 69.67 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.307 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.497 ' HB3' HG23 ' A' ' 87' ' ' ILE . 16.5 mm100 -64.08 110.53 2.19 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.747 0.308 . . . . 0.0 110.957 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -111.63 147.39 35.59 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.122 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.43 ' O ' HD13 ' A' ' 16' ' ' LEU . . . 62.91 -108.12 1.99 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.508 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.449 ' HA ' HD22 ' A' ' 16' ' ' LEU . 29.9 tt0 -82.14 124.8 30.19 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.712 0.291 . . . . 0.0 110.535 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.497 HG23 ' HB3' ' A' ' 83' ' ' GLN . 10.9 mt -124.76 122.32 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.975 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -94.06 129.77 40.46 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.891 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.12 129.78 51.44 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.267 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -123.58 115.19 21.09 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.022 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.847 HG12 ' HA ' ' A' ' 60' ' ' ILE . 16.5 m -138.67 170.6 16.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.222 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.736 HG12 ' HA ' ' A' ' 10' ' ' ILE . 22.9 m -132.9 138.82 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.808 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.426 ' CD2' ' CE1' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -67.17 116.02 7.5 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.733 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.8 p -101.68 133.8 44.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.184 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.24 -179.872 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 N--CA 1.49 1.309 0 CA-C-O 120.784 0.243 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.649 HG23 HG22 ' A' ' 92' ' ' VAL . 4.9 mp -96.84 143.47 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.136 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.96 145.88 48.87 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.19 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.1 mmtm -114.72 111.47 21.33 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.827 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.1 t -112.85 131.23 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.037 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mp -102.82 126.46 49.97 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.414 HD21 ' HB2' ' A' ' 47' ' ' PRO . 1.9 tt -117.58 141.32 48.51 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.224 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.41 127.11 54.13 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.794 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -104.34 121.61 43.72 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.138 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -100.46 156.64 17.16 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.993 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -58.29 -38.29 76.72 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.177 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -86.14 -22.07 27.25 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.32 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -90.03 176.63 6.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.815 0.34 . . . . 0.0 111.282 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.02 -145.37 4.66 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.835 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 25' ' ' ILE . 30.8 tp -77.36 -63.16 1.44 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.535 0.207 . . . . 0.0 110.939 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.74 4.52 87.31 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.035 -0.602 . . . . 0.0 114.037 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.847 HG22 HG23 ' A' ' 42' ' ' ILE . 6.1 pt -139.85 164.16 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 117.348 0.574 . . . . 0.0 111.369 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 9.0 t -121.51 137.33 54.77 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.917 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.757 HG22 HD13 ' A' ' 39' ' ' ILE . 12.4 pt -115.83 152.1 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.632 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.3 p -137.85 153.41 49.6 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.085 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.9 -169.47 13.3 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.84 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.428 ' H ' HG13 ' A' ' 35' ' ' VAL . . . 172.44 119.27 0.52 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.69 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.7 -29.63 68.23 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -31.33 69.2 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.668 0.27 . . . . 0.0 111.117 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -87.69 -28.09 22.02 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.154 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.28 35.67 1.43 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.695 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.428 HG13 ' H ' ' A' ' 30' ' ' GLY . 10.3 p -149.35 134.51 9.51 Favored Pre-proline 0 C--O 1.232 0.176 0 CA-C-O 120.652 0.263 . . . . 0.0 110.963 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.502 ' O ' HD12 ' A' ' 38' ' ' LEU . 39.6 Cg_endo -65.82 157.72 57.52 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.582 2.188 . . . . 0.0 112.107 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.439 ' HB ' HD12 ' A' ' 60' ' ' ILE . 22.5 mm -82.75 131.07 34.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 36' ' ' PRO . 3.6 mp -132.91 155.04 49.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.445 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.757 HD13 HG22 ' A' ' 27' ' ' ILE . 22.5 mm -80.56 120.13 31.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.852 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.39 -38.2 5.78 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.387 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 26' ' ' SER . 0.0 OUTLIER -124.49 145.87 49.29 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.774 0.321 . . . . 0.0 111.214 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.847 HG23 HG22 ' A' ' 25' ' ' ILE . 26.8 mt -135.19 114.33 16.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.55 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -71.95 132.87 84.41 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.095 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.82 159.35 45.38 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.819 2.346 . . . . 0.0 112.891 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.14 50.47 66.85 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.482 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.33 175.19 2.87 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 110.59 -0.152 . . . . 0.0 110.59 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.414 ' HB2' HD21 ' A' ' 15' ' ' LEU . 71.6 Cg_exo -49.84 -34.6 36.98 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.783 2.322 . . . . 0.0 112.966 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -59.57 -46.14 89.78 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.783 0.325 . . . . 0.0 110.755 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -69.78 -37.44 76.36 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.796 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -57.8 -32.78 67.88 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.416 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.4 m -82.99 -28.14 29.91 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.521 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.61 14.5 60.41 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.991 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.98 -33.58 2.77 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.311 -0.471 . . . . 0.0 112.751 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.544 HD13 HG21 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -67.37 100.82 0.87 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.984 0.421 . . . . 0.0 110.504 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -113.3 157.14 22.19 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.125 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.3 t -63.95 132.94 29.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.314 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.54 49.32 4.18 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.277 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -109.35 126.6 53.58 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.69 120.99 32.93 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.848 ' HA ' HG12 ' A' ' 91' ' ' VAL . 14.4 mt -81.06 149.17 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.469 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.9 mt -134.83 -54.9 0.82 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.014 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -148.67 159.84 43.73 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.826 0.346 . . . . 0.0 111.689 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.5 t -137.19 120.35 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.674 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 56.15 36.36 27.29 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.918 0.39 . . . . 0.0 111.138 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.67 13.63 83.33 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.226 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.6 t -98.71 134.88 35.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 117.009 0.404 . . . . 0.0 110.672 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -72.08 126.86 30.82 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.012 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tt -112.15 -17.89 12.69 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.34 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -32.6 72.55 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -98.95 11.91 37.51 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.629 HG21 ' CD1' ' A' ' 79' ' ' ILE . 1.3 m -110.02 161.66 15.31 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.815 0.34 . . . . 0.0 111.03 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.9 mmtm -95.7 161.3 14.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.24 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.525 ' O ' HG23 ' A' ' 77' ' ' VAL . 72.0 t60 -54.12 -51.54 63.9 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.017 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -62.99 -41.2 99.51 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.829 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.458 ' HB2' HG22 ' A' ' 71' ' ' THR . 3.4 mt-10 -65.02 -38.11 89.84 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.011 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.536 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.79 -30.83 71.88 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.385 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 73' ' ' HIS . 24.5 t -61.7 -41.82 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.923 0.392 . . . . 0.0 110.624 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.1 m -69.96 -37.94 75.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.101 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.629 ' CD1' HG21 ' A' ' 71' ' ' THR . 23.2 mt -67.28 -47.19 82.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.384 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 77' ' ' VAL . 3.8 pp -63.91 -34.04 77.07 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.314 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.2 p -73.28 -27.43 61.56 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.85 -0.159 . . . . 0.0 111.221 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -65.25 -28.16 69.16 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.52 0.2 . . . . 0.0 111.348 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.535 ' HG3' HG23 ' A' ' 87' ' ' ILE . 39.8 mm-40 -58.67 113.7 2.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.757 0.313 . . . . 0.0 110.902 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.55 146.29 28.35 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.369 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.89 -99.92 0.4 Allowed Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.618 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -92.28 135.8 33.71 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.761 0.315 . . . . 0.0 110.386 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.535 HG23 ' HG3' ' A' ' 83' ' ' GLN . 13.3 mt -128.36 122.08 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.063 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.37 121.28 40.11 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.513 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -114.54 129.47 56.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 110.895 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -110.1 115.78 30.37 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.154 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.848 HG12 ' HA ' ' A' ' 60' ' ' ILE . 14.4 m -137.22 168.79 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.79 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.649 HG22 HG23 ' A' ' 10' ' ' ILE . 19.4 t -134.12 132.41 55.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.656 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.28 118.52 10.77 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.741 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.1 p -118.2 135.57 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.084 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.13 -0.938 . . . . 0.0 111.34 -179.694 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo . . . . . 0 N--CA 1.489 1.247 0 CA-C-O 120.55 0.146 . . . . 0.0 111.726 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.827 ' HA ' HG12 ' A' ' 92' ' ' VAL . 2.7 tt -78.66 121.81 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.922 0.391 . . . . 0.0 111.247 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.08 135.56 54.08 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.096 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.27 111.5 21.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.638 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.94 142.33 42.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.952 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.81 135.5 39.48 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.975 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.1 tp -108.84 121.91 46.08 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.088 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.21 115.09 29.7 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.671 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -127.52 147.19 50.32 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.111 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.61 161.86 14.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.026 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -56.85 -38.8 73.19 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -80.18 -28.31 38.76 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.462 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -84.56 165.56 17.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.993 0.425 . . . . 0.0 111.606 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -112.06 -169.73 18.3 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.709 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 tp -67.93 -57.38 6.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.446 0.165 . . . . 0.0 111.342 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.54 4.55 63.9 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.767 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.848 HG22 HG23 ' A' ' 42' ' ' ILE . 20.5 pt -144.98 154.98 14.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 117.364 0.582 . . . . 0.0 111.348 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.4 m -113.62 138.14 50.6 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.0 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.585 HD12 HG21 ' A' ' 37' ' ' ILE . 13.0 pt -115.92 154.73 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.601 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.0 p -137.63 163.34 31.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.32 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.82 -150.56 19.35 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.778 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.44 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . 153.51 124.47 0.99 Allowed Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.009 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.68 -31.5 57.88 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.1 0.16 . . . . 0.0 111.409 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -57.26 -31.23 65.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.151 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -84.5 -21.36 30.61 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.422 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.05 19.5 5.93 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.993 -0.623 . . . . 0.0 113.284 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 m -147.08 139.65 14.24 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.93 0.365 . . . . 0.0 111.076 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.8 157.39 38.21 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.522 2.148 . . . . 0.0 112.032 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.585 HG21 HD12 ' A' ' 27' ' ' ILE . 4.0 mp -82.71 126.06 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.676 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.7 ' CD2' ' HB2' ' A' ' 59' ' ' ALA . 2.1 mp -122.54 162.53 21.61 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.908 0.385 . . . . 0.0 111.6 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.705 HD13 ' CD1' ' A' ' 54' ' ' LEU . 17.3 mt -94.4 125.67 46.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.797 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.434 ' O ' HG13 ' A' ' 56' ' ' VAL . 8.4 m -109.63 -34.6 6.44 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.709 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -123.0 146.79 47.32 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.742 0.306 . . . . 0.0 111.391 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.848 HG23 HG22 ' A' ' 25' ' ' ILE . 4.3 mp -134.21 112.26 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.578 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -71.6 129.88 88.0 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.144 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -74.4 155.72 45.85 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.772 2.315 . . . . 0.0 112.618 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.61 33.33 52.41 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.734 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.92 174.49 4.37 Favored Pre-proline 0 CA--C 1.53 0.205 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.58 -32.14 34.19 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.588 2.192 . . . . 0.0 112.771 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.493 ' HB1' ' CB ' ' A' ' 54' ' ' LEU . . . -61.0 -46.06 92.32 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.164 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.49 -43.86 72.31 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.986 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -58.59 -32.74 69.25 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.496 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -77.07 -27.96 54.46 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.464 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.16 17.78 68.41 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.025 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.8 -29.99 2.28 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 121.11 -0.567 . . . . 0.0 113.171 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.705 ' CD1' HD13 ' A' ' 39' ' ' ILE . 0.7 OUTLIER -64.69 96.87 0.19 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.861 0.362 . . . . 0.0 110.823 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -115.8 157.23 24.7 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.252 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 40' ' ' SER . 45.2 t -66.4 131.4 32.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.665 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.04 43.54 3.79 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.931 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.43 119.19 37.38 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.499 0.15 . . . . 0.0 110.794 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.7 ' HB2' ' CD2' ' A' ' 38' ' ' LEU . . . -92.06 123.07 35.14 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.644 0.259 . . . . 0.0 111.509 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.826 ' HA ' HG12 ' A' ' 91' ' ' VAL . 10.8 mt -72.59 137.64 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.214 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.2 mt -125.32 -52.73 1.62 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.775 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.56 145.53 45.1 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.821 0.343 . . . . 0.0 111.475 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.97 116.14 32.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.393 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 58.83 34.6 23.8 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.051 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.65 -15.95 52.37 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.386 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.5 t -88.15 134.6 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 117.146 0.473 . . . . 0.0 110.778 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -71.28 131.53 43.6 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.196 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.579 HD21 ' HB1' ' A' ' 76' ' ' ALA . 2.8 tp -117.49 1.58 12.33 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.828 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -71.37 -28.1 63.81 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.24 8.18 45.02 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 p -105.3 146.54 29.22 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.751 0.31 . . . . 0.0 111.088 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -71.82 161.19 31.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.113 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.65 ' O ' HG23 ' A' ' 77' ' ' VAL . 30.1 t60 -54.01 -50.56 66.34 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.933 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.68 -42.98 94.12 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.894 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -67.21 -37.59 83.87 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.841 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.579 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -63.86 -31.32 72.46 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.473 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 73' ' ' HIS . 22.3 t -61.83 -40.8 88.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.862 0.363 . . . . 0.0 110.358 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.9 m -65.72 -40.54 92.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.518 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.471 HG22 HE21 ' A' ' 83' ' ' GLN . 40.1 mm -58.13 -43.52 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.643 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.0 mt -60.57 -43.9 96.8 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.671 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.4 t -65.84 -31.54 72.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.091 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -65.15 -28.29 69.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.15 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.471 HE21 HG22 ' A' ' 79' ' ' ILE . 48.3 mm-40 -62.65 135.23 57.28 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.793 0.33 . . . . 0.0 111.006 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.23 144.25 48.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.175 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.06 -104.55 0.35 Allowed Glycine 0 C--N 1.335 0.52 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.634 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -82.29 118.2 22.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.853 0.358 . . . . 0.0 110.396 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.411 HG23 ' HB3' ' A' ' 83' ' ' GLN . 11.6 mt -119.32 123.77 71.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.893 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.63 121.38 35.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.52 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -113.11 129.62 56.45 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.119 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.0 115.19 22.07 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.805 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.826 HG12 ' HA ' ' A' ' 60' ' ' ILE . 16.1 m -139.2 170.73 15.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.4 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.827 HG12 ' HA ' ' A' ' 10' ' ' ILE . 18.7 m -131.33 133.52 62.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.835 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.42 115.86 10.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.715 0.293 . . . . 0.0 110.705 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.7 p -126.57 122.65 61.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.952 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.4 -0.81 . . . . 0.0 111.408 -179.536 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.526 ' O ' HG13 ' A' ' 92' ' ' VAL . 3.4 Cg_exo . . . . . 0 N--CA 1.49 1.297 0 CA-C-O 120.725 0.219 . . . . 0.0 111.924 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.536 ' HA ' HG22 ' A' ' 92' ' ' VAL . 2.6 tt -78.97 134.79 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.327 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.9 126.33 51.55 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.034 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.3 mmtm -99.75 114.62 27.87 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.571 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.24 128.91 67.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.789 0.328 . . . . 0.0 111.34 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 mp -98.37 119.92 37.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.846 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.43 HD11 ' HA ' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -113.13 137.98 50.64 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.262 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.402 ' H ' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -97.65 115.38 27.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.772 179.638 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.8 143.78 37.52 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.707 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -114.54 158.56 21.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.182 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.72 -38.35 78.15 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.807 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -77.6 -28.29 51.51 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.423 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -90.02 159.23 16.96 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.903 0.382 . . . . 0.0 111.223 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.35 -165.82 21.97 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.373 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.56 -44.9 85.31 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.673 0.273 . . . . 0.0 110.834 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.22 3.29 90.25 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.335 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.759 HD13 HD12 ' A' ' 39' ' ' ILE . 2.2 pp -146.74 147.11 18.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 117.033 0.416 . . . . 0.0 110.897 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.505 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 3.5 m -108.53 139.78 42.81 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.536 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.762 HG22 HD13 ' A' ' 39' ' ' ILE . 20.2 pt -116.2 156.01 17.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.719 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.5 t -143.96 155.98 44.24 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.33 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.05 -150.1 18.31 Favored Glycine 0 C--N 1.337 0.605 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.393 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.42 109.27 0.22 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.939 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -57.64 -37.28 73.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.586 0.231 . . . . 0.0 111.135 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -58.73 -31.17 68.05 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.949 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -75.86 -24.51 55.75 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.217 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.68 25.4 4.29 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.074 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 m -147.48 140.3 14.69 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.884 0.342 . . . . 0.0 111.244 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.58 157.42 60.78 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.603 2.202 . . . . 0.0 112.285 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.464 HG21 HD12 ' A' ' 27' ' ' ILE . 26.1 mm -82.76 137.9 20.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.757 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 59' ' ' ALA . 2.9 mp -131.82 158.69 40.61 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.594 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.762 HD13 HG22 ' A' ' 27' ' ' ILE . 17.7 mm -83.55 128.64 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.756 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.406 ' O ' HG13 ' A' ' 56' ' ' VAL . 4.1 t -124.14 -44.27 2.04 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.538 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 0.5 OUTLIER -105.38 144.47 32.12 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.758 0.313 . . . . 0.0 111.172 -179.681 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.1 mt -131.47 128.98 61.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.747 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -86.27 114.81 59.4 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.955 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.16 122.11 8.7 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.533 2.155 . . . . 0.0 112.149 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.54 34.85 4.86 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.597 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.97 174.2 4.79 Favored Pre-proline 0 C--O 1.233 0.231 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.41 -32.2 33.16 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.521 2.147 . . . . 0.0 112.76 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.43 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -59.83 -46.19 90.03 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.271 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.85 -40.39 79.42 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.703 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -60.03 -33.44 72.02 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.466 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.6 t -71.65 -28.11 63.53 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.52 15.78 62.13 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.188 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.25 -32.53 1.36 Allowed Glycine 0 C--N 1.338 0.667 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.106 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.467 ' HG ' HG21 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -66.79 94.36 0.3 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.981 0.419 . . . . 0.0 110.682 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -108.87 157.24 18.8 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.97 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 40' ' ' SER . 25.8 t -67.2 133.31 31.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.375 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.18 45.83 3.73 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.535 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.13 124.09 51.68 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 122.22 0.208 . . . . 0.0 110.595 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.542 ' HB2' HD23 ' A' ' 38' ' ' LEU . . . -91.4 120.25 32.09 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.728 0.299 . . . . 0.0 111.177 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.798 ' HA ' HG12 ' A' ' 91' ' ' VAL . 20.5 mt -75.24 139.93 18.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.556 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 61' ' ' LEU . 14.0 mt -128.11 -51.93 1.31 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.703 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -144.54 145.86 32.06 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.854 0.359 . . . . 0.0 111.637 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.0 t -132.83 115.79 25.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.401 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 56.71 38.04 29.24 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.602 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.19 -12.85 42.24 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.449 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.14 128.05 39.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 117.371 0.586 . . . . 0.0 110.83 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.69 130.62 39.84 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.169 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.562 HD11 ' HB1' ' A' ' 76' ' ' ALA . 0.5 OUTLIER -102.48 -23.03 13.95 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.641 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -61.4 -31.07 70.98 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.348 0.129 . . . . 0.0 111.348 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.03 9.74 38.33 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.2 p -120.1 159.87 23.97 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.617 0.246 . . . . 0.0 110.653 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.1 161.02 19.1 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.785 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.623 ' O ' HG23 ' A' ' 77' ' ' VAL . 76.2 t60 -53.95 -47.6 71.13 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.972 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -60.99 -43.04 99.43 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.73 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -64.5 -39.28 93.49 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.975 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.562 ' HB1' HD11 ' A' ' 68' ' ' LEU . . . -63.58 -34.24 77.37 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.57 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 73' ' ' HIS . 38.3 t -62.17 -43.28 97.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.834 0.349 . . . . 0.0 110.441 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.0 m -67.41 -45.72 75.32 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.948 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 76' ' ' ALA . 13.9 mt -60.91 -44.21 97.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.938 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.42 -37.83 79.05 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.678 0.275 . . . . 0.0 110.714 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.7 m -68.65 -28.35 66.81 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.453 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -64.88 -30.85 71.87 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.498 0.19 . . . . 0.0 111.051 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.402 ' HB2' HD13 ' A' ' 87' ' ' ILE . 31.7 mm-40 -66.05 114.47 5.23 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.817 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -114.47 151.87 32.55 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.11 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.72 -102.12 0.42 Allowed Glycine 0 C--N 1.335 0.48 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.556 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -87.98 122.39 31.53 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.654 0.264 . . . . 0.0 110.378 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.402 HD13 ' HB2' ' A' ' 83' ' ' GLN . 21.5 mt -124.73 125.78 70.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.052 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -93.65 123.37 36.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.336 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.53 130.2 56.27 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.928 0.394 . . . . 0.0 111.517 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -121.18 115.17 22.53 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.572 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.798 HG12 ' HA ' ' A' ' 60' ' ' ILE . 5.5 m -137.28 170.94 17.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.351 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.536 HG22 ' HA ' ' A' ' 10' ' ' ILE . 39.7 t -129.07 133.64 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.69 123.66 20.32 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.875 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.0 t -118.71 132.79 67.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.957 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.163 -0.923 . . . . 0.0 111.22 179.93 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 N--CA 1.491 1.34 0 CA-C-O 120.93 0.304 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.699 ' HA ' HG12 ' A' ' 92' ' ' VAL . 4.6 mp -86.06 141.17 14.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -120.82 122.03 39.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -100.21 113.51 26.23 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.773 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.454 HG11 ' HA3' ' A' ' 53' ' ' GLY . 9.2 m -128.27 140.42 49.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.458 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.441 ' C ' HD12 ' A' ' 15' ' ' LEU . 5.1 mp -107.47 126.86 53.03 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.895 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.529 HD11 HD21 ' A' ' 54' ' ' LEU . 10.0 mp -113.08 137.32 51.6 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.097 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -104.32 114.75 29.19 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.8 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -99.78 134.26 42.94 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.994 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.403 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 9.4 mm-40 -115.94 151.55 35.17 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.869 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.14 -33.89 72.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.634 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.403 ' CD2' ' HB3' ' A' ' 18' ' ' GLU . 15.4 p80 -81.6 -27.4 34.24 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.783 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -96.55 166.53 11.64 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.883 0.373 . . . . 0.0 111.451 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -105.47 -150.51 19.43 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.091 -0.575 . . . . 0.0 112.679 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 25' ' ' ILE . 6.6 tp -78.5 -58.96 2.98 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.689 0.281 . . . . 0.0 110.96 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.77 4.35 75.85 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.687 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.615 HG22 HG23 ' A' ' 42' ' ' ILE . 23.5 pt -140.61 143.46 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 117.259 0.529 . . . . 0.0 111.126 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 t -112.03 136.79 50.93 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.812 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.688 HD12 HG21 ' A' ' 37' ' ' ILE . 26.8 pt -125.29 153.86 33.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.597 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.8 p -139.18 145.35 39.23 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.224 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.18 -155.83 16.85 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.694 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.1 126.02 1.56 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.49 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.7 tptt -54.6 -35.64 63.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.393 0.14 . . . . 0.0 111.136 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.481 ' HG3' ' HG2' ' A' ' 72' ' ' LYS . 0.5 OUTLIER -62.77 -30.62 71.59 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.198 179.653 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -79.31 -34.7 42.12 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.106 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.23 -21.6 3.86 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.865 -0.684 . . . . 0.0 113.292 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 23.8 m -123.03 144.31 42.88 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 117.006 0.403 . . . . 0.0 111.201 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 34.8 Cg_exo -60.87 155.97 46.38 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.749 2.3 . . . . 0.0 112.442 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.688 HG21 HD12 ' A' ' 27' ' ' ILE . 2.2 mt -84.0 130.66 35.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.851 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.525 HD23 ' CB ' ' A' ' 59' ' ' ALA . 0.8 OUTLIER -132.24 156.52 46.34 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.027 -179.53 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.545 HD12 ' CB ' ' A' ' 58' ' ' ASP . 32.1 mt -81.08 121.87 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.902 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.4 m -106.2 -29.74 9.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.682 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.95 149.64 48.98 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.711 0.291 . . . . 0.0 111.357 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.615 HG23 HG22 ' A' ' 25' ' ' ILE . 3.4 mp -133.98 114.22 19.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.664 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -72.09 131.4 85.4 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.233 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.37 172.42 16.27 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.961 2.441 . . . . 0.0 112.903 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.62 18.52 61.56 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.784 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.46 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -124.97 169.28 11.34 Favored Pre-proline 0 N--CA 1.455 -0.184 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 9.8 Cg_endo -52.55 -29.1 39.15 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.62 2.214 . . . . 0.0 112.57 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.465 ' HB1' ' HG ' ' A' ' 54' ' ' LEU . . . -63.09 -46.46 87.29 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.317 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -65.32 -40.24 93.48 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.871 0.367 . . . . 0.0 110.605 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.69 -28.47 65.88 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.319 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 11.5 m -70.37 -28.24 64.95 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.42 -55.31 4.64 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.889 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.454 ' HA3' HG11 ' A' ' 13' ' ' VAL . . . -53.03 -27.84 31.34 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 121.474 -0.393 . . . . 0.0 113.609 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.529 HD21 HD11 ' A' ' 15' ' ' LEU . 4.3 mm? -68.14 88.86 0.3 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.003 0.401 . . . . 0.0 110.52 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -118.43 157.24 27.58 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.219 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.7 t -63.28 130.06 27.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.63 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.05 46.37 3.63 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.466 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.545 ' CB ' HD12 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -107.01 125.73 51.4 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.475 0.178 . . . . 0.0 110.544 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.525 ' CB ' HD23 ' A' ' 38' ' ' LEU . . . -91.25 121.61 33.15 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.769 0.319 . . . . 0.0 111.366 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.658 ' HA ' HG12 ' A' ' 91' ' ' VAL . 21.9 mt -78.21 130.78 35.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.268 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.1 mt -124.27 -51.97 1.75 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.643 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -145.06 148.89 34.18 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.859 0.361 . . . . 0.0 111.448 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 t -136.98 115.75 14.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.424 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 58.35 33.14 22.86 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.097 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.93 -15.24 58.31 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.181 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.07 133.77 29.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 117.143 0.471 . . . . 0.0 110.891 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -79.17 129.67 34.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.96 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.562 HD21 ' CB ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -105.8 -21.36 13.19 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.645 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.6 ttt85 -60.95 -34.58 74.96 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.662 0.267 . . . . 0.0 110.902 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -84.25 -26.14 28.87 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.656 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.2 p -78.53 167.28 21.51 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.889 0.376 . . . . 0.0 111.011 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.481 ' HG2' ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -93.87 161.03 14.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.645 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.548 ' O ' HG23 ' A' ' 77' ' ' VAL . 6.5 t-160 -54.26 -47.52 72.19 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.892 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -64.76 -40.42 95.25 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.096 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.93 -37.67 86.65 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.913 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.693 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.71 -30.88 71.93 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.328 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 73' ' ' HIS . 24.5 t -61.4 -43.43 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.847 0.356 . . . . 0.0 110.554 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.6 m -65.76 -44.69 85.1 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.706 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 76' ' ' ALA . 7.3 mt -63.78 -44.04 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.0 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.6 mt -56.4 -42.96 78.83 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.756 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.9 t -68.24 -31.2 70.53 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.038 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -65.13 -24.17 67.34 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.571 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.411 ' HB3' HG12 ' A' ' 87' ' ' ILE . 41.7 mm-40 -62.97 97.86 0.12 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.808 0.337 . . . . 0.0 110.891 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.61 146.67 26.19 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.261 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.82 -106.37 1.47 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.555 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -87.74 143.1 27.33 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.73 0.3 . . . . 0.0 110.495 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.411 HG12 ' HB3' ' A' ' 83' ' ' GLN . 11.6 mt -136.95 122.33 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.033 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -96.64 124.35 40.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.613 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -112.58 129.61 56.31 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.791 0.329 . . . . 0.0 111.139 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -118.89 115.31 24.13 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.23 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' A' ' 60' ' ' ILE . 23.7 m -143.93 169.24 10.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.499 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.699 HG12 ' HA ' ' A' ' 10' ' ' ILE . 11.1 m -134.33 138.37 50.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.055 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.0 123.67 21.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.903 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.2 m -114.45 143.82 23.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.402 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.039 -0.981 . . . . 0.0 111.545 -179.884 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo . . . . . 0 N--CA 1.49 1.319 0 CA-C-O 120.814 0.256 . . . . 0.0 111.822 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.413 ' HA ' HG22 ' A' ' 92' ' ' VAL . 73.1 mt -80.27 142.98 13.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.55 138.63 51.78 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.08 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.408 ' HD2' ' HG3' ' A' ' 90' ' ' GLU . 1.1 mptm? -115.33 117.43 30.42 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.4 t -132.67 141.01 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.143 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 87' ' ' ILE . 0.4 OUTLIER -97.83 132.5 43.38 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.978 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.07 119.44 37.87 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.749 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.458 HD11 HD22 ' A' ' 14' ' ' LEU . 7.0 mp -110.3 114.25 27.56 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.343 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.0 ptmm? -128.15 146.1 50.81 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.265 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.457 ' HB2' ' HG3' ' A' ' 21' ' ' GLU . 0.4 OUTLIER -75.95 165.23 25.28 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.117 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.07 -36.28 70.37 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.846 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 44.8 p-80 -79.91 -29.81 39.93 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.411 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.457 ' HG3' ' HB2' ' A' ' 18' ' ' GLU . 7.0 mt-10 -70.61 167.57 18.26 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.924 0.393 . . . . 0.0 111.943 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.28 -157.72 10.05 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.293 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.648 HD22 HG13 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -62.48 -62.52 1.69 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.506 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.94 -14.72 28.89 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.608 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.749 HG21 HD23 ' A' ' 54' ' ' LEU . 2.2 pt -143.74 164.1 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 117.186 0.493 . . . . 0.0 111.379 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.9 t -106.93 136.7 46.33 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.697 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.2 pt -118.69 153.11 20.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.241 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -143.2 144.63 32.25 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.248 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.19 -165.98 29.44 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.429 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.84 112.29 0.31 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.794 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -58.21 -37.94 75.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.453 0.168 . . . . 0.0 111.289 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -65.47 -30.96 71.81 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.011 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -73.35 -28.62 62.16 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.07 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.37 22.41 6.14 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.069 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.1 p -149.69 130.95 7.29 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.873 0.337 . . . . 0.0 111.044 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.34 155.61 50.98 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.612 2.208 . . . . 0.0 112.231 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mp -83.04 133.9 28.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.774 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.51 159.65 38.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.485 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.498 HD13 HD13 ' A' ' 25' ' ' ILE . 23.1 mt -80.17 122.82 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.993 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.7 -30.46 8.56 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.709 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -130.69 155.5 46.51 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.858 0.361 . . . . 0.0 111.513 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.735 ' HA ' HG22 ' A' ' 25' ' ' ILE . 48.4 mt -130.36 114.09 27.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.739 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -81.59 128.38 69.65 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.914 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.29 159.89 42.99 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.706 2.271 . . . . 0.0 112.799 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.12 33.07 57.66 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.809 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.97 170.8 8.66 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.43 -30.73 54.69 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.647 2.232 . . . . 0.0 112.953 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.81 -46.14 81.79 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.729 0.3 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -70.52 -41.25 72.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.794 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -64.59 -28.72 69.82 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.566 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -28.36 64.09 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.486 0.184 . . . . 0.0 111.473 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.41 16.85 51.35 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.054 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.06 -31.63 1.08 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.071 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.749 HD23 HG21 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -68.68 92.8 0.49 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.827 0.346 . . . . 0.0 110.592 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -98.82 156.86 16.65 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.247 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.8 t -64.2 135.43 27.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.564 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.57 50.57 3.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.127 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.462 ' CB ' HD12 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -111.3 124.56 52.47 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.491 0.186 . . . . 0.0 110.624 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.577 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -91.1 120.44 32.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.901 0.382 . . . . 0.0 111.103 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.811 ' HA ' HG12 ' A' ' 91' ' ' VAL . 17.2 mt -73.71 144.67 12.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.908 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.7 mt -129.45 -53.49 1.17 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.57 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.26 145.94 33.18 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.976 0.417 . . . . 0.0 111.829 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.597 HG11 HD23 ' A' ' 80' ' ' LEU . 21.1 t -130.87 116.77 35.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.511 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.77 36.45 27.71 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.675 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.8 -16.35 46.99 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.507 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.37 135.14 25.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 117.229 0.515 . . . . 0.0 111.179 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -78.67 131.25 36.57 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.084 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.606 HD11 ' HB1' ' A' ' 76' ' ' ALA . 0.5 OUTLIER -89.01 -27.89 20.55 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.979 179.442 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -67.3 -27.17 66.94 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.393 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -91.5 11.77 22.97 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 t -138.79 174.33 10.64 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.637 0.256 . . . . 0.0 110.812 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.43 160.97 14.12 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.047 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.669 ' O ' HG23 ' A' ' 77' ' ' VAL . 44.1 t-80 -56.11 -51.72 66.89 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.182 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.64 -43.12 84.65 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.964 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -67.2 -37.78 84.22 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.854 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.729 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.87 -33.72 76.34 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.363 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 73' ' ' HIS . 22.0 t -61.72 -39.18 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.837 0.351 . . . . 0.0 110.504 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 49.9 m -65.37 -44.65 86.94 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.493 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' ' 76' ' ' ALA . 12.8 mt -61.73 -41.37 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.919 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.597 HD23 HG11 ' A' ' 63' ' ' VAL . 6.7 mt -60.44 -39.69 88.41 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.627 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.5 t -66.22 -30.92 71.46 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.185 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -65.24 -28.92 69.69 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.333 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.475 ' HB3' HG23 ' A' ' 87' ' ' ILE . 16.8 mm-40 -68.31 111.64 4.72 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.873 0.368 . . . . 0.0 110.844 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.55 148.86 26.8 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.332 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.68 -102.18 0.42 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.581 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -90.09 132.03 35.64 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.908 0.385 . . . . 0.0 110.508 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.475 HG23 ' HB3' ' A' ' 83' ' ' GLN . 12.4 mt -129.9 133.22 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.07 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.71 122.36 36.09 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.715 0.293 . . . . 0.0 110.705 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.91 130.61 55.82 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.526 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.408 ' HG3' ' HD2' ' A' ' 12' ' ' LYS . 8.2 tt0 -122.18 115.56 22.62 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.581 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.811 HG12 ' HA ' ' A' ' 60' ' ' ILE . 5.2 m -136.64 170.57 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.479 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.413 HG22 ' HA ' ' A' ' 10' ' ' ILE . 17.3 t -133.94 143.66 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.308 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.2 126.04 28.56 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.967 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.577 HG21 ' HB2' ' A' ' 59' ' ' ALA . 21.7 t -113.6 118.79 59.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.015 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.208 179.957 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.49 1.271 0 CA-C-O 120.71 0.212 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.1 tt -89.59 124.93 42.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.277 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -123.99 153.38 41.37 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.082 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.431 ' HG3' ' HG2' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -114.79 120.05 38.72 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.56 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.0 m -129.36 135.29 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.708 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.69 136.71 40.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.834 0.349 . . . . 0.0 111.131 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.0 mp -113.12 124.04 51.65 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.692 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 tt -102.74 115.33 30.39 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.708 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -129.4 134.12 47.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.104 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -90.63 172.87 8.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.887 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.66 -36.94 70.13 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -74.84 -30.87 61.49 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.27 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -79.39 179.42 7.45 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.87 0.367 . . . . 0.0 111.323 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.1 -143.13 4.95 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.014 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.67 -66.97 0.82 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.49 0.186 . . . . 0.0 111.369 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.61 -15.56 45.36 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.614 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.746 HG22 HG23 ' A' ' 42' ' ' ILE . 2.2 pp -140.84 157.76 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 117.304 0.552 . . . . 0.0 111.241 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 t -114.49 137.4 51.9 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.557 HG22 HG12 ' A' ' 39' ' ' ILE . 17.0 pt -116.16 151.56 17.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.472 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.2 t -143.61 145.11 32.24 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.065 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 129.72 -172.96 19.87 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.441 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . -178.87 116.54 0.53 Allowed Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.454 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -52.35 -37.68 56.74 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.432 ' HB2' ' HG3' ' A' ' 72' ' ' LYS . 50.5 tt0 -59.32 -31.16 68.9 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.725 0.298 . . . . 0.0 110.993 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -72.66 -31.31 64.98 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.937 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.18 -23.63 3.16 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.999 -0.619 . . . . 0.0 113.102 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.04 149.7 54.67 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.815 0.307 . . . . 0.0 111.291 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.25 157.53 61.43 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.662 2.241 . . . . 0.0 112.275 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.414 ' H ' HD12 ' A' ' 37' ' ' ILE . 3.4 mp -82.42 129.86 36.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.578 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.76 161.55 29.49 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.857 0.361 . . . . 0.0 111.607 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.606 HD13 HD21 ' A' ' 54' ' ' LEU . 32.9 mt -82.84 123.29 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.059 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.8 m -106.9 -30.03 9.12 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.578 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -123.95 145.09 49.39 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.865 0.364 . . . . 0.0 111.395 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.746 HG23 HG22 ' A' ' 25' ' ' ILE . 32.2 mt -131.02 114.3 26.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.486 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -85.02 114.46 56.03 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.775 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -62.32 175.34 2.11 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.015 2.477 . . . . 0.0 112.967 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.73 34.91 91.16 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.147 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.16 173.18 4.94 Favored Pre-proline 0 CA--C 1.531 0.242 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.42 -30.86 36.3 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.714 2.276 . . . . 0.0 113.022 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.23 -46.19 89.14 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.696 0.284 . . . . 0.0 111.1 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.98 -38.34 76.0 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.803 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -32.02 73.43 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.216 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.11 -28.28 61.28 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.518 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.84 16.51 61.65 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.054 -0.594 . . . . 0.0 113.089 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.69 -33.75 1.15 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.203 -0.523 . . . . 0.0 113.066 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.606 HD21 HD13 ' A' ' 39' ' ' ILE . 1.1 tt -67.72 105.31 1.88 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.881 0.372 . . . . 0.0 110.662 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.512 ' C ' HD11 ' A' ' 42' ' ' ILE . 12.6 p80 -114.86 157.35 23.43 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.207 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.431 ' N ' HD11 ' A' ' 42' ' ' ILE . 13.8 p -62.97 139.69 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.127 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.5 49.66 5.08 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.216 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.8 126.63 55.27 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.433 0.159 . . . . 0.0 110.763 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -90.68 128.11 36.53 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.712 0.292 . . . . 0.0 110.687 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.766 HG21 HD22 ' A' ' 68' ' ' LEU . 12.3 mt -74.7 104.05 2.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.695 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -86.46 -50.64 6.73 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.409 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -150.13 146.15 26.73 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.605 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.1 t -127.92 115.71 40.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.652 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 54.96 37.07 28.24 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.99 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.25 -14.16 58.22 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.375 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.0 t -86.12 127.21 40.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 117.181 0.49 . . . . 0.0 110.97 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -71.55 141.16 50.1 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.949 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.766 HD22 HG21 ' A' ' 60' ' ' ILE . 1.2 tp -116.03 -1.23 12.54 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.722 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -34.25 70.69 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.3 11.59 37.9 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.3 p -109.47 163.66 13.22 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.741 0.305 . . . . 0.0 110.93 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.432 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 2.3 mppt? -94.62 161.11 14.33 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.03 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.597 ' O ' HG23 ' A' ' 77' ' ' VAL . 36.3 t60 -53.95 -49.66 68.21 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.812 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -43.06 88.15 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.758 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -64.81 -38.34 90.65 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.973 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.52 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -63.63 -41.42 98.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.991 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 73' ' ' HIS . 21.7 t -62.67 -39.88 86.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.052 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -46.62 71.39 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.009 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.446 HG22 HE21 ' A' ' 83' ' ' GLN . 14.6 mt -62.21 -39.61 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.557 0.218 . . . . 0.0 110.752 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.636 HD21 ' CE2' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -59.97 -42.39 94.02 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.178 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.9 p -64.82 -32.12 73.67 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.304 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -64.95 -28.81 69.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.05 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.485 ' HB3' HG23 ' A' ' 87' ' ' ILE . 24.4 mm-40 -62.01 114.22 3.26 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.853 0.358 . . . . 0.0 110.856 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.0 ptt85 -118.63 152.29 36.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.426 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.04 -103.23 0.55 Allowed Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.592 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -89.96 119.06 30.0 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.788 0.328 . . . . 0.0 110.402 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.485 HG23 ' HB3' ' A' ' 83' ' ' GLN . 18.4 mt -121.04 122.5 67.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.031 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -93.78 122.08 35.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.681 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.636 ' CE2' HD21 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -116.31 129.81 56.46 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.943 0.401 . . . . 0.0 111.203 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.431 ' HG2' ' HG3' ' A' ' 12' ' ' LYS . 23.6 mt-10 -120.09 115.4 23.61 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.007 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 60' ' ' ILE . 8.2 m -137.08 163.7 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.733 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.9 t -131.76 146.08 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.15 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.401 ' CG ' ' CE1' ' A' ' 55' ' ' HIS . 0.1 OUTLIER -70.47 129.07 38.27 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.758 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.32 141.19 43.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.901 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.117 -0.945 . . . . 0.0 111.315 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.532 ' O ' HG23 ' A' ' 92' ' ' VAL . 4.6 Cg_endo . . . . . 0 N--CA 1.49 1.297 0 CA-C-O 120.852 0.272 . . . . 0.0 111.939 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 tt -78.8 132.76 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.381 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -123.71 135.25 53.76 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.057 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.86 126.6 48.78 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.581 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.3 m -128.58 143.14 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.592 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 pp -114.69 132.23 56.48 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.821 0.343 . . . . 0.0 110.928 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -120.7 141.57 50.3 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.869 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.95 118.35 36.51 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.009 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.96 148.09 42.53 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.104 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -114.22 159.75 19.79 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.155 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.3 -38.22 73.64 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.963 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -79.77 -28.17 40.4 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.437 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.65 164.27 16.9 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.932 0.396 . . . . 0.0 111.595 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.41 -166.74 21.95 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.703 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.591 HD22 HG13 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -61.0 -59.53 5.22 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.539 0.209 . . . . 0.0 111.329 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.27 1.06 55.76 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.382 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.745 HG22 HG23 ' A' ' 42' ' ' ILE . 1.8 pp -145.48 161.44 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 117.177 0.488 . . . . 0.0 111.139 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.5 t -119.65 136.95 54.18 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.604 HD12 HG21 ' A' ' 37' ' ' ILE . 6.5 pt -119.9 154.38 22.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.335 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 p -137.16 153.56 50.44 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.002 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.31 -172.24 16.67 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.785 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.38 113.97 0.55 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.517 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -32.44 70.67 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.478 0.18 . . . . 0.0 111.388 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -60.11 -30.7 69.44 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.609 0.242 . . . . 0.0 110.949 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -76.59 -28.15 56.08 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.078 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.68 31.54 2.51 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.892 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.7 m -146.4 144.17 20.5 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.634 0.217 . . . . 0.0 111.0 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.7 156.97 62.11 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.624 2.216 . . . . 0.0 112.246 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.627 ' HB ' HD12 ' A' ' 60' ' ' ILE . 29.5 mm -84.21 139.29 17.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.63 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mp -131.42 160.49 34.95 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.839 0.352 . . . . 0.0 111.287 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.578 HD12 ' HB3' ' A' ' 58' ' ' ASP . 23.2 mt -89.69 122.54 41.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.946 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.468 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -109.54 -31.6 7.44 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.642 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -127.75 149.41 50.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.668 0.27 . . . . 0.0 110.823 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.745 HG23 HG22 ' A' ' 25' ' ' ILE . 17.9 mt -135.03 114.55 17.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.74 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -66.67 120.89 74.5 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.096 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.35 156.63 61.38 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.973 2.449 . . . . 0.0 112.667 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.3 36.8 93.66 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.262 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -134.06 177.07 2.42 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -49.95 -31.02 25.79 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.712 2.275 . . . . 0.0 112.912 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.495 ' HB1' ' CB ' ' A' ' 54' ' ' LEU . . . -63.55 -46.1 87.47 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.006 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -69.84 -40.4 75.83 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.792 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.6 mtp85 -56.11 -36.8 68.61 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.552 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 17.8 m -81.24 -27.9 35.03 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.457 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.75 14.58 67.76 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.999 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.34 -30.95 3.93 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.796 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.601 ' O ' HD13 ' A' ' 42' ' ' ILE . 2.2 mm? -65.72 101.32 0.62 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.757 0.313 . . . . 0.0 110.569 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.579 ' C ' HD11 ' A' ' 42' ' ' ILE . 15.8 p80 -114.41 157.49 22.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.931 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 40' ' ' SER . 40.6 t -71.7 136.18 26.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.443 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.12 47.26 4.77 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.283 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.578 ' HB3' HD12 ' A' ' 39' ' ' ILE . 3.2 t0 -111.99 132.72 54.61 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.87 123.75 35.48 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.759 0.314 . . . . 0.0 111.624 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.837 ' HA ' HG12 ' A' ' 91' ' ' VAL . 41.7 mt -75.17 132.47 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.174 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.4 mt -117.81 -67.7 0.97 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.033 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.88 145.65 46.56 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.917 0.389 . . . . 0.0 111.504 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.0 t -116.71 115.51 49.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.378 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 54.31 37.94 28.43 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.678 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.25 -14.44 54.09 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.648 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.5 t -85.26 135.2 25.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 117.221 0.51 . . . . 0.0 111.179 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -77.21 138.17 39.28 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.155 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.839 HD21 ' HB1' ' A' ' 76' ' ' ALA . 1.2 tp -116.2 -1.92 12.29 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.829 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -30.3 68.26 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -98.8 11.25 39.28 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.44 HG22 ' HB2' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -109.96 159.07 17.59 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.566 0.222 . . . . 0.0 110.775 179.754 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.13 161.27 18.96 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.449 ' O ' HG23 ' A' ' 77' ' ' VAL . 38.8 t-80 -54.3 -51.28 65.15 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.015 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -65.28 -41.39 94.21 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.776 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.44 ' HB2' HG22 ' A' ' 71' ' ' THR . 64.7 mt-10 -64.28 -37.23 86.76 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.843 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.839 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -63.39 -30.82 71.88 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.392 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 73' ' ' HIS . 38.9 t -61.9 -42.35 94.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.836 0.35 . . . . 0.0 110.085 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 32.0 m -64.4 -41.25 96.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.452 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.2 mm -57.86 -45.72 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.734 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -40.88 87.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -73.57 -13.79 61.09 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -69.23 -29.75 67.76 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.681 0.277 . . . . 0.0 111.115 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.477 ' HB3' HG12 ' A' ' 87' ' ' ILE . 17.5 mp0 -76.5 135.99 39.34 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.195 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -130.65 146.94 52.26 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.166 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.82 -90.82 0.17 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.997 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -96.25 115.19 27.03 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.746 0.308 . . . . 0.0 110.304 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.477 HG12 ' HB3' ' A' ' 83' ' ' GLN . 18.9 mt -114.47 126.24 71.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.202 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -99.81 135.52 41.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.749 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -128.63 135.87 49.89 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.921 0.391 . . . . 0.0 111.479 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -123.63 115.59 21.72 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.496 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.837 HG12 ' HA ' ' A' ' 60' ' ' ILE . 18.7 m -144.86 172.49 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.341 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 9' ' ' PRO . 9.2 p -141.37 137.03 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.059 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.74 122.6 17.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.058 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.8 m -108.25 120.5 59.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.162 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.123 -179.771 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo . . . . . 0 N--CA 1.492 1.388 0 CA-C-O 120.655 0.19 . . . . 0.0 111.919 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.783 ' HA ' HG12 ' A' ' 92' ' ' VAL . 65.7 mt -104.77 140.85 21.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.06 146.1 48.8 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.064 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.4 113.19 23.43 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.677 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.33 141.64 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.347 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 20.6 tp -105.84 127.65 53.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.898 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 tp -113.2 125.5 54.4 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.44 114.57 28.52 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.684 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -125.94 135.04 51.41 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.206 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -81.39 171.57 14.6 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.047 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.46 -38.78 75.03 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.095 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.414 ' CE1' ' HG2' ' A' ' 21' ' ' GLU . 16.8 p80 -75.42 -30.26 59.99 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.218 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HG2' ' CE1' ' A' ' 20' ' ' HIS . 2.5 mm-40 -77.02 166.16 23.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.897 0.379 . . . . 0.0 111.383 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -113.02 -152.86 11.27 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.893 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.741 HD11 HD13 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -67.98 -41.21 82.71 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.526 0.203 . . . . 0.0 111.464 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.09 -21.32 43.87 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.997 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.755 HG21 ' CD1' ' A' ' 54' ' ' LEU . 2.6 pp -146.48 171.44 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.808 0.337 . . . . 0.0 111.287 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 5.9 m -120.44 138.35 53.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.575 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.777 HD12 HG21 ' A' ' 37' ' ' ILE . 15.2 pt -115.96 156.2 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.851 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.5 p -137.26 163.26 31.36 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.365 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.0 -160.71 17.69 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.874 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.43 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . 166.5 131.7 1.29 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.133 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -56.46 -37.6 70.53 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.182 0.193 . . . . 0.0 111.33 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.39 -31.04 71.65 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.125 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -78.31 -26.6 47.02 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.236 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.87 22.93 6.07 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.048 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 10.1 p -149.57 134.97 9.74 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.926 0.363 . . . . 0.0 110.998 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.45 ' O ' HD12 ' A' ' 38' ' ' LEU . 38.4 Cg_exo -60.91 156.69 42.43 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.42 2.08 . . . . 0.0 112.181 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.777 HG21 HD12 ' A' ' 27' ' ' ILE . 3.5 mp -83.37 131.64 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.792 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.486 ' CD2' ' HB2' ' A' ' 59' ' ' ALA . 3.9 mp -131.64 160.73 34.55 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.574 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.516 HD13 HD11 ' A' ' 54' ' ' LEU . 30.4 mt -93.63 119.58 41.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.946 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.475 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -111.25 -41.2 4.22 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.262 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 4.1 tt0 -104.83 150.19 25.03 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.716 0.293 . . . . 0.0 111.067 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.705 HG23 HG22 ' A' ' 25' ' ' ILE . 32.3 mt -132.09 121.27 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.746 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -73.78 114.78 35.68 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.817 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -68.03 140.7 50.68 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.707 2.271 . . . . 0.0 112.645 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.34 29.5 52.99 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.746 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.68 172.53 6.63 Favored Pre-proline 0 CA--C 1.531 0.224 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -52.19 -31.66 46.73 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.721 2.281 . . . . 0.0 112.797 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.614 ' HB1' ' HG ' ' A' ' 54' ' ' LEU . . . -61.79 -46.3 90.16 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.09 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.84 -40.34 79.48 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.763 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.07 -31.52 72.78 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.191 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -70.29 -27.97 64.82 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.581 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.38 -56.39 4.67 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.943 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.6 -28.36 37.27 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 121.473 -0.394 . . . . 0.0 113.533 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.755 ' CD1' HG21 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -63.94 96.93 0.15 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.033 0.444 . . . . 0.0 110.527 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -119.05 157.4 27.89 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.272 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 40' ' ' SER . 40.1 t -68.38 129.67 33.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.076 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.54 41.83 2.65 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.577 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.05 122.71 47.84 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.191 0.197 . . . . 0.0 110.581 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.486 ' HB2' ' CD2' ' A' ' 38' ' ' LEU . . . -94.75 127.1 40.51 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.683 0.278 . . . . 0.0 111.402 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.824 ' HA ' HG12 ' A' ' 91' ' ' VAL . 9.5 mt -77.78 142.21 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.338 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 70.4 mt -130.36 -50.88 1.09 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.933 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.32 145.56 49.15 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.889 0.376 . . . . 0.0 111.698 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.479 HG21 HD13 ' A' ' 68' ' ' LEU . 24.0 t -115.99 115.34 48.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.238 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 53.16 34.8 18.26 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.956 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.14 -15.91 59.95 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.037 -0.602 . . . . 0.0 113.624 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.9 t -88.39 134.95 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 117.218 0.509 . . . . 0.0 111.152 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -69.65 135.59 50.09 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.319 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.592 HD21 ' HB2' ' A' ' 76' ' ' ALA . 0.5 OUTLIER -120.79 16.2 11.83 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.715 179.674 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.4 ttt85 -69.64 -32.31 70.92 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.11 12.02 37.32 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.474 HG22 ' HB2' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -103.45 162.87 12.66 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.617 0.246 . . . . 0.0 110.867 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.37 161.07 13.96 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.12 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.526 ' O ' HG23 ' A' ' 77' ' ' VAL . 58.9 t-80 -54.1 -51.1 65.25 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.066 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -60.45 -41.04 93.27 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.811 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.474 ' HB2' HG22 ' A' ' 71' ' ' THR . 26.6 mt-10 -65.22 -37.22 86.61 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.741 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.592 ' HB2' HD21 ' A' ' 68' ' ' LEU . . . -63.56 -35.23 79.79 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.104 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 73' ' ' HIS . 22.1 t -62.23 -39.84 85.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.815 0.341 . . . . 0.0 110.424 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -41.93 99.05 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.594 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.7 mm -57.98 -45.41 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.571 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.741 HD13 HD11 ' A' ' 23' ' ' LEU . 1.2 mt -57.5 -39.29 76.15 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.072 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -61.58 -37.36 83.58 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.07 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -65.72 -25.61 67.38 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.339 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.457 ' HB2' HD13 ' A' ' 87' ' ' ILE . 33.9 mm-40 -65.9 131.13 45.53 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.097 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.03 143.7 50.27 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.384 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.03 -101.31 0.22 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.859 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -91.57 126.01 36.5 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.954 0.407 . . . . 0.0 110.495 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.457 HD13 ' HB2' ' A' ' 83' ' ' GLN . 7.9 mt -117.6 122.99 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.081 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.77 124.37 37.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.414 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.471 ' CE1' HG13 ' A' ' 63' ' ' VAL . 0.7 OUTLIER -128.16 129.8 47.08 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.927 0.394 . . . . 0.0 111.178 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -101.37 115.21 29.99 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.298 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.824 HG12 ' HA ' ' A' ' 60' ' ' ILE . 15.8 m -138.23 171.5 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.394 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.783 HG12 ' HA ' ' A' ' 10' ' ' ILE . 31.0 m -133.95 149.37 30.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.292 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.98 120.98 19.36 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.867 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.35 131.27 73.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.798 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.013 179.932 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 N--CA 1.49 1.28 0 CA-C-O 120.788 0.245 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.812 ' HA ' HG12 ' A' ' 92' ' ' VAL . 67.6 mt -96.14 141.01 16.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.13 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.5 124.87 44.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.993 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.8 111.54 23.67 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.472 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -132.01 138.05 53.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.957 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.9 141.66 30.61 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.07 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -121.48 139.6 53.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.971 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tt -107.6 127.11 53.36 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.822 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -116.2 126.56 53.8 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.87 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.43 155.62 20.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.682 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.33 -38.96 74.9 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.189 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -79.0 -27.72 43.36 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.425 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -95.41 -178.34 4.4 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.741 0.305 . . . . 0.0 111.508 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.41 -149.89 5.55 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.974 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.94 -56.97 6.2 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.608 0.242 . . . . 0.0 110.781 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.02 -14.52 61.38 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.445 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.603 HD13 HG12 ' A' ' 39' ' ' ILE . 2.6 pp -140.13 154.08 22.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 117.104 0.452 . . . . 0.0 111.166 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 1.5 m -103.8 136.75 42.89 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.793 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.534 ' HB ' HG22 ' A' ' 37' ' ' ILE . 14.7 pt -119.66 149.7 22.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.464 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.456 ' C ' HG23 ' A' ' 37' ' ' ILE . 14.5 t -135.86 146.94 47.98 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.217 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.96 -154.72 25.71 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.364 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 159.45 117.5 0.48 Allowed Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.095 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.88 -33.67 72.14 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.38 0.133 . . . . 0.0 111.321 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -57.26 -29.9 64.21 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.549 0.214 . . . . 0.0 111.331 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 17.4 m80 -83.15 -29.14 28.88 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.001 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.0 26.03 5.66 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.898 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.423 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 16.1 m -144.58 131.98 10.4 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 116.75 0.275 . . . . 0.0 111.115 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 32.6 Cg_exo -61.14 153.97 60.84 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.647 2.231 . . . . 0.0 112.005 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.534 HG22 ' HB ' ' A' ' 27' ' ' ILE . 3.3 mp -82.53 132.07 32.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.426 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.4 159.05 35.64 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.618 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.603 HG12 HD13 ' A' ' 25' ' ' ILE . 13.6 mt -83.01 129.96 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.958 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.3 m -119.71 -40.95 2.71 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.353 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 18.0 tt0 -105.32 144.52 31.99 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.702 0.287 . . . . 0.0 111.081 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.42 ' HA ' HG22 ' A' ' 25' ' ' ILE . 18.9 mm -129.26 111.62 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.697 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -84.87 127.58 64.23 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.97 157.86 53.78 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.843 2.362 . . . . 0.0 113.063 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.94 37.58 43.55 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.835 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -144.06 170.29 8.68 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-O 120.45 0.166 . . . . 0.0 110.799 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.12 -31.24 34.91 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.728 2.285 . . . . 0.0 112.684 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.447 ' CB ' HG23 ' A' ' 25' ' ' ILE . . . -57.34 -46.41 83.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.463 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.77 -42.53 77.3 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.851 0.358 . . . . 0.0 110.498 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -65.02 -30.55 71.54 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.299 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -70.57 -28.34 64.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.535 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.17 -58.8 3.99 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.764 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.85 -23.27 44.54 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.541 -0.362 . . . . 0.0 113.526 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.516 HD11 HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -64.93 96.05 0.18 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.111 0.456 . . . . 0.0 110.403 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.419 ' CE1' ' CD2' ' A' ' 93' ' ' TYR . 6.0 p-80 -119.33 157.41 28.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.299 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 m -68.28 134.9 29.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.56 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.85 44.9 4.37 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.587 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.15 122.49 47.89 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.26 122.58 34.0 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.764 0.316 . . . . 0.0 111.633 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.843 ' HA ' HG12 ' A' ' 91' ' ' VAL . 15.6 mt -69.59 132.19 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.366 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.1 mt -114.88 -54.58 2.56 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.802 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -150.76 145.98 26.11 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.454 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.839 HG21 HD21 ' A' ' 80' ' ' LEU . 24.3 t -125.61 120.51 57.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.54 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 57.39 34.54 24.83 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.08 -11.08 61.26 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.359 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.58 136.33 23.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 117.258 0.529 . . . . 0.0 110.934 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.5 134.39 35.21 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.056 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.417 ' CD2' ' HB1' ' A' ' 76' ' ' ALA . 1.8 mp -108.63 -12.33 14.98 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.034 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -29.05 69.58 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -96.51 9.19 42.16 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.62 0.229 . . . . 0.0 111.62 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.6 p -119.04 157.9 26.88 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.677 0.275 . . . . 0.0 110.8 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.03 161.05 20.85 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.817 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.63 ' O ' HG23 ' A' ' 77' ' ' VAL . 86.0 t60 -53.82 -50.55 65.94 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.904 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -59.69 -41.56 91.01 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.949 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.28 -38.66 85.44 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.954 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.678 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.44 -35.2 79.65 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.402 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 73' ' ' HIS . 39.5 t -61.86 -40.46 87.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.726 0.298 . . . . 0.0 110.469 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.9 m -66.77 -44.25 81.9 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.782 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 76' ' ' ALA . 11.2 mt -62.06 -43.06 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.825 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.839 HD21 HG21 ' A' ' 63' ' ' VAL . 24.5 mt -62.4 -36.53 82.6 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.684 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.4 t -65.57 -32.69 74.41 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.012 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -65.03 -28.8 69.73 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.325 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.475 ' HB3' HG23 ' A' ' 87' ' ' ILE . 26.2 mm-40 -61.85 112.75 2.42 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.813 0.34 . . . . 0.0 110.767 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -112.57 148.88 33.61 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.378 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.56 -103.02 0.55 Allowed Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.59 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -89.07 126.41 35.43 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.812 0.339 . . . . 0.0 110.385 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.475 HG23 ' HB3' ' A' ' 83' ' ' GLN . 13.0 mt -126.05 129.23 72.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.826 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -93.82 135.49 35.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.474 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.469 ' HZ ' HD22 ' A' ' 80' ' ' LEU . 3.4 m-85 -130.58 129.28 42.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.879 0.371 . . . . 0.0 111.026 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -122.07 115.36 22.35 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.227 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.843 HG12 ' HA ' ' A' ' 60' ' ' ILE . 15.9 m -138.83 171.54 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.518 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.812 HG12 ' HA ' ' A' ' 10' ' ' ILE . 15.6 m -134.71 143.18 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.501 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.419 ' CD2' ' CE1' ' A' ' 55' ' ' HIS . 0.1 OUTLIER -79.98 122.92 27.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.961 179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.82 133.41 66.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.088 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.434 -0.794 . . . . 0.0 111.34 -179.865 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.654 ' O ' HG23 ' A' ' 92' ' ' VAL . 6.1 Cg_endo . . . . . 0 N--CA 1.491 1.364 0 CA-C-O 120.99 0.329 . . . . 0.0 111.736 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mp -78.77 143.43 12.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.204 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.17 143.95 46.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.263 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -111.97 115.1 28.4 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 t -125.68 130.15 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.776 0.322 . . . . 0.0 111.175 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.93 132.47 43.48 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.169 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.5 tt -129.67 144.53 51.33 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.985 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.76 114.81 28.92 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.95 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -94.41 136.3 34.86 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.758 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.07 154.56 32.98 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.183 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.63 -37.16 72.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.218 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.422 ' CE1' ' HG2' ' A' ' 21' ' ' GLU . 13.4 p80 -82.47 -26.78 32.33 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.503 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.422 ' HG2' ' CE1' ' A' ' 20' ' ' HIS . 5.0 mm-40 -102.17 110.04 21.89 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.659 0.266 . . . . 0.0 110.946 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.8 -152.14 0.13 Allowed Glycine 0 CA--C 1.522 0.523 0 C-N-CA 121.255 -0.498 . . . . 0.0 113.439 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.418 HD22 HG13 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -60.56 -59.98 4.54 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 -179.46 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.9 -11.95 65.92 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.598 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.549 HG21 ' CD1' ' A' ' 54' ' ' LEU . 15.0 pt -138.36 152.68 25.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 117.1 0.45 . . . . 0.0 110.977 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 0.9 OUTLIER -115.53 136.68 52.84 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.762 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.614 HD12 HG21 ' A' ' 37' ' ' ILE . 18.0 pt -117.34 155.8 18.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.592 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 t -140.46 147.13 39.16 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.993 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.63 -165.49 20.69 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.43 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.423 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . -179.35 114.41 0.44 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.679 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.2 tptp -60.99 -29.89 69.95 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -57.53 -31.15 65.78 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.653 0.263 . . . . 0.0 110.966 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -79.38 -23.11 43.53 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.324 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.15 21.25 4.93 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.309 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.1 m -145.38 140.32 15.83 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 117.007 0.403 . . . . 0.0 111.212 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.57 157.07 63.46 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.57 2.18 . . . . 0.0 112.385 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.614 HG21 HD12 ' A' ' 27' ' ' ILE . 3.3 mt -85.64 137.52 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.842 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.411 HD12 ' C ' ' A' ' 37' ' ' ILE . 6.3 mp -128.37 151.19 49.64 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.368 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.2 mt -86.92 122.12 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.824 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.54 -27.72 8.12 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.877 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 26' ' ' SER . 1.8 mt-10 -109.75 144.27 38.39 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.662 0.268 . . . . 0.0 111.121 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.409 HD12 HD12 ' A' ' 54' ' ' LEU . 22.4 mm -133.55 121.21 40.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.637 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -97.91 112.41 61.64 Favored Pre-proline 0 C--O 1.234 0.287 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.149 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.424 ' HA ' ' HB2' ' A' ' 49' ' ' ASP . 42.0 Cg_endo -68.93 151.58 73.66 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.709 2.273 . . . . 0.0 112.492 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.06 -37.27 3.84 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.734 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.66 176.14 4.11 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-O 120.45 0.167 . . . . 0.0 110.724 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -51.02 -30.65 31.83 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.918 2.412 . . . . 0.0 113.15 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.446 ' CB ' HG23 ' A' ' 25' ' ' ILE . . . -57.69 -46.19 84.65 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.685 0.278 . . . . 0.0 111.211 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.424 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.6 OUTLIER -70.54 -42.12 71.62 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.787 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.6 mtp85 -62.09 -30.08 70.76 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.108 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.94 -28.22 65.4 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.418 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.12 -56.69 3.61 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.712 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.95 -23.58 39.07 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 119.867 -0.407 . . . . 0.0 113.776 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.549 ' CD1' HG21 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -66.05 90.28 0.13 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.161 0.481 . . . . 0.0 110.422 179.721 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -114.17 157.24 22.91 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.11 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.4 t -64.01 137.71 24.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.676 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.71 46.17 4.35 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.385 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.58 121.25 44.23 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.445 0.164 . . . . 0.0 111.017 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.11 122.05 37.37 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.671 0.272 . . . . 0.0 111.258 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.834 ' HA ' HG12 ' A' ' 91' ' ' VAL . 3.2 mp -77.14 134.7 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.442 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.1 mt -121.93 -50.62 2.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.941 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.56 146.44 34.61 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.762 0.315 . . . . 0.0 111.361 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.0 t -136.02 115.88 17.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.59 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 59.79 33.03 21.64 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.015 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.55 -14.44 58.1 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.305 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 t -81.79 132.58 31.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 117.044 0.422 . . . . 0.0 110.604 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -76.26 126.74 31.54 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.658 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.67 HD21 ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -120.58 0.97 10.57 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.529 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -71.1 -31.48 67.84 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 111.247 0.091 . . . . 0.0 111.247 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.47 11.88 33.94 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.52 ' OG1' HD23 ' A' ' 68' ' ' LEU . 25.7 p -100.91 149.7 23.62 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.588 0.232 . . . . 0.0 111.002 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -75.5 161.13 29.46 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.433 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.423 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . 24.2 t-80 -54.59 -49.63 69.95 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.213 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -62.3 -37.72 86.62 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.588 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -62.67 -37.33 86.0 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.746 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.67 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -63.34 -35.34 80.07 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.347 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.16 -42.96 97.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.635 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.32 -48.3 70.73 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.814 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 mt -61.41 -42.19 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.092 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -39.24 80.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.8 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -33.27 75.44 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.009 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -65.3 -27.11 68.39 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.14 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.478 ' HB3' HG23 ' A' ' 87' ' ' ILE . 75.9 mm-40 -65.79 95.63 0.25 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 110.79 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -98.68 144.23 28.18 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.123 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.73 -109.08 2.53 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.818 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -79.99 135.96 36.5 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.692 0.282 . . . . 0.0 110.574 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.478 HG23 ' HB3' ' A' ' 83' ' ' GLN . 10.1 mt -137.03 122.36 25.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.289 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -95.79 122.25 38.38 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.428 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -111.8 128.79 56.22 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.007 0.432 . . . . 0.0 111.338 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -117.24 115.36 25.15 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.299 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.834 HG12 ' HA ' ' A' ' 60' ' ' ILE . 17.6 m -137.76 171.05 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.465 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 9' ' ' PRO . 8.6 p -135.94 137.57 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.987 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.19 119.99 13.64 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.834 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.1 t -111.13 125.03 68.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.167 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.991 179.914 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo . . . . . 0 N--CA 1.489 1.222 0 CA-C-O 120.725 0.219 . . . . 0.0 111.842 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.57 ' HA ' HG12 ' A' ' 92' ' ' VAL . 2.7 tt -109.3 124.6 66.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.067 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -113.65 127.03 55.9 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.053 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.24 113.91 27.78 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.998 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.93 135.87 60.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.003 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.415 HD21 ' CG ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -97.71 130.95 44.65 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.824 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.24 139.47 50.32 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.069 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.2 mp -109.02 114.54 28.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.87 139.03 54.13 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.056 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -109.28 168.09 9.64 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.949 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.87 -37.14 75.87 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.282 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.401 ' CE1' ' HG2' ' A' ' 21' ' ' GLU . 32.1 p80 -74.62 -29.89 61.46 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.596 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' HG2' ' CE1' ' A' ' 20' ' ' HIS . 10.0 mm-40 -94.75 166.18 12.12 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 111.641 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.88 -154.22 9.12 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.91 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.08 -67.01 0.52 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.577 0.227 . . . . 0.0 111.03 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.22 4.13 63.0 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.071 -0.585 . . . . 0.0 113.634 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.727 HG21 HD12 ' A' ' 54' ' ' LEU . 17.2 pt -138.29 145.36 28.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 117.256 0.528 . . . . 0.0 111.088 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.75 140.23 34.26 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.099 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.809 HG22 HD13 ' A' ' 39' ' ' ILE . 13.2 pt -116.49 155.62 17.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.684 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.9 p -133.9 153.79 51.51 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.347 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.49 -153.75 19.66 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.803 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.404 ' CA ' ' HB2' ' A' ' 73' ' ' HIS . . . 151.81 138.21 2.74 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.26 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -58.97 -37.74 77.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.066 0.146 . . . . 0.0 111.38 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.84 -31.19 71.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.595 0.236 . . . . 0.0 111.017 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -81.14 -28.19 35.19 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.103 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.19 25.83 5.95 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.101 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.8 m -147.82 140.08 14.37 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.864 0.332 . . . . 0.0 110.992 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.78 155.83 46.69 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.613 2.208 . . . . 0.0 112.19 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.526 HD12 HD11 ' A' ' 68' ' ' LEU . 19.7 mt -84.89 136.56 22.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.857 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.8 154.5 48.48 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.301 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.809 HD13 HG22 ' A' ' 27' ' ' ILE . 16.1 mm -83.87 118.23 30.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.763 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 56' ' ' VAL . 23.0 t -108.19 -28.51 9.44 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.705 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.67 144.45 50.2 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.735 0.302 . . . . 0.0 111.198 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.536 HG12 HG22 ' A' ' 56' ' ' VAL . 20.9 mm -128.92 112.19 25.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.383 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -87.01 130.96 46.27 Favored Pre-proline 0 C--O 1.232 0.158 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.106 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.37 172.8 15.63 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.846 2.364 . . . . 0.0 112.535 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.52 30.38 77.43 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.467 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.448 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.9 OUTLIER -137.01 169.08 14.21 Favored Pre-proline 0 C--O 1.233 0.203 0 C-N-CA 122.248 0.219 . . . . 0.0 110.44 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.448 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 9.3 Cg_endo -53.09 -27.02 34.95 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.768 2.312 . . . . 0.0 112.75 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.72 -46.35 89.37 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.061 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -67.85 -40.49 83.66 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.618 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -58.71 -33.05 69.76 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.347 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.3 m -80.57 -28.36 37.23 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.56 -51.7 4.27 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.182 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.48 -24.37 23.49 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.56 -0.353 . . . . 0.0 113.795 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.727 HD12 HG21 ' A' ' 25' ' ' ILE . 4.2 mm? -65.19 89.52 0.09 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.15 0.475 . . . . 0.0 110.743 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -114.25 157.37 22.8 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.348 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.536 HG22 HG12 ' A' ' 42' ' ' ILE . 42.1 t -72.56 136.55 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.68 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.29 40.34 4.83 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.899 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -112.08 135.03 53.25 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.602 0.201 . . . . 0.0 110.987 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.53 124.01 47.31 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.686 0.279 . . . . 0.0 111.403 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.868 ' HA ' HG12 ' A' ' 91' ' ' VAL . 3.2 mt -80.04 150.72 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.494 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 61' ' ' LEU . 13.3 mt -136.25 -50.45 0.69 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.354 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.74 145.95 32.78 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.773 0.321 . . . . 0.0 111.476 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.779 HG21 HD21 ' A' ' 80' ' ' LEU . 24.4 t -135.39 115.87 18.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.769 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 57.15 34.53 24.99 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.875 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.83 -19.73 46.68 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.321 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 t -80.13 135.98 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 117.065 0.433 . . . . 0.0 111.0 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -80.51 137.33 36.43 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.213 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.587 HD22 ' HB ' ' A' ' 60' ' ' ILE . 1.2 tp -87.12 -33.06 19.57 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.038 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -67.4 -27.69 67.29 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.427 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -89.51 9.99 24.52 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 t -134.15 154.43 51.22 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.773 0.321 . . . . 0.0 110.959 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.18 161.16 20.67 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.706 ' O ' HG23 ' A' ' 77' ' ' VAL . 51.3 t-80 -54.0 -51.66 63.24 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.008 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -61.16 -42.15 98.03 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.031 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -38.68 84.96 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.963 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.511 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.49 -33.73 76.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.348 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 73' ' ' HIS . 24.7 t -61.91 -43.46 97.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.76 0.314 . . . . 0.0 110.25 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.11 -47.34 77.53 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.544 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 76' ' ' ALA . 17.2 mt -59.23 -49.29 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.92 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.779 HD21 HG21 ' A' ' 63' ' ' VAL . 85.5 mt -55.45 -35.97 66.04 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.132 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -20.06 60.45 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.652 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -74.22 -28.86 61.45 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.748 0.308 . . . . 0.0 110.57 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.567 ' HB3' HG23 ' A' ' 87' ' ' ILE . 1.5 mp0 -68.79 104.82 2.13 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.66 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 149.9 25.68 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.375 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.98 -107.11 1.63 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.469 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.415 ' CG ' HD21 ' A' ' 14' ' ' LEU . 15.9 tt0 -79.37 115.37 18.98 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.761 0.315 . . . . 0.0 110.433 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.567 HG23 ' HB3' ' A' ' 83' ' ' GLN . 11.3 mt -122.55 122.74 66.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.042 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -93.93 121.86 35.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.447 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.404 ' CE1' HD22 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -118.06 129.69 55.71 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.877 0.37 . . . . 0.0 111.642 -179.524 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -118.1 115.35 24.66 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.394 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.868 HG12 ' HA ' ' A' ' 60' ' ' ILE . 17.2 m -136.3 169.26 20.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.513 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 10' ' ' ILE . 29.4 m -137.69 131.23 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.111 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.15 123.48 22.27 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.935 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.3 m -108.34 141.9 22.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.4 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.42 -0.8 . . . . 0.0 111.323 -179.89 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.435 ' O ' HG12 ' A' ' 92' ' ' VAL . 5.3 Cg_endo . . . . . 0 N--CA 1.49 1.274 0 CA-C-O 120.539 0.141 . . . . 0.0 111.827 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.473 ' HA ' HG12 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -100.87 128.67 52.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.462 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -123.43 121.56 36.03 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.968 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -111.47 111.61 22.75 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.566 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.42 134.95 56.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.073 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 mp -97.97 139.54 33.65 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.81 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 tp -108.32 119.6 39.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.829 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 tp -109.55 115.18 29.43 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.487 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.63 153.14 44.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.018 0.437 . . . . 0.0 111.242 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.84 173.14 7.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.997 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -58.83 -38.37 78.53 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -72.96 -30.26 63.71 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.18 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -75.19 168.95 19.0 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.852 0.358 . . . . 0.0 111.238 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.1 -149.93 8.88 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.888 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.797 HD11 HD13 ' A' ' 80' ' ' LEU . 1.9 tp -76.88 -61.08 2.09 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.517 0.199 . . . . 0.0 111.323 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.78 -14.25 49.63 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.581 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.614 HG22 HG23 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -143.89 165.09 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 117.123 0.461 . . . . 0.0 111.132 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.8 t -120.99 136.76 54.91 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.675 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.605 HD12 HG21 ' A' ' 37' ' ' ILE . 15.2 pt -117.99 153.4 20.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.496 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.2 t -139.6 145.87 39.09 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.22 -151.51 23.46 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.447 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.53 105.44 0.19 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.847 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -57.57 -34.92 69.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.474 0.178 . . . . 0.0 111.18 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -60.72 -31.17 70.48 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.186 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -82.61 -31.36 28.92 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.087 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.65 32.27 2.33 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.709 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.443 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 10.9 p -140.42 130.92 13.75 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-O 120.66 0.267 . . . . 0.0 110.846 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.445 ' O ' HD23 ' A' ' 38' ' ' LEU . 25.9 Cg_exo -62.35 156.23 52.58 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.551 2.168 . . . . 0.0 112.072 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.605 HG21 HD12 ' A' ' 27' ' ' ILE . 30.3 mm -84.85 136.96 21.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.593 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 36' ' ' PRO . 0.3 OUTLIER -145.44 158.56 43.82 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.909 0.385 . . . . 0.0 111.611 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.589 HD13 HD13 ' A' ' 25' ' ' ILE . 16.7 mt -88.48 125.88 41.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.158 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.515 ' O ' HG13 ' A' ' 56' ' ' VAL . 8.6 t -110.42 -34.26 6.38 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.395 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -123.58 147.35 47.39 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.817 0.341 . . . . 0.0 111.371 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.614 HG23 HG22 ' A' ' 25' ' ' ILE . 2.3 mt -127.13 120.11 54.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.54 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -78.68 113.58 36.13 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.703 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.17 149.78 83.15 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.745 2.296 . . . . 0.0 112.648 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.84 39.59 28.17 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.563 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.93 172.95 4.89 Favored Pre-proline 0 C--N 1.331 -0.22 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -51.33 -32.72 42.84 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.61 2.207 . . . . 0.0 112.792 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.556 ' CB ' HG23 ' A' ' 25' ' ' ILE . . . -62.35 -46.31 89.24 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.113 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.36 -41.6 96.64 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.665 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.43 -29.86 67.67 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.611 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 10.8 m -70.36 -28.38 65.07 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.18 -57.8 4.01 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.89 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.44 -25.17 33.41 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.514 -0.374 . . . . 0.0 113.47 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.471 HD12 HG21 ' A' ' 25' ' ' ILE . 3.9 mm? -65.21 90.28 0.09 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.964 0.412 . . . . 0.0 110.471 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -115.79 157.47 24.33 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.217 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 40' ' ' SER . 43.1 t -63.92 132.08 29.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.247 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.6 40.78 4.93 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.815 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.55 119.07 37.97 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.21 130.34 38.94 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.879 ' HA ' HG12 ' A' ' 91' ' ' VAL . 3.2 mp -81.6 151.04 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.357 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.9 mt -136.6 -51.75 0.69 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.976 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.91 147.39 40.5 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.806 0.336 . . . . 0.0 111.448 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.424 HG13 ' CD1' ' A' ' 89' ' ' PHE . 38.2 t -130.01 115.62 33.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.529 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 54.4 32.91 17.46 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.864 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.77 -17.0 58.91 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.339 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.8 t -83.79 137.97 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 117.063 0.432 . . . . 0.0 111.045 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -75.23 131.18 40.2 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.27 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.656 HD13 HG21 ' A' ' 60' ' ' ILE . 7.0 tt -108.09 -22.61 12.32 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.501 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -61.16 -28.48 69.16 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.6 12.12 28.66 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.4 p -113.45 162.65 15.87 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.742 0.306 . . . . 0.0 110.583 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.82 161.24 16.84 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.198 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.559 ' O ' HG23 ' A' ' 77' ' ' VAL . 7.4 t-160 -54.03 -50.68 66.12 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.069 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -68.29 -43.16 78.31 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.874 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -38.1 89.34 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.997 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.674 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.66 -30.74 71.81 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.4 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 73' ' ' HIS . 22.9 t -61.93 -41.43 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.743 0.306 . . . . 0.0 110.651 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.3 m -69.84 -39.98 76.11 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.493 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 76' ' ' ALA . 16.0 mt -65.06 -48.89 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.163 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.797 HD13 HD11 ' A' ' 23' ' ' LEU . 4.6 pp -62.67 -36.6 83.39 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.108 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.625 ' N ' HD12 ' A' ' 80' ' ' LEU . 86.9 p -74.54 -16.0 60.84 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -71.22 -30.53 66.48 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.772 0.32 . . . . 0.0 110.858 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.444 ' CB ' HG23 ' A' ' 87' ' ' ILE . 2.2 mp0 -67.47 117.02 8.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.851 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -107.33 147.26 30.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.446 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.93 -98.39 0.19 Allowed Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.559 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -82.66 115.0 21.41 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.721 0.296 . . . . 0.0 110.304 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.444 HG23 ' CB ' ' A' ' 83' ' ' GLN . 16.7 mt -119.64 122.36 68.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.974 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.39 122.88 43.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.351 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.424 ' CD1' HG13 ' A' ' 63' ' ' VAL . 0.5 OUTLIER -122.83 129.42 51.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.826 0.346 . . . . 0.0 110.736 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -111.85 114.98 28.26 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.825 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.879 HG12 ' HA ' ' A' ' 60' ' ' ILE . 19.6 m -134.52 169.31 21.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.566 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 10' ' ' ILE . 16.9 m -139.96 141.24 34.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.954 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.47 116.26 7.26 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.825 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.3 p -105.01 139.63 25.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.517 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.124 -0.941 . . . . 0.0 111.065 -179.957 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.64 ' O ' HG13 ' A' ' 92' ' ' VAL . 6.4 Cg_exo . . . . . 0 N--CA 1.494 1.541 0 CA-C-O 120.831 0.263 . . . . 0.0 112.21 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.666 HD12 HD12 ' A' ' 61' ' ' LEU . 1.2 tt -92.66 136.89 23.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.168 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.4 ttt180 -123.62 148.07 46.77 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.049 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.467 ' HD2' ' HG3' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -101.1 118.86 37.84 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.659 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.0 t -122.13 129.56 75.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.304 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.4 tp -101.91 120.06 39.79 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.672 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.56 HD11 HD23 ' A' ' 54' ' ' LEU . 5.7 mp -108.28 121.09 44.18 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.149 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.8 tp -108.32 115.22 29.72 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.635 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.08 147.27 45.99 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.209 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -86.75 172.26 10.29 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.975 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -58.89 -38.46 78.91 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.061 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -73.92 -29.53 62.09 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.108 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -68.29 154.19 42.24 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.817 0.342 . . . . 0.0 111.533 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.22 -157.85 26.11 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.937 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.55 -62.05 1.6 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.492 0.187 . . . . 0.0 111.49 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.08 -21.17 34.21 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.365 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.914 HD13 HD12 ' A' ' 39' ' ' ILE . 1.1 pp -139.93 151.96 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 117.072 0.436 . . . . 0.0 111.31 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -105.49 137.1 43.87 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.986 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.717 HG22 HD13 ' A' ' 39' ' ' ILE . 14.0 pt -119.09 158.49 20.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.576 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.6 t -144.53 150.3 37.31 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.2 -159.58 15.73 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.478 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . 161.78 123.31 0.66 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.79 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -56.35 -37.87 70.6 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.457 0.169 . . . . 0.0 111.457 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -68.07 -31.15 70.59 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.734 0.302 . . . . 0.0 110.863 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -76.79 -30.5 56.49 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.028 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.96 21.69 5.23 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.113 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.4 p -149.76 130.81 7.2 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.95 0.375 . . . . 0.0 110.921 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -61.77 154.06 63.36 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.575 2.183 . . . . 0.0 112.26 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.511 HG21 HD12 ' A' ' 27' ' ' ILE . 15.9 mt -82.79 136.79 22.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.642 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.38 163.5 32.78 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.886 0.374 . . . . 0.0 111.766 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.914 HD12 HD13 ' A' ' 25' ' ' ILE . 10.5 mm -87.83 125.19 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.59 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.417 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.6 OUTLIER -117.39 -46.77 2.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.136 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 26' ' ' SER . 45.5 mt-10 -111.24 146.4 37.02 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.228 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.567 HG23 HG22 ' A' ' 25' ' ' ILE . 12.8 mt -131.72 113.08 21.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.6 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -69.72 124.61 90.95 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.924 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.06 147.02 53.64 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.695 2.263 . . . . 0.0 112.658 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.46 40.66 22.64 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.569 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.71 173.16 5.37 Favored Pre-proline 0 C--N 1.332 -0.196 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -51.8 -31.8 43.6 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.629 2.219 . . . . 0.0 112.662 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.57 -45.87 84.67 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.225 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -70.56 -43.08 70.22 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.635 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -59.57 -30.42 68.62 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.464 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 94.8 m -80.24 -28.02 38.57 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.833 -0.167 . . . . 0.0 111.353 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.95 17.66 63.46 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.865 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.29 -30.74 2.38 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.062 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.69 HD12 HG21 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -69.9 89.16 0.58 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.845 0.355 . . . . 0.0 110.738 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -106.34 156.83 18.1 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 40' ' ' SER . 22.4 t -64.56 135.09 28.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.688 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.95 46.06 4.31 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.411 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.38 122.74 48.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.397 0.142 . . . . 0.0 110.81 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.698 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -91.35 121.3 32.97 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.816 0.341 . . . . 0.0 111.216 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.875 ' HA ' HG12 ' A' ' 91' ' ' VAL . 5.6 mt -74.06 145.92 10.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.608 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.666 HD12 HD12 ' A' ' 10' ' ' ILE . 64.0 mt -137.83 -52.58 0.63 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.092 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.45 145.58 48.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.836 0.35 . . . . 0.0 111.702 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.0 t -131.3 117.04 34.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.403 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 57.82 34.46 24.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.931 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.99 -18.54 47.27 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.589 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.31 130.77 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 117.183 0.491 . . . . 0.0 110.926 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -74.78 140.78 44.25 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.172 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.659 HD21 ' CB ' ' A' ' 76' ' ' ALA . 9.8 tp -114.83 16.27 17.33 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.416 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.13 -34.57 71.17 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.807 -0.178 . . . . 0.0 111.425 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.88 12.03 38.42 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.3 m -103.51 154.36 19.54 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.776 0.322 . . . . 0.0 111.191 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.22 161.0 15.91 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.283 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.588 ' O ' HG23 ' A' ' 77' ' ' VAL . 8.4 t-80 -54.1 -52.4 61.13 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.037 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -61.57 -38.36 87.23 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.028 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -65.23 -40.91 94.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.824 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.659 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -63.41 -34.38 77.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.481 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 73' ' ' HIS . 21.9 t -61.81 -43.76 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.72 0.295 . . . . 0.0 110.694 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.9 m -69.67 -44.92 69.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.005 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.4 mt -62.95 -47.99 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.482 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.548 HD12 ' N ' ' A' ' 81' ' ' SER . 4.4 pp -63.51 -33.62 75.98 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.46 0.172 . . . . 0.0 111.09 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.548 ' N ' HD12 ' A' ' 80' ' ' LEU . 12.7 t -66.64 -30.79 71.14 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.151 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -65.31 -29.24 69.97 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.147 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -60.88 115.14 3.47 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.725 0.298 . . . . 0.0 110.651 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -115.01 143.83 44.56 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.961 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.18 -100.8 0.27 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.567 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -77.39 119.5 21.09 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.738 0.304 . . . . 0.0 110.544 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.0 mt -129.83 122.47 54.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.101 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -94.6 126.95 40.22 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.355 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -124.52 129.43 50.59 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.899 0.38 . . . . 0.0 111.391 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.467 ' HG3' ' HD2' ' A' ' 12' ' ' LYS . 6.5 tt0 -119.9 115.57 24.07 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.233 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.875 HG12 ' HA ' ' A' ' 60' ' ' ILE . 17.0 m -138.25 169.02 19.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.0 0.429 . . . . 0.0 111.888 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 9' ' ' PRO . 32.2 t -129.5 138.53 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.751 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.27 124.18 21.52 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.87 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.698 HG21 ' HB2' ' A' ' 59' ' ' ALA . 21.7 t -126.46 130.82 71.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.242 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 94' ' ' VAL . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.588 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.45 ' O ' HG13 ' A' ' 92' ' ' VAL . 4.0 Cg_endo . . . . . 0 N--CA 1.49 1.281 0 CA-C-O 120.679 0.2 . . . . 0.0 111.983 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.529 ' HA ' HG22 ' A' ' 92' ' ' VAL . 1.0 OUTLIER -78.86 115.74 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.12 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -122.18 127.14 49.66 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.068 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.35 114.22 26.34 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.82 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.0 t -111.26 144.57 18.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.827 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.0 tt -97.72 122.09 40.4 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.594 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.516 HD21 ' HB2' ' A' ' 47' ' ' PRO . 0.5 OUTLIER -108.92 123.61 49.36 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.256 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tt -107.76 115.51 30.27 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.708 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -130.33 139.4 50.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.55 164.29 23.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.993 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.11 -38.5 73.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.969 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -76.71 -29.54 56.28 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.079 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -77.25 176.04 9.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.724 0.297 . . . . 0.0 111.38 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -132.99 -144.26 5.19 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.05 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.546 HD11 HD22 ' A' ' 80' ' ' LEU . 7.6 mt -94.11 -67.7 0.84 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.549 0.214 . . . . 0.0 111.141 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.02 4.58 51.02 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.723 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.75 HG22 HG23 ' A' ' 42' ' ' ILE . 2.6 pp -137.12 157.79 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 117.287 0.544 . . . . 0.0 111.321 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.6 m -112.99 136.71 52.38 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.822 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.551 HD12 HG21 ' A' ' 37' ' ' ILE . 2.7 pt -117.64 158.14 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.364 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 t -143.48 153.97 43.18 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.289 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.31 -167.1 24.28 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.619 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.18 122.28 0.64 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.842 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.19 -37.76 78.19 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.658 0.266 . . . . 0.0 111.058 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -59.04 -31.2 68.63 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.936 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -80.27 -28.02 38.45 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.108 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.04 30.35 4.83 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.958 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 6.8 m -146.48 132.96 9.73 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-N 116.76 0.28 . . . . 0.0 111.162 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 34.4 Cg_exo -61.26 157.41 40.35 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.718 2.279 . . . . 0.0 112.049 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.551 HG21 HD12 ' A' ' 27' ' ' ILE . 21.9 mm -82.18 135.19 25.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.563 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 pp -138.65 155.99 47.81 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.934 0.397 . . . . 0.0 111.513 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.917 HD13 HD21 ' A' ' 54' ' ' LEU . 19.3 mt -79.97 125.78 39.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.948 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.7 t -101.63 -42.42 6.22 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.623 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -127.94 150.55 49.84 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.982 0.42 . . . . 0.0 111.796 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.75 HG23 HG22 ' A' ' 25' ' ' ILE . 37.6 mt -132.91 122.67 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.571 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -82.59 132.2 52.82 Favored Pre-proline 0 N--CA 1.462 0.162 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.928 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.92 148.19 40.19 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.747 2.298 . . . . 0.0 112.58 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.42 37.99 46.08 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.65 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.9 172.49 7.25 Favored Pre-proline 0 C--O 1.233 0.191 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.516 ' HB2' HD21 ' A' ' 15' ' ' LEU . 76.2 Cg_exo -50.86 -32.4 37.26 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.669 2.246 . . . . 0.0 112.916 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.475 ' CB ' HD13 ' A' ' 54' ' ' LEU . . . -66.07 -46.27 78.33 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.088 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.28 -40.05 77.98 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.683 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -60.04 -31.7 70.22 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.395 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 m -76.53 -27.98 56.18 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.46 16.75 67.79 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.132 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.01 -35.15 1.54 Allowed Glycine 0 C--N 1.337 0.593 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.834 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.917 HD21 HD13 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -69.24 105.51 2.54 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.818 0.342 . . . . 0.0 110.907 -179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.469 ' C ' HD11 ' A' ' 42' ' ' ILE . 19.2 p80 -111.98 157.34 20.83 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.208 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.4 t -62.86 137.97 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.61 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.89 53.36 7.21 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.627 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -111.93 120.8 43.14 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.3 126.75 36.48 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.866 0.365 . . . . 0.0 111.854 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.848 ' HA ' HG12 ' A' ' 91' ' ' VAL . 3.4 mt -85.83 149.9 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.907 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.2 mt -135.47 -50.0 0.73 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.874 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.68 145.69 45.05 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.745 0.307 . . . . 0.0 111.432 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.1 t -135.1 115.99 19.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.54 36.83 28.2 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.806 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.28 -14.4 50.39 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.429 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.3 t -83.92 136.49 22.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 117.19 0.495 . . . . 0.0 110.923 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -76.91 137.53 39.16 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.285 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.401 HD11 ' HB1' ' A' ' 76' ' ' ALA . 0.4 OUTLIER -114.97 -1.53 13.08 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.652 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -71.31 -34.15 70.33 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.35 12.19 33.8 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 64.7 p -103.88 138.61 40.21 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.655 0.264 . . . . 0.0 110.939 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.35 161.16 30.79 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.816 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.537 ' O ' HG23 ' A' ' 77' ' ' VAL . 10.3 t-80 -53.91 -49.28 68.98 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.956 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.95 -41.94 99.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.683 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.7 -39.58 94.47 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.105 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.615 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.64 -34.28 77.49 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.476 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 73' ' ' HIS . 39.7 t -62.04 -43.01 97.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.791 0.329 . . . . 0.0 110.311 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 m -63.8 -44.37 93.49 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.74 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 76' ' ' ALA . 12.5 mt -62.86 -41.2 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.955 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.546 HD22 HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -59.12 -41.72 88.89 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.833 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.6 m -69.2 -27.12 65.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.442 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -65.08 -28.16 69.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.42 0.152 . . . . 0.0 111.139 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.529 ' HB3' HG23 ' A' ' 87' ' ' ILE . 50.9 mm-40 -67.06 117.33 8.96 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.65 0.262 . . . . 0.0 110.938 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.96 143.68 44.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.071 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.61 -106.88 0.95 Allowed Glycine 0 C--N 1.337 0.604 0 C-N-CA 121.298 -0.477 . . . . 0.0 112.916 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -78.6 122.78 26.36 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.661 0.267 . . . . 0.0 110.465 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.529 HG23 ' HB3' ' A' ' 83' ' ' GLN . 13.4 mt -127.7 123.12 60.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.404 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -93.84 123.89 37.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.232 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.523 ' HZ ' HD21 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -117.51 133.2 56.23 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.855 0.359 . . . . 0.0 111.654 -179.299 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.88 115.51 23.97 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.421 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.848 HG12 ' HA ' ' A' ' 60' ' ' ILE . 15.0 m -136.97 169.69 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.743 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.529 HG22 ' HA ' ' A' ' 10' ' ' ILE . 23.4 t -136.95 133.7 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.666 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.44 117.85 8.54 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.791 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 13.3 p -99.4 126.82 52.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.859 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.234 -179.601 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.489 1.22 0 CA-C-O 120.843 0.268 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.662 ' HA ' HG12 ' A' ' 92' ' ' VAL . 1.0 OUTLIER -79.87 127.39 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.175 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.67 128.28 55.22 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.104 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -100.32 117.57 34.81 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.799 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.594 HG23 ' HB3' ' A' ' 89' ' ' PHE . 5.0 m -127.52 128.43 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.461 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 tp -105.02 120.29 41.11 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.088 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 tp -108.72 137.01 47.35 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.685 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.4 114.94 28.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.786 0.326 . . . . 0.0 110.877 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.555 ' HB3' HD11 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -117.72 132.59 56.45 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.029 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.44 169.73 8.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.699 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.404 ' HA ' ' NH1' ' A' ' 84' ' ' ARG . 53.1 m-20 -57.31 -38.44 74.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.921 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -81.65 -26.27 34.9 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.726 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -88.9 153.35 21.12 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.973 0.416 . . . . 0.0 111.606 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.35 -149.7 15.75 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.804 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.38 -65.63 0.96 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.545 0.212 . . . . 0.0 111.209 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.01 4.42 60.09 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.525 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.684 HG22 HG23 ' A' ' 42' ' ' ILE . 10.4 pt -142.17 151.8 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 117.389 0.594 . . . . 0.0 111.337 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.0 136.76 49.52 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.781 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.1 pt -124.84 158.74 32.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.421 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.0 t -143.11 150.92 40.14 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.135 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.82 -148.17 17.2 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.576 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.458 ' HA2' HD11 ' A' ' 37' ' ' ILE . . . 155.54 111.65 0.39 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.532 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -58.25 -30.28 66.43 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.455 0.169 . . . . 0.0 111.205 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -58.66 -31.37 68.12 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.006 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -86.06 -24.3 26.4 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.235 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.0 27.37 2.98 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.154 -0.546 . . . . 0.0 113.003 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.6 m -142.37 138.78 16.81 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.923 0.361 . . . . 0.0 110.966 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.48 155.77 65.92 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.52 2.147 . . . . 0.0 112.322 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.458 HD11 ' HA2' ' A' ' 30' ' ' GLY . 23.6 mm -84.15 125.3 40.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.754 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.09 145.13 50.46 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.09 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.578 HD12 ' HB3' ' A' ' 58' ' ' ASP . 23.9 mt -85.31 120.64 35.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.852 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.3 -37.04 5.86 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.476 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -117.65 149.64 40.36 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.765 0.317 . . . . 0.0 111.198 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.684 HG23 HG22 ' A' ' 25' ' ' ILE . 24.2 mt -134.28 113.42 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.766 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -72.83 127.02 90.27 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.293 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.0 166.07 28.66 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.819 2.346 . . . . 0.0 112.789 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.21 23.45 74.77 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.71 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -131.82 172.77 6.79 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.01 -22.01 29.2 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.484 2.123 . . . . 0.0 113.206 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.536 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -60.32 -46.94 88.1 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -71.41 -38.03 71.46 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.671 0.272 . . . . 0.0 110.57 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -67.03 -27.72 67.64 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.015 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 7.5 t -70.28 -28.03 64.89 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.338 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.62 -60.52 3.69 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.737 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.48 -26.18 37.02 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 121.447 -0.406 . . . . 0.0 113.39 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.463 HD11 HG21 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -65.09 92.12 0.1 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.009 0.433 . . . . 0.0 110.502 179.658 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -119.19 157.65 27.54 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.294 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.0 m -63.77 138.86 22.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.49 46.14 7.02 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.739 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.578 ' HB3' HD12 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -111.99 127.82 55.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.416 0.15 . . . . 0.0 110.954 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -94.65 125.24 39.17 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.192 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.909 ' HA ' HG12 ' A' ' 91' ' ' VAL . 3.3 mt -80.14 136.85 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.461 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.24 -52.07 2.6 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.944 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.07 156.06 42.7 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.813 0.34 . . . . 0.0 111.55 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.2 t -138.51 115.76 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.761 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.401 ' HB2' ' OE1' ' A' ' 83' ' ' GLN . 4.2 t-20 55.28 42.49 30.3 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.063 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.42 2.01 62.34 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.307 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.6 t -97.27 122.59 48.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 117.149 0.474 . . . . 0.0 110.508 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -66.31 128.51 36.42 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.541 HD22 HG21 ' A' ' 60' ' ' ILE . 1.9 tp -103.84 -17.07 15.19 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.789 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.6 ttm105 -61.17 -32.5 72.23 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -98.75 7.0 46.57 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -101.92 148.11 25.73 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.746 0.307 . . . . 0.0 110.97 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.79 161.08 23.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.605 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.59 ' O ' HG23 ' A' ' 77' ' ' VAL . 58.5 t-80 -54.12 -49.66 68.66 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.958 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -40.68 90.46 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.926 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -64.75 -38.69 91.83 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.19 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.432 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.69 -34.98 79.06 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.272 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 73' ' ' HIS . 39.1 t -61.7 -42.08 92.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.38 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -44.77 93.82 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.697 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 76' ' ' ALA . 21.7 mt -63.84 -46.47 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.04 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.447 HD21 ' HZ ' ' A' ' 89' ' ' PHE . 0.4 OUTLIER -55.61 -41.33 73.32 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.112 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.94 -34.3 77.47 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.983 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -65.74 -24.82 67.04 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.422 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.45 ' HB2' HD13 ' A' ' 87' ' ' ILE . 32.5 mm-40 -63.38 103.98 0.57 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.769 0.319 . . . . 0.0 110.766 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.404 ' NH1' ' HA ' ' A' ' 19' ' ' ASP . 11.0 mmt180 -112.06 155.03 24.49 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.073 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.07 -103.23 0.68 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.39 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.61 130.97 44.6 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.706 0.289 . . . . 0.0 110.551 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.555 HD11 ' HB3' ' A' ' 17' ' ' LYS . 14.2 mt -126.19 122.48 61.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -93.91 122.87 36.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.444 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.594 ' HB3' HG23 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -116.88 134.17 55.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.991 0.424 . . . . 0.0 111.438 -179.684 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -122.69 115.44 22.08 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.096 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.909 HG12 ' HA ' ' A' ' 60' ' ' ILE . 25.9 m -138.52 170.27 16.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.59 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.662 HG12 ' HA ' ' A' ' 10' ' ' ILE . 6.2 m -134.96 136.77 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.863 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.78 121.83 16.31 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.961 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.5 t -115.28 137.47 48.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.086 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.387 179.92 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.433 ' O ' HG13 ' A' ' 92' ' ' VAL . 4.4 Cg_endo . . . . . 0 N--CA 1.49 1.301 0 CA-C-O 120.671 0.196 . . . . 0.0 111.884 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 tt -83.29 141.31 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.379 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -122.45 132.82 54.53 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.122 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -103.48 111.96 24.65 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.501 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.7 t -118.22 138.13 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.815 0.341 . . . . 0.0 111.338 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.779 HD21 ' HG3' ' A' ' 86' ' ' GLU . 2.5 tt -108.34 127.54 53.96 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.855 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 tp -115.01 144.1 44.15 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.034 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mt -109.22 116.17 31.39 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.964 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.57 137.86 52.31 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.07 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -114.99 167.66 10.6 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.706 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.82 -38.21 72.28 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.192 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -84.07 -25.26 29.94 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.529 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -92.08 173.91 7.59 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.787 0.327 . . . . 0.0 111.498 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -132.83 -146.4 5.59 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.998 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 mt -82.79 -66.59 0.87 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.525 0.203 . . . . 0.0 111.168 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.16 4.52 35.54 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.694 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.769 HD13 HD12 ' A' ' 39' ' ' ILE . 1.5 pp -146.44 147.96 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 117.297 0.549 . . . . 0.0 111.114 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.1 t -101.85 137.84 39.61 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.727 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.743 HG22 HD13 ' A' ' 39' ' ' ILE . 16.2 pt -116.11 153.82 17.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.543 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.9 t -141.9 152.16 43.31 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.37 -152.55 19.82 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.496 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . 166.57 119.74 0.49 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.934 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.91 -35.61 75.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.522 0.201 . . . . 0.0 111.328 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.39 -31.03 65.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.139 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -78.48 -27.52 46.26 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.138 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.76 26.53 5.54 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.807 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 13.1 m -141.1 133.29 14.02 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 116.787 0.293 . . . . 0.0 111.082 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 34.4 Cg_exo -61.27 157.6 39.47 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.823 2.349 . . . . 0.0 112.157 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.569 ' O ' HD12 ' A' ' 60' ' ' ILE . 23.5 mm -82.48 130.68 35.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.733 0.301 . . . . 0.0 110.44 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.561 HD12 ' C ' ' A' ' 37' ' ' ILE . 9.7 mp -121.78 156.29 33.5 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.604 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.769 HD12 HD13 ' A' ' 25' ' ' ILE . 17.8 mm -88.05 124.83 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.402 ' O ' HG13 ' A' ' 56' ' ' VAL . 3.1 m -117.73 -45.02 2.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.557 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.51 145.23 33.39 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.796 0.331 . . . . 0.0 111.254 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.617 HG23 HG22 ' A' ' 25' ' ' ILE . 12.6 mt -132.94 113.46 20.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.566 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -71.76 126.45 91.48 Favored Pre-proline 0 C--O 1.232 0.145 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.823 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.8 154.39 63.63 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.774 2.316 . . . . 0.0 112.624 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.38 32.95 80.66 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.774 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.96 175.19 3.81 Favored Pre-proline 0 C--O 1.233 0.213 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -51.13 -33.11 42.5 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.672 2.248 . . . . 0.0 112.774 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.4 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -58.03 -46.14 85.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.214 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.12 -38.75 72.31 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.837 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -61.62 -33.96 74.83 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.795 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.5 p -90.35 -27.36 19.43 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.598 0.221 . . . . 0.0 111.598 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.58 16.14 65.04 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.109 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.68 -28.7 5.87 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.403 -0.427 . . . . 0.0 112.73 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.45 HD22 HG21 ' A' ' 25' ' ' ILE . 3.5 mt -77.1 71.72 3.6 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.245 0.545 . . . . 0.0 110.497 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -86.1 157.41 20.05 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.278 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 40' ' ' SER . 26.1 t -66.42 137.95 23.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.065 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.25 36.58 9.72 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.543 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -100.29 150.1 22.92 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.55 121.08 37.63 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.619 0.247 . . . . 0.0 111.416 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.831 ' HA ' HG12 ' A' ' 91' ' ' VAL . 2.0 mt -81.72 148.05 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.519 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 36.8 mt -131.44 -51.51 1.0 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.993 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.73 145.81 47.04 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.911 0.386 . . . . 0.0 111.759 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.436 ' CG2' HD13 ' A' ' 68' ' ' LEU . 21.7 t -127.74 115.67 40.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.294 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.4 34.24 24.39 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.656 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.05 -19.02 44.85 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.68 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.8 t -88.05 137.37 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 117.268 0.534 . . . . 0.0 111.078 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -71.26 132.81 45.48 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.265 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.524 HD22 HG21 ' A' ' 60' ' ' ILE . 7.6 tp -89.95 -29.36 18.54 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.183 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -18.93 65.41 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.775 -0.193 . . . . 0.0 111.394 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.14 9.22 34.45 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.4 t -133.77 165.69 24.39 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.559 0.219 . . . . 0.0 110.751 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.05 161.0 16.79 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.064 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.662 ' O ' HG23 ' A' ' 77' ' ' VAL . 80.3 t60 -55.66 -51.4 67.36 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.181 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -61.38 -43.13 99.4 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.889 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.0 -38.26 88.03 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.917 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.75 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.79 -30.73 71.79 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.564 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 73' ' ' HIS . 22.1 t -61.86 -45.02 99.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 120.789 0.328 . . . . 0.0 110.312 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.4 -40.14 96.4 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.595 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.75 HD12 ' HA ' ' A' ' 76' ' ' ALA . 34.5 mt -61.09 -41.73 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.884 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.434 HD23 HG11 ' A' ' 63' ' ' VAL . 69.4 mt -61.71 -39.23 90.77 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.783 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.6 m -64.39 -32.48 74.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.895 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -65.18 -29.25 70.06 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.243 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -65.43 106.33 1.37 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.759 0.314 . . . . 0.0 110.808 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.52 148.7 29.87 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.222 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.94 -100.95 0.43 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.618 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.779 ' HG3' HD21 ' A' ' 14' ' ' LEU . 9.2 tt0 -88.37 128.34 35.51 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.645 0.259 . . . . 0.0 110.436 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.0 mt -128.96 122.5 56.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.149 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -97.14 138.49 34.57 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.814 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -133.37 129.91 38.06 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.088 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -113.25 115.2 27.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.272 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.831 HG12 ' HA ' ' A' ' 60' ' ' ILE . 26.8 m -134.91 169.36 21.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.511 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 9' ' ' PRO . 17.6 t -138.66 136.53 43.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.937 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.55 123.58 22.17 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.753 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.7 m -122.58 113.35 37.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.078 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.453 -179.715 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.489 1.217 0 CA-C-O 120.689 0.204 . . . . 0.0 111.834 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.424 ' HA ' HG22 ' A' ' 92' ' ' VAL . 3.7 mp -79.18 140.19 17.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.185 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.16 132.74 54.61 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.994 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.84 118.2 35.99 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.607 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.2 m -128.94 142.17 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.394 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 87' ' ' ILE . 1.7 mt -105.45 122.55 46.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -109.79 139.66 44.59 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.953 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 49.9 mt -111.77 119.08 37.39 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.768 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.41 ' HB2' ' CD1' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -107.64 130.56 54.9 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.991 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.69 163.72 16.43 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.95 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.38 -38.57 71.64 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.185 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 49.3 p-80 -86.39 -23.5 26.1 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.801 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -92.53 161.34 14.65 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.933 0.396 . . . . 0.0 111.232 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.87 -158.88 10.0 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.91 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.737 HD21 ' CD2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -71.98 -67.43 0.54 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.575 0.226 . . . . 0.0 110.982 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.63 4.43 67.78 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.701 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.855 HG22 HG23 ' A' ' 42' ' ' ILE . 2.3 pt -136.77 143.73 34.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 117.459 0.63 . . . . 0.0 111.331 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.2 m -105.17 136.61 44.34 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.716 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.847 HG22 HD13 ' A' ' 39' ' ' ILE . 43.5 pt -121.98 155.7 26.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.483 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.8 p -139.35 173.88 11.09 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.368 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.74 -159.49 19.05 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.668 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.427 ' H ' HG23 ' A' ' 35' ' ' VAL . . . 170.53 125.07 0.78 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.861 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -61.06 -37.79 83.91 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.455 0.169 . . . . 0.0 111.289 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.4 -31.22 72.33 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.206 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -78.38 -29.26 47.26 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.108 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.77 30.24 3.56 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.93 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.427 HG23 ' H ' ' A' ' 30' ' ' GLY . 14.8 m -144.06 132.62 11.09 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-N 116.838 0.319 . . . . 0.0 111.108 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.556 ' O ' HD12 ' A' ' 38' ' ' LEU . 26.7 Cg_exo -61.14 157.33 40.2 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.614 2.209 . . . . 0.0 112.153 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.491 HD12 ' ND1' ' A' ' 73' ' ' HIS . 24.6 mm -83.75 127.99 39.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.632 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.556 HD12 ' O ' ' A' ' 36' ' ' PRO . 5.3 mp -130.1 149.97 51.58 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.407 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.847 HD13 HG22 ' A' ' 27' ' ' ILE . 30.5 mm -75.98 114.9 16.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.577 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.444 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.7 OUTLIER -84.11 -45.9 12.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.382 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -145.04 161.51 39.24 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.861 0.362 . . . . 0.0 111.273 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.855 HG23 HG22 ' A' ' 25' ' ' ILE . 4.0 mp -132.13 116.69 30.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.68 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -65.9 133.48 94.91 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.069 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.91 153.08 47.37 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.797 2.331 . . . . 0.0 112.756 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.57 31.5 62.88 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.676 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.442 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.2 OUTLIER -129.34 169.4 13.27 Favored Pre-proline 0 C--O 1.233 0.196 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.442 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 9.8 Cg_endo -53.92 -26.98 42.35 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.684 2.256 . . . . 0.0 112.721 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -57.37 -46.07 83.75 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.197 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.62 -38.63 73.95 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.862 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -56.83 -39.41 74.18 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.244 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.66 -27.76 64.28 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.755 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.79 19.96 75.51 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.678 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -119.8 -31.68 1.3 Allowed Glycine 0 C--N 1.338 0.681 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.17 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.647 HD12 HG21 ' A' ' 25' ' ' ILE . 4.3 mm? -70.01 89.2 0.6 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.104 0.478 . . . . 0.0 110.413 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -111.08 157.54 19.87 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.339 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 40' ' ' SER . 20.7 t -63.19 140.05 20.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.291 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.15 52.92 8.24 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.871 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -112.19 139.02 48.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.22 0.208 . . . . 0.0 111.211 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.65 127.14 53.4 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.895 HG21 HD13 ' A' ' 68' ' ' LEU . 2.8 mt -91.54 148.08 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 120.852 0.358 . . . . 0.0 111.631 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 78.8 mt -133.33 -52.94 0.89 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.806 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.99 147.68 46.42 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.865 0.364 . . . . 0.0 111.385 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.32 115.66 16.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.409 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 57.99 33.36 23.1 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.214 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.76 -16.03 57.64 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.24 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.7 t -88.68 137.33 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 117.065 0.433 . . . . 0.0 110.912 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -76.5 135.58 39.34 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.305 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.895 HD13 HG21 ' A' ' 60' ' ' ILE . 1.1 tt -96.71 -26.71 15.07 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.406 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -18.1 63.15 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -97.52 11.78 35.67 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 t -133.48 150.69 51.72 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.752 0.311 . . . . 0.0 111.11 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -75.67 161.25 29.25 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.359 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.598 ' O ' HG23 ' A' ' 77' ' ' VAL . 1.7 t60 -53.92 -52.03 61.88 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.104 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -61.84 -42.44 99.04 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.947 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -64.61 -38.54 91.36 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.102 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.59 -33.31 75.33 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.363 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 73' ' ' HIS . 37.2 t -62.09 -43.7 98.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.76 0.314 . . . . 0.0 110.341 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 29.3 m -60.54 -43.6 97.03 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.602 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 64.7 mt -58.45 -42.72 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.623 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.737 ' CD2' HD21 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -57.25 -40.75 78.27 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.838 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.5 t -62.79 -36.26 82.54 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.773 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -65.35 -24.89 67.37 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.269 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.479 ' HB3' HG23 ' A' ' 87' ' ' ILE . 38.2 mm-40 -65.45 91.48 0.12 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.932 0.396 . . . . 0.0 110.755 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.37 149.61 24.6 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.984 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.46 -98.7 0.29 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.291 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -92.75 137.6 32.22 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.703 0.287 . . . . 0.0 110.524 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.487 ' O ' HD23 ' A' ' 14' ' ' LEU . 15.0 mt -137.62 124.44 28.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -101.27 129.9 47.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.694 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.89 129.03 54.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.782 0.325 . . . . 0.0 110.786 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.72 116.3 25.66 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.017 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.857 HG12 ' HA ' ' A' ' 60' ' ' ILE . 9.0 m -138.85 171.6 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.985 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 10' ' ' ILE . 21.6 t -137.18 132.16 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.722 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.66 127.46 33.04 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.724 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.5 t -114.84 135.33 55.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.364 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.44 -0.79 . . . . 0.0 111.11 179.802 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo . . . . . 0 N--CA 1.489 1.252 0 CA-C-O 120.685 0.202 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.726 ' HA ' HG12 ' A' ' 92' ' ' VAL . 31.3 mt -87.3 142.27 13.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.166 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -122.04 129.25 52.26 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.95 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.4 118.2 36.15 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.694 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.1 t -127.7 141.25 46.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.379 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.5 mt -102.54 128.13 49.32 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 tp -112.87 136.98 51.91 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.142 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.63 116.37 31.86 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.826 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.438 ' HG2' HD12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -129.17 153.96 47.21 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.113 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.99 164.17 13.43 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.038 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -57.63 -38.53 75.14 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.966 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -79.33 -27.94 42.1 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.298 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.68 161.84 22.01 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.849 0.357 . . . . 0.0 111.324 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.32 -146.31 19.22 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.944 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.3 tp -87.64 -52.74 5.16 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.552 0.215 . . . . 0.0 111.319 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.12 -11.64 51.99 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.418 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.662 HD12 HD13 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -140.35 151.89 21.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.931 0.366 . . . . 0.0 111.041 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.435 ' O ' HG23 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -108.51 136.71 47.66 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.029 179.9 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.443 HG21 HD11 ' A' ' 60' ' ' ILE . 14.8 pt -116.15 153.22 17.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.489 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.8 t -143.59 145.64 32.67 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.012 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.71 -170.07 15.95 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.497 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.92 122.5 0.82 Allowed Glycine 0 C--N 1.335 0.528 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.801 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -30.27 65.47 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -30.94 65.35 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.61 0.243 . . . . 0.0 111.069 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -79.45 -32.66 42.74 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.978 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.95 -29.9 3.02 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.669 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 11.6 m -101.86 132.83 21.18 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-O 120.707 0.289 . . . . 0.0 111.196 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 35.6 Cg_exo -61.09 157.21 40.44 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.799 2.333 . . . . 0.0 112.295 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.46 ' H ' HD12 ' A' ' 37' ' ' ILE . 3.9 mp -83.25 138.02 19.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.817 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.44 163.12 31.21 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.295 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 26' ' ' SER . 25.5 mt -85.28 120.19 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.262 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.469 ' O ' HG13 ' A' ' 56' ' ' VAL . 2.6 t -108.43 -33.07 7.18 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.633 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.37 144.93 44.42 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.677 0.275 . . . . 0.0 111.126 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.48 HG23 HG22 ' A' ' 25' ' ' ILE . 22.3 mm -125.96 121.63 60.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.647 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -75.73 121.07 84.35 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.881 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.8 155.57 62.27 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.774 2.316 . . . . 0.0 112.545 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.93 38.24 95.8 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.354 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.77 176.06 3.17 Favored Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.33 -29.5 30.49 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.643 2.228 . . . . 0.0 112.77 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' A' ' 54' ' ' LEU . . . -58.16 -46.19 86.15 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.992 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.55 -42.11 75.01 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.763 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -59.73 -33.27 71.42 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.429 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.2 t -83.35 -28.19 29.16 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.85 16.66 59.64 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.091 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.88 -29.39 2.86 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.197 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.662 HD13 HD12 ' A' ' 25' ' ' ILE . 32.0 mt -76.09 71.84 2.87 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.142 0.496 . . . . 0.0 110.753 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -84.15 157.25 21.75 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.058 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 40' ' ' SER . 23.4 t -65.08 135.01 28.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.44 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.25 47.11 3.91 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.554 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.06 124.28 51.2 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.5 121.2 32.98 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.722 0.296 . . . . 0.0 111.194 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.757 ' HA ' HG12 ' A' ' 91' ' ' VAL . 7.5 mt -70.72 142.2 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.575 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.4 mt -127.29 -53.82 1.37 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.969 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.54 158.76 43.99 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.882 0.372 . . . . 0.0 111.813 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.517 HG22 ' CE1' ' A' ' 89' ' ' PHE . 15.1 t -133.66 117.52 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.727 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.08 37.47 28.64 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.95 0.405 . . . . 0.0 110.964 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.52 6.09 89.43 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.441 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.4 t -97.79 119.95 46.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 117.278 0.539 . . . . 0.0 110.699 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -63.83 126.79 28.75 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.454 HD13 HG23 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -113.02 4.19 16.57 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.686 179.817 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -68.84 -34.83 76.14 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.447 0.165 . . . . 0.0 111.133 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.67 11.9 33.54 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.47 HG21 ' CD1' ' A' ' 79' ' ' ILE . 15.8 m -100.97 156.39 17.42 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.645 0.259 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -92.62 161.22 14.66 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.535 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.438 ' O ' HG23 ' A' ' 77' ' ' VAL . 81.8 t60 -54.47 -50.69 67.13 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.054 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.16 -39.5 90.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.788 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.56 -38.78 92.18 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.059 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.676 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.6 -32.79 74.37 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.362 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 73' ' ' HIS . 40.8 t -61.85 -41.53 91.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.763 0.316 . . . . 0.0 110.56 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -41.89 74.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.899 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' A' ' 76' ' ' ALA . 11.6 mt -62.74 -48.69 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.651 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 81' ' ' SER . 4.2 pp -62.36 -35.17 78.29 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.019 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.511 ' N ' HD12 ' A' ' 80' ' ' LEU . 2.3 m -65.91 -33.88 76.85 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.136 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -65.26 -27.74 68.86 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.232 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.456 ' HB3' HG23 ' A' ' 87' ' ' ILE . 46.7 mm-40 -65.16 111.74 3.08 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.904 0.383 . . . . 0.0 111.119 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -105.19 143.79 32.88 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.109 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.77 -105.12 0.83 Allowed Glycine 0 C--N 1.337 0.59 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.894 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -81.2 127.16 32.37 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.723 0.297 . . . . 0.0 110.665 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.456 HG23 ' HB3' ' A' ' 83' ' ' GLN . 11.2 mt -127.95 122.39 58.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.05 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -93.87 130.77 39.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.438 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE1' HG22 ' A' ' 63' ' ' VAL . 0.5 OUTLIER -126.25 129.75 49.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.764 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.03 115.17 29.29 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.308 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.757 HG12 ' HA ' ' A' ' 60' ' ' ILE . 15.5 m -135.62 164.03 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.352 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.726 HG12 ' HA ' ' A' ' 10' ' ' ILE . 13.1 m -129.45 133.54 65.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.838 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.09 117.24 8.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.879 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.6 m -123.76 118.31 53.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.108 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.354 -0.831 . . . . 0.0 111.391 -179.712 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.448 ' O ' HG13 ' A' ' 92' ' ' VAL . 5.2 Cg_exo . . . . . 0 N--CA 1.489 1.246 0 CA-C-O 120.802 0.251 . . . . 0.0 111.84 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.5 HD11 ' HG2' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -84.39 118.71 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.213 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.78 130.04 55.38 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.043 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.56 120.24 40.84 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.2 t -125.67 134.25 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.176 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 mt -98.38 124.7 43.19 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.855 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.1 131.55 54.5 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.57 115.42 28.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.777 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.46 129.73 33.66 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.94 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.17 170.71 9.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.992 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -59.27 -38.17 79.44 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.953 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -76.75 -25.77 53.84 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.715 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -91.51 167.61 12.12 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.918 0.39 . . . . 0.0 111.74 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.88 -166.48 12.85 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 115.932 -0.577 . . . . 0.0 113.03 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.981 HD12 HD11 ' A' ' 25' ' ' ILE . 0.3 OUTLIER -66.08 -68.33 0.38 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.517 0.199 . . . . 0.0 111.255 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.436 ' HA2' ' OE1' ' A' ' 46' ' ' GLN . . . 106.02 4.02 38.92 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.015 -0.612 . . . . 0.0 114.113 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.981 HD11 HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -145.13 153.92 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 117.341 0.571 . . . . 0.0 111.101 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.2 136.97 38.38 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.654 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.2 pt -116.77 143.59 26.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.292 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.2 t -123.2 158.03 31.72 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.173 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.3 -143.19 15.7 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.357 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.41 ' HA3' ' HB2' ' A' ' 73' ' ' HIS . . . 136.43 134.85 3.35 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.935 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -52.54 -31.15 34.3 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -57.56 -29.4 64.39 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.18 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -93.82 19.48 8.82 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.45 29.09 68.48 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.166 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 8.7 m -147.08 139.64 14.23 Favored Pre-proline 0 CA--C 1.529 0.163 0 CA-C-N 116.704 0.252 . . . . 0.0 111.402 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 29.7 Cg_exo -61.59 155.5 52.96 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.637 2.225 . . . . 0.0 112.229 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.84 139.11 17.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.865 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.746 HD23 ' HB2' ' A' ' 59' ' ' ALA . 1.1 mp -134.67 156.75 48.21 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.261 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.768 HD13 HD21 ' A' ' 54' ' ' LEU . 27.8 mt -87.6 129.55 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.567 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -121.19 -42.83 2.45 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.558 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.57 144.84 35.72 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.71 0.291 . . . . 0.0 111.159 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.727 HG23 HG22 ' A' ' 25' ' ' ILE . 41.0 mt -134.47 133.14 55.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.754 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -102.21 105.65 43.98 Favored Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.885 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.82 150.03 47.64 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.716 2.277 . . . . 0.0 112.545 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.13 -30.81 8.8 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.661 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.436 ' OE1' ' HA2' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -77.23 167.16 38.85 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-O 120.552 0.215 . . . . 0.0 110.754 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 13.6 Cg_endo -56.89 -29.01 80.15 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.68 2.253 . . . . 0.0 112.77 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.954 ' HB1' HD13 ' A' ' 54' ' ' LEU . . . -61.06 -46.07 92.17 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.784 0.326 . . . . 0.0 110.983 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -70.16 -39.48 75.31 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.744 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -61.69 -29.09 69.87 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.408 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.06 -28.31 63.25 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.34 -54.57 4.77 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.014 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.53 -34.57 27.63 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 121.542 -0.361 . . . . 0.0 113.509 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.954 HD13 ' HB1' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -71.17 93.71 1.09 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.112 0.482 . . . . 0.0 110.602 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -114.4 157.43 22.88 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.36 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 40' ' ' SER . 38.9 t -61.25 130.46 25.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.445 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.49 45.03 4.14 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.435 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.03 122.35 47.51 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 122.149 0.18 . . . . 0.0 110.739 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.746 ' HB2' HD23 ' A' ' 38' ' ' LEU . . . -91.14 122.66 33.96 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.639 0.257 . . . . 0.0 111.16 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.809 ' HA ' HG12 ' A' ' 91' ' ' VAL . 6.9 mt -76.72 145.79 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.412 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 mt -139.68 -51.48 0.51 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.123 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.47 146.02 50.27 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.972 0.415 . . . . 0.0 111.878 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.7 t -135.82 115.73 17.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.367 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 54.6 35.34 23.38 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.696 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.64 -18.68 45.21 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 120.993 -0.623 . . . . 0.0 113.713 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.21 128.03 48.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 117.315 0.557 . . . . 0.0 111.052 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -68.06 139.12 56.25 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.044 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.899 HD21 ' HB1' ' A' ' 76' ' ' ALA . 5.4 tp -108.85 13.2 25.03 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.382 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.2 ttp85 -71.18 -31.59 67.85 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.444 0.164 . . . . 0.0 111.433 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -102.3 10.83 38.91 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.73 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.433 HG22 ' HB3' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -108.04 132.71 53.26 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -64.59 158.52 24.07 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.149 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.503 ' O ' HG23 ' A' ' 77' ' ' VAL . 6.4 t-160 -56.66 -50.41 72.15 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.236 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -61.71 -39.32 91.07 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.516 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HB3' HG22 ' A' ' 71' ' ' THR . 13.5 tp10 -64.71 -38.0 89.51 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.84 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.899 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -63.92 -35.37 80.44 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.477 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 73' ' ' HIS . 23.0 t -61.95 -39.05 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.639 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 41.2 m -65.05 -48.64 73.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.641 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' A' ' 76' ' ' ALA . 7.8 mt -62.22 -42.65 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.796 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.16 -39.71 75.81 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.853 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -33.06 74.85 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.982 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -65.55 -27.89 68.76 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.325 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.419 ' HB3' HG23 ' A' ' 87' ' ' ILE . 74.2 mm-40 -61.13 114.07 2.92 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.77 0.319 . . . . 0.0 110.956 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.84 144.82 47.14 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.448 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.56 -104.78 1.13 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.513 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -88.01 122.1 31.2 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.753 0.311 . . . . 0.0 110.358 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.419 HG23 ' HB3' ' A' ' 83' ' ' GLN . 15.5 mt -122.02 125.61 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.968 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.79 127.89 39.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -121.94 129.9 52.89 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.094 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.5 ' HG2' HD11 ' A' ' 10' ' ' ILE . 16.9 tt0 -120.56 115.35 23.24 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.349 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.809 HG12 ' HA ' ' A' ' 60' ' ' ILE . 7.0 m -140.84 170.1 14.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.435 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 9' ' ' PRO . 25.1 t -132.55 139.55 49.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.875 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.09 120.2 12.75 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.839 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 92' ' ' VAL . 22.0 t -127.03 107.71 17.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.213 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.911 -179.855 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo . . . . . 0 N--CA 1.49 1.302 0 CA-C-O 120.643 0.185 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.736 ' HA ' HG12 ' A' ' 92' ' ' VAL . 4.9 mp -97.59 139.84 19.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.351 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -110.65 115.79 30.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.026 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -97.27 111.59 23.77 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.593 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.7 t -129.95 133.21 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.795 0.331 . . . . 0.0 111.326 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mt -100.97 134.98 43.15 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.583 HD11 HD12 ' A' ' 54' ' ' LEU . 3.4 mp -118.67 119.86 35.7 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.834 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -111.23 124.25 51.83 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.755 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.04 147.14 45.99 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.291 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -100.37 169.3 9.2 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.161 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.39 -37.98 82.48 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.947 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -72.77 -28.8 62.82 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.048 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -84.96 177.32 7.99 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.779 0.323 . . . . 0.0 111.144 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -125.05 -154.82 8.89 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.111 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.6 mt -71.51 -67.85 0.49 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.6 0.238 . . . . 0.0 111.153 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.7 4.38 63.74 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.059 -0.591 . . . . 0.0 113.71 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.437 HG21 ' CD1' ' A' ' 54' ' ' LEU . 2.5 pp -143.49 150.39 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 117.284 0.542 . . . . 0.0 111.252 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.524 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 1.1 m -121.62 136.93 54.93 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.733 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.732 HD12 HG21 ' A' ' 37' ' ' ILE . 31.5 pt -123.76 158.27 29.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.489 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -142.59 147.5 35.97 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.088 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.41 -159.59 21.41 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.45 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.23 120.43 0.52 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.613 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -55.22 -34.54 64.03 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.469 0.176 . . . . 0.0 111.354 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -31.23 65.6 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.082 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -77.5 -30.0 52.8 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.055 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.72 -29.96 3.04 Favored Glycine 0 C--N 1.335 0.472 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.888 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 11.5 m -109.48 138.15 20.49 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-O 120.708 0.289 . . . . 0.0 111.402 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 35.8 Cg_exo -61.11 157.17 40.77 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.761 2.308 . . . . 0.0 112.239 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.732 HG21 HD12 ' A' ' 27' ' ' ILE . 3.6 mp -82.36 136.98 21.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.832 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 pp -133.25 162.92 30.49 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.938 0.399 . . . . 0.0 111.672 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.571 HD13 HD21 ' A' ' 54' ' ' LEU . 18.4 mt -85.09 129.38 37.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.981 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.475 ' O ' HG13 ' A' ' 56' ' ' VAL . 70.9 m -117.13 -38.98 3.27 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.626 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.524 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 18.9 tt0 -114.37 145.96 41.16 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.938 0.399 . . . . 0.0 111.412 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.495 HD13 ' O ' ' A' ' 54' ' ' LEU . 26.4 mt -131.03 133.49 62.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.513 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -88.75 112.85 53.03 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.026 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.53 139.31 75.39 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.798 2.332 . . . . 0.0 112.401 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.53 -30.14 8.72 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.902 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.477 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -71.17 169.77 13.92 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.638 0.219 . . . . 0.0 110.921 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 7.1 Cg_endo -50.48 -30.52 27.84 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.753 2.302 . . . . 0.0 112.791 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.408 ' HB1' HD13 ' A' ' 54' ' ' LEU . . . -61.13 -46.01 92.33 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.711 0.291 . . . . 0.0 111.004 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.07 -38.94 75.89 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.776 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -58.1 -33.3 68.95 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.488 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.45 -28.01 64.69 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.575 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.84 15.76 60.56 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.859 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.81 -34.94 1.1 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.786 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.583 HD12 HD11 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -62.92 99.6 0.17 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.928 0.394 . . . . 0.0 110.513 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.426 ' CE1' ' CD2' ' A' ' 93' ' ' TYR . 11.4 p80 -110.43 156.69 20.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.014 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 40' ' ' SER . 38.3 t -63.86 132.58 29.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.74 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.94 46.89 2.56 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.635 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -112.59 118.97 36.55 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.96 123.49 34.49 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.928 0.394 . . . . 0.0 111.428 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.847 ' HA ' HG12 ' A' ' 91' ' ' VAL . 4.0 mt -76.51 134.12 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.785 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.4 mp -126.55 -49.78 1.51 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.565 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.76 145.54 48.52 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.323 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.486 HG23 HD13 ' A' ' 68' ' ' LEU . 25.3 t -139.47 116.59 10.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.543 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.95 33.75 23.54 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.999 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.55 -15.4 54.76 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.352 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.8 128.8 41.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 117.151 0.475 . . . . 0.0 110.789 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -80.86 141.23 34.82 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.733 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.486 HD13 HG23 ' A' ' 63' ' ' VAL . 2.7 mp -117.04 21.07 13.48 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.634 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.42 -34.07 70.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.385 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -103.73 8.49 37.29 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 50.9 p -96.06 179.98 4.88 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.655 0.264 . . . . 0.0 110.831 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.17 161.21 18.08 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.964 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.533 ' O ' HG23 ' A' ' 77' ' ' VAL . 46.9 t60 -54.05 -51.01 65.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.973 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -60.57 -42.08 95.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.652 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.24 -37.98 89.38 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.957 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.529 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.59 -38.03 89.58 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.249 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.646 ' HA ' HD12 ' A' ' 80' ' ' LEU . 22.1 t -61.85 -44.41 98.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.702 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.7 m -62.51 -45.28 93.7 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.8 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 76' ' ' ALA . 11.8 mt -61.82 -40.55 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.918 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.646 HD12 ' HA ' ' A' ' 77' ' ' VAL . 12.9 mt -58.14 -39.01 77.67 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.661 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.6 t -67.58 -32.97 74.08 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.005 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -64.91 -28.64 69.67 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.307 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.497 ' HB3' HG23 ' A' ' 87' ' ' ILE . 16.5 mm100 -64.08 110.53 2.19 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.747 0.308 . . . . 0.0 110.957 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -111.63 147.39 35.59 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.122 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.43 ' O ' HD13 ' A' ' 16' ' ' LEU . . . 62.91 -108.12 1.99 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.508 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.449 ' HA ' HD22 ' A' ' 16' ' ' LEU . 29.9 tt0 -82.14 124.8 30.19 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.712 0.291 . . . . 0.0 110.535 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.497 HG23 ' HB3' ' A' ' 83' ' ' GLN . 10.9 mt -124.76 122.32 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.975 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -94.06 129.77 40.46 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.891 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.12 129.78 51.44 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.267 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -123.58 115.19 21.09 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.022 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.847 HG12 ' HA ' ' A' ' 60' ' ' ILE . 16.5 m -138.67 170.6 16.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.222 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.736 HG12 ' HA ' ' A' ' 10' ' ' ILE . 22.9 m -132.9 138.82 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.808 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.426 ' CD2' ' CE1' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -67.17 116.02 7.5 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.733 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.8 p -101.68 133.8 44.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.184 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.24 -179.872 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 N--CA 1.49 1.309 0 CA-C-O 120.784 0.243 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.649 HG23 HG22 ' A' ' 92' ' ' VAL . 4.9 mp -96.84 143.47 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.136 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.96 145.88 48.87 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.19 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.1 mmtm -114.72 111.47 21.33 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.827 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.1 t -112.85 131.23 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.037 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mp -102.82 126.46 49.97 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.414 HD21 ' HB2' ' A' ' 47' ' ' PRO . 1.9 tt -117.58 141.32 48.51 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.224 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.41 127.11 54.13 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.794 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -104.34 121.61 43.72 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.138 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -100.46 156.64 17.16 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.993 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -58.29 -38.29 76.72 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.177 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -86.14 -22.07 27.25 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.32 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -90.03 176.63 6.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.815 0.34 . . . . 0.0 111.282 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.02 -145.37 4.66 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.835 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 25' ' ' ILE . 30.8 tp -77.36 -63.16 1.44 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.535 0.207 . . . . 0.0 110.939 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.74 4.52 87.31 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.035 -0.602 . . . . 0.0 114.037 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.847 HG22 HG23 ' A' ' 42' ' ' ILE . 6.1 pt -139.85 164.16 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 117.348 0.574 . . . . 0.0 111.369 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 9.0 t -121.51 137.33 54.77 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.917 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.757 HG22 HD13 ' A' ' 39' ' ' ILE . 12.4 pt -115.83 152.1 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.632 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.3 p -137.85 153.41 49.6 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.085 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.9 -169.47 13.3 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.84 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.428 ' H ' HG13 ' A' ' 35' ' ' VAL . . . 172.44 119.27 0.52 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.69 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.7 -29.63 68.23 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -31.33 69.2 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.668 0.27 . . . . 0.0 111.117 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -87.69 -28.09 22.02 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.154 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.28 35.67 1.43 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.695 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.428 HG13 ' H ' ' A' ' 30' ' ' GLY . 10.3 p -149.35 134.51 9.51 Favored Pre-proline 0 C--O 1.232 0.176 0 CA-C-O 120.652 0.263 . . . . 0.0 110.963 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.502 ' O ' HD12 ' A' ' 38' ' ' LEU . 39.6 Cg_endo -65.82 157.72 57.52 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.582 2.188 . . . . 0.0 112.107 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.439 ' HB ' HD12 ' A' ' 60' ' ' ILE . 22.5 mm -82.75 131.07 34.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 36' ' ' PRO . 3.6 mp -132.91 155.04 49.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.445 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.757 HD13 HG22 ' A' ' 27' ' ' ILE . 22.5 mm -80.56 120.13 31.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.852 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.39 -38.2 5.78 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.387 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 26' ' ' SER . 0.0 OUTLIER -124.49 145.87 49.29 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.774 0.321 . . . . 0.0 111.214 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.847 HG23 HG22 ' A' ' 25' ' ' ILE . 26.8 mt -135.19 114.33 16.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.55 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -71.95 132.87 84.41 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.095 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.82 159.35 45.38 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.819 2.346 . . . . 0.0 112.891 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.14 50.47 66.85 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.482 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.33 175.19 2.87 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 110.59 -0.152 . . . . 0.0 110.59 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.414 ' HB2' HD21 ' A' ' 15' ' ' LEU . 71.6 Cg_exo -49.84 -34.6 36.98 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.783 2.322 . . . . 0.0 112.966 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -59.57 -46.14 89.78 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.783 0.325 . . . . 0.0 110.755 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -69.78 -37.44 76.36 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.796 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -57.8 -32.78 67.88 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.416 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.4 m -82.99 -28.14 29.91 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.521 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.61 14.5 60.41 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.991 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.98 -33.58 2.77 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.311 -0.471 . . . . 0.0 112.751 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.544 HD13 HG21 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -67.37 100.82 0.87 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.984 0.421 . . . . 0.0 110.504 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -113.3 157.14 22.19 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.125 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.3 t -63.95 132.94 29.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.314 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.54 49.32 4.18 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.277 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -109.35 126.6 53.58 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.69 120.99 32.93 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.848 ' HA ' HG12 ' A' ' 91' ' ' VAL . 14.4 mt -81.06 149.17 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.469 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.9 mt -134.83 -54.9 0.82 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.014 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -148.67 159.84 43.73 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.826 0.346 . . . . 0.0 111.689 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.5 t -137.19 120.35 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.674 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 56.15 36.36 27.29 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.918 0.39 . . . . 0.0 111.138 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.67 13.63 83.33 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.226 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.6 t -98.71 134.88 35.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 117.009 0.404 . . . . 0.0 110.672 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -72.08 126.86 30.82 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.012 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tt -112.15 -17.89 12.69 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.34 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -32.6 72.55 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -98.95 11.91 37.51 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.629 HG21 ' CD1' ' A' ' 79' ' ' ILE . 1.3 m -110.02 161.66 15.31 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.815 0.34 . . . . 0.0 111.03 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.9 mmtm -95.7 161.3 14.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.24 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.525 ' O ' HG23 ' A' ' 77' ' ' VAL . 72.0 t60 -54.12 -51.54 63.9 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.017 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -62.99 -41.2 99.51 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.829 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.458 ' HB2' HG22 ' A' ' 71' ' ' THR . 3.4 mt-10 -65.02 -38.11 89.84 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.011 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.536 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.79 -30.83 71.88 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.385 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 73' ' ' HIS . 24.5 t -61.7 -41.82 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.923 0.392 . . . . 0.0 110.624 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.1 m -69.96 -37.94 75.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.101 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.629 ' CD1' HG21 ' A' ' 71' ' ' THR . 23.2 mt -67.28 -47.19 82.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.384 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 77' ' ' VAL . 3.8 pp -63.91 -34.04 77.07 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.314 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.2 p -73.28 -27.43 61.56 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.85 -0.159 . . . . 0.0 111.221 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -65.25 -28.16 69.16 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.52 0.2 . . . . 0.0 111.348 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.535 ' HG3' HG23 ' A' ' 87' ' ' ILE . 39.8 mm-40 -58.67 113.7 2.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.757 0.313 . . . . 0.0 110.902 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.55 146.29 28.35 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.369 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.89 -99.92 0.4 Allowed Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.618 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -92.28 135.8 33.71 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.761 0.315 . . . . 0.0 110.386 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.535 HG23 ' HG3' ' A' ' 83' ' ' GLN . 13.3 mt -128.36 122.08 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.063 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.37 121.28 40.11 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.513 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -114.54 129.47 56.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 110.895 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -110.1 115.78 30.37 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.154 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.848 HG12 ' HA ' ' A' ' 60' ' ' ILE . 14.4 m -137.22 168.79 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.79 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.649 HG22 HG23 ' A' ' 10' ' ' ILE . 19.4 t -134.12 132.41 55.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.656 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.28 118.52 10.77 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.741 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.1 p -118.2 135.57 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.084 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.13 -0.938 . . . . 0.0 111.34 -179.694 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo . . . . . 0 N--CA 1.489 1.247 0 CA-C-O 120.55 0.146 . . . . 0.0 111.726 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.827 ' HA ' HG12 ' A' ' 92' ' ' VAL . 2.7 tt -78.66 121.81 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.922 0.391 . . . . 0.0 111.247 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.08 135.56 54.08 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.096 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.27 111.5 21.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.638 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.94 142.33 42.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.952 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.81 135.5 39.48 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.975 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.1 tp -108.84 121.91 46.08 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.088 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.21 115.09 29.7 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.671 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -127.52 147.19 50.32 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.111 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.61 161.86 14.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.026 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -56.85 -38.8 73.19 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 -80.18 -28.31 38.76 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.462 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -84.56 165.56 17.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.993 0.425 . . . . 0.0 111.606 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -112.06 -169.73 18.3 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.709 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 tp -67.93 -57.38 6.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.446 0.165 . . . . 0.0 111.342 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.54 4.55 63.9 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.767 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.848 HG22 HG23 ' A' ' 42' ' ' ILE . 20.5 pt -144.98 154.98 14.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 117.364 0.582 . . . . 0.0 111.348 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.4 m -113.62 138.14 50.6 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.0 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.585 HD12 HG21 ' A' ' 37' ' ' ILE . 13.0 pt -115.92 154.73 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.601 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.0 p -137.63 163.34 31.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.32 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.82 -150.56 19.35 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.778 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.44 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . 153.51 124.47 0.99 Allowed Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.009 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.68 -31.5 57.88 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.1 0.16 . . . . 0.0 111.409 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -57.26 -31.23 65.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.151 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -84.5 -21.36 30.61 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.422 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.05 19.5 5.93 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.993 -0.623 . . . . 0.0 113.284 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 m -147.08 139.65 14.24 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.93 0.365 . . . . 0.0 111.076 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.8 157.39 38.21 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.522 2.148 . . . . 0.0 112.032 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.585 HG21 HD12 ' A' ' 27' ' ' ILE . 4.0 mp -82.71 126.06 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.676 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.7 ' CD2' ' HB2' ' A' ' 59' ' ' ALA . 2.1 mp -122.54 162.53 21.61 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.908 0.385 . . . . 0.0 111.6 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.705 HD13 ' CD1' ' A' ' 54' ' ' LEU . 17.3 mt -94.4 125.67 46.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.797 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.434 ' O ' HG13 ' A' ' 56' ' ' VAL . 8.4 m -109.63 -34.6 6.44 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.709 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -123.0 146.79 47.32 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.742 0.306 . . . . 0.0 111.391 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.848 HG23 HG22 ' A' ' 25' ' ' ILE . 4.3 mp -134.21 112.26 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.578 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -71.6 129.88 88.0 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.144 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -74.4 155.72 45.85 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.772 2.315 . . . . 0.0 112.618 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.61 33.33 52.41 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.734 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.92 174.49 4.37 Favored Pre-proline 0 CA--C 1.53 0.205 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.58 -32.14 34.19 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.588 2.192 . . . . 0.0 112.771 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.493 ' HB1' ' CB ' ' A' ' 54' ' ' LEU . . . -61.0 -46.06 92.32 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.164 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.49 -43.86 72.31 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.986 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -58.59 -32.74 69.25 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.496 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -77.07 -27.96 54.46 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.464 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.16 17.78 68.41 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.025 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.8 -29.99 2.28 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 121.11 -0.567 . . . . 0.0 113.171 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.705 ' CD1' HD13 ' A' ' 39' ' ' ILE . 0.7 OUTLIER -64.69 96.87 0.19 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.861 0.362 . . . . 0.0 110.823 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -115.8 157.23 24.7 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.252 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 40' ' ' SER . 45.2 t -66.4 131.4 32.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.665 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.04 43.54 3.79 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.931 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.43 119.19 37.38 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.499 0.15 . . . . 0.0 110.794 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.7 ' HB2' ' CD2' ' A' ' 38' ' ' LEU . . . -92.06 123.07 35.14 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.644 0.259 . . . . 0.0 111.509 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.826 ' HA ' HG12 ' A' ' 91' ' ' VAL . 10.8 mt -72.59 137.64 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.214 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.2 mt -125.32 -52.73 1.62 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.775 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.56 145.53 45.1 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.821 0.343 . . . . 0.0 111.475 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.97 116.14 32.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.393 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 58.83 34.6 23.8 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.051 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.65 -15.95 52.37 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.386 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.5 t -88.15 134.6 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 117.146 0.473 . . . . 0.0 110.778 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -71.28 131.53 43.6 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.196 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.579 HD21 ' HB1' ' A' ' 76' ' ' ALA . 2.8 tp -117.49 1.58 12.33 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.828 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -71.37 -28.1 63.81 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.24 8.18 45.02 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 p -105.3 146.54 29.22 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.751 0.31 . . . . 0.0 111.088 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -71.82 161.19 31.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.113 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.65 ' O ' HG23 ' A' ' 77' ' ' VAL . 30.1 t60 -54.01 -50.56 66.34 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.933 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.68 -42.98 94.12 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.894 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -67.21 -37.59 83.87 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.841 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.579 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -63.86 -31.32 72.46 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.473 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 73' ' ' HIS . 22.3 t -61.83 -40.8 88.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.862 0.363 . . . . 0.0 110.358 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.9 m -65.72 -40.54 92.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.518 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.471 HG22 HE21 ' A' ' 83' ' ' GLN . 40.1 mm -58.13 -43.52 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.643 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.0 mt -60.57 -43.9 96.8 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.671 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.4 t -65.84 -31.54 72.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.091 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -65.15 -28.29 69.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.15 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.471 HE21 HG22 ' A' ' 79' ' ' ILE . 48.3 mm-40 -62.65 135.23 57.28 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.793 0.33 . . . . 0.0 111.006 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.23 144.25 48.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.175 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.06 -104.55 0.35 Allowed Glycine 0 C--N 1.335 0.52 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.634 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -82.29 118.2 22.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.853 0.358 . . . . 0.0 110.396 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.411 HG23 ' HB3' ' A' ' 83' ' ' GLN . 11.6 mt -119.32 123.77 71.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.893 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.63 121.38 35.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.52 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -113.11 129.62 56.45 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.119 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.0 115.19 22.07 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.805 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.826 HG12 ' HA ' ' A' ' 60' ' ' ILE . 16.1 m -139.2 170.73 15.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.4 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.827 HG12 ' HA ' ' A' ' 10' ' ' ILE . 18.7 m -131.33 133.52 62.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.835 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.42 115.86 10.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.715 0.293 . . . . 0.0 110.705 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.7 p -126.57 122.65 61.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.952 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.4 -0.81 . . . . 0.0 111.408 -179.536 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.526 ' O ' HG13 ' A' ' 92' ' ' VAL . 3.4 Cg_exo . . . . . 0 N--CA 1.49 1.297 0 CA-C-O 120.725 0.219 . . . . 0.0 111.924 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.536 ' HA ' HG22 ' A' ' 92' ' ' VAL . 2.6 tt -78.97 134.79 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.327 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.9 126.33 51.55 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.034 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.3 mmtm -99.75 114.62 27.87 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.571 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.24 128.91 67.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.789 0.328 . . . . 0.0 111.34 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 mp -98.37 119.92 37.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.846 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.43 HD11 ' HA ' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -113.13 137.98 50.64 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.262 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.402 ' H ' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -97.65 115.38 27.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.772 179.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.8 143.78 37.52 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.707 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -114.54 158.56 21.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.182 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.72 -38.35 78.15 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.807 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -77.6 -28.29 51.51 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.423 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -90.02 159.23 16.96 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.903 0.382 . . . . 0.0 111.223 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.35 -165.82 21.97 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.373 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.56 -44.9 85.31 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.673 0.273 . . . . 0.0 110.834 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.22 3.29 90.25 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.335 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.759 HD13 HD12 ' A' ' 39' ' ' ILE . 2.2 pp -146.74 147.11 18.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 117.033 0.416 . . . . 0.0 110.897 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.505 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 3.5 m -108.53 139.78 42.81 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.536 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.762 HG22 HD13 ' A' ' 39' ' ' ILE . 20.2 pt -116.2 156.01 17.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.719 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.5 t -143.96 155.98 44.24 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.33 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.05 -150.1 18.31 Favored Glycine 0 C--N 1.337 0.605 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.393 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.42 109.27 0.22 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.939 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -57.64 -37.28 73.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.586 0.231 . . . . 0.0 111.135 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -58.73 -31.17 68.05 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.949 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -75.86 -24.51 55.75 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.217 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.68 25.4 4.29 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.074 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 m -147.48 140.3 14.69 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.884 0.342 . . . . 0.0 111.244 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.58 157.42 60.78 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.603 2.202 . . . . 0.0 112.285 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.464 HG21 HD12 ' A' ' 27' ' ' ILE . 26.1 mm -82.76 137.9 20.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.757 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 59' ' ' ALA . 2.9 mp -131.82 158.69 40.61 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.594 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.762 HD13 HG22 ' A' ' 27' ' ' ILE . 17.7 mm -83.55 128.64 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.756 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.406 ' O ' HG13 ' A' ' 56' ' ' VAL . 4.1 t -124.14 -44.27 2.04 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.538 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 0.5 OUTLIER -105.38 144.47 32.12 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.758 0.313 . . . . 0.0 111.172 -179.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.1 mt -131.47 128.98 61.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.747 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -86.27 114.81 59.4 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.955 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.16 122.11 8.7 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.533 2.155 . . . . 0.0 112.149 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.54 34.85 4.86 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.597 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.97 174.2 4.79 Favored Pre-proline 0 C--O 1.233 0.231 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.41 -32.2 33.16 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.521 2.147 . . . . 0.0 112.76 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.43 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -59.83 -46.19 90.03 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.271 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.85 -40.39 79.42 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.703 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -60.03 -33.44 72.02 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.466 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.6 t -71.65 -28.11 63.53 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.52 15.78 62.13 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.188 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.25 -32.53 1.36 Allowed Glycine 0 C--N 1.338 0.667 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.106 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.467 ' HG ' HG21 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -66.79 94.36 0.3 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.981 0.419 . . . . 0.0 110.682 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -108.87 157.24 18.8 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.97 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 40' ' ' SER . 25.8 t -67.2 133.31 31.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.375 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.18 45.83 3.73 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.535 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.13 124.09 51.68 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 122.22 0.208 . . . . 0.0 110.595 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.542 ' HB2' HD23 ' A' ' 38' ' ' LEU . . . -91.4 120.25 32.09 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.728 0.299 . . . . 0.0 111.177 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.798 ' HA ' HG12 ' A' ' 91' ' ' VAL . 20.5 mt -75.24 139.93 18.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.556 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 61' ' ' LEU . 14.0 mt -128.11 -51.93 1.31 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.703 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -144.54 145.86 32.06 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.854 0.359 . . . . 0.0 111.637 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.0 t -132.83 115.79 25.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.401 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 56.71 38.04 29.24 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.602 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.19 -12.85 42.24 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.449 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.14 128.05 39.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 117.371 0.586 . . . . 0.0 110.83 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.69 130.62 39.84 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.169 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.562 HD11 ' HB1' ' A' ' 76' ' ' ALA . 0.5 OUTLIER -102.48 -23.03 13.95 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.641 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -61.4 -31.07 70.98 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.348 0.129 . . . . 0.0 111.348 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.03 9.74 38.33 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.2 p -120.1 159.87 23.97 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.617 0.246 . . . . 0.0 110.653 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.1 161.02 19.1 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.785 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.623 ' O ' HG23 ' A' ' 77' ' ' VAL . 57.8 t-80 -53.95 -47.6 71.13 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.972 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -60.99 -43.04 99.43 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.73 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -64.5 -39.28 93.49 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.975 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.562 ' HB1' HD11 ' A' ' 68' ' ' LEU . . . -63.58 -34.24 77.37 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.57 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 73' ' ' HIS . 38.3 t -62.17 -43.28 97.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.834 0.349 . . . . 0.0 110.441 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.0 m -67.41 -45.72 75.32 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.948 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 76' ' ' ALA . 13.9 mt -60.91 -44.21 97.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.938 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.42 -37.83 79.05 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.678 0.275 . . . . 0.0 110.714 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.7 m -68.65 -28.35 66.81 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.453 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -64.88 -30.85 71.87 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.498 0.19 . . . . 0.0 111.051 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.402 ' HB2' HD13 ' A' ' 87' ' ' ILE . 31.7 mm-40 -66.05 114.47 5.23 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.817 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -114.47 151.87 32.55 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.11 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.72 -102.12 0.42 Allowed Glycine 0 C--N 1.335 0.48 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.556 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -87.98 122.39 31.53 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.654 0.264 . . . . 0.0 110.378 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.402 HD13 ' HB2' ' A' ' 83' ' ' GLN . 21.5 mt -124.73 125.78 70.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.052 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -93.65 123.37 36.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.336 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.53 130.2 56.27 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.928 0.394 . . . . 0.0 111.517 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -121.18 115.17 22.53 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.572 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.798 HG12 ' HA ' ' A' ' 60' ' ' ILE . 5.5 m -137.28 170.94 17.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.351 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.536 HG22 ' HA ' ' A' ' 10' ' ' ILE . 39.7 t -129.07 133.64 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.69 123.66 20.32 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.875 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.0 t -118.71 132.79 67.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.957 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.163 -0.923 . . . . 0.0 111.22 179.93 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 N--CA 1.491 1.34 0 CA-C-O 120.93 0.304 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.699 ' HA ' HG12 ' A' ' 92' ' ' VAL . 4.6 mp -86.06 141.17 14.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -120.82 122.03 39.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -100.21 113.51 26.23 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.773 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.454 HG11 ' HA3' ' A' ' 53' ' ' GLY . 9.2 m -128.27 140.42 49.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.458 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.441 ' C ' HD12 ' A' ' 15' ' ' LEU . 5.1 mp -107.47 126.86 53.03 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.895 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.529 HD11 HD21 ' A' ' 54' ' ' LEU . 10.0 mp -113.08 137.32 51.6 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.097 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -104.32 114.75 29.19 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.8 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -99.78 134.26 42.94 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.994 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.403 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 9.4 mm-40 -115.94 151.55 35.17 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.869 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.14 -33.89 72.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.634 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.403 ' CD2' ' HB3' ' A' ' 18' ' ' GLU . 15.4 p80 -81.6 -27.4 34.24 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.783 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -96.55 166.53 11.64 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.883 0.373 . . . . 0.0 111.451 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -105.47 -150.51 19.43 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.091 -0.575 . . . . 0.0 112.679 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 25' ' ' ILE . 6.6 tp -78.5 -58.96 2.98 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.689 0.281 . . . . 0.0 110.96 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.77 4.35 75.85 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.687 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.615 HG22 HG23 ' A' ' 42' ' ' ILE . 23.5 pt -140.61 143.46 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 117.259 0.529 . . . . 0.0 111.126 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 t -112.03 136.79 50.93 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.812 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.688 HD12 HG21 ' A' ' 37' ' ' ILE . 26.8 pt -125.29 153.86 33.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.597 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.8 p -139.18 145.35 39.23 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.224 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.18 -155.83 16.85 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.694 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.1 126.02 1.56 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.49 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.7 tptt -54.6 -35.64 63.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.393 0.14 . . . . 0.0 111.136 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.481 ' HG3' ' HG2' ' A' ' 72' ' ' LYS . 0.5 OUTLIER -62.77 -30.62 71.59 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.198 179.653 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -79.31 -34.7 42.12 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.106 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.23 -21.6 3.86 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.865 -0.684 . . . . 0.0 113.292 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 23.8 m -123.03 144.31 42.88 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 117.006 0.403 . . . . 0.0 111.201 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 34.8 Cg_exo -60.87 155.97 46.38 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.749 2.3 . . . . 0.0 112.442 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.688 HG21 HD12 ' A' ' 27' ' ' ILE . 2.2 mt -84.0 130.66 35.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.851 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.525 HD23 ' CB ' ' A' ' 59' ' ' ALA . 0.8 OUTLIER -132.24 156.52 46.34 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.027 -179.53 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.545 HD12 ' CB ' ' A' ' 58' ' ' ASP . 32.1 mt -81.08 121.87 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.902 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.4 m -106.2 -29.74 9.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.682 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.95 149.64 48.98 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.711 0.291 . . . . 0.0 111.357 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.615 HG23 HG22 ' A' ' 25' ' ' ILE . 3.4 mp -133.98 114.22 19.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.664 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -72.09 131.4 85.4 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.233 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.37 172.42 16.27 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.961 2.441 . . . . 0.0 112.903 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.62 18.52 61.56 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.784 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.46 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -124.97 169.28 11.34 Favored Pre-proline 0 N--CA 1.455 -0.184 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 9.8 Cg_endo -52.55 -29.1 39.15 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.62 2.214 . . . . 0.0 112.57 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.465 ' HB1' ' HG ' ' A' ' 54' ' ' LEU . . . -63.09 -46.46 87.29 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.317 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -65.32 -40.24 93.48 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.871 0.367 . . . . 0.0 110.605 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.69 -28.47 65.88 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.319 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 11.5 m -70.37 -28.24 64.95 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.42 -55.31 4.64 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.889 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.454 ' HA3' HG11 ' A' ' 13' ' ' VAL . . . -53.03 -27.84 31.34 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 121.474 -0.393 . . . . 0.0 113.609 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.529 HD21 HD11 ' A' ' 15' ' ' LEU . 4.3 mm? -68.14 88.86 0.3 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.003 0.401 . . . . 0.0 110.52 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -118.43 157.24 27.58 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.219 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.7 t -63.28 130.06 27.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.63 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.05 46.37 3.63 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.466 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.545 ' CB ' HD12 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -107.01 125.73 51.4 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.475 0.178 . . . . 0.0 110.544 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.525 ' CB ' HD23 ' A' ' 38' ' ' LEU . . . -91.25 121.61 33.15 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.769 0.319 . . . . 0.0 111.366 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.658 ' HA ' HG12 ' A' ' 91' ' ' VAL . 21.9 mt -78.21 130.78 35.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.268 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.1 mt -124.27 -51.97 1.75 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.643 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -145.06 148.89 34.18 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.859 0.361 . . . . 0.0 111.448 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 t -136.98 115.75 14.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.424 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 58.35 33.14 22.86 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.097 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.93 -15.24 58.31 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.181 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.07 133.77 29.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 117.143 0.471 . . . . 0.0 110.891 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -79.17 129.67 34.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.96 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.562 HD21 ' CB ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -105.8 -21.36 13.19 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.645 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.6 ttt85 -60.95 -34.58 74.96 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.662 0.267 . . . . 0.0 110.902 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -84.25 -26.14 28.87 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.656 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.2 p -78.53 167.28 21.51 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.889 0.376 . . . . 0.0 111.011 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.481 ' HG2' ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -93.87 161.03 14.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.645 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.548 ' O ' HG23 ' A' ' 77' ' ' VAL . 6.5 t-160 -54.26 -47.52 72.19 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.892 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -64.76 -40.42 95.25 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.096 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.93 -37.67 86.65 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.913 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.693 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.71 -30.88 71.93 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.328 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 73' ' ' HIS . 24.5 t -61.4 -43.43 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.847 0.356 . . . . 0.0 110.554 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.6 m -65.76 -44.69 85.1 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.706 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 76' ' ' ALA . 7.3 mt -63.78 -44.04 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.0 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.6 mt -56.4 -42.96 78.83 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.756 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.9 t -68.24 -31.2 70.53 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.038 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -65.13 -24.17 67.34 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.571 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.411 ' HB3' HG12 ' A' ' 87' ' ' ILE . 41.7 mm-40 -62.97 97.86 0.12 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.808 0.337 . . . . 0.0 110.891 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.61 146.67 26.19 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.261 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.82 -106.37 1.47 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.555 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -87.74 143.1 27.33 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.73 0.3 . . . . 0.0 110.495 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.411 HG12 ' HB3' ' A' ' 83' ' ' GLN . 11.6 mt -136.95 122.33 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.033 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -96.64 124.35 40.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.613 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -112.58 129.61 56.31 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.791 0.329 . . . . 0.0 111.139 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -118.89 115.31 24.13 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.23 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' A' ' 60' ' ' ILE . 23.7 m -143.93 169.24 10.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.499 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.699 HG12 ' HA ' ' A' ' 10' ' ' ILE . 11.1 m -134.33 138.37 50.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.055 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.0 123.67 21.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.903 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.2 m -114.45 143.82 23.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.402 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.039 -0.981 . . . . 0.0 111.545 -179.884 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo . . . . . 0 N--CA 1.49 1.319 0 CA-C-O 120.814 0.256 . . . . 0.0 111.822 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.413 ' HA ' HG22 ' A' ' 92' ' ' VAL . 73.1 mt -80.27 142.98 13.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.55 138.63 51.78 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.08 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.408 ' HD2' ' HG3' ' A' ' 90' ' ' GLU . 1.1 mptm? -115.33 117.43 30.42 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.4 t -132.67 141.01 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.143 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 87' ' ' ILE . 0.4 OUTLIER -97.83 132.5 43.38 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.978 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.07 119.44 37.87 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.749 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.458 HD11 HD22 ' A' ' 14' ' ' LEU . 7.0 mp -110.3 114.25 27.56 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.343 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.0 ptmm? -128.15 146.1 50.81 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.265 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.457 ' HB2' ' HG3' ' A' ' 21' ' ' GLU . 0.4 OUTLIER -75.95 165.23 25.28 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.117 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.07 -36.28 70.37 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.846 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.405 ' CD2' ' HB3' ' A' ' 18' ' ' GLU . 29.0 p80 -79.91 -29.81 39.93 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.411 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.457 ' HG3' ' HB2' ' A' ' 18' ' ' GLU . 7.0 mt-10 -70.61 167.57 18.26 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.924 0.393 . . . . 0.0 111.943 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.28 -157.72 10.05 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.293 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.648 HD22 HG13 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -62.48 -62.52 1.69 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.94 -14.72 28.89 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.608 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.749 HG21 HD23 ' A' ' 54' ' ' LEU . 2.2 pt -143.74 164.1 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 117.186 0.493 . . . . 0.0 111.379 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.9 t -106.93 136.7 46.33 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.697 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.2 pt -118.69 153.11 20.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.241 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -143.2 144.63 32.25 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.248 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.19 -165.98 29.44 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.429 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.84 112.29 0.31 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.794 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -58.21 -37.94 75.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.453 0.168 . . . . 0.0 111.289 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -65.47 -30.96 71.81 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.011 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -73.35 -28.62 62.16 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.07 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.37 22.41 6.14 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.069 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.1 p -149.69 130.95 7.29 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.873 0.337 . . . . 0.0 111.044 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.34 155.61 50.98 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.612 2.208 . . . . 0.0 112.231 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mp -83.04 133.9 28.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.774 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.51 159.65 38.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.485 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.498 HD13 HD13 ' A' ' 25' ' ' ILE . 23.1 mt -80.17 122.82 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.993 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.7 -30.46 8.56 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.709 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -130.69 155.5 46.51 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.858 0.361 . . . . 0.0 111.513 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.735 ' HA ' HG22 ' A' ' 25' ' ' ILE . 48.4 mt -130.36 114.09 27.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.739 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -81.59 128.38 69.65 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.914 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.29 159.89 42.99 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.706 2.271 . . . . 0.0 112.799 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.12 33.07 57.66 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.809 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.97 170.8 8.66 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.43 -30.73 54.69 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.647 2.232 . . . . 0.0 112.953 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.81 -46.14 81.79 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.729 0.3 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -70.52 -41.25 72.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.794 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -64.59 -28.72 69.82 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.566 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -28.36 64.09 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.486 0.184 . . . . 0.0 111.473 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.41 16.85 51.35 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.054 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.06 -31.63 1.08 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.071 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.749 HD23 HG21 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -68.68 92.8 0.49 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.827 0.346 . . . . 0.0 110.592 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -98.82 156.86 16.65 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.247 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.8 t -64.2 135.43 27.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.564 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.57 50.57 3.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.127 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.462 ' CB ' HD12 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -111.3 124.56 52.47 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.491 0.186 . . . . 0.0 110.624 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.577 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -91.1 120.44 32.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.901 0.382 . . . . 0.0 111.103 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.811 ' HA ' HG12 ' A' ' 91' ' ' VAL . 17.2 mt -73.71 144.67 12.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.908 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.7 mt -129.45 -53.49 1.17 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.57 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.26 145.94 33.18 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.976 0.417 . . . . 0.0 111.829 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.597 HG11 HD23 ' A' ' 80' ' ' LEU . 21.1 t -130.87 116.77 35.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.511 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 56.77 36.45 27.71 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.675 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.8 -16.35 46.99 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.507 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.37 135.14 25.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 117.229 0.515 . . . . 0.0 111.179 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -78.67 131.25 36.57 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.084 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.606 HD11 ' HB1' ' A' ' 76' ' ' ALA . 0.5 OUTLIER -89.01 -27.89 20.55 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.979 179.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -67.3 -27.17 66.94 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.393 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -91.5 11.77 22.97 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 t -138.79 174.33 10.64 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.637 0.256 . . . . 0.0 110.812 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.43 160.97 14.12 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.047 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.669 ' O ' HG23 ' A' ' 77' ' ' VAL . 44.1 t-80 -56.11 -51.72 66.89 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.182 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.64 -43.12 84.65 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.964 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -67.2 -37.78 84.22 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.854 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.729 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.87 -33.72 76.34 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.363 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 73' ' ' HIS . 22.0 t -61.72 -39.18 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.837 0.351 . . . . 0.0 110.504 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 49.9 m -65.37 -44.65 86.94 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.493 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' ' 76' ' ' ALA . 12.8 mt -61.73 -41.37 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.919 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.597 HD23 HG11 ' A' ' 63' ' ' VAL . 6.7 mt -60.44 -39.69 88.41 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.627 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.5 t -66.22 -30.92 71.46 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.185 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -65.24 -28.92 69.69 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.333 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.475 ' HB3' HG23 ' A' ' 87' ' ' ILE . 16.8 mm-40 -68.31 111.64 4.72 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.873 0.368 . . . . 0.0 110.844 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.55 148.86 26.8 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.332 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.68 -102.18 0.42 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.581 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -90.09 132.03 35.64 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.908 0.385 . . . . 0.0 110.508 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.475 HG23 ' HB3' ' A' ' 83' ' ' GLN . 12.4 mt -129.9 133.22 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.07 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.71 122.36 36.09 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.715 0.293 . . . . 0.0 110.705 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.91 130.61 55.82 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.526 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.408 ' HG3' ' HD2' ' A' ' 12' ' ' LYS . 8.2 tt0 -122.18 115.56 22.62 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.581 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.811 HG12 ' HA ' ' A' ' 60' ' ' ILE . 5.2 m -136.64 170.57 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.479 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.413 HG22 ' HA ' ' A' ' 10' ' ' ILE . 17.3 t -133.94 143.66 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.308 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.2 126.04 28.56 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.967 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.577 HG21 ' HB2' ' A' ' 59' ' ' ALA . 21.7 t -113.6 118.79 59.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.015 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.208 179.957 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.49 1.271 0 CA-C-O 120.71 0.212 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.1 tt -89.59 124.93 42.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.277 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -123.99 153.38 41.37 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.082 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.431 ' HG3' ' HG2' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -114.79 120.05 38.72 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.56 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.0 m -129.36 135.29 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.708 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.69 136.71 40.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.834 0.349 . . . . 0.0 111.131 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.0 mp -113.12 124.04 51.65 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.692 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 tt -102.74 115.33 30.39 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.708 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -129.4 134.12 47.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.104 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -90.63 172.87 8.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.887 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.66 -36.94 70.13 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -74.84 -30.87 61.49 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.27 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -79.39 179.42 7.45 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.87 0.367 . . . . 0.0 111.323 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.1 -143.13 4.95 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.014 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.67 -66.97 0.82 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.49 0.186 . . . . 0.0 111.369 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.61 -15.56 45.36 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.614 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.746 HG22 HG23 ' A' ' 42' ' ' ILE . 2.2 pp -140.84 157.76 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 117.304 0.552 . . . . 0.0 111.241 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 t -114.49 137.4 51.9 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.557 HG22 HG12 ' A' ' 39' ' ' ILE . 17.0 pt -116.16 151.56 17.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.472 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.2 t -143.61 145.11 32.24 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.065 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 129.72 -172.96 19.87 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.441 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . -178.87 116.54 0.53 Allowed Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.454 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -52.35 -37.68 56.74 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.432 ' HB2' ' HG3' ' A' ' 72' ' ' LYS . 50.5 tt0 -59.32 -31.16 68.9 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.725 0.298 . . . . 0.0 110.993 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -72.66 -31.31 64.98 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.937 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.18 -23.63 3.16 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.999 -0.619 . . . . 0.0 113.102 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.04 149.7 54.67 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.815 0.307 . . . . 0.0 111.291 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.25 157.53 61.43 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.662 2.241 . . . . 0.0 112.275 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.414 ' H ' HD12 ' A' ' 37' ' ' ILE . 3.4 mp -82.42 129.86 36.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.578 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.76 161.55 29.49 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.857 0.361 . . . . 0.0 111.607 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.606 HD13 HD21 ' A' ' 54' ' ' LEU . 32.9 mt -82.84 123.29 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.059 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.8 m -106.9 -30.03 9.12 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.578 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -123.95 145.09 49.39 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.865 0.364 . . . . 0.0 111.395 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.746 HG23 HG22 ' A' ' 25' ' ' ILE . 32.2 mt -131.02 114.3 26.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.486 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -85.02 114.46 56.03 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.775 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -62.32 175.34 2.11 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.015 2.477 . . . . 0.0 112.967 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.73 34.91 91.16 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.147 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.16 173.18 4.94 Favored Pre-proline 0 CA--C 1.531 0.242 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.42 -30.86 36.3 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.714 2.276 . . . . 0.0 113.022 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.23 -46.19 89.14 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.696 0.284 . . . . 0.0 111.1 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.98 -38.34 76.0 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.803 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -32.02 73.43 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.216 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.11 -28.28 61.28 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.518 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.84 16.51 61.65 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.054 -0.594 . . . . 0.0 113.089 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.69 -33.75 1.15 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.203 -0.523 . . . . 0.0 113.066 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.606 HD21 HD13 ' A' ' 39' ' ' ILE . 1.1 tt -67.72 105.31 1.88 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.881 0.372 . . . . 0.0 110.662 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.512 ' C ' HD11 ' A' ' 42' ' ' ILE . 12.6 p80 -114.86 157.35 23.43 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.207 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.431 ' N ' HD11 ' A' ' 42' ' ' ILE . 13.8 p -62.97 139.69 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.127 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.5 49.66 5.08 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.216 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.8 126.63 55.27 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.433 0.159 . . . . 0.0 110.763 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -90.68 128.11 36.53 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.712 0.292 . . . . 0.0 110.687 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.766 HG21 HD22 ' A' ' 68' ' ' LEU . 12.3 mt -74.7 104.05 2.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.695 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -86.46 -50.64 6.73 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.409 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -150.13 146.15 26.73 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.605 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.1 t -127.92 115.71 40.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.652 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 54.96 37.07 28.24 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.99 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.25 -14.16 58.22 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.375 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.0 t -86.12 127.21 40.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 117.181 0.49 . . . . 0.0 110.97 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -71.55 141.16 50.1 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.949 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.766 HD22 HG21 ' A' ' 60' ' ' ILE . 1.2 tp -116.03 -1.23 12.54 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.722 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -34.25 70.69 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.3 11.59 37.9 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.3 p -109.47 163.66 13.22 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.741 0.305 . . . . 0.0 110.93 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.432 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 2.3 mppt? -94.62 161.11 14.33 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.03 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.597 ' O ' HG23 ' A' ' 77' ' ' VAL . 12.3 t-80 -53.95 -49.66 68.21 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.812 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -43.06 88.15 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.758 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -64.81 -38.34 90.65 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.973 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.52 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -63.63 -41.42 98.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.991 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 73' ' ' HIS . 21.7 t -62.67 -39.88 86.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.052 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -46.62 71.39 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.009 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.446 HG22 HE21 ' A' ' 83' ' ' GLN . 14.6 mt -62.21 -39.61 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.557 0.218 . . . . 0.0 110.752 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.636 HD21 ' CE2' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -59.97 -42.39 94.02 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.178 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.9 p -64.82 -32.12 73.67 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.304 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -64.95 -28.81 69.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.05 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.485 ' HB3' HG23 ' A' ' 87' ' ' ILE . 24.4 mm-40 -62.01 114.22 3.26 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.853 0.358 . . . . 0.0 110.856 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.0 ptt85 -118.63 152.29 36.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.426 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.04 -103.23 0.55 Allowed Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.592 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -89.96 119.06 30.0 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.788 0.328 . . . . 0.0 110.402 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.485 HG23 ' HB3' ' A' ' 83' ' ' GLN . 18.4 mt -121.04 122.5 67.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.031 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -93.78 122.08 35.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.681 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.636 ' CE2' HD21 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -116.31 129.81 56.46 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.943 0.401 . . . . 0.0 111.203 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.431 ' HG2' ' HG3' ' A' ' 12' ' ' LYS . 23.6 mt-10 -120.09 115.4 23.61 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.007 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 60' ' ' ILE . 8.2 m -137.08 163.7 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.733 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.9 t -131.76 146.08 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.15 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.401 ' CG ' ' CE1' ' A' ' 55' ' ' HIS . 0.1 OUTLIER -70.47 129.07 38.27 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.758 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.32 141.19 43.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.901 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.117 -0.945 . . . . 0.0 111.315 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.532 ' O ' HG23 ' A' ' 92' ' ' VAL . 4.6 Cg_endo . . . . . 0 N--CA 1.49 1.297 0 CA-C-O 120.852 0.272 . . . . 0.0 111.939 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 tt -78.8 132.76 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.381 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -123.71 135.25 53.76 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.057 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.86 126.6 48.78 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.581 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.3 m -128.58 143.14 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.592 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 pp -114.69 132.23 56.48 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.821 0.343 . . . . 0.0 110.928 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -120.7 141.57 50.3 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.869 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.95 118.35 36.51 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.009 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.96 148.09 42.53 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.104 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.408 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 3.4 mp0 -114.22 159.75 19.79 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.155 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.3 -38.22 73.64 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.963 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.408 ' CD2' ' HB3' ' A' ' 18' ' ' GLU . 23.7 p80 -79.77 -28.17 40.4 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.437 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.65 164.27 16.9 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.932 0.396 . . . . 0.0 111.595 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.41 -166.74 21.95 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.703 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.591 HD22 HG13 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -61.0 -59.53 5.22 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.539 0.209 . . . . 0.0 111.329 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.27 1.06 55.76 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.382 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.745 HG22 HG23 ' A' ' 42' ' ' ILE . 1.8 pp -145.48 161.44 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 117.177 0.488 . . . . 0.0 111.139 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.5 t -119.65 136.95 54.18 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.604 HD12 HG21 ' A' ' 37' ' ' ILE . 6.5 pt -119.9 154.38 22.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.335 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 p -137.16 153.56 50.44 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.002 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.31 -172.24 16.67 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.785 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.38 113.97 0.55 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.517 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -32.44 70.67 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.478 0.18 . . . . 0.0 111.388 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -60.11 -30.7 69.44 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.609 0.242 . . . . 0.0 110.949 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -76.59 -28.15 56.08 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.078 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.68 31.54 2.51 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.892 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.7 m -146.4 144.17 20.5 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.634 0.217 . . . . 0.0 111.0 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.7 156.97 62.11 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.624 2.216 . . . . 0.0 112.246 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.627 ' HB ' HD12 ' A' ' 60' ' ' ILE . 29.5 mm -84.21 139.29 17.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.63 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mp -131.42 160.49 34.95 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.839 0.352 . . . . 0.0 111.287 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.578 HD12 ' HB3' ' A' ' 58' ' ' ASP . 23.2 mt -89.69 122.54 41.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.946 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.468 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -109.54 -31.6 7.44 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.642 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -127.75 149.41 50.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.668 0.27 . . . . 0.0 110.823 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.745 HG23 HG22 ' A' ' 25' ' ' ILE . 17.9 mt -135.03 114.55 17.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.74 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -66.67 120.89 74.5 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.096 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.35 156.63 61.38 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.973 2.449 . . . . 0.0 112.667 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.3 36.8 93.66 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.262 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -134.06 177.07 2.42 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -49.95 -31.02 25.79 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.712 2.275 . . . . 0.0 112.912 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.495 ' HB1' ' CB ' ' A' ' 54' ' ' LEU . . . -63.55 -46.1 87.47 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.006 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -69.84 -40.4 75.83 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.792 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.6 mtp85 -56.11 -36.8 68.61 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.552 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 17.8 m -81.24 -27.9 35.03 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.457 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.75 14.58 67.76 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.999 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.34 -30.95 3.93 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.796 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.601 ' O ' HD13 ' A' ' 42' ' ' ILE . 2.2 mm? -65.72 101.32 0.62 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.757 0.313 . . . . 0.0 110.569 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.579 ' C ' HD11 ' A' ' 42' ' ' ILE . 15.8 p80 -114.41 157.49 22.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.931 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 40' ' ' SER . 40.6 t -71.7 136.18 26.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.443 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.12 47.26 4.77 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.283 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.578 ' HB3' HD12 ' A' ' 39' ' ' ILE . 3.2 t0 -111.99 132.72 54.61 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.87 123.75 35.48 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.759 0.314 . . . . 0.0 111.624 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.837 ' HA ' HG12 ' A' ' 91' ' ' VAL . 41.7 mt -75.17 132.47 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.174 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.4 mt -117.81 -67.7 0.97 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.033 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.88 145.65 46.56 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.917 0.389 . . . . 0.0 111.504 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.0 t -116.71 115.51 49.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.378 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 54.31 37.94 28.43 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.678 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.25 -14.44 54.09 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.648 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.5 t -85.26 135.2 25.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 117.221 0.51 . . . . 0.0 111.179 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -77.21 138.17 39.28 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.155 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.839 HD21 ' HB1' ' A' ' 76' ' ' ALA . 1.2 tp -116.2 -1.92 12.29 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.829 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -30.3 68.26 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -98.8 11.25 39.28 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.44 HG22 ' HB2' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -109.96 159.07 17.59 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.566 0.222 . . . . 0.0 110.775 179.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.13 161.27 18.96 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.449 ' O ' HG23 ' A' ' 77' ' ' VAL . 38.8 t-80 -54.3 -51.28 65.15 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.015 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -65.28 -41.39 94.21 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.776 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.44 ' HB2' HG22 ' A' ' 71' ' ' THR . 64.7 mt-10 -64.28 -37.23 86.76 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.843 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.839 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -63.39 -30.82 71.88 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.392 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 73' ' ' HIS . 38.9 t -61.9 -42.35 94.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.836 0.35 . . . . 0.0 110.085 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 32.0 m -64.4 -41.25 96.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.452 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.2 mm -57.86 -45.72 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.734 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -40.88 87.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -73.57 -13.79 61.09 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -69.23 -29.75 67.76 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.681 0.277 . . . . 0.0 111.115 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.477 ' HB3' HG12 ' A' ' 87' ' ' ILE . 17.5 mp0 -76.5 135.99 39.34 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.195 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -130.65 146.94 52.26 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.166 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.82 -90.82 0.17 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.997 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -96.25 115.19 27.03 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.746 0.308 . . . . 0.0 110.304 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.477 HG12 ' HB3' ' A' ' 83' ' ' GLN . 18.9 mt -114.47 126.24 71.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.202 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -99.81 135.52 41.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.749 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -128.63 135.87 49.89 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.921 0.391 . . . . 0.0 111.479 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -123.63 115.59 21.72 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.496 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.837 HG12 ' HA ' ' A' ' 60' ' ' ILE . 18.7 m -144.86 172.49 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.341 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 9' ' ' PRO . 9.2 p -141.37 137.03 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.059 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.74 122.6 17.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.058 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.8 m -108.25 120.5 59.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.162 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.123 -179.771 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo . . . . . 0 N--CA 1.492 1.388 0 CA-C-O 120.655 0.19 . . . . 0.0 111.919 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.783 ' HA ' HG12 ' A' ' 92' ' ' VAL . 65.7 mt -104.77 140.85 21.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.06 146.1 48.8 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.064 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.4 113.19 23.43 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.677 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.33 141.64 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.347 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 20.6 tp -105.84 127.65 53.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.898 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 tp -113.2 125.5 54.4 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.44 114.57 28.52 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.684 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -125.94 135.04 51.41 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.206 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -81.39 171.57 14.6 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.047 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.46 -38.78 75.03 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.095 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.414 ' CE1' ' HG2' ' A' ' 21' ' ' GLU . 16.8 p80 -75.42 -30.26 59.99 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.218 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HG2' ' CE1' ' A' ' 20' ' ' HIS . 2.5 mm-40 -77.02 166.16 23.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.897 0.379 . . . . 0.0 111.383 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -113.02 -152.86 11.27 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.893 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.741 HD11 HD13 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -67.98 -41.21 82.71 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.526 0.203 . . . . 0.0 111.464 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.09 -21.32 43.87 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.997 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.755 HG21 ' CD1' ' A' ' 54' ' ' LEU . 2.6 pp -146.48 171.44 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.808 0.337 . . . . 0.0 111.287 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 5.9 m -120.44 138.35 53.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.575 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.777 HD12 HG21 ' A' ' 37' ' ' ILE . 15.2 pt -115.96 156.2 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.851 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.5 p -137.26 163.26 31.36 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.365 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.0 -160.71 17.69 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.874 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.43 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . 166.5 131.7 1.29 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.133 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -56.46 -37.6 70.53 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.182 0.193 . . . . 0.0 111.33 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.39 -31.04 71.65 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.125 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -78.31 -26.6 47.02 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.236 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.87 22.93 6.07 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.048 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 10.1 p -149.57 134.97 9.74 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.926 0.363 . . . . 0.0 110.998 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.45 ' O ' HD12 ' A' ' 38' ' ' LEU . 38.4 Cg_exo -60.91 156.69 42.43 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.42 2.08 . . . . 0.0 112.181 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.777 HG21 HD12 ' A' ' 27' ' ' ILE . 3.5 mp -83.37 131.64 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.792 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.486 ' CD2' ' HB2' ' A' ' 59' ' ' ALA . 3.9 mp -131.64 160.73 34.55 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.574 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.516 HD13 HD11 ' A' ' 54' ' ' LEU . 30.4 mt -93.63 119.58 41.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.946 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.475 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -111.25 -41.2 4.22 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.262 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 4.1 tt0 -104.83 150.19 25.03 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.716 0.293 . . . . 0.0 111.067 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.705 HG23 HG22 ' A' ' 25' ' ' ILE . 32.3 mt -132.09 121.27 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.746 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -73.78 114.78 35.68 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.817 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -68.03 140.7 50.68 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.707 2.271 . . . . 0.0 112.645 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.34 29.5 52.99 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.746 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.68 172.53 6.63 Favored Pre-proline 0 CA--C 1.531 0.224 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -52.19 -31.66 46.73 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.721 2.281 . . . . 0.0 112.797 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.614 ' HB1' ' HG ' ' A' ' 54' ' ' LEU . . . -61.79 -46.3 90.16 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.09 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.84 -40.34 79.48 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.763 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.07 -31.52 72.78 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.191 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -70.29 -27.97 64.82 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.581 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.38 -56.39 4.67 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.943 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.6 -28.36 37.27 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 121.473 -0.394 . . . . 0.0 113.533 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.755 ' CD1' HG21 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -63.94 96.93 0.15 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.033 0.444 . . . . 0.0 110.527 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -119.05 157.4 27.89 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.272 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 40' ' ' SER . 40.1 t -68.38 129.67 33.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.076 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.54 41.83 2.65 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.577 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.05 122.71 47.84 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.191 0.197 . . . . 0.0 110.581 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.486 ' HB2' ' CD2' ' A' ' 38' ' ' LEU . . . -94.75 127.1 40.51 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.683 0.278 . . . . 0.0 111.402 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.824 ' HA ' HG12 ' A' ' 91' ' ' VAL . 9.5 mt -77.78 142.21 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.338 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 70.4 mt -130.36 -50.88 1.09 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.933 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.32 145.56 49.15 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.889 0.376 . . . . 0.0 111.698 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.479 HG21 HD13 ' A' ' 68' ' ' LEU . 24.0 t -115.99 115.34 48.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.238 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 53.16 34.8 18.26 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.956 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.14 -15.91 59.95 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.037 -0.602 . . . . 0.0 113.624 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.9 t -88.39 134.95 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 117.218 0.509 . . . . 0.0 111.152 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -69.65 135.59 50.09 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.319 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.592 HD21 ' HB2' ' A' ' 76' ' ' ALA . 0.5 OUTLIER -120.79 16.2 11.83 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.715 179.674 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.4 ttt85 -69.64 -32.31 70.92 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.11 12.02 37.32 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.474 HG22 ' HB2' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -103.45 162.87 12.66 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.617 0.246 . . . . 0.0 110.867 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.37 161.07 13.96 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.12 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.526 ' O ' HG23 ' A' ' 77' ' ' VAL . 58.9 t-80 -54.1 -51.1 65.25 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.066 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -60.45 -41.04 93.27 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.811 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.474 ' HB2' HG22 ' A' ' 71' ' ' THR . 26.6 mt-10 -65.22 -37.22 86.61 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.741 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.592 ' HB2' HD21 ' A' ' 68' ' ' LEU . . . -63.56 -35.23 79.79 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.104 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 73' ' ' HIS . 22.1 t -62.23 -39.84 85.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.815 0.341 . . . . 0.0 110.424 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -41.93 99.05 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.594 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.7 mm -57.98 -45.41 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.571 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.741 HD13 HD11 ' A' ' 23' ' ' LEU . 1.2 mt -57.5 -39.29 76.15 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.072 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -61.58 -37.36 83.58 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.07 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -65.72 -25.61 67.38 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.339 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.457 ' HB2' HD13 ' A' ' 87' ' ' ILE . 33.9 mm-40 -65.9 131.13 45.53 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.097 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.03 143.7 50.27 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.384 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.03 -101.31 0.22 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.859 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -91.57 126.01 36.5 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.954 0.407 . . . . 0.0 110.495 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.457 HD13 ' HB2' ' A' ' 83' ' ' GLN . 7.9 mt -117.6 122.99 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.081 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.77 124.37 37.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.414 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.471 ' CE1' HG13 ' A' ' 63' ' ' VAL . 0.7 OUTLIER -128.16 129.8 47.08 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.927 0.394 . . . . 0.0 111.178 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -101.37 115.21 29.99 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.298 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.824 HG12 ' HA ' ' A' ' 60' ' ' ILE . 15.8 m -138.23 171.5 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.394 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.783 HG12 ' HA ' ' A' ' 10' ' ' ILE . 31.0 m -133.95 149.37 30.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.292 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.98 120.98 19.36 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.867 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.35 131.27 73.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.798 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.013 179.932 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 N--CA 1.49 1.28 0 CA-C-O 120.788 0.245 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.812 ' HA ' HG12 ' A' ' 92' ' ' VAL . 67.6 mt -96.14 141.01 16.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.13 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.5 124.87 44.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.993 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.8 111.54 23.67 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.472 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -132.01 138.05 53.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.957 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.9 141.66 30.61 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.07 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -121.48 139.6 53.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.971 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tt -107.6 127.11 53.36 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.822 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -116.2 126.56 53.8 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.87 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.43 155.62 20.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.682 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.33 -38.96 74.9 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.189 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -79.0 -27.72 43.36 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.425 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -95.41 -178.34 4.4 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.741 0.305 . . . . 0.0 111.508 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.41 -149.89 5.55 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.974 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.94 -56.97 6.2 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.608 0.242 . . . . 0.0 110.781 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.02 -14.52 61.38 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.445 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.603 HD13 HG12 ' A' ' 39' ' ' ILE . 2.6 pp -140.13 154.08 22.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 117.104 0.452 . . . . 0.0 111.166 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 1.5 m -103.8 136.75 42.89 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.793 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.534 ' HB ' HG22 ' A' ' 37' ' ' ILE . 14.7 pt -119.66 149.7 22.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.464 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.456 ' C ' HG23 ' A' ' 37' ' ' ILE . 14.5 t -135.86 146.94 47.98 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.217 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.96 -154.72 25.71 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.364 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 159.45 117.5 0.48 Allowed Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.095 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.88 -33.67 72.14 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.38 0.133 . . . . 0.0 111.321 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -57.26 -29.9 64.21 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.549 0.214 . . . . 0.0 111.331 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -83.15 -29.14 28.88 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.001 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.0 26.03 5.66 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.898 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.423 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 16.1 m -144.58 131.98 10.4 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 116.75 0.275 . . . . 0.0 111.115 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 32.6 Cg_exo -61.14 153.97 60.84 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.647 2.231 . . . . 0.0 112.005 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.534 HG22 ' HB ' ' A' ' 27' ' ' ILE . 3.3 mp -82.53 132.07 32.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.426 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.4 159.05 35.64 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.618 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.603 HG12 HD13 ' A' ' 25' ' ' ILE . 13.6 mt -83.01 129.96 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.958 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.3 m -119.71 -40.95 2.71 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.353 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 18.0 tt0 -105.32 144.52 31.99 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.702 0.287 . . . . 0.0 111.081 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.42 ' HA ' HG22 ' A' ' 25' ' ' ILE . 18.9 mm -129.26 111.62 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.697 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -84.87 127.58 64.23 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.97 157.86 53.78 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.843 2.362 . . . . 0.0 113.063 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.94 37.58 43.55 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.835 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.06 170.29 8.68 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-O 120.45 0.166 . . . . 0.0 110.799 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.12 -31.24 34.91 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.728 2.285 . . . . 0.0 112.684 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.447 ' CB ' HG23 ' A' ' 25' ' ' ILE . . . -57.34 -46.41 83.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.463 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.77 -42.53 77.3 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.851 0.358 . . . . 0.0 110.498 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -65.02 -30.55 71.54 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.299 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -70.57 -28.34 64.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.535 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.17 -58.8 3.99 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.764 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.85 -23.27 44.54 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.541 -0.362 . . . . 0.0 113.526 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.516 HD11 HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -64.93 96.05 0.18 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.111 0.456 . . . . 0.0 110.403 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -119.33 157.41 28.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.299 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 m -68.28 134.9 29.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.56 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.85 44.9 4.37 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.587 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.15 122.49 47.89 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.26 122.58 34.0 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.764 0.316 . . . . 0.0 111.633 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.843 ' HA ' HG12 ' A' ' 91' ' ' VAL . 15.6 mt -69.59 132.19 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.366 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.1 mt -114.88 -54.58 2.56 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.802 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -150.76 145.98 26.11 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.454 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.839 HG21 HD21 ' A' ' 80' ' ' LEU . 24.3 t -125.61 120.51 57.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.54 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 57.39 34.54 24.83 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.08 -11.08 61.26 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.359 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.58 136.33 23.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 117.258 0.529 . . . . 0.0 110.934 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.5 134.39 35.21 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.056 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.417 ' CD2' ' HB1' ' A' ' 76' ' ' ALA . 1.8 mp -108.63 -12.33 14.98 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.034 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -29.05 69.58 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -96.51 9.19 42.16 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.62 0.229 . . . . 0.0 111.62 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.6 p -119.04 157.9 26.88 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.677 0.275 . . . . 0.0 110.8 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.03 161.05 20.85 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.817 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.63 ' O ' HG23 ' A' ' 77' ' ' VAL . 41.4 t-80 -53.82 -50.55 65.94 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.904 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -59.69 -41.56 91.01 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.949 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.28 -38.66 85.44 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.954 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.678 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.44 -35.2 79.65 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.402 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 73' ' ' HIS . 39.5 t -61.86 -40.46 87.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.726 0.298 . . . . 0.0 110.469 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.9 m -66.77 -44.25 81.9 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.782 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 76' ' ' ALA . 11.2 mt -62.06 -43.06 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.825 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.839 HD21 HG21 ' A' ' 63' ' ' VAL . 24.5 mt -62.4 -36.53 82.6 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.684 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.4 t -65.57 -32.69 74.41 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.012 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -65.03 -28.8 69.73 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.325 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.475 ' HB3' HG23 ' A' ' 87' ' ' ILE . 26.2 mm-40 -61.85 112.75 2.42 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.813 0.34 . . . . 0.0 110.767 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -112.57 148.88 33.61 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.378 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.56 -103.02 0.55 Allowed Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.59 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -89.07 126.41 35.43 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.812 0.339 . . . . 0.0 110.385 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.475 HG23 ' HB3' ' A' ' 83' ' ' GLN . 13.0 mt -126.05 129.23 72.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.826 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -93.82 135.49 35.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.474 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.469 ' HZ ' HD22 ' A' ' 80' ' ' LEU . 3.4 m-85 -130.58 129.28 42.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.879 0.371 . . . . 0.0 111.026 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -122.07 115.36 22.35 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.227 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.843 HG12 ' HA ' ' A' ' 60' ' ' ILE . 15.9 m -138.83 171.54 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.518 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.812 HG12 ' HA ' ' A' ' 10' ' ' ILE . 15.6 m -134.71 143.18 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.501 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.98 122.92 27.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.961 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.82 133.41 66.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.088 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.434 -0.794 . . . . 0.0 111.34 -179.865 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.654 ' O ' HG23 ' A' ' 92' ' ' VAL . 6.1 Cg_endo . . . . . 0 N--CA 1.491 1.364 0 CA-C-O 120.99 0.329 . . . . 0.0 111.736 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mp -78.77 143.43 12.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.204 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.17 143.95 46.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.263 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -111.97 115.1 28.4 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 t -125.68 130.15 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.776 0.322 . . . . 0.0 111.175 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.93 132.47 43.48 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.169 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.5 tt -129.67 144.53 51.33 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.985 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.76 114.81 28.92 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.95 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -94.41 136.3 34.86 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.758 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.07 154.56 32.98 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.183 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.63 -37.16 72.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.218 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.422 ' CE1' ' HG2' ' A' ' 21' ' ' GLU . 13.4 p80 -82.47 -26.78 32.33 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.503 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.422 ' HG2' ' CE1' ' A' ' 20' ' ' HIS . 5.0 mm-40 -102.17 110.04 21.89 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.659 0.266 . . . . 0.0 110.946 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.8 -152.14 0.13 Allowed Glycine 0 CA--C 1.522 0.523 0 C-N-CA 121.255 -0.498 . . . . 0.0 113.439 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.418 HD22 HG13 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -60.56 -59.98 4.54 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 -179.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.9 -11.95 65.92 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.598 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.549 HG21 ' CD1' ' A' ' 54' ' ' LEU . 15.0 pt -138.36 152.68 25.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 117.1 0.45 . . . . 0.0 110.977 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 0.9 OUTLIER -115.53 136.68 52.84 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.762 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.614 HD12 HG21 ' A' ' 37' ' ' ILE . 18.0 pt -117.34 155.8 18.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.592 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 t -140.46 147.13 39.16 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.993 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.63 -165.49 20.69 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.43 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.423 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . -179.35 114.41 0.44 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.679 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.2 tptp -60.99 -29.89 69.95 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -57.53 -31.15 65.78 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.653 0.263 . . . . 0.0 110.966 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -79.38 -23.11 43.53 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.324 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.15 21.25 4.93 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.309 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.1 m -145.38 140.32 15.83 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 117.007 0.403 . . . . 0.0 111.212 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.57 157.07 63.46 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.57 2.18 . . . . 0.0 112.385 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.614 HG21 HD12 ' A' ' 27' ' ' ILE . 3.3 mt -85.64 137.52 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.842 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.411 HD12 ' C ' ' A' ' 37' ' ' ILE . 6.3 mp -128.37 151.19 49.64 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.368 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.2 mt -86.92 122.12 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.824 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.54 -27.72 8.12 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.877 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 26' ' ' SER . 1.8 mt-10 -109.75 144.27 38.39 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.662 0.268 . . . . 0.0 111.121 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.409 HD12 HD12 ' A' ' 54' ' ' LEU . 22.4 mm -133.55 121.21 40.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.637 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -97.91 112.41 61.64 Favored Pre-proline 0 C--O 1.234 0.287 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.149 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.424 ' HA ' ' HB2' ' A' ' 49' ' ' ASP . 42.0 Cg_endo -68.93 151.58 73.66 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.709 2.273 . . . . 0.0 112.492 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.06 -37.27 3.84 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.734 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.66 176.14 4.11 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-O 120.45 0.167 . . . . 0.0 110.724 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -51.02 -30.65 31.83 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.918 2.412 . . . . 0.0 113.15 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.446 ' CB ' HG23 ' A' ' 25' ' ' ILE . . . -57.69 -46.19 84.65 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.685 0.278 . . . . 0.0 111.211 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.424 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.6 OUTLIER -70.54 -42.12 71.62 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.787 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.6 mtp85 -62.09 -30.08 70.76 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.108 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.94 -28.22 65.4 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.418 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.12 -56.69 3.61 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.712 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.95 -23.58 39.07 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 119.867 -0.407 . . . . 0.0 113.776 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.549 ' CD1' HG21 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -66.05 90.28 0.13 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.161 0.481 . . . . 0.0 110.422 179.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -114.17 157.24 22.91 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.11 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.4 t -64.01 137.71 24.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.676 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.71 46.17 4.35 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.385 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.58 121.25 44.23 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.445 0.164 . . . . 0.0 111.017 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.11 122.05 37.37 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.671 0.272 . . . . 0.0 111.258 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.834 ' HA ' HG12 ' A' ' 91' ' ' VAL . 3.2 mp -77.14 134.7 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.442 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.1 mt -121.93 -50.62 2.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.941 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.56 146.44 34.61 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.762 0.315 . . . . 0.0 111.361 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.0 t -136.02 115.88 17.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.59 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 59.79 33.03 21.64 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.015 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.55 -14.44 58.1 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.305 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 t -81.79 132.58 31.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 117.044 0.422 . . . . 0.0 110.604 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -76.26 126.74 31.54 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.658 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.67 HD21 ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -120.58 0.97 10.57 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.529 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -71.1 -31.48 67.84 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 111.247 0.091 . . . . 0.0 111.247 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.47 11.88 33.94 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.52 ' OG1' HD23 ' A' ' 68' ' ' LEU . 25.7 p -100.91 149.7 23.62 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.588 0.232 . . . . 0.0 111.002 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -75.5 161.13 29.46 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.433 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.423 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . 24.2 t-80 -54.59 -49.63 69.95 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.213 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -62.3 -37.72 86.62 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.588 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -62.67 -37.33 86.0 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.746 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.67 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -63.34 -35.34 80.07 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.347 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.16 -42.96 97.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.635 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.32 -48.3 70.73 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.814 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 mt -61.41 -42.19 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.092 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -39.24 80.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.8 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -33.27 75.44 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.009 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -65.3 -27.11 68.39 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.14 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.478 ' HB3' HG23 ' A' ' 87' ' ' ILE . 75.9 mm-40 -65.79 95.63 0.25 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 110.79 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -98.68 144.23 28.18 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.123 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.73 -109.08 2.53 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.818 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -79.99 135.96 36.5 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.692 0.282 . . . . 0.0 110.574 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.478 HG23 ' HB3' ' A' ' 83' ' ' GLN . 10.1 mt -137.03 122.36 25.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.289 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -95.79 122.25 38.38 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.428 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -111.8 128.79 56.22 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.007 0.432 . . . . 0.0 111.338 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -117.24 115.36 25.15 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.299 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.834 HG12 ' HA ' ' A' ' 60' ' ' ILE . 17.6 m -137.76 171.05 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.465 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 9' ' ' PRO . 8.6 p -135.94 137.57 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.987 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.19 119.99 13.64 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.834 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.1 t -111.13 125.03 68.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.167 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.991 179.914 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo . . . . . 0 N--CA 1.489 1.222 0 CA-C-O 120.725 0.219 . . . . 0.0 111.842 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.57 ' HA ' HG12 ' A' ' 92' ' ' VAL . 2.7 tt -109.3 124.6 66.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.067 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -113.65 127.03 55.9 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.053 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.24 113.91 27.78 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.998 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.93 135.87 60.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.003 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.415 HD21 ' CG ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -97.71 130.95 44.65 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.824 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.24 139.47 50.32 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.069 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.2 mp -109.02 114.54 28.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.87 139.03 54.13 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.056 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -109.28 168.09 9.64 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.949 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.87 -37.14 75.87 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.282 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.401 ' CE1' ' HG2' ' A' ' 21' ' ' GLU . 32.1 p80 -74.62 -29.89 61.46 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.596 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.401 ' HG2' ' CE1' ' A' ' 20' ' ' HIS . 10.0 mm-40 -94.75 166.18 12.12 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 111.641 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.88 -154.22 9.12 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.91 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.08 -67.01 0.52 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.577 0.227 . . . . 0.0 111.03 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.22 4.13 63.0 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.071 -0.585 . . . . 0.0 113.634 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.727 HG21 HD12 ' A' ' 54' ' ' LEU . 17.2 pt -138.29 145.36 28.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 117.256 0.528 . . . . 0.0 111.088 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.75 140.23 34.26 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.099 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.809 HG22 HD13 ' A' ' 39' ' ' ILE . 13.2 pt -116.49 155.62 17.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.684 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.9 p -133.9 153.79 51.51 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.347 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.49 -153.75 19.66 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.803 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.404 ' CA ' ' HB2' ' A' ' 73' ' ' HIS . . . 151.81 138.21 2.74 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.26 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -58.97 -37.74 77.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.066 0.146 . . . . 0.0 111.38 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.84 -31.19 71.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.595 0.236 . . . . 0.0 111.017 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -81.14 -28.19 35.19 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.103 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.19 25.83 5.95 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.101 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.8 m -147.82 140.08 14.37 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.864 0.332 . . . . 0.0 110.992 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.78 155.83 46.69 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.613 2.208 . . . . 0.0 112.19 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.526 HD12 HD11 ' A' ' 68' ' ' LEU . 19.7 mt -84.89 136.56 22.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.857 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.8 154.5 48.48 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.301 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.809 HD13 HG22 ' A' ' 27' ' ' ILE . 16.1 mm -83.87 118.23 30.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.763 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 56' ' ' VAL . 23.0 t -108.19 -28.51 9.44 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.705 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.67 144.45 50.2 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.735 0.302 . . . . 0.0 111.198 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.536 HG12 HG22 ' A' ' 56' ' ' VAL . 20.9 mm -128.92 112.19 25.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.383 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -87.01 130.96 46.27 Favored Pre-proline 0 C--O 1.232 0.158 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.106 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.37 172.8 15.63 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.846 2.364 . . . . 0.0 112.535 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.52 30.38 77.43 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.467 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.448 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -137.01 169.08 14.21 Favored Pre-proline 0 C--O 1.233 0.203 0 C-N-CA 122.248 0.219 . . . . 0.0 110.44 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.448 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 9.3 Cg_endo -53.09 -27.02 34.95 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.768 2.312 . . . . 0.0 112.75 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.72 -46.35 89.37 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.061 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -67.85 -40.49 83.66 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.618 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -58.71 -33.05 69.76 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.347 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.3 m -80.57 -28.36 37.23 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.56 -51.7 4.27 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.182 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.48 -24.37 23.49 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.56 -0.353 . . . . 0.0 113.795 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.727 HD12 HG21 ' A' ' 25' ' ' ILE . 4.2 mm? -65.19 89.52 0.09 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.15 0.475 . . . . 0.0 110.743 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -114.25 157.37 22.8 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.348 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.536 HG22 HG12 ' A' ' 42' ' ' ILE . 42.1 t -72.56 136.55 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.68 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.29 40.34 4.83 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.899 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -112.08 135.03 53.25 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.602 0.201 . . . . 0.0 110.987 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.53 124.01 47.31 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.686 0.279 . . . . 0.0 111.403 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.868 ' HA ' HG12 ' A' ' 91' ' ' VAL . 3.2 mt -80.04 150.72 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.494 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 61' ' ' LEU . 13.3 mt -136.25 -50.45 0.69 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.354 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.74 145.95 32.78 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.773 0.321 . . . . 0.0 111.476 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.779 HG21 HD21 ' A' ' 80' ' ' LEU . 24.4 t -135.39 115.87 18.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.769 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 57.15 34.53 24.99 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.875 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.83 -19.73 46.68 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.321 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 t -80.13 135.98 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 117.065 0.433 . . . . 0.0 111.0 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -80.51 137.33 36.43 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.213 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.587 HD22 ' HB ' ' A' ' 60' ' ' ILE . 1.2 tp -87.12 -33.06 19.57 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.038 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -67.4 -27.69 67.29 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.427 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -89.51 9.99 24.52 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 t -134.15 154.43 51.22 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.773 0.321 . . . . 0.0 110.959 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.18 161.16 20.67 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.706 ' O ' HG23 ' A' ' 77' ' ' VAL . 51.3 t-80 -54.0 -51.66 63.24 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.008 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -61.16 -42.15 98.03 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.031 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -38.68 84.96 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.963 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.511 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.49 -33.73 76.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.348 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 73' ' ' HIS . 24.7 t -61.91 -43.46 97.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.76 0.314 . . . . 0.0 110.25 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.11 -47.34 77.53 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.544 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 76' ' ' ALA . 17.2 mt -59.23 -49.29 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.92 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.779 HD21 HG21 ' A' ' 63' ' ' VAL . 85.5 mt -55.45 -35.97 66.04 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.132 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -20.06 60.45 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.652 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -74.22 -28.86 61.45 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.748 0.308 . . . . 0.0 110.57 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.567 ' HB3' HG23 ' A' ' 87' ' ' ILE . 1.5 mp0 -68.79 104.82 2.13 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.66 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 149.9 25.68 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.375 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.98 -107.11 1.63 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.469 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.415 ' CG ' HD21 ' A' ' 14' ' ' LEU . 15.9 tt0 -79.37 115.37 18.98 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.761 0.315 . . . . 0.0 110.433 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.567 HG23 ' HB3' ' A' ' 83' ' ' GLN . 11.3 mt -122.55 122.74 66.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.042 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -93.93 121.86 35.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.447 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.404 ' CE1' HD22 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -118.06 129.69 55.71 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.877 0.37 . . . . 0.0 111.642 -179.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -118.1 115.35 24.66 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.394 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.868 HG12 ' HA ' ' A' ' 60' ' ' ILE . 17.2 m -136.3 169.26 20.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.513 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 10' ' ' ILE . 29.4 m -137.69 131.23 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.111 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.15 123.48 22.27 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.935 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.3 m -108.34 141.9 22.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.4 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.42 -0.8 . . . . 0.0 111.323 -179.89 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.435 ' O ' HG12 ' A' ' 92' ' ' VAL . 5.3 Cg_endo . . . . . 0 N--CA 1.49 1.274 0 CA-C-O 120.539 0.141 . . . . 0.0 111.827 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.473 ' HA ' HG12 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -100.87 128.67 52.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.462 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -123.43 121.56 36.03 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.968 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -111.47 111.61 22.75 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.566 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.42 134.95 56.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.073 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 mp -97.97 139.54 33.65 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.81 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 tp -108.32 119.6 39.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.829 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 tp -109.55 115.18 29.43 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.487 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.63 153.14 44.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.018 0.437 . . . . 0.0 111.242 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.84 173.14 7.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.997 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -58.83 -38.37 78.53 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -72.96 -30.26 63.71 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.18 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -75.19 168.95 19.0 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.852 0.358 . . . . 0.0 111.238 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.1 -149.93 8.88 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.888 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.797 HD11 HD13 ' A' ' 80' ' ' LEU . 1.9 tp -76.88 -61.08 2.09 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.517 0.199 . . . . 0.0 111.323 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.78 -14.25 49.63 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.581 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.614 HG22 HG23 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -143.89 165.09 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 117.123 0.461 . . . . 0.0 111.132 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.8 t -120.99 136.76 54.91 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.675 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.605 HD12 HG21 ' A' ' 37' ' ' ILE . 15.2 pt -117.99 153.4 20.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.496 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.2 t -139.6 145.87 39.09 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.22 -151.51 23.46 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.447 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.53 105.44 0.19 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.847 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -57.57 -34.92 69.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.474 0.178 . . . . 0.0 111.18 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -60.72 -31.17 70.48 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.186 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -82.61 -31.36 28.92 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.087 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.65 32.27 2.33 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.709 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.443 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 10.9 p -140.42 130.92 13.75 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-O 120.66 0.267 . . . . 0.0 110.846 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.445 ' O ' HD23 ' A' ' 38' ' ' LEU . 25.9 Cg_exo -62.35 156.23 52.58 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.551 2.168 . . . . 0.0 112.072 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.605 HG21 HD12 ' A' ' 27' ' ' ILE . 30.3 mm -84.85 136.96 21.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.593 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 36' ' ' PRO . 0.3 OUTLIER -145.44 158.56 43.82 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.909 0.385 . . . . 0.0 111.611 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.589 HD13 HD13 ' A' ' 25' ' ' ILE . 16.7 mt -88.48 125.88 41.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.158 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.515 ' O ' HG13 ' A' ' 56' ' ' VAL . 8.6 t -110.42 -34.26 6.38 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.395 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -123.58 147.35 47.39 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.817 0.341 . . . . 0.0 111.371 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.614 HG23 HG22 ' A' ' 25' ' ' ILE . 2.3 mt -127.13 120.11 54.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.54 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -78.68 113.58 36.13 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.703 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.17 149.78 83.15 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.745 2.296 . . . . 0.0 112.648 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.84 39.59 28.17 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.563 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.93 172.95 4.89 Favored Pre-proline 0 C--N 1.331 -0.22 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -51.33 -32.72 42.84 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.61 2.207 . . . . 0.0 112.792 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.556 ' CB ' HG23 ' A' ' 25' ' ' ILE . . . -62.35 -46.31 89.24 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.113 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.36 -41.6 96.64 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.665 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.43 -29.86 67.67 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.611 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 10.8 m -70.36 -28.38 65.07 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.18 -57.8 4.01 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.89 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.44 -25.17 33.41 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.514 -0.374 . . . . 0.0 113.47 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.471 HD12 HG21 ' A' ' 25' ' ' ILE . 3.9 mm? -65.21 90.28 0.09 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.964 0.412 . . . . 0.0 110.471 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -115.79 157.47 24.33 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.217 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 40' ' ' SER . 43.1 t -63.92 132.08 29.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.247 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.6 40.78 4.93 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.815 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.55 119.07 37.97 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.21 130.34 38.94 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.879 ' HA ' HG12 ' A' ' 91' ' ' VAL . 3.2 mp -81.6 151.04 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.357 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.9 mt -136.6 -51.75 0.69 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.976 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.91 147.39 40.5 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.806 0.336 . . . . 0.0 111.448 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.424 HG13 ' CD1' ' A' ' 89' ' ' PHE . 38.2 t -130.01 115.62 33.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.529 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 54.4 32.91 17.46 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.864 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.77 -17.0 58.91 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.339 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.8 t -83.79 137.97 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 117.063 0.432 . . . . 0.0 111.045 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -75.23 131.18 40.2 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.27 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.656 HD13 HG21 ' A' ' 60' ' ' ILE . 7.0 tt -108.09 -22.61 12.32 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.501 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -61.16 -28.48 69.16 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.6 12.12 28.66 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.4 p -113.45 162.65 15.87 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.742 0.306 . . . . 0.0 110.583 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.82 161.24 16.84 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.198 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.559 ' O ' HG23 ' A' ' 77' ' ' VAL . 7.4 t-160 -54.03 -50.68 66.12 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.069 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -68.29 -43.16 78.31 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.874 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -38.1 89.34 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.997 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.674 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.66 -30.74 71.81 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.4 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 73' ' ' HIS . 22.9 t -61.93 -41.43 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.743 0.306 . . . . 0.0 110.651 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.3 m -69.84 -39.98 76.11 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.493 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 76' ' ' ALA . 16.0 mt -65.06 -48.89 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.163 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.797 HD13 HD11 ' A' ' 23' ' ' LEU . 4.6 pp -62.67 -36.6 83.39 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.108 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.625 ' N ' HD12 ' A' ' 80' ' ' LEU . 86.9 p -74.54 -16.0 60.84 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -71.22 -30.53 66.48 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.772 0.32 . . . . 0.0 110.858 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.444 ' CB ' HG23 ' A' ' 87' ' ' ILE . 2.2 mp0 -67.47 117.02 8.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.851 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -107.33 147.26 30.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.446 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.93 -98.39 0.19 Allowed Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.559 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -82.66 115.0 21.41 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.721 0.296 . . . . 0.0 110.304 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.444 HG23 ' CB ' ' A' ' 83' ' ' GLN . 16.7 mt -119.64 122.36 68.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.974 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.39 122.88 43.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.351 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.424 ' CD1' HG13 ' A' ' 63' ' ' VAL . 0.5 OUTLIER -122.83 129.42 51.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.826 0.346 . . . . 0.0 110.736 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -111.85 114.98 28.26 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.825 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.879 HG12 ' HA ' ' A' ' 60' ' ' ILE . 19.6 m -134.52 169.31 21.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.566 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 10' ' ' ILE . 16.9 m -139.96 141.24 34.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.954 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.47 116.26 7.26 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.825 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.3 p -105.01 139.63 25.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.517 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.124 -0.941 . . . . 0.0 111.065 -179.957 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.64 ' O ' HG13 ' A' ' 92' ' ' VAL . 6.4 Cg_exo . . . . . 0 N--CA 1.494 1.541 0 CA-C-O 120.831 0.263 . . . . 0.0 112.21 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.666 HD12 HD12 ' A' ' 61' ' ' LEU . 1.2 tt -92.66 136.89 23.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.168 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.4 ttt180 -123.62 148.07 46.77 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.049 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.467 ' HD2' ' HG3' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -101.1 118.86 37.84 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.659 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.0 t -122.13 129.56 75.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.304 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.4 tp -101.91 120.06 39.79 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.672 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.56 HD11 HD23 ' A' ' 54' ' ' LEU . 5.7 mp -108.28 121.09 44.18 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.149 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.8 tp -108.32 115.22 29.72 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.635 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.08 147.27 45.99 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.209 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -86.75 172.26 10.29 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.975 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -58.89 -38.46 78.91 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.061 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -73.92 -29.53 62.09 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.108 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -68.29 154.19 42.24 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.817 0.342 . . . . 0.0 111.533 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.22 -157.85 26.11 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.937 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.55 -62.05 1.6 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.492 0.187 . . . . 0.0 111.49 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.08 -21.17 34.21 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.365 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.914 HD13 HD12 ' A' ' 39' ' ' ILE . 1.1 pp -139.93 151.96 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 117.072 0.436 . . . . 0.0 111.31 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -105.49 137.1 43.87 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.986 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.717 HG22 HD13 ' A' ' 39' ' ' ILE . 14.0 pt -119.09 158.49 20.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.576 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.6 t -144.53 150.3 37.31 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.2 -159.58 15.73 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.478 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . 161.78 123.31 0.66 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.79 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -56.35 -37.87 70.6 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.457 0.169 . . . . 0.0 111.457 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -68.07 -31.15 70.59 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.734 0.302 . . . . 0.0 110.863 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -76.79 -30.5 56.49 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.028 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.96 21.69 5.23 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.113 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.4 p -149.76 130.81 7.2 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.95 0.375 . . . . 0.0 110.921 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -61.77 154.06 63.36 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.575 2.183 . . . . 0.0 112.26 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.511 HG21 HD12 ' A' ' 27' ' ' ILE . 15.9 mt -82.79 136.79 22.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.642 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.38 163.5 32.78 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.886 0.374 . . . . 0.0 111.766 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.914 HD12 HD13 ' A' ' 25' ' ' ILE . 10.5 mm -87.83 125.19 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.59 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.417 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.6 OUTLIER -117.39 -46.77 2.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.136 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 26' ' ' SER . 45.5 mt-10 -111.24 146.4 37.02 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.228 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.567 HG23 HG22 ' A' ' 25' ' ' ILE . 12.8 mt -131.72 113.08 21.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.6 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -69.72 124.61 90.95 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.924 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.06 147.02 53.64 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.695 2.263 . . . . 0.0 112.658 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.46 40.66 22.64 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.569 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.71 173.16 5.37 Favored Pre-proline 0 C--N 1.332 -0.196 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -51.8 -31.8 43.6 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.629 2.219 . . . . 0.0 112.662 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.57 -45.87 84.67 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.225 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -70.56 -43.08 70.22 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.635 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -59.57 -30.42 68.62 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.464 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 94.8 m -80.24 -28.02 38.57 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.833 -0.167 . . . . 0.0 111.353 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.95 17.66 63.46 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.865 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.29 -30.74 2.38 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.062 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.69 HD12 HG21 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -69.9 89.16 0.58 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.845 0.355 . . . . 0.0 110.738 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -106.34 156.83 18.1 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 40' ' ' SER . 22.4 t -64.56 135.09 28.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.688 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.95 46.06 4.31 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.411 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.38 122.74 48.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.397 0.142 . . . . 0.0 110.81 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.698 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -91.35 121.3 32.97 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.816 0.341 . . . . 0.0 111.216 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.875 ' HA ' HG12 ' A' ' 91' ' ' VAL . 5.6 mt -74.06 145.92 10.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.608 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.666 HD12 HD12 ' A' ' 10' ' ' ILE . 64.0 mt -137.83 -52.58 0.63 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.092 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.45 145.58 48.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.836 0.35 . . . . 0.0 111.702 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.0 t -131.3 117.04 34.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.403 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 57.82 34.46 24.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.931 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.99 -18.54 47.27 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.589 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.31 130.77 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 117.183 0.491 . . . . 0.0 110.926 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -74.78 140.78 44.25 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.172 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.659 HD21 ' CB ' ' A' ' 76' ' ' ALA . 9.8 tp -114.83 16.27 17.33 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.416 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.13 -34.57 71.17 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.807 -0.178 . . . . 0.0 111.425 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.88 12.03 38.42 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.3 m -103.51 154.36 19.54 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.776 0.322 . . . . 0.0 111.191 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.22 161.0 15.91 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.283 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.588 ' O ' HG23 ' A' ' 77' ' ' VAL . 8.4 t-80 -54.1 -52.4 61.13 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.037 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -61.57 -38.36 87.23 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.028 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -65.23 -40.91 94.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.824 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.659 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -63.41 -34.38 77.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.481 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 73' ' ' HIS . 21.9 t -61.81 -43.76 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.72 0.295 . . . . 0.0 110.694 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.9 m -69.67 -44.92 69.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.005 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.4 mt -62.95 -47.99 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.482 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.548 HD12 ' N ' ' A' ' 81' ' ' SER . 4.4 pp -63.51 -33.62 75.98 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.46 0.172 . . . . 0.0 111.09 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.548 ' N ' HD12 ' A' ' 80' ' ' LEU . 12.7 t -66.64 -30.79 71.14 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.151 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -65.31 -29.24 69.97 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.147 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -60.88 115.14 3.47 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.725 0.298 . . . . 0.0 110.651 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -115.01 143.83 44.56 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.961 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.18 -100.8 0.27 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.567 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -77.39 119.5 21.09 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.738 0.304 . . . . 0.0 110.544 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.0 mt -129.83 122.47 54.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.101 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -94.6 126.95 40.22 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.355 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -124.52 129.43 50.59 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.899 0.38 . . . . 0.0 111.391 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.467 ' HG3' ' HD2' ' A' ' 12' ' ' LYS . 6.5 tt0 -119.9 115.57 24.07 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.233 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.875 HG12 ' HA ' ' A' ' 60' ' ' ILE . 17.0 m -138.25 169.02 19.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.0 0.429 . . . . 0.0 111.888 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 9' ' ' PRO . 32.2 t -129.5 138.53 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.751 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.27 124.18 21.52 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.87 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.698 HG21 ' HB2' ' A' ' 59' ' ' ALA . 21.7 t -126.46 130.82 71.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.242 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 94' ' ' VAL . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.588 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.45 ' O ' HG13 ' A' ' 92' ' ' VAL . 4.0 Cg_endo . . . . . 0 N--CA 1.49 1.281 0 CA-C-O 120.679 0.2 . . . . 0.0 111.983 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.529 ' HA ' HG22 ' A' ' 92' ' ' VAL . 1.0 OUTLIER -78.86 115.74 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.12 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -122.18 127.14 49.66 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.068 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.35 114.22 26.34 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.82 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.0 t -111.26 144.57 18.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.827 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.0 tt -97.72 122.09 40.4 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.594 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.516 HD21 ' HB2' ' A' ' 47' ' ' PRO . 0.5 OUTLIER -108.92 123.61 49.36 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.256 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tt -107.76 115.51 30.27 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.708 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -130.33 139.4 50.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.55 164.29 23.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.993 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.11 -38.5 73.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.969 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -76.71 -29.54 56.28 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.079 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -77.25 176.04 9.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.724 0.297 . . . . 0.0 111.38 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -132.99 -144.26 5.19 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.05 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.546 HD11 HD22 ' A' ' 80' ' ' LEU . 7.6 mt -94.11 -67.7 0.84 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.549 0.214 . . . . 0.0 111.141 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.02 4.58 51.02 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.723 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.75 HG22 HG23 ' A' ' 42' ' ' ILE . 2.6 pp -137.12 157.79 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 117.287 0.544 . . . . 0.0 111.321 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.6 m -112.99 136.71 52.38 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.822 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.551 HD12 HG21 ' A' ' 37' ' ' ILE . 2.7 pt -117.64 158.14 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.364 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 t -143.48 153.97 43.18 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.289 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.31 -167.1 24.28 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.619 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.18 122.28 0.64 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.842 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.19 -37.76 78.19 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.658 0.266 . . . . 0.0 111.058 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -59.04 -31.2 68.63 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.936 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -80.27 -28.02 38.45 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.108 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.04 30.35 4.83 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.958 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 6.8 m -146.48 132.96 9.73 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-N 116.76 0.28 . . . . 0.0 111.162 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 34.4 Cg_exo -61.26 157.41 40.35 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.718 2.279 . . . . 0.0 112.049 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.551 HG21 HD12 ' A' ' 27' ' ' ILE . 21.9 mm -82.18 135.19 25.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.563 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 pp -138.65 155.99 47.81 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.934 0.397 . . . . 0.0 111.513 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.917 HD13 HD21 ' A' ' 54' ' ' LEU . 19.3 mt -79.97 125.78 39.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.948 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.7 t -101.63 -42.42 6.22 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.623 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -127.94 150.55 49.84 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.982 0.42 . . . . 0.0 111.796 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.75 HG23 HG22 ' A' ' 25' ' ' ILE . 37.6 mt -132.91 122.67 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.571 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -82.59 132.2 52.82 Favored Pre-proline 0 N--CA 1.462 0.162 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.928 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.92 148.19 40.19 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.747 2.298 . . . . 0.0 112.58 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.42 37.99 46.08 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.65 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.9 172.49 7.25 Favored Pre-proline 0 C--O 1.233 0.191 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.516 ' HB2' HD21 ' A' ' 15' ' ' LEU . 76.2 Cg_exo -50.86 -32.4 37.26 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.669 2.246 . . . . 0.0 112.916 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.475 ' CB ' HD13 ' A' ' 54' ' ' LEU . . . -66.07 -46.27 78.33 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.088 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.28 -40.05 77.98 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.683 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -60.04 -31.7 70.22 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.395 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 m -76.53 -27.98 56.18 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.46 16.75 67.79 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.132 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.01 -35.15 1.54 Allowed Glycine 0 C--N 1.337 0.593 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.834 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.917 HD21 HD13 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -69.24 105.51 2.54 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.818 0.342 . . . . 0.0 110.907 -179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.469 ' C ' HD11 ' A' ' 42' ' ' ILE . 19.2 p80 -111.98 157.34 20.83 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.208 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.4 t -62.86 137.97 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.61 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.89 53.36 7.21 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.627 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -111.93 120.8 43.14 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.3 126.75 36.48 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.866 0.365 . . . . 0.0 111.854 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.848 ' HA ' HG12 ' A' ' 91' ' ' VAL . 3.4 mt -85.83 149.9 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.907 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.2 mt -135.47 -50.0 0.73 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.874 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.68 145.69 45.05 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.745 0.307 . . . . 0.0 111.432 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.1 t -135.1 115.99 19.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 56.54 36.83 28.2 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.806 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.28 -14.4 50.39 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.429 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.3 t -83.92 136.49 22.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 117.19 0.495 . . . . 0.0 110.923 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -76.91 137.53 39.16 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.285 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.401 HD11 ' HB1' ' A' ' 76' ' ' ALA . 0.4 OUTLIER -114.97 -1.53 13.08 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.652 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -71.31 -34.15 70.33 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.35 12.19 33.8 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 64.7 p -103.88 138.61 40.21 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.655 0.264 . . . . 0.0 110.939 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.35 161.16 30.79 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.816 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.537 ' O ' HG23 ' A' ' 77' ' ' VAL . 10.3 t-80 -53.91 -49.28 68.98 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.956 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.95 -41.94 99.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.683 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.7 -39.58 94.47 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.105 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.615 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.64 -34.28 77.49 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.476 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 73' ' ' HIS . 39.7 t -62.04 -43.01 97.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.791 0.329 . . . . 0.0 110.311 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 m -63.8 -44.37 93.49 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.74 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 76' ' ' ALA . 12.5 mt -62.86 -41.2 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.955 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.546 HD22 HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -59.12 -41.72 88.89 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.833 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.6 m -69.2 -27.12 65.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.442 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -65.08 -28.16 69.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.42 0.152 . . . . 0.0 111.139 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.529 ' HB3' HG23 ' A' ' 87' ' ' ILE . 50.9 mm-40 -67.06 117.33 8.96 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.65 0.262 . . . . 0.0 110.938 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.96 143.68 44.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.071 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.61 -106.88 0.95 Allowed Glycine 0 C--N 1.337 0.604 0 C-N-CA 121.298 -0.477 . . . . 0.0 112.916 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -78.6 122.78 26.36 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.661 0.267 . . . . 0.0 110.465 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.529 HG23 ' HB3' ' A' ' 83' ' ' GLN . 13.4 mt -127.7 123.12 60.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.404 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -93.84 123.89 37.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.232 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.523 ' HZ ' HD21 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -117.51 133.2 56.23 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.855 0.359 . . . . 0.0 111.654 -179.299 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.88 115.51 23.97 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.421 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.848 HG12 ' HA ' ' A' ' 60' ' ' ILE . 15.0 m -136.97 169.69 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.743 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.529 HG22 ' HA ' ' A' ' 10' ' ' ILE . 23.4 t -136.95 133.7 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.666 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.44 117.85 8.54 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.791 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 13.3 p -99.4 126.82 52.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.859 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.234 -179.601 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.489 1.22 0 CA-C-O 120.843 0.268 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.662 ' HA ' HG12 ' A' ' 92' ' ' VAL . 1.0 OUTLIER -79.87 127.39 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.175 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.67 128.28 55.22 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.104 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -100.32 117.57 34.81 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.799 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.594 HG23 ' HB3' ' A' ' 89' ' ' PHE . 5.0 m -127.52 128.43 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.461 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 tp -105.02 120.29 41.11 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.088 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 tp -108.72 137.01 47.35 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.685 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.4 114.94 28.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.786 0.326 . . . . 0.0 110.877 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.555 ' HB3' HD11 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -117.72 132.59 56.45 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.029 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.44 169.73 8.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.699 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.404 ' HA ' ' NH1' ' A' ' 84' ' ' ARG . 53.1 m-20 -57.31 -38.44 74.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.921 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -81.65 -26.27 34.9 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.726 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -88.9 153.35 21.12 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.973 0.416 . . . . 0.0 111.606 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.35 -149.7 15.75 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.804 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.38 -65.63 0.96 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.545 0.212 . . . . 0.0 111.209 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.01 4.42 60.09 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.525 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.684 HG22 HG23 ' A' ' 42' ' ' ILE . 10.4 pt -142.17 151.8 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 117.389 0.594 . . . . 0.0 111.337 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.0 136.76 49.52 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.781 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.1 pt -124.84 158.74 32.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.421 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.0 t -143.11 150.92 40.14 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.135 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.82 -148.17 17.2 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.576 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.458 ' HA2' HD11 ' A' ' 37' ' ' ILE . . . 155.54 111.65 0.39 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.532 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -58.25 -30.28 66.43 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.455 0.169 . . . . 0.0 111.205 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -58.66 -31.37 68.12 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.006 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -86.06 -24.3 26.4 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.235 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.0 27.37 2.98 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.154 -0.546 . . . . 0.0 113.003 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.6 m -142.37 138.78 16.81 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.923 0.361 . . . . 0.0 110.966 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.48 155.77 65.92 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.52 2.147 . . . . 0.0 112.322 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.458 HD11 ' HA2' ' A' ' 30' ' ' GLY . 23.6 mm -84.15 125.3 40.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.754 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.09 145.13 50.46 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.09 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.578 HD12 ' HB3' ' A' ' 58' ' ' ASP . 23.9 mt -85.31 120.64 35.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.852 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.3 -37.04 5.86 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.476 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -117.65 149.64 40.36 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.765 0.317 . . . . 0.0 111.198 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.684 HG23 HG22 ' A' ' 25' ' ' ILE . 24.2 mt -134.28 113.42 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.766 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -72.83 127.02 90.27 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.293 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.0 166.07 28.66 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.819 2.346 . . . . 0.0 112.789 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.21 23.45 74.77 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.71 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -131.82 172.77 6.79 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.01 -22.01 29.2 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.484 2.123 . . . . 0.0 113.206 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.536 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -60.32 -46.94 88.1 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -71.41 -38.03 71.46 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.671 0.272 . . . . 0.0 110.57 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -67.03 -27.72 67.64 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.015 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 7.5 t -70.28 -28.03 64.89 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.338 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.62 -60.52 3.69 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.737 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.48 -26.18 37.02 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 121.447 -0.406 . . . . 0.0 113.39 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.463 HD11 HG21 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -65.09 92.12 0.1 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.009 0.433 . . . . 0.0 110.502 179.658 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -119.19 157.65 27.54 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.294 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.0 m -63.77 138.86 22.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.49 46.14 7.02 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.739 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.578 ' HB3' HD12 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -111.99 127.82 55.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.416 0.15 . . . . 0.0 110.954 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -94.65 125.24 39.17 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.192 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.909 ' HA ' HG12 ' A' ' 91' ' ' VAL . 3.3 mt -80.14 136.85 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.461 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.24 -52.07 2.6 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.944 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.07 156.06 42.7 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.813 0.34 . . . . 0.0 111.55 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.2 t -138.51 115.76 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.761 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.401 ' HB2' ' OE1' ' A' ' 83' ' ' GLN . 4.2 t-20 55.28 42.49 30.3 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.063 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.42 2.01 62.34 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.307 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.6 t -97.27 122.59 48.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 117.149 0.474 . . . . 0.0 110.508 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -66.31 128.51 36.42 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.541 HD22 HG21 ' A' ' 60' ' ' ILE . 1.9 tp -103.84 -17.07 15.19 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.789 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.6 ttm105 -61.17 -32.5 72.23 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -98.75 7.0 46.57 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -101.92 148.11 25.73 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.746 0.307 . . . . 0.0 110.97 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.79 161.08 23.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.605 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.59 ' O ' HG23 ' A' ' 77' ' ' VAL . 58.5 t-80 -54.12 -49.66 68.66 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.958 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -40.68 90.46 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.926 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -64.75 -38.69 91.83 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.19 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.432 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.69 -34.98 79.06 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.272 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 73' ' ' HIS . 39.1 t -61.7 -42.08 92.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.38 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -44.77 93.82 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.697 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 76' ' ' ALA . 21.7 mt -63.84 -46.47 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.04 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.447 HD21 ' HZ ' ' A' ' 89' ' ' PHE . 0.4 OUTLIER -55.61 -41.33 73.32 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.112 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.94 -34.3 77.47 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.983 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -65.74 -24.82 67.04 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.422 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.45 ' HB2' HD13 ' A' ' 87' ' ' ILE . 32.5 mm-40 -63.38 103.98 0.57 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.769 0.319 . . . . 0.0 110.766 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.404 ' NH1' ' HA ' ' A' ' 19' ' ' ASP . 11.0 mmt180 -112.06 155.03 24.49 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.073 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.07 -103.23 0.68 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.39 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.61 130.97 44.6 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.706 0.289 . . . . 0.0 110.551 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.555 HD11 ' HB3' ' A' ' 17' ' ' LYS . 14.2 mt -126.19 122.48 61.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -93.91 122.87 36.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.444 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.594 ' HB3' HG23 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -116.88 134.17 55.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.991 0.424 . . . . 0.0 111.438 -179.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -122.69 115.44 22.08 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.096 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.909 HG12 ' HA ' ' A' ' 60' ' ' ILE . 25.9 m -138.52 170.27 16.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.59 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.662 HG12 ' HA ' ' A' ' 10' ' ' ILE . 6.2 m -134.96 136.77 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.863 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.78 121.83 16.31 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.961 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.5 t -115.28 137.47 48.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.086 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.387 179.92 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.433 ' O ' HG13 ' A' ' 92' ' ' VAL . 4.4 Cg_endo . . . . . 0 N--CA 1.49 1.301 0 CA-C-O 120.671 0.196 . . . . 0.0 111.884 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 tt -83.29 141.31 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.379 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -122.45 132.82 54.53 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.122 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -103.48 111.96 24.65 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.501 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.7 t -118.22 138.13 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.815 0.341 . . . . 0.0 111.338 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.779 HD21 ' HG3' ' A' ' 86' ' ' GLU . 2.5 tt -108.34 127.54 53.96 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.855 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 tp -115.01 144.1 44.15 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.034 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mt -109.22 116.17 31.39 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.964 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.57 137.86 52.31 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.07 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -114.99 167.66 10.6 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.706 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.82 -38.21 72.28 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.192 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -84.07 -25.26 29.94 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.529 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -92.08 173.91 7.59 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.787 0.327 . . . . 0.0 111.498 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -132.83 -146.4 5.59 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.998 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 mt -82.79 -66.59 0.87 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.525 0.203 . . . . 0.0 111.168 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.16 4.52 35.54 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.694 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.769 HD13 HD12 ' A' ' 39' ' ' ILE . 1.5 pp -146.44 147.96 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 117.297 0.549 . . . . 0.0 111.114 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.1 t -101.85 137.84 39.61 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.727 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.743 HG22 HD13 ' A' ' 39' ' ' ILE . 16.2 pt -116.11 153.82 17.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.543 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.9 t -141.9 152.16 43.31 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.37 -152.55 19.82 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.496 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . 166.57 119.74 0.49 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.934 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.91 -35.61 75.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.522 0.201 . . . . 0.0 111.328 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.39 -31.03 65.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.139 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -78.48 -27.52 46.26 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.138 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.76 26.53 5.54 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.807 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 13.1 m -141.1 133.29 14.02 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 116.787 0.293 . . . . 0.0 111.082 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 34.4 Cg_exo -61.27 157.6 39.47 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.823 2.349 . . . . 0.0 112.157 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.569 ' O ' HD12 ' A' ' 60' ' ' ILE . 23.5 mm -82.48 130.68 35.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.733 0.301 . . . . 0.0 110.44 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.561 HD12 ' C ' ' A' ' 37' ' ' ILE . 9.7 mp -121.78 156.29 33.5 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.604 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.769 HD12 HD13 ' A' ' 25' ' ' ILE . 17.8 mm -88.05 124.83 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.402 ' O ' HG13 ' A' ' 56' ' ' VAL . 3.1 m -117.73 -45.02 2.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.557 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.51 145.23 33.39 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.796 0.331 . . . . 0.0 111.254 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.617 HG23 HG22 ' A' ' 25' ' ' ILE . 12.6 mt -132.94 113.46 20.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.566 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -71.76 126.45 91.48 Favored Pre-proline 0 C--O 1.232 0.145 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.823 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.8 154.39 63.63 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.774 2.316 . . . . 0.0 112.624 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.38 32.95 80.66 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.774 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.96 175.19 3.81 Favored Pre-proline 0 C--O 1.233 0.213 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -51.13 -33.11 42.5 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.672 2.248 . . . . 0.0 112.774 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.4 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -58.03 -46.14 85.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.214 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.12 -38.75 72.31 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.837 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -61.62 -33.96 74.83 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.795 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.5 p -90.35 -27.36 19.43 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.598 0.221 . . . . 0.0 111.598 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.58 16.14 65.04 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.109 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.68 -28.7 5.87 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.403 -0.427 . . . . 0.0 112.73 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.45 HD22 HG21 ' A' ' 25' ' ' ILE . 3.5 mt -77.1 71.72 3.6 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.245 0.545 . . . . 0.0 110.497 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -86.1 157.41 20.05 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.278 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 40' ' ' SER . 26.1 t -66.42 137.95 23.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.065 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.25 36.58 9.72 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.543 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -100.29 150.1 22.92 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.55 121.08 37.63 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.619 0.247 . . . . 0.0 111.416 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.831 ' HA ' HG12 ' A' ' 91' ' ' VAL . 2.0 mt -81.72 148.05 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.519 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 36.8 mt -131.44 -51.51 1.0 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.993 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.73 145.81 47.04 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.911 0.386 . . . . 0.0 111.759 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.436 ' CG2' HD13 ' A' ' 68' ' ' LEU . 21.7 t -127.74 115.67 40.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.294 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 57.4 34.24 24.39 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.656 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.05 -19.02 44.85 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.68 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.8 t -88.05 137.37 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 117.268 0.534 . . . . 0.0 111.078 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -71.26 132.81 45.48 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.265 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.524 HD22 HG21 ' A' ' 60' ' ' ILE . 7.6 tp -89.95 -29.36 18.54 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.183 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -18.93 65.41 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.775 -0.193 . . . . 0.0 111.394 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.14 9.22 34.45 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.4 t -133.77 165.69 24.39 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.559 0.219 . . . . 0.0 110.751 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.05 161.0 16.79 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.064 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.662 ' O ' HG23 ' A' ' 77' ' ' VAL . 53.6 t-80 -55.66 -51.4 67.36 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.181 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -61.38 -43.13 99.4 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.889 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.0 -38.26 88.03 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.917 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.75 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.79 -30.73 71.79 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.564 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 73' ' ' HIS . 22.1 t -61.86 -45.02 99.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 120.789 0.328 . . . . 0.0 110.312 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.4 -40.14 96.4 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.595 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.75 HD12 ' HA ' ' A' ' 76' ' ' ALA . 34.5 mt -61.09 -41.73 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.884 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.434 HD23 HG11 ' A' ' 63' ' ' VAL . 69.4 mt -61.71 -39.23 90.77 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.783 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.6 m -64.39 -32.48 74.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.895 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -65.18 -29.25 70.06 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.243 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -65.43 106.33 1.37 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.759 0.314 . . . . 0.0 110.808 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.52 148.7 29.87 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.222 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.94 -100.95 0.43 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.618 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.779 ' HG3' HD21 ' A' ' 14' ' ' LEU . 9.2 tt0 -88.37 128.34 35.51 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.645 0.259 . . . . 0.0 110.436 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.0 mt -128.96 122.5 56.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.149 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -97.14 138.49 34.57 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.814 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -133.37 129.91 38.06 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.088 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -113.25 115.2 27.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.272 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.831 HG12 ' HA ' ' A' ' 60' ' ' ILE . 26.8 m -134.91 169.36 21.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.511 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 9' ' ' PRO . 17.6 t -138.66 136.53 43.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.937 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.55 123.58 22.17 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.753 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.7 m -122.58 113.35 37.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.078 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.453 -179.715 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.489 1.217 0 CA-C-O 120.689 0.204 . . . . 0.0 111.834 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.424 ' HA ' HG22 ' A' ' 92' ' ' VAL . 3.7 mp -79.18 140.19 17.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.185 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.16 132.74 54.61 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.994 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.84 118.2 35.99 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.607 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.2 m -128.94 142.17 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.394 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 87' ' ' ILE . 1.7 mt -105.45 122.55 46.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -109.79 139.66 44.59 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.953 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 49.9 mt -111.77 119.08 37.39 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.768 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.41 ' HB2' ' CD1' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -107.64 130.56 54.9 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.991 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.69 163.72 16.43 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.95 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.38 -38.57 71.64 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.185 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -86.39 -23.5 26.1 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.801 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -92.53 161.34 14.65 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.933 0.396 . . . . 0.0 111.232 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.87 -158.88 10.0 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.91 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.737 HD21 ' CD2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -71.98 -67.43 0.54 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.575 0.226 . . . . 0.0 110.982 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.63 4.43 67.78 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.701 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.855 HG22 HG23 ' A' ' 42' ' ' ILE . 2.3 pt -136.77 143.73 34.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 117.459 0.63 . . . . 0.0 111.331 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.2 m -105.17 136.61 44.34 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.716 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.847 HG22 HD13 ' A' ' 39' ' ' ILE . 43.5 pt -121.98 155.7 26.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.483 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.8 p -139.35 173.88 11.09 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.368 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.74 -159.49 19.05 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.668 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.427 ' H ' HG23 ' A' ' 35' ' ' VAL . . . 170.53 125.07 0.78 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.861 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -61.06 -37.79 83.91 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.455 0.169 . . . . 0.0 111.289 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.4 -31.22 72.33 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.206 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -78.38 -29.26 47.26 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.108 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.77 30.24 3.56 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.93 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.427 HG23 ' H ' ' A' ' 30' ' ' GLY . 14.8 m -144.06 132.62 11.09 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-N 116.838 0.319 . . . . 0.0 111.108 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.556 ' O ' HD12 ' A' ' 38' ' ' LEU . 26.7 Cg_exo -61.14 157.33 40.2 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.614 2.209 . . . . 0.0 112.153 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.491 HD12 ' ND1' ' A' ' 73' ' ' HIS . 24.6 mm -83.75 127.99 39.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.632 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.556 HD12 ' O ' ' A' ' 36' ' ' PRO . 5.3 mp -130.1 149.97 51.58 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.407 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.847 HD13 HG22 ' A' ' 27' ' ' ILE . 30.5 mm -75.98 114.9 16.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.577 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.444 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.7 OUTLIER -84.11 -45.9 12.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.382 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -145.04 161.51 39.24 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.861 0.362 . . . . 0.0 111.273 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.855 HG23 HG22 ' A' ' 25' ' ' ILE . 4.0 mp -132.13 116.69 30.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.68 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -65.9 133.48 94.91 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.069 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.91 153.08 47.37 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.797 2.331 . . . . 0.0 112.756 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.57 31.5 62.88 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.676 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.442 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.2 OUTLIER -129.34 169.4 13.27 Favored Pre-proline 0 C--O 1.233 0.196 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.442 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 9.8 Cg_endo -53.92 -26.98 42.35 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.684 2.256 . . . . 0.0 112.721 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -57.37 -46.07 83.75 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.197 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.62 -38.63 73.95 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.862 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -56.83 -39.41 74.18 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.244 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.66 -27.76 64.28 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.755 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.79 19.96 75.51 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.678 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -119.8 -31.68 1.3 Allowed Glycine 0 C--N 1.338 0.681 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.17 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.647 HD12 HG21 ' A' ' 25' ' ' ILE . 4.3 mm? -70.01 89.2 0.6 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.104 0.478 . . . . 0.0 110.413 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -111.08 157.54 19.87 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.339 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 40' ' ' SER . 20.7 t -63.19 140.05 20.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.291 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.15 52.92 8.24 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.871 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -112.19 139.02 48.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.22 0.208 . . . . 0.0 111.211 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.65 127.14 53.4 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.895 HG21 HD13 ' A' ' 68' ' ' LEU . 2.8 mt -91.54 148.08 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 120.852 0.358 . . . . 0.0 111.631 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 78.8 mt -133.33 -52.94 0.89 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.806 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.99 147.68 46.42 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.865 0.364 . . . . 0.0 111.385 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.32 115.66 16.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.409 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 57.99 33.36 23.1 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.214 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.76 -16.03 57.64 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.24 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.7 t -88.68 137.33 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 117.065 0.433 . . . . 0.0 110.912 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -76.5 135.58 39.34 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.305 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.895 HD13 HG21 ' A' ' 60' ' ' ILE . 1.1 tt -96.71 -26.71 15.07 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.406 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -18.1 63.15 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -97.52 11.78 35.67 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 t -133.48 150.69 51.72 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.752 0.311 . . . . 0.0 111.11 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -75.67 161.25 29.25 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.359 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.598 ' O ' HG23 ' A' ' 77' ' ' VAL . 1.7 t60 -53.92 -52.03 61.88 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.104 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -61.84 -42.44 99.04 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.947 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -64.61 -38.54 91.36 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.102 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.59 -33.31 75.33 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.363 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 73' ' ' HIS . 37.2 t -62.09 -43.7 98.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.76 0.314 . . . . 0.0 110.341 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 29.3 m -60.54 -43.6 97.03 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.602 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 64.7 mt -58.45 -42.72 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.623 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.737 ' CD2' HD21 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -57.25 -40.75 78.27 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.838 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.5 t -62.79 -36.26 82.54 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.773 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -65.35 -24.89 67.37 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.269 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.479 ' HB3' HG23 ' A' ' 87' ' ' ILE . 38.2 mm-40 -65.45 91.48 0.12 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.932 0.396 . . . . 0.0 110.755 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.37 149.61 24.6 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.984 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.46 -98.7 0.29 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.291 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -92.75 137.6 32.22 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.703 0.287 . . . . 0.0 110.524 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.487 ' O ' HD23 ' A' ' 14' ' ' LEU . 15.0 mt -137.62 124.44 28.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -101.27 129.9 47.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.694 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.89 129.03 54.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.782 0.325 . . . . 0.0 110.786 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.72 116.3 25.66 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.017 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.857 HG12 ' HA ' ' A' ' 60' ' ' ILE . 9.0 m -138.85 171.6 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.985 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 10' ' ' ILE . 21.6 t -137.18 132.16 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.722 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.66 127.46 33.04 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.724 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.5 t -114.84 135.33 55.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.364 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.44 -0.79 . . . . 0.0 111.11 179.802 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo . . . . . 0 N--CA 1.489 1.252 0 CA-C-O 120.685 0.202 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.726 ' HA ' HG12 ' A' ' 92' ' ' VAL . 31.3 mt -87.3 142.27 13.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.166 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -122.04 129.25 52.26 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.95 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.4 118.2 36.15 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.694 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.1 t -127.7 141.25 46.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.379 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.5 mt -102.54 128.13 49.32 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 tp -112.87 136.98 51.91 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.142 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.63 116.37 31.86 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.826 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.438 ' HG2' HD12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -129.17 153.96 47.21 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.113 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.99 164.17 13.43 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.038 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -57.63 -38.53 75.14 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.966 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -79.33 -27.94 42.1 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.298 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.68 161.84 22.01 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.849 0.357 . . . . 0.0 111.324 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.32 -146.31 19.22 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.944 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.3 tp -87.64 -52.74 5.16 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.552 0.215 . . . . 0.0 111.319 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.12 -11.64 51.99 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.418 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.662 HD12 HD13 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -140.35 151.89 21.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.931 0.366 . . . . 0.0 111.041 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.435 ' O ' HG23 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -108.51 136.71 47.66 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.029 179.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.443 HG21 HD11 ' A' ' 60' ' ' ILE . 14.8 pt -116.15 153.22 17.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.489 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.8 t -143.59 145.64 32.67 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.012 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.71 -170.07 15.95 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.497 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.92 122.5 0.82 Allowed Glycine 0 C--N 1.335 0.528 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.801 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -30.27 65.47 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -30.94 65.35 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.61 0.243 . . . . 0.0 111.069 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -79.45 -32.66 42.74 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.978 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.95 -29.9 3.02 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.669 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 11.6 m -101.86 132.83 21.18 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-O 120.707 0.289 . . . . 0.0 111.196 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 35.6 Cg_exo -61.09 157.21 40.44 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.799 2.333 . . . . 0.0 112.295 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.46 ' H ' HD12 ' A' ' 37' ' ' ILE . 3.9 mp -83.25 138.02 19.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.817 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.44 163.12 31.21 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.295 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 26' ' ' SER . 25.5 mt -85.28 120.19 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.262 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.469 ' O ' HG13 ' A' ' 56' ' ' VAL . 2.6 t -108.43 -33.07 7.18 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.633 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.37 144.93 44.42 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.677 0.275 . . . . 0.0 111.126 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.48 HG23 HG22 ' A' ' 25' ' ' ILE . 22.3 mm -125.96 121.63 60.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.647 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -75.73 121.07 84.35 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.881 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.8 155.57 62.27 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.774 2.316 . . . . 0.0 112.545 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.93 38.24 95.8 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.354 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.77 176.06 3.17 Favored Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.33 -29.5 30.49 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.643 2.228 . . . . 0.0 112.77 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' A' ' 54' ' ' LEU . . . -58.16 -46.19 86.15 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.992 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.55 -42.11 75.01 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.763 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -59.73 -33.27 71.42 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.429 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.2 t -83.35 -28.19 29.16 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.85 16.66 59.64 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.091 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.88 -29.39 2.86 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.197 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.662 HD13 HD12 ' A' ' 25' ' ' ILE . 32.0 mt -76.09 71.84 2.87 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.142 0.496 . . . . 0.0 110.753 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -84.15 157.25 21.75 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.058 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 40' ' ' SER . 23.4 t -65.08 135.01 28.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.44 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.25 47.11 3.91 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.554 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.06 124.28 51.2 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.5 121.2 32.98 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.722 0.296 . . . . 0.0 111.194 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.757 ' HA ' HG12 ' A' ' 91' ' ' VAL . 7.5 mt -70.72 142.2 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.575 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.4 mt -127.29 -53.82 1.37 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.969 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.54 158.76 43.99 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.882 0.372 . . . . 0.0 111.813 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.517 HG22 ' CE1' ' A' ' 89' ' ' PHE . 15.1 t -133.66 117.52 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.727 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.08 37.47 28.64 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.95 0.405 . . . . 0.0 110.964 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.52 6.09 89.43 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.441 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.4 t -97.79 119.95 46.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 117.278 0.539 . . . . 0.0 110.699 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -63.83 126.79 28.75 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.454 HD13 HG23 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -113.02 4.19 16.57 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.686 179.817 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -68.84 -34.83 76.14 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.447 0.165 . . . . 0.0 111.133 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.67 11.9 33.54 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.47 HG21 ' CD1' ' A' ' 79' ' ' ILE . 15.8 m -100.97 156.39 17.42 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.645 0.259 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -92.62 161.22 14.66 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.535 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.438 ' O ' HG23 ' A' ' 77' ' ' VAL . 30.2 t-80 -54.47 -50.69 67.13 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.054 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.16 -39.5 90.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.788 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.56 -38.78 92.18 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.059 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.676 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.6 -32.79 74.37 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.362 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 73' ' ' HIS . 40.8 t -61.85 -41.53 91.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.763 0.316 . . . . 0.0 110.56 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -41.89 74.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.899 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' A' ' 76' ' ' ALA . 11.6 mt -62.74 -48.69 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.651 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 81' ' ' SER . 4.2 pp -62.36 -35.17 78.29 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.019 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.511 ' N ' HD12 ' A' ' 80' ' ' LEU . 2.3 m -65.91 -33.88 76.85 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.136 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -65.26 -27.74 68.86 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.232 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.456 ' HB3' HG23 ' A' ' 87' ' ' ILE . 46.7 mm-40 -65.16 111.74 3.08 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.904 0.383 . . . . 0.0 111.119 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -105.19 143.79 32.88 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.109 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.77 -105.12 0.83 Allowed Glycine 0 C--N 1.337 0.59 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.894 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -81.2 127.16 32.37 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.723 0.297 . . . . 0.0 110.665 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.456 HG23 ' HB3' ' A' ' 83' ' ' GLN . 11.2 mt -127.95 122.39 58.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.05 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -93.87 130.77 39.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.438 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE1' HG22 ' A' ' 63' ' ' VAL . 0.5 OUTLIER -126.25 129.75 49.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.764 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.03 115.17 29.29 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.308 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.757 HG12 ' HA ' ' A' ' 60' ' ' ILE . 15.5 m -135.62 164.03 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.352 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.726 HG12 ' HA ' ' A' ' 10' ' ' ILE . 13.1 m -129.45 133.54 65.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.838 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.09 117.24 8.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.879 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.6 m -123.76 118.31 53.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.108 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.354 -0.831 . . . . 0.0 111.391 -179.712 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.448 ' O ' HG13 ' A' ' 92' ' ' VAL . 5.2 Cg_exo . . . . . 0 N--CA 1.489 1.246 0 CA-C-O 120.802 0.251 . . . . 0.0 111.84 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.5 HD11 ' HG2' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -84.39 118.71 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.213 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.78 130.04 55.38 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.043 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.56 120.24 40.84 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.2 t -125.67 134.25 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.176 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 mt -98.38 124.7 43.19 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.855 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.1 131.55 54.5 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.57 115.42 28.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.777 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.46 129.73 33.66 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.94 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.17 170.71 9.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.992 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -59.27 -38.17 79.44 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.953 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -76.75 -25.77 53.84 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.715 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -91.51 167.61 12.12 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.918 0.39 . . . . 0.0 111.74 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.88 -166.48 12.85 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 115.932 -0.577 . . . . 0.0 113.03 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.981 HD12 HD11 ' A' ' 25' ' ' ILE . 0.3 OUTLIER -66.08 -68.33 0.38 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.517 0.199 . . . . 0.0 111.255 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.436 ' HA2' ' OE1' ' A' ' 46' ' ' GLN . . . 106.02 4.02 38.92 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.015 -0.612 . . . . 0.0 114.113 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.981 HD11 HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -145.13 153.92 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 117.341 0.571 . . . . 0.0 111.101 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.2 136.97 38.38 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.654 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.647 HD12 ' HE1' ' A' ' 73' ' ' HIS . 10.2 pt -116.77 143.59 26.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.292 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.2 t -123.2 158.03 31.72 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.173 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.3 -143.19 15.7 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.357 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.41 ' HA3' ' HB2' ' A' ' 73' ' ' HIS . . . 136.43 134.85 3.35 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.935 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -52.54 -31.15 34.3 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -57.56 -29.4 64.39 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.18 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -93.82 19.48 8.82 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.45 29.09 68.48 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.166 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 8.7 m -147.08 139.64 14.23 Favored Pre-proline 0 CA--C 1.529 0.163 0 CA-C-N 116.704 0.252 . . . . 0.0 111.402 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 29.7 Cg_exo -61.59 155.5 52.96 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.637 2.225 . . . . 0.0 112.229 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.84 139.11 17.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.865 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.746 HD23 ' HB2' ' A' ' 59' ' ' ALA . 1.1 mp -134.67 156.75 48.21 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.261 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.768 HD13 HD21 ' A' ' 54' ' ' LEU . 27.8 mt -87.6 129.55 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.567 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -121.19 -42.83 2.45 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.558 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.57 144.84 35.72 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.71 0.291 . . . . 0.0 111.159 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.727 HG23 HG22 ' A' ' 25' ' ' ILE . 41.0 mt -134.47 133.14 55.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.754 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -102.21 105.65 43.98 Favored Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.885 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.82 150.03 47.64 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.716 2.277 . . . . 0.0 112.545 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.13 -30.81 8.8 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.661 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.436 ' OE1' ' HA2' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -77.23 167.16 38.85 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-O 120.552 0.215 . . . . 0.0 110.754 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 13.6 Cg_endo -56.89 -29.01 80.15 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.68 2.253 . . . . 0.0 112.77 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.954 ' HB1' HD13 ' A' ' 54' ' ' LEU . . . -61.06 -46.07 92.17 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.784 0.326 . . . . 0.0 110.983 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -70.16 -39.48 75.31 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.744 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -61.69 -29.09 69.87 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.408 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.06 -28.31 63.25 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.34 -54.57 4.77 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.014 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.53 -34.57 27.63 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 121.542 -0.361 . . . . 0.0 113.509 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.954 HD13 ' HB1' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -71.17 93.71 1.09 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.112 0.482 . . . . 0.0 110.602 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -114.4 157.43 22.88 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.36 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 40' ' ' SER . 38.9 t -61.25 130.46 25.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.445 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.49 45.03 4.14 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.435 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.03 122.35 47.51 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 122.149 0.18 . . . . 0.0 110.739 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.746 ' HB2' HD23 ' A' ' 38' ' ' LEU . . . -91.14 122.66 33.96 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.639 0.257 . . . . 0.0 111.16 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.809 ' HA ' HG12 ' A' ' 91' ' ' VAL . 6.9 mt -76.72 145.79 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.412 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 mt -139.68 -51.48 0.51 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.123 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.47 146.02 50.27 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.972 0.415 . . . . 0.0 111.878 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.7 t -135.82 115.73 17.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.367 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 54.6 35.34 23.38 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.696 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.64 -18.68 45.21 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 120.993 -0.623 . . . . 0.0 113.713 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.21 128.03 48.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 117.315 0.557 . . . . 0.0 111.052 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -68.06 139.12 56.25 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.044 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.899 HD21 ' HB1' ' A' ' 76' ' ' ALA . 5.4 tp -108.85 13.2 25.03 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.382 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.2 ttp85 -71.18 -31.59 67.85 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.444 0.164 . . . . 0.0 111.433 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -102.3 10.83 38.91 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.73 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.433 HG22 ' HB3' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -108.04 132.71 53.26 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -64.59 158.52 24.07 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.149 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.647 ' HE1' HD12 ' A' ' 27' ' ' ILE . 1.3 t60 -56.66 -50.41 72.15 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.236 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -61.71 -39.32 91.07 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.516 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HB3' HG22 ' A' ' 71' ' ' THR . 13.5 tp10 -64.71 -38.0 89.51 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.84 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.899 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -63.92 -35.37 80.44 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.477 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 73' ' ' HIS . 23.0 t -61.95 -39.05 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.639 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 41.2 m -65.05 -48.64 73.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.641 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' A' ' 76' ' ' ALA . 7.8 mt -62.22 -42.65 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.796 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.16 -39.71 75.81 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.853 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -33.06 74.85 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.982 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -65.55 -27.89 68.76 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.325 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.419 ' HB3' HG23 ' A' ' 87' ' ' ILE . 74.2 mm-40 -61.13 114.07 2.92 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.77 0.319 . . . . 0.0 110.956 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.84 144.82 47.14 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.448 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.56 -104.78 1.13 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.513 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -88.01 122.1 31.2 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.753 0.311 . . . . 0.0 110.358 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.419 HG23 ' HB3' ' A' ' 83' ' ' GLN . 15.5 mt -122.02 125.61 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.968 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.79 127.89 39.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -121.94 129.9 52.89 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.094 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.5 ' HG2' HD11 ' A' ' 10' ' ' ILE . 16.9 tt0 -120.56 115.35 23.24 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.349 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.809 HG12 ' HA ' ' A' ' 60' ' ' ILE . 7.0 m -140.84 170.1 14.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.435 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 9' ' ' PRO . 25.1 t -132.55 139.55 49.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.875 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.09 120.2 12.75 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.839 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 92' ' ' VAL . 22.0 t -127.03 107.71 17.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.213 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.911 -179.855 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo . . . . . 0 N--CA 1.49 1.302 0 CA-C-O 120.643 0.185 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.736 ' HA ' HG12 ' A' ' 92' ' ' VAL . 4.9 mp -97.59 139.84 19.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.351 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -110.65 115.79 30.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.026 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -97.27 111.59 23.77 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.593 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.7 t -129.95 133.21 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.795 0.331 . . . . 0.0 111.326 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mt -100.97 134.98 43.15 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.583 HD11 HD12 ' A' ' 54' ' ' LEU . 3.4 mp -118.67 119.86 35.7 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.834 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -111.23 124.25 51.83 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.755 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.04 147.14 45.99 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.291 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -100.37 169.3 9.2 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.161 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.39 -37.98 82.48 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.947 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -72.77 -28.8 62.82 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.048 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -84.96 177.32 7.99 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.779 0.323 . . . . 0.0 111.144 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -125.05 -154.82 8.89 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.111 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.6 mt -71.51 -67.85 0.49 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.6 0.238 . . . . 0.0 111.153 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.7 4.38 63.74 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.059 -0.591 . . . . 0.0 113.71 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.437 HG21 ' CD1' ' A' ' 54' ' ' LEU . 2.5 pp -143.49 150.39 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 117.284 0.542 . . . . 0.0 111.252 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.524 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 1.1 m -121.62 136.93 54.93 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.733 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.732 HD12 HG21 ' A' ' 37' ' ' ILE . 31.5 pt -123.76 158.27 29.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.489 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -142.59 147.5 35.97 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.088 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.41 -159.59 21.41 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.45 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.23 120.43 0.52 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.613 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -55.22 -34.54 64.03 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.469 0.176 . . . . 0.0 111.354 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -31.23 65.6 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.082 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -77.5 -30.0 52.8 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.055 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.72 -29.96 3.04 Favored Glycine 0 C--N 1.335 0.472 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.888 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 11.5 m -109.48 138.15 20.49 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-O 120.708 0.289 . . . . 0.0 111.402 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 35.8 Cg_exo -61.11 157.17 40.77 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.761 2.308 . . . . 0.0 112.239 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.732 HG21 HD12 ' A' ' 27' ' ' ILE . 3.6 mp -82.36 136.98 21.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.832 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 pp -133.25 162.92 30.49 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.938 0.399 . . . . 0.0 111.672 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.571 HD13 HD21 ' A' ' 54' ' ' LEU . 18.4 mt -85.09 129.38 37.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.981 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.475 ' O ' HG13 ' A' ' 56' ' ' VAL . 70.9 m -117.13 -38.98 3.27 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.626 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.524 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 18.9 tt0 -114.37 145.96 41.16 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.938 0.399 . . . . 0.0 111.412 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.495 HD13 ' O ' ' A' ' 54' ' ' LEU . 26.4 mt -131.03 133.49 62.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.513 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -88.75 112.85 53.03 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.026 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.53 139.31 75.39 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.798 2.332 . . . . 0.0 112.401 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.53 -30.14 8.72 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.902 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.477 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -71.17 169.77 13.92 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.638 0.219 . . . . 0.0 110.921 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 7.1 Cg_endo -50.48 -30.52 27.84 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.753 2.302 . . . . 0.0 112.791 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.408 ' HB1' HD13 ' A' ' 54' ' ' LEU . . . -61.13 -46.01 92.33 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.711 0.291 . . . . 0.0 111.004 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.07 -38.94 75.89 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.776 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -58.1 -33.3 68.95 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.488 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.45 -28.01 64.69 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.575 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.84 15.76 60.56 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.859 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.81 -34.94 1.1 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.786 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.583 HD12 HD11 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -62.92 99.6 0.17 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.928 0.394 . . . . 0.0 110.513 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.426 ' CE1' ' CD2' ' A' ' 93' ' ' TYR . 11.4 p80 -110.43 156.69 20.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.014 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 40' ' ' SER . 38.3 t -63.86 132.58 29.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.74 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.94 46.89 2.56 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.635 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -112.59 118.97 36.55 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.96 123.49 34.49 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.928 0.394 . . . . 0.0 111.428 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.847 ' HA ' HG12 ' A' ' 91' ' ' VAL . 4.0 mt -76.51 134.12 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.785 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.4 mp -126.55 -49.78 1.51 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.565 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.76 145.54 48.52 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.323 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.486 HG23 HD13 ' A' ' 68' ' ' LEU . 25.3 t -139.47 116.59 10.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.543 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 57.95 33.75 23.54 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.999 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.55 -15.4 54.76 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.352 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.8 128.8 41.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 117.151 0.475 . . . . 0.0 110.789 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -80.86 141.23 34.82 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.733 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.486 HD13 HG23 ' A' ' 63' ' ' VAL . 2.7 mp -117.04 21.07 13.48 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.634 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.42 -34.07 70.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.385 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -103.73 8.49 37.29 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 50.9 p -96.06 179.98 4.88 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.655 0.264 . . . . 0.0 110.831 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.17 161.21 18.08 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.964 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.533 ' O ' HG23 ' A' ' 77' ' ' VAL . 13.6 t-80 -54.05 -51.01 65.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.973 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -60.57 -42.08 95.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.652 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.24 -37.98 89.38 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.957 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.529 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.59 -38.03 89.58 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.249 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.646 ' HA ' HD12 ' A' ' 80' ' ' LEU . 22.1 t -61.85 -44.41 98.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.702 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.7 m -62.51 -45.28 93.7 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.8 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 76' ' ' ALA . 11.8 mt -61.82 -40.55 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.918 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.646 HD12 ' HA ' ' A' ' 77' ' ' VAL . 12.9 mt -58.14 -39.01 77.67 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.661 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.6 t -67.58 -32.97 74.08 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.005 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -64.91 -28.64 69.67 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.307 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.497 ' HB3' HG23 ' A' ' 87' ' ' ILE . 63.1 mm-40 -64.08 110.53 2.19 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.747 0.308 . . . . 0.0 110.957 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -111.63 147.39 35.59 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.122 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.43 ' O ' HD13 ' A' ' 16' ' ' LEU . . . 62.91 -108.12 1.99 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.508 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.449 ' HA ' HD22 ' A' ' 16' ' ' LEU . 29.9 tt0 -82.14 124.8 30.19 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.712 0.291 . . . . 0.0 110.535 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.497 HG23 ' HB3' ' A' ' 83' ' ' GLN . 10.9 mt -124.76 122.32 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.975 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -94.06 129.77 40.46 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.891 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.12 129.78 51.44 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.267 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -123.58 115.19 21.09 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.022 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.847 HG12 ' HA ' ' A' ' 60' ' ' ILE . 16.5 m -138.67 170.6 16.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.222 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.736 HG12 ' HA ' ' A' ' 10' ' ' ILE . 22.9 m -132.9 138.82 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.808 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.426 ' CD2' ' CE1' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -67.17 116.02 7.5 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.733 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.8 p -101.68 133.8 44.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.184 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.24 -179.872 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 N--CA 1.49 1.309 0 CA-C-O 120.784 0.243 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.649 HG23 HG22 ' A' ' 92' ' ' VAL . 4.9 mp -96.84 143.47 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.136 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.96 145.88 48.87 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.19 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.1 mmtm -114.72 111.47 21.33 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.827 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.1 t -112.85 131.23 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.037 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mp -102.82 126.46 49.97 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.414 HD21 ' HB2' ' A' ' 47' ' ' PRO . 1.9 tt -117.58 141.32 48.51 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.224 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.41 127.11 54.13 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.794 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -104.34 121.61 43.72 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.138 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -100.46 156.64 17.16 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.993 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -58.29 -38.29 76.72 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.177 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -86.14 -22.07 27.25 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.32 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -90.03 176.63 6.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.815 0.34 . . . . 0.0 111.282 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.02 -145.37 4.66 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.835 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 25' ' ' ILE . 30.8 tp -77.36 -63.16 1.44 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.535 0.207 . . . . 0.0 110.939 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.74 4.52 87.31 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.035 -0.602 . . . . 0.0 114.037 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.847 HG22 HG23 ' A' ' 42' ' ' ILE . 6.1 pt -139.85 164.16 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 117.348 0.574 . . . . 0.0 111.369 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 9.0 t -121.51 137.33 54.77 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.917 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.757 HG22 HD13 ' A' ' 39' ' ' ILE . 12.4 pt -115.83 152.1 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.632 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.3 p -137.85 153.41 49.6 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.085 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.9 -169.47 13.3 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.84 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.428 ' H ' HG13 ' A' ' 35' ' ' VAL . . . 172.44 119.27 0.52 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.69 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.7 -29.63 68.23 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -31.33 69.2 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.668 0.27 . . . . 0.0 111.117 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -87.69 -28.09 22.02 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.154 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.28 35.67 1.43 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.695 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.428 HG13 ' H ' ' A' ' 30' ' ' GLY . 10.3 p -149.35 134.51 9.51 Favored Pre-proline 0 C--O 1.232 0.176 0 CA-C-O 120.652 0.263 . . . . 0.0 110.963 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.502 ' O ' HD12 ' A' ' 38' ' ' LEU . 39.6 Cg_endo -65.82 157.72 57.52 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.582 2.188 . . . . 0.0 112.107 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.52 HD12 ' CD2' ' A' ' 73' ' ' HIS . 22.5 mm -82.75 131.07 34.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 36' ' ' PRO . 3.6 mp -132.91 155.04 49.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.445 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.757 HD13 HG22 ' A' ' 27' ' ' ILE . 22.5 mm -80.56 120.13 31.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.852 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.39 -38.2 5.78 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.387 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 26' ' ' SER . 0.0 OUTLIER -124.49 145.87 49.29 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.774 0.321 . . . . 0.0 111.214 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.847 HG23 HG22 ' A' ' 25' ' ' ILE . 26.8 mt -135.19 114.33 16.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.55 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -71.95 132.87 84.41 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.095 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.82 159.35 45.38 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.819 2.346 . . . . 0.0 112.891 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.14 50.47 66.85 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.482 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.33 175.19 2.87 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 110.59 -0.152 . . . . 0.0 110.59 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.414 ' HB2' HD21 ' A' ' 15' ' ' LEU . 71.6 Cg_exo -49.84 -34.6 36.98 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.783 2.322 . . . . 0.0 112.966 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -59.57 -46.14 89.78 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.783 0.325 . . . . 0.0 110.755 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -69.78 -37.44 76.36 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.796 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -57.8 -32.78 67.88 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.416 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.4 m -82.99 -28.14 29.91 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.521 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.61 14.5 60.41 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.991 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.98 -33.58 2.77 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.311 -0.471 . . . . 0.0 112.751 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.544 HD13 HG21 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -67.37 100.82 0.87 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.984 0.421 . . . . 0.0 110.504 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -113.3 157.14 22.19 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.125 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.3 t -63.95 132.94 29.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.314 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.54 49.32 4.18 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.277 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -109.35 126.6 53.58 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.69 120.99 32.93 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.848 ' HA ' HG12 ' A' ' 91' ' ' VAL . 14.4 mt -81.06 149.17 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.469 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.9 mt -134.83 -54.9 0.82 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.014 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -148.67 159.84 43.73 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.826 0.346 . . . . 0.0 111.689 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.5 t -137.19 120.35 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.674 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 56.15 36.36 27.29 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.918 0.39 . . . . 0.0 111.138 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.67 13.63 83.33 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.226 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.6 t -98.71 134.88 35.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 117.009 0.404 . . . . 0.0 110.672 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -72.08 126.86 30.82 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.012 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tt -112.15 -17.89 12.69 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.34 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -32.6 72.55 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -98.95 11.91 37.51 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.629 HG21 ' CD1' ' A' ' 79' ' ' ILE . 1.3 m -110.02 161.66 15.31 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.815 0.34 . . . . 0.0 111.03 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.9 mmtm -95.7 161.3 14.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.24 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.525 ' O ' HG23 ' A' ' 77' ' ' VAL . 19.9 t-80 -54.12 -51.54 63.9 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.017 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -62.99 -41.2 99.51 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.829 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.458 ' HB2' HG22 ' A' ' 71' ' ' THR . 3.4 mt-10 -65.02 -38.11 89.84 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.011 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.536 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.79 -30.83 71.88 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.385 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 73' ' ' HIS . 24.5 t -61.7 -41.82 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.923 0.392 . . . . 0.0 110.624 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.1 m -69.96 -37.94 75.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.101 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.629 ' CD1' HG21 ' A' ' 71' ' ' THR . 23.2 mt -67.28 -47.19 82.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.384 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 77' ' ' VAL . 3.8 pp -63.91 -34.04 77.07 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.314 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.2 p -73.28 -27.43 61.56 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.85 -0.159 . . . . 0.0 111.221 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -65.25 -28.16 69.16 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.52 0.2 . . . . 0.0 111.348 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.535 ' HG3' HG23 ' A' ' 87' ' ' ILE . 39.8 mm-40 -58.67 113.7 2.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.757 0.313 . . . . 0.0 110.902 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.55 146.29 28.35 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.369 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.89 -99.92 0.4 Allowed Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.618 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -92.28 135.8 33.71 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.761 0.315 . . . . 0.0 110.386 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.535 HG23 ' HG3' ' A' ' 83' ' ' GLN . 13.3 mt -128.36 122.08 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.063 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.37 121.28 40.11 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.513 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -114.54 129.47 56.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 110.895 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -110.1 115.78 30.37 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.154 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.848 HG12 ' HA ' ' A' ' 60' ' ' ILE . 14.4 m -137.22 168.79 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.79 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.649 HG22 HG23 ' A' ' 10' ' ' ILE . 19.4 t -134.12 132.41 55.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.656 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.28 118.52 10.77 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.741 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.1 p -118.2 135.57 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.084 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.13 -0.938 . . . . 0.0 111.34 -179.694 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo . . . . . 0 N--CA 1.489 1.247 0 CA-C-O 120.55 0.146 . . . . 0.0 111.726 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.827 ' HA ' HG12 ' A' ' 92' ' ' VAL . 2.7 tt -78.66 121.81 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.922 0.391 . . . . 0.0 111.247 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.08 135.56 54.08 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.096 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.27 111.5 21.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.638 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.94 142.33 42.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.952 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.81 135.5 39.48 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.975 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.1 tp -108.84 121.91 46.08 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.088 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.21 115.09 29.7 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.671 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -127.52 147.19 50.32 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.111 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.403 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 1.0 OUTLIER -108.61 161.86 14.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.026 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -56.85 -38.8 73.19 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.403 ' CD2' ' HB3' ' A' ' 18' ' ' GLU . 25.2 p80 -80.18 -28.31 38.76 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.462 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -84.56 165.56 17.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.993 0.425 . . . . 0.0 111.606 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -112.06 -169.73 18.3 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.709 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 tp -67.93 -57.38 6.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.446 0.165 . . . . 0.0 111.342 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.54 4.55 63.9 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.767 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.848 HG22 HG23 ' A' ' 42' ' ' ILE . 20.5 pt -144.98 154.98 14.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 117.364 0.582 . . . . 0.0 111.348 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.4 m -113.62 138.14 50.6 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.0 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.585 HD12 HG21 ' A' ' 37' ' ' ILE . 13.0 pt -115.92 154.73 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.601 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.0 p -137.63 163.34 31.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.32 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.82 -150.56 19.35 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.778 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.44 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . 153.51 124.47 0.99 Allowed Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.009 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.68 -31.5 57.88 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.1 0.16 . . . . 0.0 111.409 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -57.26 -31.23 65.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.151 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -84.5 -21.36 30.61 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.422 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.05 19.5 5.93 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.993 -0.623 . . . . 0.0 113.284 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 m -147.08 139.65 14.24 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.93 0.365 . . . . 0.0 111.076 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.8 157.39 38.21 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.522 2.148 . . . . 0.0 112.032 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.585 HG21 HD12 ' A' ' 27' ' ' ILE . 4.0 mp -82.71 126.06 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.676 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.7 ' CD2' ' HB2' ' A' ' 59' ' ' ALA . 2.1 mp -122.54 162.53 21.61 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.908 0.385 . . . . 0.0 111.6 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.705 HD13 ' CD1' ' A' ' 54' ' ' LEU . 17.3 mt -94.4 125.67 46.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.797 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.434 ' O ' HG13 ' A' ' 56' ' ' VAL . 8.4 m -109.63 -34.6 6.44 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.709 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -123.0 146.79 47.32 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.742 0.306 . . . . 0.0 111.391 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.848 HG23 HG22 ' A' ' 25' ' ' ILE . 4.3 mp -134.21 112.26 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.578 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -71.6 129.88 88.0 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.144 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -74.4 155.72 45.85 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.772 2.315 . . . . 0.0 112.618 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.61 33.33 52.41 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.734 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.92 174.49 4.37 Favored Pre-proline 0 CA--C 1.53 0.205 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.58 -32.14 34.19 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.588 2.192 . . . . 0.0 112.771 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.493 ' HB1' ' CB ' ' A' ' 54' ' ' LEU . . . -61.0 -46.06 92.32 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.164 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.49 -43.86 72.31 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.986 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -58.59 -32.74 69.25 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.496 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -77.07 -27.96 54.46 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.464 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.16 17.78 68.41 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.025 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.8 -29.99 2.28 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 121.11 -0.567 . . . . 0.0 113.171 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.705 ' CD1' HD13 ' A' ' 39' ' ' ILE . 0.7 OUTLIER -64.69 96.87 0.19 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.861 0.362 . . . . 0.0 110.823 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -115.8 157.23 24.7 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.252 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 40' ' ' SER . 45.2 t -66.4 131.4 32.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.665 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.04 43.54 3.79 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.931 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.43 119.19 37.38 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.499 0.15 . . . . 0.0 110.794 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.7 ' HB2' ' CD2' ' A' ' 38' ' ' LEU . . . -92.06 123.07 35.14 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.644 0.259 . . . . 0.0 111.509 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.826 ' HA ' HG12 ' A' ' 91' ' ' VAL . 10.8 mt -72.59 137.64 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.214 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.2 mt -125.32 -52.73 1.62 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.775 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.56 145.53 45.1 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.821 0.343 . . . . 0.0 111.475 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.97 116.14 32.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.393 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 58.83 34.6 23.8 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.051 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.65 -15.95 52.37 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.386 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.5 t -88.15 134.6 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 117.146 0.473 . . . . 0.0 110.778 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -71.28 131.53 43.6 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.196 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.579 HD21 ' HB1' ' A' ' 76' ' ' ALA . 2.8 tp -117.49 1.58 12.33 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.828 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -71.37 -28.1 63.81 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.24 8.18 45.02 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 p -105.3 146.54 29.22 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.751 0.31 . . . . 0.0 111.088 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -71.82 161.19 31.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.113 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.65 ' O ' HG23 ' A' ' 77' ' ' VAL . 46.2 t-80 -54.01 -50.56 66.34 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.933 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.68 -42.98 94.12 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.894 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -67.21 -37.59 83.87 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.841 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.579 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -63.86 -31.32 72.46 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.473 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 73' ' ' HIS . 22.3 t -61.83 -40.8 88.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.862 0.363 . . . . 0.0 110.358 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.9 m -65.72 -40.54 92.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.518 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.471 HG22 HE21 ' A' ' 83' ' ' GLN . 40.1 mm -58.13 -43.52 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.643 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.0 mt -60.57 -43.9 96.8 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.671 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.4 t -65.84 -31.54 72.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.091 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -65.15 -28.29 69.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.15 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.471 HE21 HG22 ' A' ' 79' ' ' ILE . 48.3 mm-40 -62.65 135.23 57.28 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.793 0.33 . . . . 0.0 111.006 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.23 144.25 48.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.175 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.06 -104.55 0.35 Allowed Glycine 0 C--N 1.335 0.52 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.634 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -82.29 118.2 22.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.853 0.358 . . . . 0.0 110.396 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.411 HG23 ' HB3' ' A' ' 83' ' ' GLN . 11.6 mt -119.32 123.77 71.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.893 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.63 121.38 35.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.52 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -113.11 129.62 56.45 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.119 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.0 115.19 22.07 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.805 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.826 HG12 ' HA ' ' A' ' 60' ' ' ILE . 16.1 m -139.2 170.73 15.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.4 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.827 HG12 ' HA ' ' A' ' 10' ' ' ILE . 18.7 m -131.33 133.52 62.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.835 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.42 115.86 10.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.715 0.293 . . . . 0.0 110.705 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.7 p -126.57 122.65 61.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.952 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.4 -0.81 . . . . 0.0 111.408 -179.536 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.526 ' O ' HG13 ' A' ' 92' ' ' VAL . 3.4 Cg_exo . . . . . 0 N--CA 1.49 1.297 0 CA-C-O 120.725 0.219 . . . . 0.0 111.924 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.536 ' HA ' HG22 ' A' ' 92' ' ' VAL . 2.6 tt -78.97 134.79 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.327 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.9 126.33 51.55 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.034 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.3 mmtm -99.75 114.62 27.87 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.571 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.24 128.91 67.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.789 0.328 . . . . 0.0 111.34 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 mp -98.37 119.92 37.89 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.846 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.43 HD11 ' HA ' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -113.13 137.98 50.64 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.262 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.402 ' H ' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -97.65 115.38 27.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.772 179.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.8 143.78 37.52 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.707 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -114.54 158.56 21.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.182 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.72 -38.35 78.15 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.807 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -77.6 -28.29 51.51 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.423 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -90.02 159.23 16.96 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.903 0.382 . . . . 0.0 111.223 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.35 -165.82 21.97 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.056 -0.593 . . . . 0.0 112.373 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.56 -44.9 85.31 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.673 0.273 . . . . 0.0 110.834 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.22 3.29 90.25 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.335 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.759 HD13 HD12 ' A' ' 39' ' ' ILE . 2.2 pp -146.74 147.11 18.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 117.033 0.416 . . . . 0.0 110.897 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.505 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 3.5 m -108.53 139.78 42.81 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.536 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.762 HG22 HD13 ' A' ' 39' ' ' ILE . 20.2 pt -116.2 156.01 17.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.719 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.5 t -143.96 155.98 44.24 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.33 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.05 -150.1 18.31 Favored Glycine 0 C--N 1.337 0.605 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.393 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.42 109.27 0.22 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.939 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -57.64 -37.28 73.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.586 0.231 . . . . 0.0 111.135 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -58.73 -31.17 68.05 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.949 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -75.86 -24.51 55.75 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.217 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.68 25.4 4.29 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 121.061 -0.59 . . . . 0.0 113.074 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 m -147.48 140.3 14.69 Favored Pre-proline 0 C--O 1.233 0.211 0 CA-C-N 116.884 0.342 . . . . 0.0 111.244 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.58 157.42 60.78 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.603 2.202 . . . . 0.0 112.285 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.464 HG21 HD12 ' A' ' 27' ' ' ILE . 26.1 mm -82.76 137.9 20.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.757 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 59' ' ' ALA . 2.9 mp -131.82 158.69 40.61 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.594 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.762 HD13 HG22 ' A' ' 27' ' ' ILE . 17.7 mm -83.55 128.64 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.756 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.406 ' O ' HG13 ' A' ' 56' ' ' VAL . 4.1 t -124.14 -44.27 2.04 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.538 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 0.5 OUTLIER -105.38 144.47 32.12 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.758 0.313 . . . . 0.0 111.172 -179.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.1 mt -131.47 128.98 61.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.747 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 -86.27 114.81 59.4 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.955 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.16 122.11 8.7 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.533 2.155 . . . . 0.0 112.149 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.54 34.85 4.86 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.597 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.97 174.2 4.79 Favored Pre-proline 0 C--O 1.233 0.231 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.41 -32.2 33.16 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.521 2.147 . . . . 0.0 112.76 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.43 ' HA ' HD11 ' A' ' 15' ' ' LEU . . . -59.83 -46.19 90.03 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.271 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.85 -40.39 79.42 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.703 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -60.03 -33.44 72.02 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.466 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.6 t -71.65 -28.11 63.53 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.52 15.78 62.13 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.188 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.25 -32.53 1.36 Allowed Glycine 0 C--N 1.338 0.667 0 C-N-CA 121.22 -0.514 . . . . 0.0 113.106 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.467 ' HG ' HG21 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -66.79 94.36 0.3 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.981 0.419 . . . . 0.0 110.682 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -108.87 157.24 18.8 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.97 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.406 HG13 ' O ' ' A' ' 40' ' ' SER . 25.8 t -67.2 133.31 31.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.375 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.18 45.83 3.73 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.535 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.13 124.09 51.68 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 122.22 0.208 . . . . 0.0 110.595 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.542 ' HB2' HD23 ' A' ' 38' ' ' LEU . . . -91.4 120.25 32.09 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.728 0.299 . . . . 0.0 111.177 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.798 ' HA ' HG12 ' A' ' 91' ' ' VAL . 20.5 mt -75.24 139.93 18.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.556 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 61' ' ' LEU . 14.0 mt -128.11 -51.93 1.31 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.703 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -144.54 145.86 32.06 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.854 0.359 . . . . 0.0 111.637 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.0 t -132.83 115.79 25.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.401 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 56.71 38.04 29.24 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.602 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.19 -12.85 42.24 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.449 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -85.14 128.05 39.38 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 117.371 0.586 . . . . 0.0 110.83 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.69 130.62 39.84 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.169 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.562 HD11 ' HB1' ' A' ' 76' ' ' ALA . 0.5 OUTLIER -102.48 -23.03 13.95 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.641 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 30.2 mtt180 -61.4 -31.07 70.98 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 111.348 0.129 . . . . 0.0 111.348 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.03 9.74 38.33 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.2 p -120.1 159.87 23.97 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.617 0.246 . . . . 0.0 110.653 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.1 161.02 19.1 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.785 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.623 ' O ' HG23 ' A' ' 77' ' ' VAL . 57.8 t-80 -53.95 -47.6 71.13 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.972 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -60.99 -43.04 99.43 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.73 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -64.5 -39.28 93.49 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.975 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.562 ' HB1' HD11 ' A' ' 68' ' ' LEU . . . -63.58 -34.24 77.37 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.57 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 73' ' ' HIS . 38.3 t -62.17 -43.28 97.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 120.834 0.349 . . . . 0.0 110.441 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.0 m -67.41 -45.72 75.32 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.948 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 76' ' ' ALA . 13.9 mt -60.91 -44.21 97.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.938 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.42 -37.83 79.05 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.678 0.275 . . . . 0.0 110.714 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.7 m -68.65 -28.35 66.81 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.453 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -64.88 -30.85 71.87 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.498 0.19 . . . . 0.0 111.051 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.402 ' HB2' HD13 ' A' ' 87' ' ' ILE . 31.7 mm-40 -66.05 114.47 5.23 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.817 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 8.2 mtt180 -114.47 151.87 32.55 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.11 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.72 -102.12 0.42 Allowed Glycine 0 C--N 1.335 0.48 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.556 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -87.98 122.39 31.53 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.654 0.264 . . . . 0.0 110.378 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.402 HD13 ' HB2' ' A' ' 83' ' ' GLN . 21.5 mt -124.73 125.78 70.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.052 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -93.65 123.37 36.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.336 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.53 130.2 56.27 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.928 0.394 . . . . 0.0 111.517 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -121.18 115.17 22.53 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.572 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.798 HG12 ' HA ' ' A' ' 60' ' ' ILE . 5.5 m -137.28 170.94 17.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.351 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.536 HG22 ' HA ' ' A' ' 10' ' ' ILE . 39.7 t -129.07 133.64 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.69 123.66 20.32 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.875 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.0 t -118.71 132.79 67.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.957 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.163 -0.923 . . . . 0.0 111.22 179.93 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo . . . . . 0 N--CA 1.491 1.34 0 CA-C-O 120.93 0.304 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.699 ' HA ' HG12 ' A' ' 92' ' ' VAL . 4.6 mp -86.06 141.17 14.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -120.82 122.03 39.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -100.21 113.51 26.23 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.773 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.454 HG11 ' HA3' ' A' ' 53' ' ' GLY . 9.2 m -128.27 140.42 49.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.458 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.441 ' C ' HD12 ' A' ' 15' ' ' LEU . 5.1 mp -107.47 126.86 53.03 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.895 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.529 HD11 HD21 ' A' ' 54' ' ' LEU . 10.0 mp -113.08 137.32 51.6 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.097 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -104.32 114.75 29.19 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.8 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 20.0 ttpp -99.78 134.26 42.94 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.994 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.403 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 9.4 mm-40 -115.94 151.55 35.17 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.869 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.14 -33.89 72.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.634 179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.403 ' CD2' ' HB3' ' A' ' 18' ' ' GLU . 15.4 p80 -81.6 -27.4 34.24 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.783 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -96.55 166.53 11.64 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.883 0.373 . . . . 0.0 111.451 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -105.47 -150.51 19.43 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 121.091 -0.575 . . . . 0.0 112.679 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.44 HD23 ' O ' ' A' ' 25' ' ' ILE . 6.6 tp -78.5 -58.96 2.98 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.689 0.281 . . . . 0.0 110.96 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.77 4.35 75.85 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.687 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.615 HG22 HG23 ' A' ' 42' ' ' ILE . 23.5 pt -140.61 143.46 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 117.259 0.529 . . . . 0.0 111.126 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 t -112.03 136.79 50.93 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.812 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.688 HD12 HG21 ' A' ' 37' ' ' ILE . 26.8 pt -125.29 153.86 33.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.597 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.8 p -139.18 145.35 39.23 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.224 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.18 -155.83 16.85 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.694 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.1 126.02 1.56 Allowed Glycine 0 C--N 1.335 0.499 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.49 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 42.7 tptt -54.6 -35.64 63.58 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.393 0.14 . . . . 0.0 111.136 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.481 ' HG3' ' HG2' ' A' ' 72' ' ' LYS . 0.5 OUTLIER -62.77 -30.62 71.59 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.198 179.653 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -79.31 -34.7 42.12 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.106 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 134.23 -21.6 3.86 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.865 -0.684 . . . . 0.0 113.292 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 23.8 m -123.03 144.31 42.88 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-N 117.006 0.403 . . . . 0.0 111.201 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 34.8 Cg_exo -60.87 155.97 46.38 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.749 2.3 . . . . 0.0 112.442 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.688 HG21 HD12 ' A' ' 27' ' ' ILE . 2.2 mt -84.0 130.66 35.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.851 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.525 HD23 ' CB ' ' A' ' 59' ' ' ALA . 0.8 OUTLIER -132.24 156.52 46.34 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.027 -179.53 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.545 HD12 ' CB ' ' A' ' 58' ' ' ASP . 32.1 mt -81.08 121.87 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.902 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.4 m -106.2 -29.74 9.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.682 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.95 149.64 48.98 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.711 0.291 . . . . 0.0 111.357 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.615 HG23 HG22 ' A' ' 25' ' ' ILE . 3.4 mp -133.98 114.22 19.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.664 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -72.09 131.4 85.4 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.233 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.37 172.42 16.27 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.961 2.441 . . . . 0.0 112.903 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.62 18.52 61.56 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.784 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.46 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -124.97 169.28 11.34 Favored Pre-proline 0 N--CA 1.455 -0.184 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 9.8 Cg_endo -52.55 -29.1 39.15 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.62 2.214 . . . . 0.0 112.57 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.465 ' HB1' ' HG ' ' A' ' 54' ' ' LEU . . . -63.09 -46.46 87.29 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.317 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -65.32 -40.24 93.48 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.871 0.367 . . . . 0.0 110.605 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.69 -28.47 65.88 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.319 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 11.5 m -70.37 -28.24 64.95 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.42 -55.31 4.64 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.889 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.454 ' HA3' HG11 ' A' ' 13' ' ' VAL . . . -53.03 -27.84 31.34 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 121.474 -0.393 . . . . 0.0 113.609 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.529 HD21 HD11 ' A' ' 15' ' ' LEU . 4.3 mm? -68.14 88.86 0.3 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 117.003 0.401 . . . . 0.0 110.52 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -118.43 157.24 27.58 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.219 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.7 t -63.28 130.06 27.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.63 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.05 46.37 3.63 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.466 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.545 ' CB ' HD12 ' A' ' 39' ' ' ILE . 0.5 OUTLIER -107.01 125.73 51.4 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.475 0.178 . . . . 0.0 110.544 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.525 ' CB ' HD23 ' A' ' 38' ' ' LEU . . . -91.25 121.61 33.15 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.769 0.319 . . . . 0.0 111.366 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.658 ' HA ' HG12 ' A' ' 91' ' ' VAL . 21.9 mt -78.21 130.78 35.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.268 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.1 mt -124.27 -51.97 1.75 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.643 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -145.06 148.89 34.18 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.859 0.361 . . . . 0.0 111.448 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.7 t -136.98 115.75 14.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.424 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 58.35 33.14 22.86 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.097 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.93 -15.24 58.31 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.181 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -88.07 133.77 29.76 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 117.143 0.471 . . . . 0.0 110.891 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -79.17 129.67 34.69 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.96 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.562 HD21 ' CB ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -105.8 -21.36 13.19 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.645 -179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.6 ttt85 -60.95 -34.58 74.96 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.662 0.267 . . . . 0.0 110.902 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -84.25 -26.14 28.87 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.656 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 27.2 p -78.53 167.28 21.51 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.889 0.376 . . . . 0.0 111.011 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.481 ' HG2' ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -93.87 161.03 14.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.645 179.693 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.548 ' O ' HG23 ' A' ' 77' ' ' VAL . 6.5 t-160 -54.26 -47.52 72.19 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.892 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -64.76 -40.42 95.25 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.096 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -65.93 -37.67 86.65 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.913 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.693 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.71 -30.88 71.93 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.328 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 73' ' ' HIS . 24.5 t -61.4 -43.43 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-O 120.847 0.356 . . . . 0.0 110.554 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.6 m -65.76 -44.69 85.1 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.706 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 76' ' ' ALA . 7.3 mt -63.78 -44.04 98.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.0 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.6 mt -56.4 -42.96 78.83 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.756 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 38.9 t -68.24 -31.2 70.53 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.038 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -65.13 -24.17 67.34 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.571 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.411 ' HB3' HG12 ' A' ' 87' ' ' ILE . 41.7 mm-40 -62.97 97.86 0.12 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.808 0.337 . . . . 0.0 110.891 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.61 146.67 26.19 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.261 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.82 -106.37 1.47 Allowed Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.555 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -87.74 143.1 27.33 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.73 0.3 . . . . 0.0 110.495 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.411 HG12 ' HB3' ' A' ' 83' ' ' GLN . 11.6 mt -136.95 122.33 26.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.033 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -96.64 124.35 40.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.613 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -112.58 129.61 56.31 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.791 0.329 . . . . 0.0 111.139 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -118.89 115.31 24.13 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.23 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' A' ' 60' ' ' ILE . 23.7 m -143.93 169.24 10.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.499 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.699 HG12 ' HA ' ' A' ' 10' ' ' ILE . 11.1 m -134.33 138.37 50.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.055 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.0 123.67 21.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.903 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 15.2 m -114.45 143.82 23.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.402 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.039 -0.981 . . . . 0.0 111.545 -179.884 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo . . . . . 0 N--CA 1.49 1.319 0 CA-C-O 120.814 0.256 . . . . 0.0 111.822 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.413 ' HA ' HG22 ' A' ' 92' ' ' VAL . 73.1 mt -80.27 142.98 13.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.55 138.63 51.78 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.08 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.408 ' HD2' ' HG3' ' A' ' 90' ' ' GLU . 1.1 mptm? -115.33 117.43 30.42 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.4 t -132.67 141.01 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.143 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 87' ' ' ILE . 0.4 OUTLIER -97.83 132.5 43.38 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.978 179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.07 119.44 37.87 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.749 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.458 HD11 HD22 ' A' ' 14' ' ' LEU . 7.0 mp -110.3 114.25 27.56 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.343 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.0 ptmm? -128.15 146.1 50.81 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.265 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.457 ' HB2' ' HG3' ' A' ' 21' ' ' GLU . 0.4 OUTLIER -75.95 165.23 25.28 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.117 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -57.07 -36.28 70.37 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.846 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.405 ' CD2' ' HB3' ' A' ' 18' ' ' GLU . 29.0 p80 -79.91 -29.81 39.93 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.411 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.457 ' HG3' ' HB2' ' A' ' 18' ' ' GLU . 7.0 mt-10 -70.61 167.57 18.26 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.924 0.393 . . . . 0.0 111.943 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -122.28 -157.72 10.05 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.293 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.648 HD22 HG13 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -62.48 -62.52 1.69 Allowed 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.94 -14.72 28.89 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.608 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.749 HG21 HD23 ' A' ' 54' ' ' LEU . 2.2 pt -143.74 164.1 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 117.186 0.493 . . . . 0.0 111.379 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.9 t -106.93 136.7 46.33 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.697 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.2 pt -118.69 153.11 20.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.241 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -143.2 144.63 32.25 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.248 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 149.19 -165.98 29.44 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.429 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.84 112.29 0.31 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.794 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.8 tptt -58.21 -37.94 75.79 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.453 0.168 . . . . 0.0 111.289 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -65.47 -30.96 71.81 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.011 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -73.35 -28.62 62.16 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.07 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.37 22.41 6.14 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.069 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.1 p -149.69 130.95 7.29 Favored Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 116.873 0.337 . . . . 0.0 111.044 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.34 155.61 50.98 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.612 2.208 . . . . 0.0 112.231 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mp -83.04 133.9 28.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.774 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.51 159.65 38.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.485 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.498 HD13 HD13 ' A' ' 25' ' ' ILE . 23.1 mt -80.17 122.82 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.993 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.7 -30.46 8.56 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.709 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -130.69 155.5 46.51 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.858 0.361 . . . . 0.0 111.513 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.735 ' HA ' HG22 ' A' ' 25' ' ' ILE . 48.4 mt -130.36 114.09 27.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.739 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 -81.59 128.38 69.65 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.914 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.29 159.89 42.99 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.706 2.271 . . . . 0.0 112.799 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.12 33.07 57.66 Favored Glycine 0 C--N 1.334 0.452 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.809 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.97 170.8 8.66 Favored Pre-proline 0 C--N 1.332 -0.172 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.43 -30.73 54.69 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.647 2.232 . . . . 0.0 112.953 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.81 -46.14 81.79 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.729 0.3 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -70.52 -41.25 72.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.794 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -64.59 -28.72 69.82 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.566 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.27 -28.36 64.09 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.486 0.184 . . . . 0.0 111.473 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 61.41 16.85 51.35 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.054 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.06 -31.63 1.08 Allowed Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.071 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.749 HD23 HG21 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -68.68 92.8 0.49 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.827 0.346 . . . . 0.0 110.592 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -98.82 156.86 16.65 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.247 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 18.8 t -64.2 135.43 27.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.564 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.57 50.57 3.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.127 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.462 ' CB ' HD12 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -111.3 124.56 52.47 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.491 0.186 . . . . 0.0 110.624 -179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.577 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -91.1 120.44 32.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.901 0.382 . . . . 0.0 111.103 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.811 ' HA ' HG12 ' A' ' 91' ' ' VAL . 17.2 mt -73.71 144.67 12.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.908 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.7 mt -129.45 -53.49 1.17 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.57 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.26 145.94 33.18 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.976 0.417 . . . . 0.0 111.829 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.597 HG11 HD23 ' A' ' 80' ' ' LEU . 21.1 t -130.87 116.77 35.47 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.511 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 56.77 36.45 27.71 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.675 -179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.8 -16.35 46.99 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.507 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.8 t -85.37 135.14 25.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 117.229 0.515 . . . . 0.0 111.179 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -78.67 131.25 36.57 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.084 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.606 HD11 ' HB1' ' A' ' 76' ' ' ALA . 0.5 OUTLIER -89.01 -27.89 20.55 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.979 179.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -67.3 -27.17 66.94 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.393 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -91.5 11.77 22.97 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 t -138.79 174.33 10.64 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.637 0.256 . . . . 0.0 110.812 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.43 160.97 14.12 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.047 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.669 ' O ' HG23 ' A' ' 77' ' ' VAL . 44.1 t-80 -56.11 -51.72 66.89 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.182 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.64 -43.12 84.65 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.964 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -67.2 -37.78 84.22 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.854 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.729 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.87 -33.72 76.34 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.363 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 73' ' ' HIS . 22.0 t -61.72 -39.18 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-O 120.837 0.351 . . . . 0.0 110.504 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 49.9 m -65.37 -44.65 86.94 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.493 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' ' 76' ' ' ALA . 12.8 mt -61.73 -41.37 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.195 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.919 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.597 HD23 HG11 ' A' ' 63' ' ' VAL . 6.7 mt -60.44 -39.69 88.41 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.627 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 27.5 t -66.22 -30.92 71.46 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.185 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -65.24 -28.92 69.69 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.333 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.475 ' HB3' HG23 ' A' ' 87' ' ' ILE . 16.8 mm-40 -68.31 111.64 4.72 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.873 0.368 . . . . 0.0 110.844 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -105.55 148.86 26.8 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.332 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.68 -102.18 0.42 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.581 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -90.09 132.03 35.64 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.908 0.385 . . . . 0.0 110.508 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.475 HG23 ' HB3' ' A' ' 83' ' ' GLN . 12.4 mt -129.9 133.22 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.07 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.71 122.36 36.09 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.715 0.293 . . . . 0.0 110.705 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.91 130.61 55.82 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.526 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.408 ' HG3' ' HD2' ' A' ' 12' ' ' LYS . 8.2 tt0 -122.18 115.56 22.62 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.581 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.811 HG12 ' HA ' ' A' ' 60' ' ' ILE . 5.2 m -136.64 170.57 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.479 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.413 HG22 ' HA ' ' A' ' 10' ' ' ILE . 17.3 t -133.94 143.66 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.308 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.2 126.04 28.56 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.967 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.577 HG21 ' HB2' ' A' ' 59' ' ' ALA . 21.7 t -113.6 118.79 59.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.015 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.52 -0.752 . . . . 0.0 111.208 179.957 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.49 1.271 0 CA-C-O 120.71 0.212 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.1 tt -89.59 124.93 42.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.277 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -123.99 153.38 41.37 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.082 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.431 ' HG3' ' HG2' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -114.79 120.05 38.72 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.56 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.0 m -129.36 135.29 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.708 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.69 136.71 40.13 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.834 0.349 . . . . 0.0 111.131 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.0 mp -113.12 124.04 51.65 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.692 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 tt -102.74 115.33 30.39 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.708 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.0 pttp -129.4 134.12 47.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.104 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -90.63 172.87 8.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.887 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.66 -36.94 70.13 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.836 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 20.8 p80 -74.84 -30.87 61.49 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.27 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -79.39 179.42 7.45 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.87 0.367 . . . . 0.0 111.323 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.1 -143.13 4.95 Favored Glycine 0 C--N 1.337 0.609 0 C-N-CA 121.014 -0.612 . . . . 0.0 113.014 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.67 -66.97 0.82 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.49 0.186 . . . . 0.0 111.369 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.61 -15.56 45.36 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.614 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.746 HG22 HG23 ' A' ' 42' ' ' ILE . 2.2 pp -140.84 157.76 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 117.304 0.552 . . . . 0.0 111.241 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 t -114.49 137.4 51.9 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.557 HG22 HG12 ' A' ' 39' ' ' ILE . 17.0 pt -116.16 151.56 17.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.472 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.2 t -143.61 145.11 32.24 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.065 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 129.72 -172.96 19.87 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 121.195 -0.526 . . . . 0.0 112.441 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . -178.87 116.54 0.53 Allowed Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.454 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.6 tptt -52.35 -37.68 56.74 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.432 ' HB2' ' HG3' ' A' ' 72' ' ' LYS . 50.5 tt0 -59.32 -31.16 68.9 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.725 0.298 . . . . 0.0 110.993 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -72.66 -31.31 64.98 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.937 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.18 -23.63 3.16 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 120.999 -0.619 . . . . 0.0 113.102 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 27.9 m -122.04 149.7 54.67 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.815 0.307 . . . . 0.0 111.291 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.25 157.53 61.43 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.662 2.241 . . . . 0.0 112.275 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.414 ' H ' HD12 ' A' ' 37' ' ' ILE . 3.4 mp -82.42 129.86 36.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.578 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.76 161.55 29.49 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.857 0.361 . . . . 0.0 111.607 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.606 HD13 HD21 ' A' ' 54' ' ' LEU . 32.9 mt -82.84 123.29 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.059 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.8 m -106.9 -30.03 9.12 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.578 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -123.95 145.09 49.39 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.865 0.364 . . . . 0.0 111.395 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.746 HG23 HG22 ' A' ' 25' ' ' ILE . 32.2 mt -131.02 114.3 26.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.486 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -85.02 114.46 56.03 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.775 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -62.32 175.34 2.11 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.015 2.477 . . . . 0.0 112.967 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.73 34.91 91.16 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.147 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.16 173.18 4.94 Favored Pre-proline 0 CA--C 1.531 0.242 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -51.42 -30.86 36.3 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.714 2.276 . . . . 0.0 113.022 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.23 -46.19 89.14 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.696 0.284 . . . . 0.0 111.1 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -69.98 -38.34 76.0 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.803 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -32.02 73.43 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.216 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.11 -28.28 61.28 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.518 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.84 16.51 61.65 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.054 -0.594 . . . . 0.0 113.089 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.69 -33.75 1.15 Allowed Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.203 -0.523 . . . . 0.0 113.066 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.606 HD21 HD13 ' A' ' 39' ' ' ILE . 1.1 tt -67.72 105.31 1.88 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.881 0.372 . . . . 0.0 110.662 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.512 ' C ' HD11 ' A' ' 42' ' ' ILE . 12.6 p80 -114.86 157.35 23.43 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.207 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.431 ' N ' HD11 ' A' ' 42' ' ' ILE . 13.8 p -62.97 139.69 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.127 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.5 49.66 5.08 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.216 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -111.8 126.63 55.27 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.433 0.159 . . . . 0.0 110.763 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 91' ' ' VAL . . . -90.68 128.11 36.53 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.712 0.292 . . . . 0.0 110.687 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.766 HG21 HD22 ' A' ' 68' ' ' LEU . 12.3 mt -74.7 104.05 2.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.695 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -86.46 -50.64 6.73 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.409 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -150.13 146.15 26.73 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.605 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.1 t -127.92 115.71 40.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.652 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 54.96 37.07 28.24 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.99 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.25 -14.16 58.22 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 120.953 -0.641 . . . . 0.0 113.375 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.0 t -86.12 127.21 40.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.148 0 CA-C-N 117.181 0.49 . . . . 0.0 110.97 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -71.55 141.16 50.1 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.949 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.766 HD22 HG21 ' A' ' 60' ' ' ILE . 1.2 tp -116.03 -1.23 12.54 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.722 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.2 -34.25 70.69 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.3 11.59 37.9 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.3 p -109.47 163.66 13.22 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.741 0.305 . . . . 0.0 110.93 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.432 ' HG3' ' HB2' ' A' ' 32' ' ' GLU . 2.3 mppt? -94.62 161.11 14.33 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.03 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.597 ' O ' HG23 ' A' ' 77' ' ' VAL . 12.3 t-80 -53.95 -49.66 68.21 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.812 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -43.06 88.15 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.758 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -64.81 -38.34 90.65 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.973 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.52 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -63.63 -41.42 98.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.991 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 73' ' ' HIS . 21.7 t -62.67 -39.88 86.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.052 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.81 -46.62 71.39 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.009 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.446 HG22 HE21 ' A' ' 83' ' ' GLN . 14.6 mt -62.21 -39.61 84.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.557 0.218 . . . . 0.0 110.752 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.636 HD21 ' CE2' ' A' ' 89' ' ' PHE . 0.2 OUTLIER -59.97 -42.39 94.02 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.178 179.757 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.9 p -64.82 -32.12 73.67 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.304 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -64.95 -28.81 69.78 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.05 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.485 ' HB3' HG23 ' A' ' 87' ' ' ILE . 24.4 mm-40 -62.01 114.22 3.26 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.853 0.358 . . . . 0.0 110.856 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.0 ptt85 -118.63 152.29 36.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.426 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.04 -103.23 0.55 Allowed Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.592 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -89.96 119.06 30.0 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.788 0.328 . . . . 0.0 110.402 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.485 HG23 ' HB3' ' A' ' 83' ' ' GLN . 18.4 mt -121.04 122.5 67.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.031 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -93.78 122.08 35.89 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.681 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.636 ' CE2' HD21 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -116.31 129.81 56.46 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.943 0.401 . . . . 0.0 111.203 -179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.431 ' HG2' ' HG3' ' A' ' 12' ' ' LYS . 23.6 mt-10 -120.09 115.4 23.61 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.007 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 60' ' ' ILE . 8.2 m -137.08 163.7 31.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.733 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.9 t -131.76 146.08 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.15 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.401 ' CG ' ' CE1' ' A' ' 55' ' ' HIS . 0.1 OUTLIER -70.47 129.07 38.27 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.758 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.32 141.19 43.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.901 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.117 -0.945 . . . . 0.0 111.315 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.532 ' O ' HG23 ' A' ' 92' ' ' VAL . 4.6 Cg_endo . . . . . 0 N--CA 1.49 1.297 0 CA-C-O 120.852 0.272 . . . . 0.0 111.939 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 tt -78.8 132.76 31.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.381 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -123.71 135.25 53.76 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.057 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.86 126.6 48.78 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.581 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.3 m -128.58 143.14 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.592 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 pp -114.69 132.23 56.48 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.821 0.343 . . . . 0.0 110.928 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -120.7 141.57 50.3 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.869 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.95 118.35 36.51 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.009 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.96 148.09 42.53 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.104 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.408 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 3.4 mp0 -114.22 159.75 19.79 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.155 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.3 -38.22 73.64 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.963 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.408 ' CD2' ' HB3' ' A' ' 18' ' ' GLU . 23.7 p80 -79.77 -28.17 40.4 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.437 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.65 164.27 16.9 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.932 0.396 . . . . 0.0 111.595 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.41 -166.74 21.95 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.703 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.591 HD22 HG13 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -61.0 -59.53 5.22 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.539 0.209 . . . . 0.0 111.329 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.27 1.06 55.76 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.382 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.745 HG22 HG23 ' A' ' 42' ' ' ILE . 1.8 pp -145.48 161.44 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 117.177 0.488 . . . . 0.0 111.139 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.5 t -119.65 136.95 54.18 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.965 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.604 HD12 HG21 ' A' ' 37' ' ' ILE . 6.5 pt -119.9 154.38 22.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.335 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 24.4 p -137.16 153.56 50.44 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.002 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.31 -172.24 16.67 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.785 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -168.38 113.97 0.55 Allowed Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.517 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -32.44 70.67 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.478 0.18 . . . . 0.0 111.388 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -60.11 -30.7 69.44 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.609 0.242 . . . . 0.0 110.949 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -76.59 -28.15 56.08 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.078 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.68 31.54 2.51 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.892 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.7 m -146.4 144.17 20.5 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.634 0.217 . . . . 0.0 111.0 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.7 156.97 62.11 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.624 2.216 . . . . 0.0 112.246 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.627 ' HB ' HD12 ' A' ' 60' ' ' ILE . 29.5 mm -84.21 139.29 17.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.63 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 mp -131.42 160.49 34.95 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.839 0.352 . . . . 0.0 111.287 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.578 HD12 ' HB3' ' A' ' 58' ' ' ASP . 23.2 mt -89.69 122.54 41.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.946 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.468 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -109.54 -31.6 7.44 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.642 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -127.75 149.41 50.26 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.668 0.27 . . . . 0.0 110.823 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.745 HG23 HG22 ' A' ' 25' ' ' ILE . 17.9 mt -135.03 114.55 17.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.74 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 52.5 m-70 -66.67 120.89 74.5 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.096 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.35 156.63 61.38 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.973 2.449 . . . . 0.0 112.667 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 64.3 36.8 93.66 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.262 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -134.06 177.07 2.42 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -49.95 -31.02 25.79 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.712 2.275 . . . . 0.0 112.912 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.495 ' HB1' ' CB ' ' A' ' 54' ' ' LEU . . . -63.55 -46.1 87.47 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.006 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -69.84 -40.4 75.83 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.792 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.6 mtp85 -56.11 -36.8 68.61 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.552 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 17.8 m -81.24 -27.9 35.03 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.457 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.75 14.58 67.76 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.999 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.34 -30.95 3.93 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 121.275 -0.488 . . . . 0.0 112.796 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.601 ' O ' HD13 ' A' ' 42' ' ' ILE . 2.2 mm? -65.72 101.32 0.62 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.757 0.313 . . . . 0.0 110.569 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.579 ' C ' HD11 ' A' ' 42' ' ' ILE . 15.8 p80 -114.41 157.49 22.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.931 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 40' ' ' SER . 40.6 t -71.7 136.18 26.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.443 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.12 47.26 4.77 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.283 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.578 ' HB3' HD12 ' A' ' 39' ' ' ILE . 3.2 t0 -111.99 132.72 54.61 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.87 123.75 35.48 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.759 0.314 . . . . 0.0 111.624 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.837 ' HA ' HG12 ' A' ' 91' ' ' VAL . 41.7 mt -75.17 132.47 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.174 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.4 mt -117.81 -67.7 0.97 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.033 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.88 145.65 46.56 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.917 0.389 . . . . 0.0 111.504 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.0 t -116.71 115.51 49.24 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.378 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 54.31 37.94 28.43 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.678 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.25 -14.44 54.09 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.648 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.5 t -85.26 135.2 25.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 117.221 0.51 . . . . 0.0 111.179 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -77.21 138.17 39.28 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.155 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.839 HD21 ' HB1' ' A' ' 76' ' ' ALA . 1.2 tp -116.2 -1.92 12.29 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.829 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -30.3 68.26 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -98.8 11.25 39.28 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.44 HG22 ' HB2' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -109.96 159.07 17.59 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.566 0.222 . . . . 0.0 110.775 179.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.13 161.27 18.96 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.063 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.449 ' O ' HG23 ' A' ' 77' ' ' VAL . 38.8 t-80 -54.3 -51.28 65.15 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.015 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -65.28 -41.39 94.21 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.776 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.44 ' HB2' HG22 ' A' ' 71' ' ' THR . 64.7 mt-10 -64.28 -37.23 86.76 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.843 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.839 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -63.39 -30.82 71.88 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.392 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 73' ' ' HIS . 38.9 t -61.9 -42.35 94.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.836 0.35 . . . . 0.0 110.085 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 32.0 m -64.4 -41.25 96.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.452 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.2 mm -57.86 -45.72 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.734 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.19 -40.88 87.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.001 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.8 m -73.57 -13.79 61.09 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -69.23 -29.75 67.76 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.681 0.277 . . . . 0.0 111.115 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.477 ' HB3' HG12 ' A' ' 87' ' ' ILE . 17.5 mp0 -76.5 135.99 39.34 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.195 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -130.65 146.94 52.26 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.166 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.82 -90.82 0.17 Allowed Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.987 -0.625 . . . . 0.0 111.997 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -96.25 115.19 27.03 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.746 0.308 . . . . 0.0 110.304 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.477 HG12 ' HB3' ' A' ' 83' ' ' GLN . 18.9 mt -114.47 126.24 71.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.202 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -99.81 135.52 41.1 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.749 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -128.63 135.87 49.89 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.921 0.391 . . . . 0.0 111.479 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -123.63 115.59 21.72 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.496 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.837 HG12 ' HA ' ' A' ' 60' ' ' ILE . 18.7 m -144.86 172.49 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.341 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 9' ' ' PRO . 9.2 p -141.37 137.03 32.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.059 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.74 122.6 17.66 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.058 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 6.8 m -108.25 120.5 59.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.162 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.123 -179.771 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo . . . . . 0 N--CA 1.492 1.388 0 CA-C-O 120.655 0.19 . . . . 0.0 111.919 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.783 ' HA ' HG12 ' A' ' 92' ' ' VAL . 65.7 mt -104.77 140.85 21.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -124.06 146.1 48.8 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.064 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.4 113.19 23.43 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.677 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.33 141.64 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.347 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 20.6 tp -105.84 127.65 53.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.898 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 tp -113.2 125.5 54.4 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.9 mp -108.44 114.57 28.52 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.684 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -125.94 135.04 51.41 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.206 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -81.39 171.57 14.6 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.047 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.46 -38.78 75.03 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.095 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.414 ' CE1' ' HG2' ' A' ' 21' ' ' GLU . 16.8 p80 -75.42 -30.26 59.99 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.218 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HG2' ' CE1' ' A' ' 20' ' ' HIS . 2.5 mm-40 -77.02 166.16 23.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.897 0.379 . . . . 0.0 111.383 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -113.02 -152.86 11.27 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.893 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.741 HD11 HD13 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -67.98 -41.21 82.71 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.526 0.203 . . . . 0.0 111.464 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.09 -21.32 43.87 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.997 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.755 HG21 ' CD1' ' A' ' 54' ' ' LEU . 2.6 pp -146.48 171.44 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.808 0.337 . . . . 0.0 111.287 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 5.9 m -120.44 138.35 53.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.575 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.777 HD12 HG21 ' A' ' 37' ' ' ILE . 15.2 pt -115.96 156.2 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.851 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.5 p -137.26 163.26 31.36 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.365 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.0 -160.71 17.69 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.874 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.43 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . 166.5 131.7 1.29 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.676 -0.773 . . . . 0.0 113.133 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -56.46 -37.6 70.53 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.182 0.193 . . . . 0.0 111.33 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -62.39 -31.04 71.65 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.125 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -78.31 -26.6 47.02 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.236 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.87 22.93 6.07 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.048 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 10.1 p -149.57 134.97 9.74 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-N 116.926 0.363 . . . . 0.0 110.998 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.45 ' O ' HD12 ' A' ' 38' ' ' LEU . 38.4 Cg_exo -60.91 156.69 42.43 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.42 2.08 . . . . 0.0 112.181 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.777 HG21 HD12 ' A' ' 27' ' ' ILE . 3.5 mp -83.37 131.64 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.792 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.486 ' CD2' ' HB2' ' A' ' 59' ' ' ALA . 3.9 mp -131.64 160.73 34.55 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.574 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.516 HD13 HD11 ' A' ' 54' ' ' LEU . 30.4 mt -93.63 119.58 41.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.946 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.475 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -111.25 -41.2 4.22 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.262 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.457 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 4.1 tt0 -104.83 150.19 25.03 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.716 0.293 . . . . 0.0 111.067 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.705 HG23 HG22 ' A' ' 25' ' ' ILE . 32.3 mt -132.09 121.27 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.746 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -73.78 114.78 35.68 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.817 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -68.03 140.7 50.68 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.707 2.271 . . . . 0.0 112.645 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.34 29.5 52.99 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.746 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.68 172.53 6.63 Favored Pre-proline 0 CA--C 1.531 0.224 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -52.19 -31.66 46.73 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.721 2.281 . . . . 0.0 112.797 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.614 ' HB1' ' HG ' ' A' ' 54' ' ' LEU . . . -61.79 -46.3 90.16 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.09 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.84 -40.34 79.48 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.763 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.07 -31.52 72.78 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.191 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -70.29 -27.97 64.82 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.581 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.38 -56.39 4.67 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.943 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.6 -28.36 37.27 Favored Glycine 0 C--N 1.336 0.579 0 C-N-CA 121.473 -0.394 . . . . 0.0 113.533 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.755 ' CD1' HG21 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -63.94 96.93 0.15 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 121.033 0.444 . . . . 0.0 110.527 179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -119.05 157.4 27.89 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.272 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 40' ' ' SER . 40.1 t -68.38 129.67 33.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.076 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.54 41.83 2.65 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.577 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -109.05 122.71 47.84 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.191 0.197 . . . . 0.0 110.581 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.486 ' HB2' ' CD2' ' A' ' 38' ' ' LEU . . . -94.75 127.1 40.51 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.683 0.278 . . . . 0.0 111.402 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.824 ' HA ' HG12 ' A' ' 91' ' ' VAL . 9.5 mt -77.78 142.21 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.338 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 70.4 mt -130.36 -50.88 1.09 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.933 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.32 145.56 49.15 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.889 0.376 . . . . 0.0 111.698 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.479 HG21 HD13 ' A' ' 68' ' ' LEU . 24.0 t -115.99 115.34 48.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.238 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 53.16 34.8 18.26 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.956 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.14 -15.91 59.95 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.037 -0.602 . . . . 0.0 113.624 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.9 t -88.39 134.95 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 117.218 0.509 . . . . 0.0 111.152 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -69.65 135.59 50.09 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.319 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.592 HD21 ' HB2' ' A' ' 76' ' ' ALA . 0.5 OUTLIER -120.79 16.2 11.83 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.715 179.674 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.4 ttt85 -69.64 -32.31 70.92 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.521 0.193 . . . . 0.0 111.521 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.11 12.02 37.32 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.474 HG22 ' HB2' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -103.45 162.87 12.66 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.617 0.246 . . . . 0.0 110.867 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.37 161.07 13.96 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.12 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.526 ' O ' HG23 ' A' ' 77' ' ' VAL . 58.9 t-80 -54.1 -51.1 65.25 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.066 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 mmtp -60.45 -41.04 93.27 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.811 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.474 ' HB2' HG22 ' A' ' 71' ' ' THR . 26.6 mt-10 -65.22 -37.22 86.61 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.741 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.592 ' HB2' HD21 ' A' ' 68' ' ' LEU . . . -63.56 -35.23 79.79 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.104 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 73' ' ' HIS . 22.1 t -62.23 -39.84 85.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.815 0.341 . . . . 0.0 110.424 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -41.93 99.05 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.594 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 28.7 mm -57.98 -45.41 87.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.571 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.741 HD13 HD11 ' A' ' 23' ' ' LEU . 1.2 mt -57.5 -39.29 76.15 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.072 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 m -61.58 -37.36 83.58 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.07 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -65.72 -25.61 67.38 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.339 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.457 ' HB2' HD13 ' A' ' 87' ' ' ILE . 33.9 mm-40 -65.9 131.13 45.53 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.097 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.03 143.7 50.27 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.384 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.03 -101.31 0.22 Allowed Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.859 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -91.57 126.01 36.5 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.954 0.407 . . . . 0.0 110.495 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.457 HD13 ' HB2' ' A' ' 83' ' ' GLN . 7.9 mt -117.6 122.99 71.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.081 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.77 124.37 37.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.414 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.471 ' CE1' HG13 ' A' ' 63' ' ' VAL . 0.7 OUTLIER -128.16 129.8 47.08 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.927 0.394 . . . . 0.0 111.178 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -101.37 115.21 29.99 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.298 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.824 HG12 ' HA ' ' A' ' 60' ' ' ILE . 15.8 m -138.23 171.5 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.394 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.783 HG12 ' HA ' ' A' ' 10' ' ' ILE . 31.0 m -133.95 149.37 30.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.292 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -72.98 120.98 19.36 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.867 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.35 131.27 73.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.798 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.013 179.932 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo . . . . . 0 N--CA 1.49 1.28 0 CA-C-O 120.788 0.245 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.812 ' HA ' HG12 ' A' ' 92' ' ' VAL . 67.6 mt -96.14 141.01 16.07 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.13 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.5 124.87 44.56 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.993 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.8 111.54 23.67 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.472 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.3 t -132.01 138.05 53.44 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.957 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.9 141.66 30.61 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.07 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -121.48 139.6 53.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.971 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tt -107.6 127.11 53.36 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.822 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -116.2 126.56 53.8 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.87 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.43 155.62 20.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.682 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.33 -38.96 74.9 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.189 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -79.0 -27.72 43.36 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.425 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -95.41 -178.34 4.4 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 120.741 0.305 . . . . 0.0 111.508 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.41 -149.89 5.55 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.974 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.94 -56.97 6.2 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.608 0.242 . . . . 0.0 110.781 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.02 -14.52 61.38 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 121.088 -0.577 . . . . 0.0 113.445 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.603 HD13 HG12 ' A' ' 39' ' ' ILE . 2.6 pp -140.13 154.08 22.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 117.104 0.452 . . . . 0.0 111.166 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 1.5 m -103.8 136.75 42.89 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.793 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.534 ' HB ' HG22 ' A' ' 37' ' ' ILE . 14.7 pt -119.66 149.7 22.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.464 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.456 ' C ' HG23 ' A' ' 37' ' ' ILE . 14.5 t -135.86 146.94 47.98 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.217 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.96 -154.72 25.71 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.364 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 159.45 117.5 0.48 Allowed Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.095 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.88 -33.67 72.14 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.38 0.133 . . . . 0.0 111.321 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -57.26 -29.9 64.21 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.549 0.214 . . . . 0.0 111.331 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -83.15 -29.14 28.88 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.001 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.0 26.03 5.66 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.898 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.423 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 16.1 m -144.58 131.98 10.4 Favored Pre-proline 0 C--O 1.233 0.23 0 CA-C-N 116.75 0.275 . . . . 0.0 111.115 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 32.6 Cg_exo -61.14 153.97 60.84 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.647 2.231 . . . . 0.0 112.005 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.534 HG22 ' HB ' ' A' ' 27' ' ' ILE . 3.3 mp -82.53 132.07 32.28 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.426 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.4 159.05 35.64 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.618 -179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.603 HG12 HD13 ' A' ' 25' ' ' ILE . 13.6 mt -83.01 129.96 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.958 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.3 m -119.71 -40.95 2.71 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.353 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 18.0 tt0 -105.32 144.52 31.99 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.702 0.287 . . . . 0.0 111.081 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.42 ' HA ' HG22 ' A' ' 25' ' ' ILE . 18.9 mm -129.26 111.62 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.697 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -84.87 127.58 64.23 Favored Pre-proline 0 N--CA 1.464 0.245 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.869 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.97 157.86 53.78 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.843 2.362 . . . . 0.0 113.063 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.94 37.58 43.55 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.965 -0.562 . . . . 0.0 112.835 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.06 170.29 8.68 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-O 120.45 0.166 . . . . 0.0 110.799 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.12 -31.24 34.91 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.728 2.285 . . . . 0.0 112.684 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.447 ' CB ' HG23 ' A' ' 25' ' ' ILE . . . -57.34 -46.41 83.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.463 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -68.77 -42.53 77.3 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.851 0.358 . . . . 0.0 110.498 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -65.02 -30.55 71.54 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.299 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -70.57 -28.34 64.82 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.535 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.17 -58.8 3.99 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.764 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -56.85 -23.27 44.54 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.541 -0.362 . . . . 0.0 113.526 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.516 HD11 HD13 ' A' ' 39' ' ' ILE . 0.1 OUTLIER -64.93 96.05 0.18 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 117.111 0.456 . . . . 0.0 110.403 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -119.33 157.41 28.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.299 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.1 m -68.28 134.9 29.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.56 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.85 44.9 4.37 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.587 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.15 122.49 47.89 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.26 122.58 34.0 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.764 0.316 . . . . 0.0 111.633 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.843 ' HA ' HG12 ' A' ' 91' ' ' VAL . 15.6 mt -69.59 132.19 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.366 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.1 mt -114.88 -54.58 2.56 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.802 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -150.76 145.98 26.11 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.454 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.839 HG21 HD21 ' A' ' 80' ' ' LEU . 24.3 t -125.61 120.51 57.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.54 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 57.39 34.54 24.83 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.893 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.08 -11.08 61.26 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.359 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.6 t -88.58 136.33 23.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 117.258 0.529 . . . . 0.0 110.934 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.5 134.39 35.21 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.056 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.417 ' CD2' ' HB1' ' A' ' 76' ' ' ALA . 1.8 mp -108.63 -12.33 14.98 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.034 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -29.05 69.58 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -96.51 9.19 42.16 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.62 0.229 . . . . 0.0 111.62 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.6 p -119.04 157.9 26.88 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.677 0.275 . . . . 0.0 110.8 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.03 161.05 20.85 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.817 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.63 ' O ' HG23 ' A' ' 77' ' ' VAL . 41.4 t-80 -53.82 -50.55 65.94 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.904 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -59.69 -41.56 91.01 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.949 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.28 -38.66 85.44 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.954 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.678 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.44 -35.2 79.65 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.402 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 73' ' ' HIS . 39.5 t -61.86 -40.46 87.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.726 0.298 . . . . 0.0 110.469 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.9 m -66.77 -44.25 81.9 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.782 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 76' ' ' ALA . 11.2 mt -62.06 -43.06 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.825 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.839 HD21 HG21 ' A' ' 63' ' ' VAL . 24.5 mt -62.4 -36.53 82.6 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.684 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.4 t -65.57 -32.69 74.41 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.012 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -65.03 -28.8 69.73 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.325 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.475 ' HB3' HG23 ' A' ' 87' ' ' ILE . 26.2 mm-40 -61.85 112.75 2.42 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.813 0.34 . . . . 0.0 110.767 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.1 ptp85 -112.57 148.88 33.61 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.378 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.56 -103.02 0.55 Allowed Glycine 0 C--N 1.335 0.481 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.59 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -89.07 126.41 35.43 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.812 0.339 . . . . 0.0 110.385 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.475 HG23 ' HB3' ' A' ' 83' ' ' GLN . 13.0 mt -126.05 129.23 72.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.826 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -93.82 135.49 35.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.474 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.469 ' HZ ' HD22 ' A' ' 80' ' ' LEU . 3.4 m-85 -130.58 129.28 42.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.879 0.371 . . . . 0.0 111.026 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -122.07 115.36 22.35 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.227 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.843 HG12 ' HA ' ' A' ' 60' ' ' ILE . 15.9 m -138.83 171.54 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.518 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.812 HG12 ' HA ' ' A' ' 10' ' ' ILE . 15.6 m -134.71 143.18 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.501 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.98 122.92 27.32 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.961 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 29.9 m -119.82 133.41 66.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.088 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.434 -0.794 . . . . 0.0 111.34 -179.865 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.654 ' O ' HG23 ' A' ' 92' ' ' VAL . 6.1 Cg_endo . . . . . 0 N--CA 1.491 1.364 0 CA-C-O 120.99 0.329 . . . . 0.0 111.736 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 mp -78.77 143.43 12.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.204 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.17 143.95 46.95 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.263 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -111.97 115.1 28.4 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 t -125.68 130.15 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.776 0.322 . . . . 0.0 111.175 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.93 132.47 43.48 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.169 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.5 tt -129.67 144.53 51.33 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.985 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.76 114.81 28.92 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.95 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -94.41 136.3 34.86 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.758 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.07 154.56 32.98 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.183 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.63 -37.16 72.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.218 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.422 ' CE1' ' HG2' ' A' ' 21' ' ' GLU . 13.4 p80 -82.47 -26.78 32.33 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.503 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.422 ' HG2' ' CE1' ' A' ' 20' ' ' HIS . 5.0 mm-40 -102.17 110.04 21.89 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.659 0.266 . . . . 0.0 110.946 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -65.8 -152.14 0.13 Allowed Glycine 0 CA--C 1.522 0.523 0 C-N-CA 121.255 -0.498 . . . . 0.0 113.439 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.418 HD22 HG13 ' A' ' 25' ' ' ILE . 0.4 OUTLIER -60.56 -59.98 4.54 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.54 0.2 . . . . 0.0 111.54 -179.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.9 -11.95 65.92 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.598 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.549 HG21 ' CD1' ' A' ' 54' ' ' LEU . 15.0 pt -138.36 152.68 25.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 117.1 0.45 . . . . 0.0 110.977 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.414 ' HB2' ' HB2' ' A' ' 41' ' ' GLU . 0.9 OUTLIER -115.53 136.68 52.84 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.762 179.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.614 HD12 HG21 ' A' ' 37' ' ' ILE . 18.0 pt -117.34 155.8 18.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.592 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 t -140.46 147.13 39.16 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.993 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.63 -165.49 20.69 Favored Glycine 0 C--N 1.336 0.536 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.43 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.423 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . -179.35 114.41 0.44 Allowed Glycine 0 C--N 1.335 0.516 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.679 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.2 tptp -60.99 -29.89 69.95 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -57.53 -31.15 65.78 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.653 0.263 . . . . 0.0 110.966 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.2 m-70 -79.38 -23.11 43.53 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.324 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.15 21.25 4.93 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 121.07 -0.586 . . . . 0.0 113.309 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.1 m -145.38 140.32 15.83 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 117.007 0.403 . . . . 0.0 111.212 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.57 157.07 63.46 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.57 2.18 . . . . 0.0 112.385 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.614 HG21 HD12 ' A' ' 27' ' ' ILE . 3.3 mt -85.64 137.52 20.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.842 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.411 HD12 ' C ' ' A' ' 37' ' ' ILE . 6.3 mp -128.37 151.19 49.64 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.368 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 16.2 mt -86.92 122.12 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.824 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.54 -27.72 8.12 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.877 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 26' ' ' SER . 1.8 mt-10 -109.75 144.27 38.39 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.662 0.268 . . . . 0.0 111.121 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.409 HD12 HD12 ' A' ' 54' ' ' LEU . 22.4 mm -133.55 121.21 40.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.637 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -97.91 112.41 61.64 Favored Pre-proline 0 C--O 1.234 0.287 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.149 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.424 ' HA ' ' HB2' ' A' ' 49' ' ' ASP . 42.0 Cg_endo -68.93 151.58 73.66 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.709 2.273 . . . . 0.0 112.492 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.06 -37.27 3.84 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.734 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.66 176.14 4.11 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-O 120.45 0.167 . . . . 0.0 110.724 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -51.02 -30.65 31.83 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.918 2.412 . . . . 0.0 113.15 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.446 ' CB ' HG23 ' A' ' 25' ' ' ILE . . . -57.69 -46.19 84.65 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.685 0.278 . . . . 0.0 111.211 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.424 ' HB2' ' HA ' ' A' ' 44' ' ' PRO . 0.6 OUTLIER -70.54 -42.12 71.62 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.787 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.6 mtp85 -62.09 -30.08 70.76 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.108 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -69.94 -28.22 65.4 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.418 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.12 -56.69 3.61 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.712 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.95 -23.58 39.07 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-O 119.867 -0.407 . . . . 0.0 113.776 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.549 ' CD1' HG21 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -66.05 90.28 0.13 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 117.161 0.481 . . . . 0.0 110.422 179.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -114.17 157.24 22.91 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.11 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.4 t -64.01 137.71 24.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.676 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.71 46.17 4.35 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.385 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.58 121.25 44.23 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.445 0.164 . . . . 0.0 111.017 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.11 122.05 37.37 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.671 0.272 . . . . 0.0 111.258 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.834 ' HA ' HG12 ' A' ' 91' ' ' VAL . 3.2 mp -77.14 134.7 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.442 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 25.1 mt -121.93 -50.62 2.04 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.941 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -142.56 146.44 34.61 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.762 0.315 . . . . 0.0 111.361 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.0 t -136.02 115.88 17.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.59 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 59.79 33.03 21.64 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.015 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.55 -14.44 58.1 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.305 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.6 t -81.79 132.58 31.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 117.044 0.422 . . . . 0.0 110.604 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -76.26 126.74 31.54 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.658 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.67 HD21 ' CB ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -120.58 0.97 10.57 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.529 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -71.1 -31.48 67.84 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 111.247 0.091 . . . . 0.0 111.247 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.47 11.88 33.94 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.52 ' OG1' HD23 ' A' ' 68' ' ' LEU . 25.7 p -100.91 149.7 23.62 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.588 0.232 . . . . 0.0 111.002 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -75.5 161.13 29.46 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.433 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.423 ' HB2' ' HA2' ' A' ' 30' ' ' GLY . 24.2 t-80 -54.59 -49.63 69.95 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.213 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -62.3 -37.72 86.62 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.588 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -62.67 -37.33 86.0 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.746 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.67 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -63.34 -35.34 80.07 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.347 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.6 t -62.16 -42.96 97.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.635 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.32 -48.3 70.73 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.814 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.8 mt -61.41 -42.19 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.092 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.71 -39.24 80.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.8 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -33.27 75.44 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.009 179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -65.3 -27.11 68.39 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.14 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.478 ' HB3' HG23 ' A' ' 87' ' ' ILE . 75.9 mm-40 -65.79 95.63 0.25 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 110.79 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 -98.68 144.23 28.18 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.123 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.73 -109.08 2.53 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.818 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -79.99 135.96 36.5 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.692 0.282 . . . . 0.0 110.574 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.478 HG23 ' HB3' ' A' ' 83' ' ' GLN . 10.1 mt -137.03 122.36 25.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.289 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -95.79 122.25 38.38 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.428 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -111.8 128.79 56.22 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.007 0.432 . . . . 0.0 111.338 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -117.24 115.36 25.15 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.299 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.834 HG12 ' HA ' ' A' ' 60' ' ' ILE . 17.6 m -137.76 171.05 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.465 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 9' ' ' PRO . 8.6 p -135.94 137.57 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.987 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.19 119.99 13.64 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.834 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.1 t -111.13 125.03 68.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.167 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.991 179.914 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo . . . . . 0 N--CA 1.489 1.222 0 CA-C-O 120.725 0.219 . . . . 0.0 111.842 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.57 ' HA ' HG12 ' A' ' 92' ' ' VAL . 2.7 tt -109.3 124.6 66.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.067 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -113.65 127.03 55.9 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.053 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.24 113.91 27.78 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.998 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.93 135.87 60.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.003 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.415 HD21 ' CG ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -97.71 130.95 44.65 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.824 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.24 139.47 50.32 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.069 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.2 mp -109.02 114.54 28.38 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.844 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.87 139.03 54.13 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.056 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -109.28 168.09 9.64 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.949 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.87 -37.14 75.87 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.282 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.401 ' CE1' ' HG2' ' A' ' 21' ' ' GLU . 32.1 p80 -74.62 -29.89 61.46 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.596 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' HG2' ' CE1' ' A' ' 20' ' ' HIS . 10.0 mm-40 -94.75 166.18 12.12 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 111.641 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.88 -154.22 9.12 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.91 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.08 -67.01 0.52 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.577 0.227 . . . . 0.0 111.03 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.22 4.13 63.0 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.071 -0.585 . . . . 0.0 113.634 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.727 HG21 HD12 ' A' ' 54' ' ' LEU . 17.2 pt -138.29 145.36 28.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 117.256 0.528 . . . . 0.0 111.088 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.75 140.23 34.26 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.099 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.809 HG22 HD13 ' A' ' 39' ' ' ILE . 13.2 pt -116.49 155.62 17.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.684 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.9 p -133.9 153.79 51.51 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.347 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.49 -153.75 19.66 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.803 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.404 ' CA ' ' HB2' ' A' ' 73' ' ' HIS . . . 151.81 138.21 2.74 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.26 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -58.97 -37.74 77.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 122.066 0.146 . . . . 0.0 111.38 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.84 -31.19 71.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.595 0.236 . . . . 0.0 111.017 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -81.14 -28.19 35.19 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.103 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.19 25.83 5.95 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.101 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.8 m -147.82 140.08 14.37 Favored Pre-proline 0 N--CA 1.463 0.202 0 CA-C-N 116.864 0.332 . . . . 0.0 110.992 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.78 155.83 46.69 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.613 2.208 . . . . 0.0 112.19 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.526 HD12 HD11 ' A' ' 68' ' ' LEU . 19.7 mt -84.89 136.56 22.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.857 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.8 154.5 48.48 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.301 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.809 HD13 HG22 ' A' ' 27' ' ' ILE . 16.1 mm -83.87 118.23 30.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.763 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 56' ' ' VAL . 23.0 t -108.19 -28.51 9.44 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.705 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.67 144.45 50.2 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.735 0.302 . . . . 0.0 111.198 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.536 HG12 HG22 ' A' ' 56' ' ' VAL . 20.9 mm -128.92 112.19 25.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.383 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -87.01 130.96 46.27 Favored Pre-proline 0 C--O 1.232 0.158 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.106 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.37 172.8 15.63 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.846 2.364 . . . . 0.0 112.535 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.52 30.38 77.43 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.467 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.448 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -137.01 169.08 14.21 Favored Pre-proline 0 C--O 1.233 0.203 0 C-N-CA 122.248 0.219 . . . . 0.0 110.44 -179.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.448 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 9.3 Cg_endo -53.09 -27.02 34.95 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.768 2.312 . . . . 0.0 112.75 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.72 -46.35 89.37 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.061 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -67.85 -40.49 83.66 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.618 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 -58.71 -33.05 69.76 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.347 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.3 m -80.57 -28.36 37.23 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.56 -51.7 4.27 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.182 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -53.48 -24.37 23.49 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.56 -0.353 . . . . 0.0 113.795 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.727 HD12 HG21 ' A' ' 25' ' ' ILE . 4.2 mm? -65.19 89.52 0.09 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 117.15 0.475 . . . . 0.0 110.743 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -114.25 157.37 22.8 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.348 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.536 HG22 HG12 ' A' ' 42' ' ' ILE . 42.1 t -72.56 136.55 25.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.68 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.29 40.34 4.83 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.899 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -112.08 135.03 53.25 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.602 0.201 . . . . 0.0 110.987 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.53 124.01 47.31 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.686 0.279 . . . . 0.0 111.403 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.868 ' HA ' HG12 ' A' ' 91' ' ' VAL . 3.2 mt -80.04 150.72 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.494 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 61' ' ' LEU . 13.3 mt -136.25 -50.45 0.69 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.354 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -143.74 145.95 32.78 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.773 0.321 . . . . 0.0 111.476 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.779 HG21 HD21 ' A' ' 80' ' ' LEU . 24.4 t -135.39 115.87 18.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.769 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 57.15 34.53 24.99 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.875 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.83 -19.73 46.68 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 120.944 -0.646 . . . . 0.0 113.321 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 t -80.13 135.98 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 117.065 0.433 . . . . 0.0 111.0 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -80.51 137.33 36.43 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.213 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.587 HD22 ' HB ' ' A' ' 60' ' ' ILE . 1.2 tp -87.12 -33.06 19.57 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.038 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -67.4 -27.69 67.29 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.427 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -89.51 9.99 24.52 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 t -134.15 154.43 51.22 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.773 0.321 . . . . 0.0 110.959 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -84.18 161.16 20.67 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.706 ' O ' HG23 ' A' ' 77' ' ' VAL . 51.3 t-80 -54.0 -51.66 63.24 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.008 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -61.16 -42.15 98.03 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.031 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -38.68 84.96 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.963 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.511 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.49 -33.73 76.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.348 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 73' ' ' HIS . 24.7 t -61.91 -43.46 97.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-O 120.76 0.314 . . . . 0.0 110.25 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -65.11 -47.34 77.53 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.544 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 76' ' ' ALA . 17.2 mt -59.23 -49.29 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.92 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.779 HD21 HG21 ' A' ' 63' ' ' VAL . 85.5 mt -55.45 -35.97 66.04 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.497 -0.319 . . . . 0.0 111.132 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.0 -20.06 60.45 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.652 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -74.22 -28.86 61.45 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.748 0.308 . . . . 0.0 110.57 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.567 ' HB3' HG23 ' A' ' 87' ' ' ILE . 1.5 mp0 -68.79 104.82 2.13 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.66 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 149.9 25.68 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.375 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.98 -107.11 1.63 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.469 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.415 ' CG ' HD21 ' A' ' 14' ' ' LEU . 15.9 tt0 -79.37 115.37 18.98 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.761 0.315 . . . . 0.0 110.433 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.567 HG23 ' HB3' ' A' ' 83' ' ' GLN . 11.3 mt -122.55 122.74 66.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.042 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -93.93 121.86 35.83 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.447 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.404 ' CE1' HD22 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -118.06 129.69 55.71 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.877 0.37 . . . . 0.0 111.642 -179.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -118.1 115.35 24.66 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.394 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.868 HG12 ' HA ' ' A' ' 60' ' ' ILE . 17.2 m -136.3 169.26 20.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.513 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 10' ' ' ILE . 29.4 m -137.69 131.23 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.111 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.15 123.48 22.27 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.935 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.3 m -108.34 141.9 22.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.4 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.42 -0.8 . . . . 0.0 111.323 -179.89 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.435 ' O ' HG12 ' A' ' 92' ' ' VAL . 5.3 Cg_endo . . . . . 0 N--CA 1.49 1.274 0 CA-C-O 120.539 0.141 . . . . 0.0 111.827 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.473 ' HA ' HG12 ' A' ' 92' ' ' VAL . 0.6 OUTLIER -100.87 128.67 52.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.462 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.0 ttm180 -123.43 121.56 36.03 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.968 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.5 mmtp -111.47 111.61 22.75 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.566 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.2 t -133.42 134.95 56.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.073 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 mp -97.97 139.54 33.65 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.81 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 tp -108.32 119.6 39.96 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.829 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.6 tp -109.55 115.18 29.43 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.487 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.63 153.14 44.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.018 0.437 . . . . 0.0 111.242 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.84 173.14 7.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.997 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -58.83 -38.37 78.53 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.885 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -72.96 -30.26 63.71 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.18 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -75.19 168.95 19.0 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.852 0.358 . . . . 0.0 111.238 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.1 -149.93 8.88 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.888 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.797 HD11 HD13 ' A' ' 80' ' ' LEU . 1.9 tp -76.88 -61.08 2.09 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.517 0.199 . . . . 0.0 111.323 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.78 -14.25 49.63 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.581 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.614 HG22 HG23 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -143.89 165.09 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-N 117.123 0.461 . . . . 0.0 111.132 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.8 t -120.99 136.76 54.91 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.675 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.605 HD12 HG21 ' A' ' 37' ' ' ILE . 15.2 pt -117.99 153.4 20.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.496 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.2 t -139.6 145.87 39.09 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 151.22 -151.51 23.46 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.447 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 162.53 105.44 0.19 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.847 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -57.57 -34.92 69.71 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.474 0.178 . . . . 0.0 111.18 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -60.72 -31.17 70.48 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.186 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -82.61 -31.36 28.92 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.087 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.65 32.27 2.33 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.709 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.443 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 10.9 p -140.42 130.92 13.75 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-O 120.66 0.267 . . . . 0.0 110.846 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.445 ' O ' HD23 ' A' ' 38' ' ' LEU . 25.9 Cg_exo -62.35 156.23 52.58 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.551 2.168 . . . . 0.0 112.072 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.605 HG21 HD12 ' A' ' 27' ' ' ILE . 30.3 mm -84.85 136.96 21.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.593 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 36' ' ' PRO . 0.3 OUTLIER -145.44 158.56 43.82 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.909 0.385 . . . . 0.0 111.611 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.589 HD13 HD13 ' A' ' 25' ' ' ILE . 16.7 mt -88.48 125.88 41.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.158 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.515 ' O ' HG13 ' A' ' 56' ' ' VAL . 8.6 t -110.42 -34.26 6.38 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.395 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -123.58 147.35 47.39 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.817 0.341 . . . . 0.0 111.371 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.614 HG23 HG22 ' A' ' 25' ' ' ILE . 2.3 mt -127.13 120.11 54.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.54 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -78.68 113.58 36.13 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.703 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.17 149.78 83.15 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.745 2.296 . . . . 0.0 112.648 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.84 39.59 28.17 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.563 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.93 172.95 4.89 Favored Pre-proline 0 C--N 1.331 -0.22 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -51.33 -32.72 42.84 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.61 2.207 . . . . 0.0 112.792 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.556 ' CB ' HG23 ' A' ' 25' ' ' ILE . . . -62.35 -46.31 89.24 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.113 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -64.36 -41.6 96.64 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.665 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.43 -29.86 67.67 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.611 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 10.8 m -70.36 -28.38 65.07 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.18 -57.8 4.01 Favored Glycine 0 C--N 1.338 0.665 0 C-N-CA 120.972 -0.633 . . . . 0.0 112.89 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.44 -25.17 33.41 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 121.514 -0.374 . . . . 0.0 113.47 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.471 HD12 HG21 ' A' ' 25' ' ' ILE . 3.9 mm? -65.21 90.28 0.09 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.964 0.412 . . . . 0.0 110.471 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -115.79 157.47 24.33 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.217 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 40' ' ' SER . 43.1 t -63.92 132.08 29.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.247 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.6 40.78 4.93 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.815 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.55 119.07 37.97 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.21 130.34 38.94 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.879 ' HA ' HG12 ' A' ' 91' ' ' VAL . 3.2 mp -81.6 151.04 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.357 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 22.9 mt -136.6 -51.75 0.69 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.976 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -139.91 147.39 40.5 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.806 0.336 . . . . 0.0 111.448 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.424 HG13 ' CD1' ' A' ' 89' ' ' PHE . 38.2 t -130.01 115.62 33.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.529 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 54.4 32.91 17.46 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.864 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.77 -17.0 58.91 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.95 -0.643 . . . . 0.0 113.339 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.8 t -83.79 137.97 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 117.063 0.432 . . . . 0.0 111.045 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -75.23 131.18 40.2 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.27 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.656 HD13 HG21 ' A' ' 60' ' ' ILE . 7.0 tt -108.09 -22.61 12.32 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.501 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -61.16 -28.48 69.16 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -94.6 12.12 28.66 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.4 p -113.45 162.65 15.87 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.742 0.306 . . . . 0.0 110.583 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.82 161.24 16.84 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.198 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.559 ' O ' HG23 ' A' ' 77' ' ' VAL . 7.4 t-160 -54.03 -50.68 66.12 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.069 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -68.29 -43.16 78.31 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.874 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.8 -38.1 89.34 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.997 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.674 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.66 -30.74 71.81 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.4 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 73' ' ' HIS . 22.9 t -61.93 -41.43 90.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.743 0.306 . . . . 0.0 110.651 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.3 m -69.84 -39.98 76.11 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.493 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.674 HD12 ' HA ' ' A' ' 76' ' ' ALA . 16.0 mt -65.06 -48.89 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.163 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.797 HD13 HD11 ' A' ' 23' ' ' LEU . 4.6 pp -62.67 -36.6 83.39 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.108 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.625 ' N ' HD12 ' A' ' 80' ' ' LEU . 86.9 p -74.54 -16.0 60.84 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -71.22 -30.53 66.48 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.772 0.32 . . . . 0.0 110.858 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.444 ' CB ' HG23 ' A' ' 87' ' ' ILE . 2.2 mp0 -67.47 117.02 8.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.851 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -107.33 147.26 30.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.446 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.93 -98.39 0.19 Allowed Glycine 0 C--N 1.335 0.509 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.559 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -82.66 115.0 21.41 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.721 0.296 . . . . 0.0 110.304 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.444 HG23 ' CB ' ' A' ' 83' ' ' GLN . 16.7 mt -119.64 122.36 68.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.974 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.39 122.88 43.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.351 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.424 ' CD1' HG13 ' A' ' 63' ' ' VAL . 0.5 OUTLIER -122.83 129.42 51.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.826 0.346 . . . . 0.0 110.736 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -111.85 114.98 28.26 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.825 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.879 HG12 ' HA ' ' A' ' 60' ' ' ILE . 19.6 m -134.52 169.31 21.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.566 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.473 HG12 ' HA ' ' A' ' 10' ' ' ILE . 16.9 m -139.96 141.24 34.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.954 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.47 116.26 7.26 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.825 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.3 p -105.01 139.63 25.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.517 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.124 -0.941 . . . . 0.0 111.065 -179.957 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.64 ' O ' HG13 ' A' ' 92' ' ' VAL . 6.4 Cg_exo . . . . . 0 N--CA 1.494 1.541 0 CA-C-O 120.831 0.263 . . . . 0.0 112.21 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.666 HD12 HD12 ' A' ' 61' ' ' LEU . 1.2 tt -92.66 136.89 23.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.168 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.4 ttt180 -123.62 148.07 46.77 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.049 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.467 ' HD2' ' HG3' ' A' ' 90' ' ' GLU . 0.1 OUTLIER -101.1 118.86 37.84 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.659 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.0 t -122.13 129.56 75.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.304 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.4 tp -101.91 120.06 39.79 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.672 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.56 HD11 HD23 ' A' ' 54' ' ' LEU . 5.7 mp -108.28 121.09 44.18 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.149 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.8 tp -108.32 115.22 29.72 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.635 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.08 147.27 45.99 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.209 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -86.75 172.26 10.29 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.975 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -58.89 -38.46 78.91 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.061 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -73.92 -29.53 62.09 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.108 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -68.29 154.19 42.24 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.817 0.342 . . . . 0.0 111.533 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -102.22 -157.85 26.11 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.937 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.55 -62.05 1.6 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.492 0.187 . . . . 0.0 111.49 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.08 -21.17 34.21 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.833 -0.699 . . . . 0.0 113.365 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.914 HD13 HD12 ' A' ' 39' ' ' ILE . 1.1 pp -139.93 151.96 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 117.072 0.436 . . . . 0.0 111.31 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -105.49 137.1 43.87 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.986 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.717 HG22 HD13 ' A' ' 39' ' ' ILE . 14.0 pt -119.09 158.49 20.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.576 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.6 t -144.53 150.3 37.31 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.118 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.2 -159.58 15.73 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.478 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . 161.78 123.31 0.66 Allowed Glycine 0 C--N 1.335 0.485 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.79 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -56.35 -37.87 70.6 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.457 0.169 . . . . 0.0 111.457 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -68.07 -31.15 70.59 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.734 0.302 . . . . 0.0 110.863 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -76.79 -30.5 56.49 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.028 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.96 21.69 5.23 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.113 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.4 p -149.76 130.81 7.2 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.95 0.375 . . . . 0.0 110.921 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -61.77 154.06 63.36 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.575 2.183 . . . . 0.0 112.26 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.511 HG21 HD12 ' A' ' 27' ' ' ILE . 15.9 mt -82.79 136.79 22.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.642 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.38 163.5 32.78 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.886 0.374 . . . . 0.0 111.766 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.914 HD12 HD13 ' A' ' 25' ' ' ILE . 10.5 mm -87.83 125.19 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.59 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.417 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.6 OUTLIER -117.39 -46.77 2.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.136 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.421 ' HB2' ' CB ' ' A' ' 26' ' ' SER . 45.5 mt-10 -111.24 146.4 37.02 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.228 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.567 HG23 HG22 ' A' ' 25' ' ' ILE . 12.8 mt -131.72 113.08 21.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.6 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -69.72 124.61 90.95 Favored Pre-proline 0 C--O 1.232 0.179 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.924 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.06 147.02 53.64 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.695 2.263 . . . . 0.0 112.658 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.46 40.66 22.64 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.569 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.71 173.16 5.37 Favored Pre-proline 0 C--N 1.332 -0.196 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -51.8 -31.8 43.6 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.629 2.219 . . . . 0.0 112.662 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.57 -45.87 84.67 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.225 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -70.56 -43.08 70.22 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.635 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -59.57 -30.42 68.62 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.464 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 94.8 m -80.24 -28.02 38.57 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.833 -0.167 . . . . 0.0 111.353 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.95 17.66 63.46 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.865 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.29 -30.74 2.38 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.062 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.69 HD12 HG21 ' A' ' 25' ' ' ILE . 1.0 OUTLIER -69.9 89.16 0.58 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.845 0.355 . . . . 0.0 110.738 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -106.34 156.83 18.1 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 40' ' ' SER . 22.4 t -64.56 135.09 28.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.688 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.95 46.06 4.31 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.411 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.38 122.74 48.57 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.397 0.142 . . . . 0.0 110.81 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.698 ' HB2' HG21 ' A' ' 94' ' ' VAL . . . -91.35 121.3 32.97 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.816 0.341 . . . . 0.0 111.216 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.875 ' HA ' HG12 ' A' ' 91' ' ' VAL . 5.6 mt -74.06 145.92 10.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.608 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.666 HD12 HD12 ' A' ' 10' ' ' ILE . 64.0 mt -137.83 -52.58 0.63 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.092 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.45 145.58 48.98 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.836 0.35 . . . . 0.0 111.702 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.0 t -131.3 117.04 34.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.403 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 57.82 34.46 24.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.931 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.99 -18.54 47.27 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.589 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.31 130.77 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 117.183 0.491 . . . . 0.0 110.926 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.2 p30 -74.78 140.78 44.25 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.172 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.659 HD21 ' CB ' ' A' ' 76' ' ' ALA . 9.8 tp -114.83 16.27 17.33 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.416 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.13 -34.57 71.17 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.807 -0.178 . . . . 0.0 111.425 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.88 12.03 38.42 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 111.58 0.215 . . . . 0.0 111.58 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.3 m -103.51 154.36 19.54 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.776 0.322 . . . . 0.0 111.191 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.22 161.0 15.91 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.283 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.588 ' O ' HG23 ' A' ' 77' ' ' VAL . 8.4 t-80 -54.1 -52.4 61.13 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.037 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -61.57 -38.36 87.23 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.028 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -65.23 -40.91 94.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.824 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.659 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -63.41 -34.38 77.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.481 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 73' ' ' HIS . 21.9 t -61.81 -43.76 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.72 0.295 . . . . 0.0 110.694 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.9 m -69.67 -44.92 69.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.005 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.4 mt -62.95 -47.99 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.482 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.548 HD12 ' N ' ' A' ' 81' ' ' SER . 4.4 pp -63.51 -33.62 75.98 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.46 0.172 . . . . 0.0 111.09 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.548 ' N ' HD12 ' A' ' 80' ' ' LEU . 12.7 t -66.64 -30.79 71.14 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.151 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -65.31 -29.24 69.97 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.147 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 40.8 mm-40 -60.88 115.14 3.47 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.725 0.298 . . . . 0.0 110.651 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -115.01 143.83 44.56 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.961 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.18 -100.8 0.27 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.567 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -77.39 119.5 21.09 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.738 0.304 . . . . 0.0 110.544 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 22.0 mt -129.83 122.47 54.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.101 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -94.6 126.95 40.22 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.355 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -124.52 129.43 50.59 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.899 0.38 . . . . 0.0 111.391 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.467 ' HG3' ' HD2' ' A' ' 12' ' ' LYS . 6.5 tt0 -119.9 115.57 24.07 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.233 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.875 HG12 ' HA ' ' A' ' 60' ' ' ILE . 17.0 m -138.25 169.02 19.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.0 0.429 . . . . 0.0 111.888 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 9' ' ' PRO . 32.2 t -129.5 138.53 54.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.751 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.27 124.18 21.52 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.87 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.698 HG21 ' HB2' ' A' ' 59' ' ' ALA . 21.7 t -126.46 130.82 71.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.242 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' A' ' 94' ' ' VAL . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.645 -0.693 . . . . 0.0 111.588 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.45 ' O ' HG13 ' A' ' 92' ' ' VAL . 4.0 Cg_endo . . . . . 0 N--CA 1.49 1.281 0 CA-C-O 120.679 0.2 . . . . 0.0 111.983 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.529 ' HA ' HG22 ' A' ' 92' ' ' VAL . 1.0 OUTLIER -78.86 115.74 21.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.12 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 ttt-85 -122.18 127.14 49.66 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.068 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.35 114.22 26.34 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.82 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.0 t -111.26 144.57 18.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.827 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.0 tt -97.72 122.09 40.4 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.594 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.516 HD21 ' HB2' ' A' ' 47' ' ' PRO . 0.5 OUTLIER -108.92 123.61 49.36 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.256 -179.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.5 tt -107.76 115.51 30.27 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.708 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -130.33 139.4 50.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.55 164.29 23.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.993 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.11 -38.5 73.5 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.969 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -76.71 -29.54 56.28 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.079 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -77.25 176.04 9.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.724 0.297 . . . . 0.0 111.38 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -132.99 -144.26 5.19 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.05 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.546 HD11 HD22 ' A' ' 80' ' ' LEU . 7.6 mt -94.11 -67.7 0.84 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.549 0.214 . . . . 0.0 111.141 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.02 4.58 51.02 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.723 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.75 HG22 HG23 ' A' ' 42' ' ' ILE . 2.6 pp -137.12 157.79 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 117.287 0.544 . . . . 0.0 111.321 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.6 m -112.99 136.71 52.38 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.822 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.551 HD12 HG21 ' A' ' 37' ' ' ILE . 2.7 pt -117.64 158.14 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.364 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.4 t -143.48 153.97 43.18 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.289 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 135.31 -167.1 24.28 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.619 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 172.18 122.28 0.64 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.842 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.19 -37.76 78.19 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.658 0.266 . . . . 0.0 111.058 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -59.04 -31.2 68.63 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.936 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -80.27 -28.02 38.45 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.108 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.04 30.35 4.83 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.958 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 6.8 m -146.48 132.96 9.73 Favored Pre-proline 0 C--O 1.234 0.262 0 CA-C-N 116.76 0.28 . . . . 0.0 111.162 179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 34.4 Cg_exo -61.26 157.41 40.35 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.718 2.279 . . . . 0.0 112.049 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.551 HG21 HD12 ' A' ' 27' ' ' ILE . 21.9 mm -82.18 135.19 25.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.563 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 pp -138.65 155.99 47.81 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.934 0.397 . . . . 0.0 111.513 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.917 HD13 HD21 ' A' ' 54' ' ' LEU . 19.3 mt -79.97 125.78 39.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.948 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.7 t -101.63 -42.42 6.22 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.623 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -127.94 150.55 49.84 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.982 0.42 . . . . 0.0 111.796 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.75 HG23 HG22 ' A' ' 25' ' ' ILE . 37.6 mt -132.91 122.67 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.571 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -82.59 132.2 52.82 Favored Pre-proline 0 N--CA 1.462 0.162 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.928 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.92 148.19 40.19 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.747 2.298 . . . . 0.0 112.58 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.42 37.99 46.08 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.65 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.9 172.49 7.25 Favored Pre-proline 0 C--O 1.233 0.191 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.516 ' HB2' HD21 ' A' ' 15' ' ' LEU . 76.2 Cg_exo -50.86 -32.4 37.26 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.669 2.246 . . . . 0.0 112.916 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.475 ' CB ' HD13 ' A' ' 54' ' ' LEU . . . -66.07 -46.27 78.33 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.088 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -69.28 -40.05 77.98 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.683 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -60.04 -31.7 70.22 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.395 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.8 m -76.53 -27.98 56.18 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.46 16.75 67.79 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.132 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.01 -35.15 1.54 Allowed Glycine 0 C--N 1.337 0.593 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.834 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.917 HD21 HD13 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -69.24 105.51 2.54 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.818 0.342 . . . . 0.0 110.907 -179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.469 ' C ' HD11 ' A' ' 42' ' ' ILE . 19.2 p80 -111.98 157.34 20.83 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.208 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.4 t -62.86 137.97 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.61 179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.89 53.36 7.21 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.627 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -111.93 120.8 43.14 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.3 126.75 36.48 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.866 0.365 . . . . 0.0 111.854 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.848 ' HA ' HG12 ' A' ' 91' ' ' VAL . 3.4 mt -85.83 149.9 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.907 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.2 mt -135.47 -50.0 0.73 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.874 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.68 145.69 45.05 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.745 0.307 . . . . 0.0 111.432 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.1 t -135.1 115.99 19.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.569 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 56.54 36.83 28.2 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.806 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.28 -14.4 50.39 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.429 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.3 t -83.92 136.49 22.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 117.19 0.495 . . . . 0.0 110.923 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -76.91 137.53 39.16 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.285 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.401 HD11 ' HB1' ' A' ' 76' ' ' ALA . 0.4 OUTLIER -114.97 -1.53 13.08 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.652 179.586 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.4 ttp180 -71.31 -34.15 70.33 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.35 12.19 33.8 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 64.7 p -103.88 138.61 40.21 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.655 0.264 . . . . 0.0 110.939 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.35 161.16 30.79 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.816 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.537 ' O ' HG23 ' A' ' 77' ' ' VAL . 10.3 t-80 -53.91 -49.28 68.98 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.956 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.95 -41.94 99.66 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.683 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.7 -39.58 94.47 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.105 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.615 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.64 -34.28 77.49 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.476 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 73' ' ' HIS . 39.7 t -62.04 -43.01 97.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.791 0.329 . . . . 0.0 110.311 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.2 m -63.8 -44.37 93.49 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.74 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 76' ' ' ALA . 12.5 mt -62.86 -41.2 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.955 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.546 HD22 HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -59.12 -41.72 88.89 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.833 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 3.6 m -69.2 -27.12 65.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.442 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -65.08 -28.16 69.27 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.42 0.152 . . . . 0.0 111.139 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.529 ' HB3' HG23 ' A' ' 87' ' ' ILE . 50.9 mm-40 -67.06 117.33 8.96 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.65 0.262 . . . . 0.0 110.938 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.96 143.68 44.77 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.071 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 58.61 -106.88 0.95 Allowed Glycine 0 C--N 1.337 0.604 0 C-N-CA 121.298 -0.477 . . . . 0.0 112.916 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -78.6 122.78 26.36 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.661 0.267 . . . . 0.0 110.465 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.529 HG23 ' HB3' ' A' ' 83' ' ' GLN . 13.4 mt -127.7 123.12 60.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.404 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -93.84 123.89 37.49 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.232 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.523 ' HZ ' HD21 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -117.51 133.2 56.23 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.855 0.359 . . . . 0.0 111.654 -179.299 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.88 115.51 23.97 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.421 179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.848 HG12 ' HA ' ' A' ' 60' ' ' ILE . 15.0 m -136.97 169.69 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.743 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.529 HG22 ' HA ' ' A' ' 10' ' ' ILE . 23.4 t -136.95 133.7 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.666 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.44 117.85 8.54 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.791 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 13.3 p -99.4 126.82 52.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.859 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.234 -179.601 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.489 1.22 0 CA-C-O 120.843 0.268 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.662 ' HA ' HG12 ' A' ' 92' ' ' VAL . 1.0 OUTLIER -79.87 127.39 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.175 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.67 128.28 55.22 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.104 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -100.32 117.57 34.81 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.799 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.594 HG23 ' HB3' ' A' ' 89' ' ' PHE . 5.0 m -127.52 128.43 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.461 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 tp -105.02 120.29 41.11 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.088 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 tp -108.72 137.01 47.35 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.685 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.4 114.94 28.43 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.786 0.326 . . . . 0.0 110.877 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.555 ' HB3' HD11 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -117.72 132.59 56.45 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.029 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -103.44 169.73 8.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.699 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.404 ' HA ' ' NH1' ' A' ' 84' ' ' ARG . 53.1 m-20 -57.31 -38.44 74.04 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.921 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -81.65 -26.27 34.9 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.726 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -88.9 153.35 21.12 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.973 0.416 . . . . 0.0 111.606 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -107.35 -149.7 15.75 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.804 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.38 -65.63 0.96 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.545 0.212 . . . . 0.0 111.209 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 96.01 4.42 60.09 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.525 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.684 HG22 HG23 ' A' ' 42' ' ' ILE . 10.4 pt -142.17 151.8 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 117.389 0.594 . . . . 0.0 111.337 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -111.0 136.76 49.52 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.781 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.1 pt -124.84 158.74 32.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.421 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.0 t -143.11 150.92 40.14 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.135 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.82 -148.17 17.2 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.576 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.458 ' HA2' HD11 ' A' ' 37' ' ' ILE . . . 155.54 111.65 0.39 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.532 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -58.25 -30.28 66.43 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.455 0.169 . . . . 0.0 111.205 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -58.66 -31.37 68.12 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.006 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -86.06 -24.3 26.4 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.235 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.0 27.37 2.98 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.154 -0.546 . . . . 0.0 113.003 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.6 m -142.37 138.78 16.81 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 116.923 0.361 . . . . 0.0 110.966 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.48 155.77 65.92 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.52 2.147 . . . . 0.0 112.322 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.458 HD11 ' HA2' ' A' ' 30' ' ' GLY . 23.6 mm -84.15 125.3 40.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.754 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.09 145.13 50.46 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.09 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.578 HD12 ' HB3' ' A' ' 58' ' ' ASP . 23.9 mt -85.31 120.64 35.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.852 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.3 -37.04 5.86 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.476 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -117.65 149.64 40.36 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.765 0.317 . . . . 0.0 111.198 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.684 HG23 HG22 ' A' ' 25' ' ' ILE . 24.2 mt -134.28 113.42 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.766 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -72.83 127.02 90.27 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.293 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.0 166.07 28.66 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.819 2.346 . . . . 0.0 112.789 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.21 23.45 74.77 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.71 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -131.82 172.77 6.79 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.01 -22.01 29.2 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.484 2.123 . . . . 0.0 113.206 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.536 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -60.32 -46.94 88.1 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.322 0.489 . . . . 0.0 112.322 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -71.41 -38.03 71.46 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.671 0.272 . . . . 0.0 110.57 179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -67.03 -27.72 67.64 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.015 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 7.5 t -70.28 -28.03 64.89 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.338 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.62 -60.52 3.69 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.737 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -54.48 -26.18 37.02 Favored Glycine 0 C--N 1.338 0.66 0 C-N-CA 121.447 -0.406 . . . . 0.0 113.39 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.463 HD11 HG21 ' A' ' 25' ' ' ILE . 0.1 OUTLIER -65.09 92.12 0.1 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.009 0.433 . . . . 0.0 110.502 179.658 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -119.19 157.65 27.54 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.294 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.0 m -63.77 138.86 22.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.49 46.14 7.02 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.739 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.578 ' HB3' HD12 ' A' ' 39' ' ' ILE . 0.6 OUTLIER -111.99 127.82 55.99 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.416 0.15 . . . . 0.0 110.954 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -94.65 125.24 39.17 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.192 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.909 ' HA ' HG12 ' A' ' 91' ' ' VAL . 3.3 mt -80.14 136.85 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.461 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.1 mt -116.24 -52.07 2.6 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.944 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -147.07 156.06 42.7 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.813 0.34 . . . . 0.0 111.55 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.2 t -138.51 115.76 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.761 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.401 ' HB2' ' OE1' ' A' ' 83' ' ' GLN . 4.2 t-20 55.28 42.49 30.3 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.063 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.42 2.01 62.34 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.307 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.6 t -97.27 122.59 48.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-N 117.149 0.474 . . . . 0.0 110.508 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -66.31 128.51 36.42 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.86 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.541 HD22 HG21 ' A' ' 60' ' ' ILE . 1.9 tp -103.84 -17.07 15.19 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.789 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.6 ttm105 -61.17 -32.5 72.23 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -98.75 7.0 46.57 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -101.92 148.11 25.73 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.746 0.307 . . . . 0.0 110.97 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.79 161.08 23.4 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.605 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.59 ' O ' HG23 ' A' ' 77' ' ' VAL . 58.5 t-80 -54.12 -49.66 68.66 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.958 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -40.68 90.46 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.926 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -64.75 -38.69 91.83 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.19 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.432 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.69 -34.98 79.06 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.272 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 73' ' ' HIS . 39.1 t -61.7 -42.08 92.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.38 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.37 -44.77 93.82 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.697 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.432 HD12 ' HA ' ' A' ' 76' ' ' ALA . 21.7 mt -63.84 -46.47 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.04 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.447 HD21 ' HZ ' ' A' ' 89' ' ' PHE . 0.4 OUTLIER -55.61 -41.33 73.32 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.112 179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.94 -34.3 77.47 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.983 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -65.74 -24.82 67.04 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.422 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.45 ' HB2' HD13 ' A' ' 87' ' ' ILE . 32.5 mm-40 -63.38 103.98 0.57 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.769 0.319 . . . . 0.0 110.766 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.404 ' NH1' ' HA ' ' A' ' 19' ' ' ASP . 11.0 mmt180 -112.06 155.03 24.49 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.073 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.07 -103.23 0.68 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.39 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.61 130.97 44.6 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.706 0.289 . . . . 0.0 110.551 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.555 HD11 ' HB3' ' A' ' 17' ' ' LYS . 14.2 mt -126.19 122.48 61.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.841 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -93.91 122.87 36.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.444 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.594 ' HB3' HG23 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -116.88 134.17 55.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.991 0.424 . . . . 0.0 111.438 -179.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -122.69 115.44 22.08 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.096 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.909 HG12 ' HA ' ' A' ' 60' ' ' ILE . 25.9 m -138.52 170.27 16.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.59 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.662 HG12 ' HA ' ' A' ' 10' ' ' ILE . 6.2 m -134.96 136.77 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.863 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.78 121.83 16.31 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.961 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.5 t -115.28 137.47 48.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.086 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.387 179.92 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.433 ' O ' HG13 ' A' ' 92' ' ' VAL . 4.4 Cg_endo . . . . . 0 N--CA 1.49 1.301 0 CA-C-O 120.671 0.196 . . . . 0.0 111.884 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 tt -83.29 141.31 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.379 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -122.45 132.82 54.53 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.122 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -103.48 111.96 24.65 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.501 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.7 t -118.22 138.13 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.815 0.341 . . . . 0.0 111.338 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.779 HD21 ' HG3' ' A' ' 86' ' ' GLU . 2.5 tt -108.34 127.54 53.96 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.855 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.5 tp -115.01 144.1 44.15 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.034 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.4 mt -109.22 116.17 31.39 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.964 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.57 137.86 52.31 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.07 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -114.99 167.66 10.6 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.706 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.82 -38.21 72.28 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.192 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -84.07 -25.26 29.94 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.529 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -92.08 173.91 7.59 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.787 0.327 . . . . 0.0 111.498 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -132.83 -146.4 5.59 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.998 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.8 mt -82.79 -66.59 0.87 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.525 0.203 . . . . 0.0 111.168 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.16 4.52 35.54 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.694 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.769 HD13 HD12 ' A' ' 39' ' ' ILE . 1.5 pp -146.44 147.96 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 117.297 0.549 . . . . 0.0 111.114 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.1 t -101.85 137.84 39.61 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.727 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.743 HG22 HD13 ' A' ' 39' ' ' ILE . 16.2 pt -116.11 153.82 17.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.543 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.9 t -141.9 152.16 43.31 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 130.37 -152.55 19.82 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.496 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . 166.57 119.74 0.49 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.934 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.91 -35.61 75.24 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.522 0.201 . . . . 0.0 111.328 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.39 -31.03 65.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.139 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -78.48 -27.52 46.26 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.138 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.76 26.53 5.54 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.807 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 13.1 m -141.1 133.29 14.02 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 116.787 0.293 . . . . 0.0 111.082 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 34.4 Cg_exo -61.27 157.6 39.47 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.823 2.349 . . . . 0.0 112.157 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.569 ' O ' HD12 ' A' ' 60' ' ' ILE . 23.5 mm -82.48 130.68 35.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.733 0.301 . . . . 0.0 110.44 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.561 HD12 ' C ' ' A' ' 37' ' ' ILE . 9.7 mp -121.78 156.29 33.5 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.604 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.769 HD12 HD13 ' A' ' 25' ' ' ILE . 17.8 mm -88.05 124.83 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.956 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.402 ' O ' HG13 ' A' ' 56' ' ' VAL . 3.1 m -117.73 -45.02 2.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.557 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.51 145.23 33.39 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.796 0.331 . . . . 0.0 111.254 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.617 HG23 HG22 ' A' ' 25' ' ' ILE . 12.6 mt -132.94 113.46 20.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.566 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -71.76 126.45 91.48 Favored Pre-proline 0 C--O 1.232 0.145 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.823 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.8 154.39 63.63 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.774 2.316 . . . . 0.0 112.624 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.38 32.95 80.66 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.774 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.96 175.19 3.81 Favored Pre-proline 0 C--O 1.233 0.213 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -51.13 -33.11 42.5 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.672 2.248 . . . . 0.0 112.774 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.4 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -58.03 -46.14 85.81 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.214 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.12 -38.75 72.31 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.837 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.3 mtt-85 -61.62 -33.96 74.83 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.795 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 27.5 p -90.35 -27.36 19.43 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.598 0.221 . . . . 0.0 111.598 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 66.58 16.14 65.04 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.109 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.68 -28.7 5.87 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.403 -0.427 . . . . 0.0 112.73 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.45 HD22 HG21 ' A' ' 25' ' ' ILE . 3.5 mt -77.1 71.72 3.6 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.245 0.545 . . . . 0.0 110.497 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -86.1 157.41 20.05 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.278 -179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 40' ' ' SER . 26.1 t -66.42 137.95 23.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.065 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.25 36.58 9.72 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.543 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -100.29 150.1 22.92 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.55 121.08 37.63 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.619 0.247 . . . . 0.0 111.416 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.831 ' HA ' HG12 ' A' ' 91' ' ' VAL . 2.0 mt -81.72 148.05 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.519 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 36.8 mt -131.44 -51.51 1.0 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.993 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -135.73 145.81 47.04 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.911 0.386 . . . . 0.0 111.759 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.436 ' CG2' HD13 ' A' ' 68' ' ' LEU . 21.7 t -127.74 115.67 40.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.294 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 57.4 34.24 24.39 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.656 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.05 -19.02 44.85 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.68 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.8 t -88.05 137.37 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 117.268 0.534 . . . . 0.0 111.078 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -71.26 132.81 45.48 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.265 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.524 HD22 HG21 ' A' ' 60' ' ' ILE . 7.6 tp -89.95 -29.36 18.54 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.183 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -18.93 65.41 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.775 -0.193 . . . . 0.0 111.394 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.14 9.22 34.45 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.4 t -133.77 165.69 24.39 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.559 0.219 . . . . 0.0 110.751 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.05 161.0 16.79 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.064 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.662 ' O ' HG23 ' A' ' 77' ' ' VAL . 53.6 t-80 -55.66 -51.4 67.36 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.181 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -61.38 -43.13 99.4 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.889 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.0 -38.26 88.03 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.917 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.75 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.79 -30.73 71.79 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.564 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 73' ' ' HIS . 22.1 t -61.86 -45.02 99.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 120.789 0.328 . . . . 0.0 110.312 179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.4 -40.14 96.4 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.595 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.75 HD12 ' HA ' ' A' ' 76' ' ' ALA . 34.5 mt -61.09 -41.73 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.884 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.434 HD23 HG11 ' A' ' 63' ' ' VAL . 69.4 mt -61.71 -39.23 90.77 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.783 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.6 m -64.39 -32.48 74.11 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.895 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -65.18 -29.25 70.06 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.243 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 37.3 mm-40 -65.43 106.33 1.37 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.759 0.314 . . . . 0.0 110.808 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.52 148.7 29.87 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.222 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.94 -100.95 0.43 Allowed Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.618 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.779 ' HG3' HD21 ' A' ' 14' ' ' LEU . 9.2 tt0 -88.37 128.34 35.51 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.645 0.259 . . . . 0.0 110.436 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.0 mt -128.96 122.5 56.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.149 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -97.14 138.49 34.57 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.814 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -133.37 129.91 38.06 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.088 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -113.25 115.2 27.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.272 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.831 HG12 ' HA ' ' A' ' 60' ' ' ILE . 26.8 m -134.91 169.36 21.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.511 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 9' ' ' PRO . 17.6 t -138.66 136.53 43.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.937 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.55 123.58 22.17 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.753 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.7 m -122.58 113.35 37.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.078 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.453 -179.715 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.489 1.217 0 CA-C-O 120.689 0.204 . . . . 0.0 111.834 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.424 ' HA ' HG22 ' A' ' 92' ' ' VAL . 3.7 mp -79.18 140.19 17.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.185 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.16 132.74 54.61 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.994 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.84 118.2 35.99 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.607 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 16.2 m -128.94 142.17 44.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.394 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.487 HD23 ' O ' ' A' ' 87' ' ' ILE . 1.7 mt -105.45 122.55 46.22 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -109.79 139.66 44.59 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.953 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 49.9 mt -111.77 119.08 37.39 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.768 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.41 ' HB2' ' CD1' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -107.64 130.56 54.9 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.991 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.69 163.72 16.43 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.95 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.38 -38.57 71.64 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.185 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -86.39 -23.5 26.1 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.801 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -92.53 161.34 14.65 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.933 0.396 . . . . 0.0 111.232 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -126.87 -158.88 10.0 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.91 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.737 HD21 ' CD2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -71.98 -67.43 0.54 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.575 0.226 . . . . 0.0 110.982 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.63 4.43 67.78 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.994 -0.622 . . . . 0.0 113.701 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.855 HG22 HG23 ' A' ' 42' ' ' ILE . 2.3 pt -136.77 143.73 34.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 117.459 0.63 . . . . 0.0 111.331 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.2 m -105.17 136.61 44.34 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.716 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.847 HG22 HD13 ' A' ' 39' ' ' ILE . 43.5 pt -121.98 155.7 26.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.483 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 29.8 p -139.35 173.88 11.09 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.368 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.74 -159.49 19.05 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.668 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.427 ' H ' HG23 ' A' ' 35' ' ' VAL . . . 170.53 125.07 0.78 Allowed Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.861 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? -61.06 -37.79 83.91 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.455 0.169 . . . . 0.0 111.289 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.4 -31.22 72.33 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.206 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 25.3 m-70 -78.38 -29.26 47.26 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.108 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.77 30.24 3.56 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.93 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.427 HG23 ' H ' ' A' ' 30' ' ' GLY . 14.8 m -144.06 132.62 11.09 Favored Pre-proline 0 C--O 1.234 0.25 0 CA-C-N 116.838 0.319 . . . . 0.0 111.108 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.556 ' O ' HD12 ' A' ' 38' ' ' LEU . 26.7 Cg_exo -61.14 157.33 40.2 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.614 2.209 . . . . 0.0 112.153 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.491 HD12 ' ND1' ' A' ' 73' ' ' HIS . 24.6 mm -83.75 127.99 39.24 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.632 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.556 HD12 ' O ' ' A' ' 36' ' ' PRO . 5.3 mp -130.1 149.97 51.58 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.407 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.847 HD13 HG22 ' A' ' 27' ' ' ILE . 30.5 mm -75.98 114.9 16.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.577 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.444 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.7 OUTLIER -84.11 -45.9 12.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.382 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -145.04 161.51 39.24 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.861 0.362 . . . . 0.0 111.273 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.855 HG23 HG22 ' A' ' 25' ' ' ILE . 4.0 mp -132.13 116.69 30.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.68 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -65.9 133.48 94.91 Favored Pre-proline 0 C--O 1.232 0.159 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.069 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -73.91 153.08 47.37 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.797 2.331 . . . . 0.0 112.756 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.57 31.5 62.88 Favored Glycine 0 C--N 1.333 0.409 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.676 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.442 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.2 OUTLIER -129.34 169.4 13.27 Favored Pre-proline 0 C--O 1.233 0.196 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.442 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 9.8 Cg_endo -53.92 -26.98 42.35 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.684 2.256 . . . . 0.0 112.721 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -57.37 -46.07 83.75 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.197 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.62 -38.63 73.95 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.862 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -56.83 -39.41 74.18 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.244 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.66 -27.76 64.28 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.755 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.79 19.96 75.51 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.678 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -119.8 -31.68 1.3 Allowed Glycine 0 C--N 1.338 0.681 0 C-N-CA 121.262 -0.494 . . . . 0.0 113.17 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.647 HD12 HG21 ' A' ' 25' ' ' ILE . 4.3 mm? -70.01 89.2 0.6 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.104 0.478 . . . . 0.0 110.413 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -111.08 157.54 19.87 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.339 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 40' ' ' SER . 20.7 t -63.19 140.05 20.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.291 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 73.15 52.92 8.24 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.871 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -112.19 139.02 48.08 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.22 0.208 . . . . 0.0 111.211 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.65 127.14 53.4 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.895 HG21 HD13 ' A' ' 68' ' ' LEU . 2.8 mt -91.54 148.08 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 120.852 0.358 . . . . 0.0 111.631 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 78.8 mt -133.33 -52.94 0.89 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.806 179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.99 147.68 46.42 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.865 0.364 . . . . 0.0 111.385 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -136.32 115.66 16.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.409 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 57.99 33.36 23.1 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.214 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.76 -16.03 57.64 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 120.896 -0.668 . . . . 0.0 113.24 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.7 t -88.68 137.33 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 117.065 0.433 . . . . 0.0 110.912 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -76.5 135.58 39.34 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.305 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.895 HD13 HG21 ' A' ' 60' ' ' ILE . 1.1 tt -96.71 -26.71 15.07 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.406 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -18.1 63.15 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -97.52 11.78 35.67 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.0 t -133.48 150.69 51.72 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.752 0.311 . . . . 0.0 111.11 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.5 mptm? -75.67 161.25 29.25 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.359 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.598 ' O ' HG23 ' A' ' 77' ' ' VAL . 1.7 t60 -53.92 -52.03 61.88 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.104 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -61.84 -42.44 99.04 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.947 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -64.61 -38.54 91.36 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.102 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.59 -33.31 75.33 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.363 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 73' ' ' HIS . 37.2 t -62.09 -43.7 98.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.76 0.314 . . . . 0.0 110.341 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 29.3 m -60.54 -43.6 97.03 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.602 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 64.7 mt -58.45 -42.72 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.623 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.737 ' CD2' HD21 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -57.25 -40.75 78.27 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.838 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.5 t -62.79 -36.26 82.54 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.773 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -65.35 -24.89 67.37 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.269 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.479 ' HB3' HG23 ' A' ' 87' ' ' ILE . 38.2 mm-40 -65.45 91.48 0.12 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.932 0.396 . . . . 0.0 110.755 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.37 149.61 24.6 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.984 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.46 -98.7 0.29 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.291 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -92.75 137.6 32.22 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.703 0.287 . . . . 0.0 110.524 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.487 ' O ' HD23 ' A' ' 14' ' ' LEU . 15.0 mt -137.62 124.44 28.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -101.27 129.9 47.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.694 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.89 129.03 54.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.782 0.325 . . . . 0.0 110.786 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.72 116.3 25.66 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.017 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.857 HG12 ' HA ' ' A' ' 60' ' ' ILE . 9.0 m -138.85 171.6 14.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.985 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 10' ' ' ILE . 21.6 t -137.18 132.16 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.722 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.66 127.46 33.04 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.724 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.5 t -114.84 135.33 55.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.364 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 118.44 -0.79 . . . . 0.0 111.11 179.802 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo . . . . . 0 N--CA 1.489 1.252 0 CA-C-O 120.685 0.202 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.726 ' HA ' HG12 ' A' ' 92' ' ' VAL . 31.3 mt -87.3 142.27 13.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.166 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -122.04 129.25 52.26 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.95 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.4 118.2 36.15 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.694 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.1 t -127.7 141.25 46.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.379 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.5 mt -102.54 128.13 49.32 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.832 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 tp -112.87 136.98 51.91 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.142 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.63 116.37 31.86 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.826 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.438 ' HG2' HD12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -129.17 153.96 47.21 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.113 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.99 164.17 13.43 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.038 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -57.63 -38.53 75.14 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.966 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -79.33 -27.94 42.1 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.298 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.68 161.84 22.01 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.849 0.357 . . . . 0.0 111.324 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -100.32 -146.31 19.22 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.944 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.3 tp -87.64 -52.74 5.16 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.552 0.215 . . . . 0.0 111.319 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.12 -11.64 51.99 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.418 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.662 HD12 HD13 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -140.35 151.89 21.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 116.931 0.366 . . . . 0.0 111.041 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.435 ' O ' HG23 ' A' ' 39' ' ' ILE . 0.3 OUTLIER -108.51 136.71 47.66 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.029 179.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.443 HG21 HD11 ' A' ' 60' ' ' ILE . 14.8 pt -116.15 153.22 17.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.489 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.8 t -143.59 145.64 32.67 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.012 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 123.71 -170.07 15.95 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.497 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.92 122.5 0.82 Allowed Glycine 0 C--N 1.335 0.528 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.801 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.75 -30.27 65.47 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.4 -30.94 65.35 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.61 0.243 . . . . 0.0 111.069 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -79.45 -32.66 42.74 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.978 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.95 -29.9 3.02 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.669 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 11.6 m -101.86 132.83 21.18 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-O 120.707 0.289 . . . . 0.0 111.196 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 35.6 Cg_exo -61.09 157.21 40.44 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.799 2.333 . . . . 0.0 112.295 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.46 ' H ' HD12 ' A' ' 37' ' ' ILE . 3.9 mp -83.25 138.02 19.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.817 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.44 163.12 31.21 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.295 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 26' ' ' SER . 25.5 mt -85.28 120.19 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.262 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.469 ' O ' HG13 ' A' ' 56' ' ' VAL . 2.6 t -108.43 -33.07 7.18 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.633 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.37 144.93 44.42 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.677 0.275 . . . . 0.0 111.126 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.48 HG23 HG22 ' A' ' 25' ' ' ILE . 22.3 mm -125.96 121.63 60.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.647 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -75.73 121.07 84.35 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.881 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.8 155.57 62.27 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.774 2.316 . . . . 0.0 112.545 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.93 38.24 95.8 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.354 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.77 176.06 3.17 Favored Pre-proline 0 CA--C 1.531 0.23 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.33 -29.5 30.49 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.643 2.228 . . . . 0.0 112.77 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' A' ' 54' ' ' LEU . . . -58.16 -46.19 86.15 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.992 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.55 -42.11 75.01 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.763 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -59.73 -33.27 71.42 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.429 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 3.2 t -83.35 -28.19 29.16 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 63.85 16.66 59.64 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.091 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.88 -29.39 2.86 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 121.234 -0.508 . . . . 0.0 113.197 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.662 HD13 HD12 ' A' ' 25' ' ' ILE . 32.0 mt -76.09 71.84 2.87 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.142 0.496 . . . . 0.0 110.753 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -84.15 157.25 21.75 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.058 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 40' ' ' SER . 23.4 t -65.08 135.01 28.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.44 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 90.25 47.11 3.91 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.554 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -110.06 124.28 51.2 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.5 121.2 32.98 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.722 0.296 . . . . 0.0 111.194 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.757 ' HA ' HG12 ' A' ' 91' ' ' VAL . 7.5 mt -70.72 142.2 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.575 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.4 mt -127.29 -53.82 1.37 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.969 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.54 158.76 43.99 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.882 0.372 . . . . 0.0 111.813 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.517 HG22 ' CE1' ' A' ' 89' ' ' PHE . 15.1 t -133.66 117.52 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.727 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 57.08 37.47 28.64 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.95 0.405 . . . . 0.0 110.964 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.52 6.09 89.43 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.441 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.4 t -97.79 119.95 46.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.178 0 CA-C-N 117.278 0.539 . . . . 0.0 110.699 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -63.83 126.79 28.75 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.946 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.454 HD13 HG23 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -113.02 4.19 16.57 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.686 179.817 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -68.84 -34.83 76.14 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.447 0.165 . . . . 0.0 111.133 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -104.67 11.9 33.54 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.47 HG21 ' CD1' ' A' ' 79' ' ' ILE . 15.8 m -100.97 156.39 17.42 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.645 0.259 . . . . 0.0 110.905 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -92.62 161.22 14.66 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.535 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.438 ' O ' HG23 ' A' ' 77' ' ' VAL . 30.2 t-80 -54.47 -50.69 67.13 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.054 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.16 -39.5 90.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.788 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -64.56 -38.78 92.18 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.059 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.676 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.6 -32.79 74.37 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.362 -179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 73' ' ' HIS . 40.8 t -61.85 -41.53 91.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.763 0.316 . . . . 0.0 110.56 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.9 -41.89 74.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.899 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' A' ' 76' ' ' ALA . 11.6 mt -62.74 -48.69 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.651 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 81' ' ' SER . 4.2 pp -62.36 -35.17 78.29 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.019 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.511 ' N ' HD12 ' A' ' 80' ' ' LEU . 2.3 m -65.91 -33.88 76.85 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.136 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -65.26 -27.74 68.86 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.232 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.456 ' HB3' HG23 ' A' ' 87' ' ' ILE . 46.7 mm-40 -65.16 111.74 3.08 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.904 0.383 . . . . 0.0 111.119 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -105.19 143.79 32.88 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.109 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.77 -105.12 0.83 Allowed Glycine 0 C--N 1.337 0.59 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.894 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -81.2 127.16 32.37 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.723 0.297 . . . . 0.0 110.665 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.456 HG23 ' HB3' ' A' ' 83' ' ' GLN . 11.2 mt -127.95 122.39 58.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.05 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -93.87 130.77 39.79 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.438 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CE1' HG22 ' A' ' 63' ' ' VAL . 0.5 OUTLIER -126.25 129.75 49.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.764 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.03 115.17 29.29 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.308 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.757 HG12 ' HA ' ' A' ' 60' ' ' ILE . 15.5 m -135.62 164.03 33.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.352 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.726 HG12 ' HA ' ' A' ' 10' ' ' ILE . 13.1 m -129.45 133.54 65.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.838 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.09 117.24 8.13 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.879 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.6 m -123.76 118.31 53.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.108 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.354 -0.831 . . . . 0.0 111.391 -179.712 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.448 ' O ' HG13 ' A' ' 92' ' ' VAL . 5.2 Cg_exo . . . . . 0 N--CA 1.489 1.246 0 CA-C-O 120.802 0.251 . . . . 0.0 111.84 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.5 HD11 ' HG2' ' A' ' 90' ' ' GLU . 0.9 OUTLIER -84.39 118.71 32.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.213 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.78 130.04 55.38 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.043 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.56 120.24 40.84 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.2 t -125.67 134.25 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.176 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 mt -98.38 124.7 43.19 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.855 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.1 131.55 54.5 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.57 115.42 28.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.777 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.46 129.73 33.66 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.94 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.17 170.71 9.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.992 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -59.27 -38.17 79.44 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.953 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -76.75 -25.77 53.84 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.715 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -91.51 167.61 12.12 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.918 0.39 . . . . 0.0 111.74 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -121.88 -166.48 12.85 Favored Glycine 0 C--N 1.339 0.724 0 CA-C-N 115.932 -0.577 . . . . 0.0 113.03 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.981 HD12 HD11 ' A' ' 25' ' ' ILE . 0.3 OUTLIER -66.08 -68.33 0.38 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.517 0.199 . . . . 0.0 111.255 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.436 ' HA2' ' OE1' ' A' ' 46' ' ' GLN . . . 106.02 4.02 38.92 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.015 -0.612 . . . . 0.0 114.113 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.981 HD11 HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -145.13 153.92 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 117.341 0.571 . . . . 0.0 111.101 179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.2 136.97 38.38 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.654 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.647 HD12 ' HE1' ' A' ' 73' ' ' HIS . 10.2 pt -116.77 143.59 26.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.292 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.2 t -123.2 158.03 31.72 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.173 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.3 -143.19 15.7 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.145 -0.55 . . . . 0.0 112.357 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.41 ' HA3' ' HB2' ' A' ' 73' ' ' HIS . . . 136.43 134.85 3.35 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.935 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -52.54 -31.15 34.3 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -57.56 -29.4 64.39 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.18 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -93.82 19.48 8.82 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.45 29.09 68.48 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.166 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 8.7 m -147.08 139.64 14.23 Favored Pre-proline 0 CA--C 1.529 0.163 0 CA-C-N 116.704 0.252 . . . . 0.0 111.402 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 29.7 Cg_exo -61.59 155.5 52.96 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.637 2.225 . . . . 0.0 112.229 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.6 mt -87.84 139.11 17.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.865 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.746 HD23 ' HB2' ' A' ' 59' ' ' ALA . 1.1 mp -134.67 156.75 48.21 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.261 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.768 HD13 HD21 ' A' ' 54' ' ' LEU . 27.8 mt -87.6 129.55 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.97 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.567 ' O ' HG13 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -121.19 -42.83 2.45 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.558 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.57 144.84 35.72 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.71 0.291 . . . . 0.0 111.159 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.727 HG23 HG22 ' A' ' 25' ' ' ILE . 41.0 mt -134.47 133.14 55.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.754 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -102.21 105.65 43.98 Favored Pre-proline 0 C--O 1.233 0.202 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.885 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.82 150.03 47.64 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.716 2.277 . . . . 0.0 112.545 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.13 -30.81 8.8 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.661 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.436 ' OE1' ' HA2' ' A' ' 24' ' ' GLY . 0.0 OUTLIER -77.23 167.16 38.85 Favored Pre-proline 0 CA--C 1.532 0.255 0 CA-C-O 120.552 0.215 . . . . 0.0 110.754 179.744 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 13.6 Cg_endo -56.89 -29.01 80.15 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.68 2.253 . . . . 0.0 112.77 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.954 ' HB1' HD13 ' A' ' 54' ' ' LEU . . . -61.06 -46.07 92.17 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.784 0.326 . . . . 0.0 110.983 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -70.16 -39.48 75.31 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.744 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -61.69 -29.09 69.87 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.408 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.06 -28.31 63.25 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.34 -54.57 4.77 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.014 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -50.53 -34.57 27.63 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 121.542 -0.361 . . . . 0.0 113.509 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.954 HD13 ' HB1' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -71.17 93.71 1.09 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.112 0.482 . . . . 0.0 110.602 179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -114.4 157.43 22.88 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.36 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 40' ' ' SER . 38.9 t -61.25 130.46 25.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.445 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.49 45.03 4.14 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.435 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.03 122.35 47.51 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 122.149 0.18 . . . . 0.0 110.739 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.746 ' HB2' HD23 ' A' ' 38' ' ' LEU . . . -91.14 122.66 33.96 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.639 0.257 . . . . 0.0 111.16 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.809 ' HA ' HG12 ' A' ' 91' ' ' VAL . 6.9 mt -76.72 145.79 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.412 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 mt -139.68 -51.48 0.51 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.123 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.47 146.02 50.27 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.972 0.415 . . . . 0.0 111.878 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 20.7 t -135.82 115.73 17.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.367 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 54.6 35.34 23.38 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.696 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.64 -18.68 45.21 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 120.993 -0.623 . . . . 0.0 113.713 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.21 128.03 48.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 117.315 0.557 . . . . 0.0 111.052 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -68.06 139.12 56.25 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.044 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.899 HD21 ' HB1' ' A' ' 76' ' ' ALA . 5.4 tp -108.85 13.2 25.03 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.382 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 41.2 ttp85 -71.18 -31.59 67.85 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.444 0.164 . . . . 0.0 111.433 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -102.3 10.83 38.91 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.73 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.433 HG22 ' HB3' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -108.04 132.71 53.26 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -64.59 158.52 24.07 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.149 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.647 ' HE1' HD12 ' A' ' 27' ' ' ILE . 1.3 t60 -56.66 -50.41 72.15 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.236 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -61.71 -39.32 91.07 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.516 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.433 ' HB3' HG22 ' A' ' 71' ' ' THR . 13.5 tp10 -64.71 -38.0 89.51 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.84 179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.899 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -63.92 -35.37 80.44 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.477 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 73' ' ' HIS . 23.0 t -61.95 -39.05 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.639 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 41.2 m -65.05 -48.64 73.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.641 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.458 HD12 ' HA ' ' A' ' 76' ' ' ALA . 7.8 mt -62.22 -42.65 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.796 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.16 -39.71 75.81 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.853 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -33.06 74.85 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.982 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -65.55 -27.89 68.76 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.325 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.419 ' HB3' HG23 ' A' ' 87' ' ' ILE . 74.2 mm-40 -61.13 114.07 2.92 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.77 0.319 . . . . 0.0 110.956 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -119.84 144.82 47.14 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.448 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 66.56 -104.78 1.13 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.513 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -88.01 122.1 31.2 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.753 0.311 . . . . 0.0 110.358 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.419 HG23 ' HB3' ' A' ' 83' ' ' GLN . 15.5 mt -122.02 125.61 73.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.968 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -93.79 127.89 39.75 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -121.94 129.9 52.89 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.094 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.5 ' HG2' HD11 ' A' ' 10' ' ' ILE . 16.9 tt0 -120.56 115.35 23.24 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.349 179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.809 HG12 ' HA ' ' A' ' 60' ' ' ILE . 7.0 m -140.84 170.1 14.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.435 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 9' ' ' PRO . 25.1 t -132.55 139.55 49.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.875 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.09 120.2 12.75 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.839 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 92' ' ' VAL . 22.0 t -127.03 107.71 17.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.213 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.173 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.911 -179.855 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo . . . . . 0 N--CA 1.49 1.302 0 CA-C-O 120.643 0.185 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.736 ' HA ' HG12 ' A' ' 92' ' ' VAL . 4.9 mp -97.59 139.84 19.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.351 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -110.65 115.79 30.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.026 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -97.27 111.59 23.77 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.593 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 20.7 t -129.95 133.21 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-O 120.795 0.331 . . . . 0.0 111.326 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mt -100.97 134.98 43.15 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.583 HD11 HD12 ' A' ' 54' ' ' LEU . 3.4 mp -118.67 119.86 35.7 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.834 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -111.23 124.25 51.83 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.755 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.04 147.14 45.99 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.291 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -100.37 169.3 9.2 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.161 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.39 -37.98 82.48 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.947 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -72.77 -28.8 62.82 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.048 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -84.96 177.32 7.99 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.779 0.323 . . . . 0.0 111.144 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -125.05 -154.82 8.89 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 121.025 -0.607 . . . . 0.0 113.111 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.6 mt -71.51 -67.85 0.49 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.6 0.238 . . . . 0.0 111.153 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.7 4.38 63.74 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.059 -0.591 . . . . 0.0 113.71 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.437 HG21 ' CD1' ' A' ' 54' ' ' LEU . 2.5 pp -143.49 150.39 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 117.284 0.542 . . . . 0.0 111.252 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.524 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 1.1 m -121.62 136.93 54.93 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.733 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.732 HD12 HG21 ' A' ' 37' ' ' ILE . 31.5 pt -123.76 158.27 29.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.489 -179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.9 t -142.59 147.5 35.97 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.088 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.41 -159.59 21.41 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.45 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.23 120.43 0.52 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.613 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -55.22 -34.54 64.03 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.469 0.176 . . . . 0.0 111.354 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -31.23 65.6 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.082 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -77.5 -30.0 52.8 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.055 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 133.72 -29.96 3.04 Favored Glycine 0 C--N 1.335 0.472 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.888 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 11.5 m -109.48 138.15 20.49 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-O 120.708 0.289 . . . . 0.0 111.402 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 35' ' ' VAL . 35.8 Cg_exo -61.11 157.17 40.77 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.761 2.308 . . . . 0.0 112.239 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.732 HG21 HD12 ' A' ' 27' ' ' ILE . 3.6 mp -82.36 136.98 21.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.832 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 pp -133.25 162.92 30.49 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.938 0.399 . . . . 0.0 111.672 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.571 HD13 HD21 ' A' ' 54' ' ' LEU . 18.4 mt -85.09 129.38 37.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.981 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.475 ' O ' HG13 ' A' ' 56' ' ' VAL . 70.9 m -117.13 -38.98 3.27 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.626 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.524 ' HB3' ' HB2' ' A' ' 26' ' ' SER . 18.9 tt0 -114.37 145.96 41.16 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.938 0.399 . . . . 0.0 111.412 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.495 HD13 ' O ' ' A' ' 54' ' ' LEU . 26.4 mt -131.03 133.49 62.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.513 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -88.75 112.85 53.03 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.026 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.53 139.31 75.39 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.798 2.332 . . . . 0.0 112.401 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.53 -30.14 8.72 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.902 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.477 ' CB ' ' HD2' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -71.17 169.77 13.92 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.638 0.219 . . . . 0.0 110.921 179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' A' ' 46' ' ' GLN . 7.1 Cg_endo -50.48 -30.52 27.84 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.753 2.302 . . . . 0.0 112.791 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.408 ' HB1' HD13 ' A' ' 54' ' ' LEU . . . -61.13 -46.01 92.33 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.711 0.291 . . . . 0.0 111.004 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.07 -38.94 75.89 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.776 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -58.1 -33.3 68.95 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.488 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.45 -28.01 64.69 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.575 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 64.84 15.76 60.56 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.859 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.81 -34.94 1.1 Allowed Glycine 0 C--N 1.337 0.636 0 C-N-CA 121.369 -0.443 . . . . 0.0 112.786 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.583 HD12 HD11 ' A' ' 15' ' ' LEU . 0.3 OUTLIER -62.92 99.6 0.17 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.928 0.394 . . . . 0.0 110.513 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.426 ' CE1' ' CD2' ' A' ' 93' ' ' TYR . 11.4 p80 -110.43 156.69 20.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.014 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 40' ' ' SER . 38.3 t -63.86 132.58 29.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.74 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.94 46.89 2.56 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.635 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -112.59 118.97 36.55 Favored 'General case' 0 C--O 1.231 0.098 0 N-CA-C 110.584 -0.154 . . . . 0.0 110.584 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.96 123.49 34.49 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.928 0.394 . . . . 0.0 111.428 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.847 ' HA ' HG12 ' A' ' 91' ' ' VAL . 4.0 mt -76.51 134.12 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.785 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.4 mp -126.55 -49.78 1.51 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.565 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -134.76 145.54 48.52 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.323 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.486 HG23 HD13 ' A' ' 68' ' ' LEU . 25.3 t -139.47 116.59 10.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.543 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 57.95 33.75 23.54 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.999 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.55 -15.4 54.76 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.352 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -89.8 128.8 41.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 117.151 0.475 . . . . 0.0 110.789 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -80.86 141.23 34.82 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.733 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.486 HD13 HG23 ' A' ' 63' ' ' VAL . 2.7 mp -117.04 21.07 13.48 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.634 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -71.42 -34.07 70.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.385 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -103.73 8.49 37.29 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 50.9 p -96.06 179.98 4.88 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.655 0.264 . . . . 0.0 110.831 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -114.17 161.21 18.08 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.964 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.533 ' O ' HG23 ' A' ' 77' ' ' VAL . 13.6 t-80 -54.05 -51.01 65.41 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.973 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.2 ttmt -60.57 -42.08 95.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.652 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.24 -37.98 89.38 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.957 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.529 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.59 -38.03 89.58 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.249 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.646 ' HA ' HD12 ' A' ' 80' ' ' LEU . 22.1 t -61.85 -44.41 98.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.702 179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.7 m -62.51 -45.28 93.7 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.8 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 76' ' ' ALA . 11.8 mt -61.82 -40.55 87.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.918 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.646 HD12 ' HA ' ' A' ' 77' ' ' VAL . 12.9 mt -58.14 -39.01 77.67 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.661 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.6 t -67.58 -32.97 74.08 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.005 179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -64.91 -28.64 69.67 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.307 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.497 ' HB3' HG23 ' A' ' 87' ' ' ILE . 63.1 mm-40 -64.08 110.53 2.19 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.747 0.308 . . . . 0.0 110.957 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -111.63 147.39 35.59 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.122 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.43 ' O ' HD13 ' A' ' 16' ' ' LEU . . . 62.91 -108.12 1.99 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.508 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.449 ' HA ' HD22 ' A' ' 16' ' ' LEU . 29.9 tt0 -82.14 124.8 30.19 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.712 0.291 . . . . 0.0 110.535 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.497 HG23 ' HB3' ' A' ' 83' ' ' GLN . 10.9 mt -124.76 122.32 63.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.975 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -94.06 129.77 40.46 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.891 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -124.12 129.78 51.44 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.267 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -123.58 115.19 21.09 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.022 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.847 HG12 ' HA ' ' A' ' 60' ' ' ILE . 16.5 m -138.67 170.6 16.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.222 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.736 HG12 ' HA ' ' A' ' 10' ' ' ILE . 22.9 m -132.9 138.82 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.808 179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.426 ' CD2' ' CE1' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -67.17 116.02 7.5 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.733 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 11.8 p -101.68 133.8 44.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.184 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.324 -0.846 . . . . 0.0 111.24 -179.872 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 N--CA 1.49 1.309 0 CA-C-O 120.784 0.243 . . . . 0.0 111.938 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.649 HG23 HG22 ' A' ' 92' ' ' VAL . 4.9 mp -96.84 143.47 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.136 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.96 145.88 48.87 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.19 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.1 mmtm -114.72 111.47 21.33 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.827 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.1 t -112.85 131.23 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.037 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.0 mp -102.82 126.46 49.97 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.414 HD21 ' HB2' ' A' ' 47' ' ' PRO . 1.9 tt -117.58 141.32 48.51 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.224 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.41 127.11 54.13 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.794 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -104.34 121.61 43.72 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.138 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -100.46 156.64 17.16 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.993 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -58.29 -38.29 76.72 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.177 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -86.14 -22.07 27.25 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.32 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -90.03 176.63 6.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.815 0.34 . . . . 0.0 111.282 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.02 -145.37 4.66 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.835 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 25' ' ' ILE . 30.8 tp -77.36 -63.16 1.44 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.535 0.207 . . . . 0.0 110.939 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.74 4.52 87.31 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.035 -0.602 . . . . 0.0 114.037 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.847 HG22 HG23 ' A' ' 42' ' ' ILE . 6.1 pt -139.85 164.16 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 117.348 0.574 . . . . 0.0 111.369 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.407 ' HB3' ' HB2' ' A' ' 41' ' ' GLU . 9.0 t -121.51 137.33 54.77 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.917 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.757 HG22 HD13 ' A' ' 39' ' ' ILE . 12.4 pt -115.83 152.1 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.632 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.3 p -137.85 153.41 49.6 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.085 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.9 -169.47 13.3 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 121.16 -0.543 . . . . 0.0 112.84 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.428 ' H ' HG13 ' A' ' 35' ' ' VAL . . . 172.44 119.27 0.52 Allowed Glycine 0 C--N 1.335 0.526 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.69 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.7 -29.63 68.23 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -31.33 69.2 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.668 0.27 . . . . 0.0 111.117 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 -87.69 -28.09 22.02 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.154 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.28 35.67 1.43 Allowed Glycine 0 C--N 1.334 0.445 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.695 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.428 HG13 ' H ' ' A' ' 30' ' ' GLY . 10.3 p -149.35 134.51 9.51 Favored Pre-proline 0 C--O 1.232 0.176 0 CA-C-O 120.652 0.263 . . . . 0.0 110.963 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.502 ' O ' HD12 ' A' ' 38' ' ' LEU . 39.6 Cg_endo -65.82 157.72 57.52 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.582 2.188 . . . . 0.0 112.107 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.52 HD12 ' CD2' ' A' ' 73' ' ' HIS . 22.5 mm -82.75 131.07 34.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 36' ' ' PRO . 3.6 mp -132.91 155.04 49.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.445 -179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.757 HD13 HG22 ' A' ' 27' ' ' ILE . 22.5 mm -80.56 120.13 31.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.852 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.39 -38.2 5.78 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.387 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.407 ' HB2' ' HB3' ' A' ' 26' ' ' SER . 0.0 OUTLIER -124.49 145.87 49.29 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.774 0.321 . . . . 0.0 111.214 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.847 HG23 HG22 ' A' ' 25' ' ' ILE . 26.8 mt -135.19 114.33 16.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.55 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -71.95 132.87 84.41 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.095 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -73.82 159.35 45.38 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.819 2.346 . . . . 0.0 112.891 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.14 50.47 66.85 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.482 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.33 175.19 2.87 Favored Pre-proline 0 CA--C 1.532 0.253 0 N-CA-C 110.59 -0.152 . . . . 0.0 110.59 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.414 ' HB2' HD21 ' A' ' 15' ' ' LEU . 71.6 Cg_exo -49.84 -34.6 36.98 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.783 2.322 . . . . 0.0 112.966 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.404 ' HB2' HG23 ' A' ' 25' ' ' ILE . . . -59.57 -46.14 89.78 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.783 0.325 . . . . 0.0 110.755 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -69.78 -37.44 76.36 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.796 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -57.8 -32.78 67.88 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.416 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 2.4 m -82.99 -28.14 29.91 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.521 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 65.61 14.5 60.41 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.991 -179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.98 -33.58 2.77 Favored Glycine 0 C--N 1.338 0.676 0 C-N-CA 121.311 -0.471 . . . . 0.0 112.751 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.544 HD13 HG21 ' A' ' 25' ' ' ILE . 0.2 OUTLIER -67.37 100.82 0.87 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.984 0.421 . . . . 0.0 110.504 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -113.3 157.14 22.19 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.125 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 40.3 t -63.95 132.94 29.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.314 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.54 49.32 4.18 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.277 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -109.35 126.6 53.58 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -91.69 120.99 32.93 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.848 ' HA ' HG12 ' A' ' 91' ' ' VAL . 14.4 mt -81.06 149.17 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.469 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.9 mt -134.83 -54.9 0.82 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.014 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -148.67 159.84 43.73 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.826 0.346 . . . . 0.0 111.689 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 32.5 t -137.19 120.35 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.674 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 56.15 36.36 27.29 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.918 0.39 . . . . 0.0 111.138 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.67 13.63 83.33 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 120.957 -0.64 . . . . 0.0 113.226 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.6 t -98.71 134.88 35.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 117.009 0.404 . . . . 0.0 110.672 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -72.08 126.86 30.82 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.012 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.2 tt -112.15 -17.89 12.69 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.34 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -32.6 72.55 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 111.555 0.206 . . . . 0.0 111.555 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -98.95 11.91 37.51 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.629 HG21 ' CD1' ' A' ' 79' ' ' ILE . 1.3 m -110.02 161.66 15.31 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.815 0.34 . . . . 0.0 111.03 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.9 mmtm -95.7 161.3 14.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.24 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.525 ' O ' HG23 ' A' ' 77' ' ' VAL . 19.9 t-80 -54.12 -51.54 63.9 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.017 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -62.99 -41.2 99.51 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.829 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.458 ' HB2' HG22 ' A' ' 71' ' ' THR . 3.4 mt-10 -65.02 -38.11 89.84 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.011 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.536 ' HA ' HD12 ' A' ' 79' ' ' ILE . . . -63.79 -30.83 71.88 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.385 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 73' ' ' HIS . 24.5 t -61.7 -41.82 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.923 0.392 . . . . 0.0 110.624 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.1 m -69.96 -37.94 75.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.101 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.629 ' CD1' HG21 ' A' ' 71' ' ' THR . 23.2 mt -67.28 -47.19 82.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.384 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 77' ' ' VAL . 3.8 pp -63.91 -34.04 77.07 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 121.242 -0.183 . . . . 0.0 111.314 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.2 p -73.28 -27.43 61.56 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.85 -0.159 . . . . 0.0 111.221 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -65.25 -28.16 69.16 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.52 0.2 . . . . 0.0 111.348 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.535 ' HG3' HG23 ' A' ' 87' ' ' ILE . 39.8 mm-40 -58.67 113.7 2.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.757 0.313 . . . . 0.0 110.902 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.55 146.29 28.35 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.369 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.89 -99.92 0.4 Allowed Glycine 0 C--N 1.336 0.58 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.618 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -92.28 135.8 33.71 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.761 0.315 . . . . 0.0 110.386 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.535 HG23 ' HG3' ' A' ' 83' ' ' GLN . 13.3 mt -128.36 122.08 56.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.063 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.37 121.28 40.11 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.513 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -114.54 129.47 56.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.776 0.322 . . . . 0.0 110.895 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -110.1 115.78 30.37 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.154 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.848 HG12 ' HA ' ' A' ' 60' ' ' ILE . 14.4 m -137.22 168.79 20.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.79 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.649 HG22 HG23 ' A' ' 10' ' ' ILE . 19.4 t -134.12 132.41 55.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.656 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.28 118.52 10.77 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.548 -0.297 . . . . 0.0 110.741 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.1 p -118.2 135.57 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.084 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.13 -0.938 . . . . 0.0 111.34 -179.694 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo . . . . . 0 N--CA 1.489 1.247 0 CA-C-O 120.55 0.146 . . . . 0.0 111.726 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.827 ' HA ' HG12 ' A' ' 92' ' ' VAL . 2.7 tt -78.66 121.81 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.922 0.391 . . . . 0.0 111.247 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.08 135.56 54.08 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.096 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.27 111.5 21.62 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.638 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.8 t -132.94 142.33 42.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.952 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.1 mp -97.81 135.5 39.48 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.975 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.1 tp -108.84 121.91 46.08 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.088 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.21 115.09 29.7 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.671 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -127.52 147.19 50.32 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.111 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.403 ' HB3' ' CD2' ' A' ' 20' ' ' HIS . 1.0 OUTLIER -108.61 161.86 14.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.026 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -56.85 -38.8 73.19 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.93 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.403 ' CD2' ' HB3' ' A' ' 18' ' ' GLU . 25.2 p80 -80.18 -28.31 38.76 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.462 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -84.56 165.56 17.92 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.993 0.425 . . . . 0.0 111.606 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -112.06 -169.73 18.3 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.709 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.8 tp -67.93 -57.38 6.3 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.446 0.165 . . . . 0.0 111.342 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.54 4.55 63.9 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.767 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.848 HG22 HG23 ' A' ' 42' ' ' ILE . 20.5 pt -144.98 154.98 14.03 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 117.364 0.582 . . . . 0.0 111.348 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.4 m -113.62 138.14 50.6 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.0 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.585 HD12 HG21 ' A' ' 37' ' ' ILE . 13.0 pt -115.92 154.73 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.601 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.0 p -137.63 163.34 31.48 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.32 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.82 -150.56 19.35 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 121.192 -0.528 . . . . 0.0 112.778 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.44 ' HA2' ' HB2' ' A' ' 73' ' ' HIS . . . 153.51 124.47 0.99 Allowed Glycine 0 C--N 1.337 0.622 0 C-N-CA 120.906 -0.664 . . . . 0.0 113.009 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.68 -31.5 57.88 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.1 0.16 . . . . 0.0 111.409 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -57.26 -31.23 65.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.151 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -84.5 -21.36 30.61 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.422 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 115.05 19.5 5.93 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.993 -0.623 . . . . 0.0 113.284 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.7 m -147.08 139.65 14.24 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.93 0.365 . . . . 0.0 111.076 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -60.8 157.39 38.21 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.522 2.148 . . . . 0.0 112.032 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.585 HG21 HD12 ' A' ' 27' ' ' ILE . 4.0 mp -82.71 126.06 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.676 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.7 ' CD2' ' HB2' ' A' ' 59' ' ' ALA . 2.1 mp -122.54 162.53 21.61 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.908 0.385 . . . . 0.0 111.6 -179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.705 HD13 ' CD1' ' A' ' 54' ' ' LEU . 17.3 mt -94.4 125.67 46.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.797 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.434 ' O ' HG13 ' A' ' 56' ' ' VAL . 8.4 m -109.63 -34.6 6.44 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.709 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -123.0 146.79 47.32 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.742 0.306 . . . . 0.0 111.391 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.848 HG23 HG22 ' A' ' 25' ' ' ILE . 4.3 mp -134.21 112.26 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.578 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -71.6 129.88 88.0 Favored Pre-proline 0 C--O 1.232 0.168 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.144 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -74.4 155.72 45.85 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.772 2.315 . . . . 0.0 112.618 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.61 33.33 52.41 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.734 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.92 174.49 4.37 Favored Pre-proline 0 CA--C 1.53 0.205 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -50.58 -32.14 34.19 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.588 2.192 . . . . 0.0 112.771 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.493 ' HB1' ' CB ' ' A' ' 54' ' ' LEU . . . -61.0 -46.06 92.32 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.164 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.49 -43.86 72.31 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.986 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 -58.59 -32.74 69.25 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.496 179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -77.07 -27.96 54.46 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.464 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.16 17.78 68.41 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.025 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.8 -29.99 2.28 Favored Glycine 0 C--N 1.339 0.697 0 C-N-CA 121.11 -0.567 . . . . 0.0 113.171 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.705 ' CD1' HD13 ' A' ' 39' ' ' ILE . 0.7 OUTLIER -64.69 96.87 0.19 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.861 0.362 . . . . 0.0 110.823 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -115.8 157.23 24.7 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.252 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.434 HG13 ' O ' ' A' ' 40' ' ' SER . 45.2 t -66.4 131.4 32.14 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.665 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 94.04 43.54 3.79 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.931 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.43 119.19 37.38 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.499 0.15 . . . . 0.0 110.794 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.7 ' HB2' ' CD2' ' A' ' 38' ' ' LEU . . . -92.06 123.07 35.14 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.644 0.259 . . . . 0.0 111.509 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.826 ' HA ' HG12 ' A' ' 91' ' ' VAL . 10.8 mt -72.59 137.64 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.214 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.2 mt -125.32 -52.73 1.62 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.775 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -136.56 145.53 45.1 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.821 0.343 . . . . 0.0 111.475 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -130.97 116.14 32.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.393 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 58.83 34.6 23.8 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.051 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.65 -15.95 52.37 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.883 -0.675 . . . . 0.0 113.386 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.5 t -88.15 134.6 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 117.146 0.473 . . . . 0.0 110.778 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -71.28 131.53 43.6 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.196 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.579 HD21 ' HB1' ' A' ' 76' ' ' ALA . 2.8 tp -117.49 1.58 12.33 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.828 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -71.37 -28.1 63.81 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.24 8.18 45.02 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.2 p -105.3 146.54 29.22 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.751 0.31 . . . . 0.0 111.088 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 13.0 mmtm -71.82 161.19 31.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.113 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.65 ' O ' HG23 ' A' ' 77' ' ' VAL . 46.2 t-80 -54.01 -50.56 66.34 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.933 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.68 -42.98 94.12 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.894 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -67.21 -37.59 83.87 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.841 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.579 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -63.86 -31.32 72.46 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.473 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 73' ' ' HIS . 22.3 t -61.83 -40.8 88.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.862 0.363 . . . . 0.0 110.358 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.9 m -65.72 -40.54 92.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.518 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.471 HG22 HE21 ' A' ' 83' ' ' GLN . 40.1 mm -58.13 -43.52 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.643 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.0 mt -60.57 -43.9 96.8 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.671 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.4 t -65.84 -31.54 72.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.091 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -65.15 -28.29 69.31 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.669 -0.241 . . . . 0.0 111.15 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.471 HE21 HG22 ' A' ' 79' ' ' ILE . 48.3 mm-40 -62.65 135.23 57.28 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.793 0.33 . . . . 0.0 111.006 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.23 144.25 48.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.175 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 56.06 -104.55 0.35 Allowed Glycine 0 C--N 1.335 0.52 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.634 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -82.29 118.2 22.96 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.853 0.358 . . . . 0.0 110.396 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.411 HG23 ' HB3' ' A' ' 83' ' ' GLN . 11.6 mt -119.32 123.77 71.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.893 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -93.63 121.38 35.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.52 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -113.11 129.62 56.45 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.119 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.0 115.19 22.07 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.805 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.826 HG12 ' HA ' ' A' ' 60' ' ' ILE . 16.1 m -139.2 170.73 15.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.4 -178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.827 HG12 ' HA ' ' A' ' 10' ' ' ILE . 18.7 m -131.33 133.52 62.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.835 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -70.42 115.86 10.09 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.715 0.293 . . . . 0.0 110.705 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.7 p -126.57 122.65 61.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.952 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.4 -0.81 . . . . 0.0 111.408 -179.536 . . . . . . . . 0 0 . 1 stop_ save_